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United States Cancer Statistics: 1999 Incidence is a joint publication of the
Centers for Disease Control and Prevention (CDC) in Atlanta,
Georgia, and the National Cancer Institute (NCI) in Bethesda,
Maryland, in collaboration with the North American Association of
Central Cancer Registries (NAACCR) in Springfield, Illinois. This is
the first joint report from the two federal programs that support
population-based cancer registries in the United States: CDC’s National
Program of Cancer Registries (NPCR) and NCI’s Surveillance,
Epidemiology, and End Results (SEER) Program. The report contains,
for the first time, official federal government cancer statistics for more
than 1 million invasive cancer cases diagnosed during 1999 among
residents of 37 states, 6 metropolitan areas, and the District of
Columbia, geographic areas in which approximately 78% of the U.S.
population reside. Data from population-based central cancer registries
in these states and metropolitan areas meet the selected criteria for
inclusion in this report (see “Registry Eligibility Criteria”).  
Beginning with 1999 data, the Department of Health and Human
Services adopted the 2000 U.S. standard population for age adjustment.1–5
Therefore, the age-adjusted rates presented in this report are adjusted to
the new 2000 U.S. standard population, and caution should be used when
comparing these data with previously published cancer incidence rates
that were adjusted to the 1970 U.S. standard population.
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This report has five major sections:
•  Technical Notes
•  Cancer Incidence: All Areas Combined
•  Cancer Incidence, by U.S. Census Region and Division, State, 
and Metropolitan Area
•  State and Metropolitan Area Incidence Rates for Most Common Cancers
•  Appendices
Technical Notes. In this section, we describe the background for the report and provide
information about the two federal programs that support cancer registration in the United
States and their collaborating partner, the North American Association of Central Cancer
Registries. Also provided are (1) criteria required for inclusion of a registry’s data in the
report and (2) information about the data sources and the statistical methods used in
preparing the report. Suggestions for interpreting the data conclude the technical notes.
Statistical tables and figures are the primary focus of the report. The next three sections
of the report provide tables and figures.
Cancer Incidence: All Areas Combined. Figure 1 is a map showing all the states and
metropolitan areas that contributed data to the report. Tables 1.1 through 1.4 provide
cancer incidence rates by sex and race (all races, white, black) for all the contributing
areas combined. Tables 1.1 and 1.2 provide crude and age-adjusted incidence rates, by
sex and race, for invasive cancers at 66 selected primary sites for males and 70 selected
primary sites for females (including in situ breast cancer), and for invasive cancers at all
sites combined; case counts used in calculating the rates in Tables 1.1 and 1.2 are in
Appendix D. Tables 1.3 and 1.4 provide age-specific incidence rates for all cancer sites
combined, by sex and race.
Cancer Incidence, by U.S. Census Region and Division, State, and Metropolitan
Area. Figure 2 is a map showing the states and metropolitan areas, by U.S. census region
and division, that contributed data to the report. Tables 2.1.1 through 2.25.2 show the
incidence rates for U.S. census regions and divisions, states, and metropolitan areas by
sex and race (all races, white, black), for invasive cancers at each of 23 major primary
sites, in situ female breast cancer, and invasive cancers at all sites combined. Case counts
used in calculating the rates in Tables 2.1.1 through 2.25.2 are in Appendix E.
State and Metropolitan Area Incidence Rates for Most Common Cancers. Figures
3.1 through 3.44 are a set of bar graphs for each of the 44 contributing state or
metropolitan area cancer registries. The graphs rank the incidence rates for the 15
cancer sites with the highest age-adjusted incidence rates within sex- and race-specific
population subgroups in each state or metropolitan area. The rates are the same as those
shown in Tables 2.1.1 through 2.25.2, with the following exception: for populations of
less than 50,000, incidence rates were not ranked and therefore are not shown. Case
counts used to calculate the rates for these figures are in Appendix E.
Appendices. These supplement information in the report and assist readers in
interpreting the data in the statistical tables and figures.
Format and Content of the Report
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Cancer is the second leading cause of death among
Americans.6–8 In the United States, one of every four
deaths is due to cancer. The American Cancer
Society estimates that, in 2002, about 1,284,900
Americans will receive a new diagnosis of cancer and
about 555,500 Americans will die of this disease.
The National Cancer Institute (NCI) estimates
that approximately 8.9 million Americans are now
alive with a history of cancer.4 These estimates 
do not include in situ cancer or the approximately 
1 million cases of basal and squamous cell skin
cancers expected to be diagnosed this year.
According to the 2002 annual report to the nation
on the status of cancer, age-adjusted cancer death
rates—as well as age-specific cancer death rates 
in all age groups—are declining and age-adjusted
cancer incidence rates stabilized from 1995 to
1999.9 Even if the age-adjusted incidence rates
remain stable, however, the number of Americans
diagnosed with cancer is expected to double in the
next 50 years, from 1.3 million to 2.6 million per
year.9 The anticipated growth and aging of the U.S.
population are factors that will increase the number
of people who are diagnosed with, and treated for,
cancer.9
The National Institutes of Health estimates that, in
2002, the overall annual cost of cancer will be
about $171.6 billion, broken down as follows:10
•  Direct medical costs, including health
expenditures: $60.9 billion.
•  Indirect morbidity costs associated with lost
productivity due to illness: $15.5 billion.
•  Indirect mortality costs associated with lost
productivity due to premature death: 
$95.2 billion. 
These costs are likely to increase because of the
anticipated growth and aging of the U.S. population.
There are effective primary and secondary
prevention measures that could substantially reduce
the number of new cancer cases and prevent many
cancer-related deaths. To reduce the nation’s cancer
burden, we must reduce the prevalence of
behavioral and environmental factors that increase
cancer risk, and we must ensure that high-quality
screening services and evidence-based treatment
protocols are available and accessible, particularly
to medically underserved populations.11
Information derived from population-based central
cancer registries is critical for directing effective
location- or population-specific cancer prevention
and control programs that focus on preventing
behaviors that put people at increased risk 
for cancer (e.g., smoking) and on reducing
environmental risk factors (e.g., occupational
exposure to known carcinogens). Such information
is also essential for identifying when and where
cancer-screening programs should be set up or
improved and for making long-term plans for
adequate diagnostic and treatment resources.
Pooled data at the national, U.S. census region, 
and U.S. census division levels will help federal 
and state public health officials establish, prioritize,
and monitor national public health surveillance
initiatives and track progress toward the national
goals and objectives set forth in Healthy People 2010.12
Cancer registries collect data about the occurrence
of cancer (incidence), the types of cancer that occur
(morphology), the site in the body where the cancer
first occurred (primary site), the extent of disease at
the time of diagnosis (stage), the planned first course
of treatment received by cancer patients,13,14 and the
outcome of treatment and clinical management
(vital status). Cancer data are reported to statewide
and metropolitan area cancer registries from a
variety of medical facilities, including hospitals,
physicians’ offices, radiation facilities, freestanding
surgical centers, and pathology laboratories.
Federal Programs
Surveillance, Epidemiology, and End
Results (SEER) Program 
In 1971, Congress passed the National Cancer 
Act that mandated the collection, analysis, and
dissemination of data useful for the prevention,
diagnosis, and treatment of cancer.15 This mandate
led to the establishment of the Surveillance,
Epidemiology, and End Results (SEER) Program.16
A continuing program of the NCI, SEER consists
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of population-based cancer registries that routinely
collect data on all cancers that occur among
residents of the participating geographic areas.
Trends since 1973 in cancer incidence and patient
survival in the United States are derived from this
database.
The goals of the SEER Program are as follows:
•  Assemble and report, on a periodic basis,
estimates of cancer incidence, survival, and
mortality in the United States.
•  Monitor annual cancer incidence trends in
order to identify unusual changes in specific
forms of cancer that occur in population
subgroups, which are defined by geographic
and demographic characteristics.
• Provide continuing information on trends
over time in the extent of disease at
diagnosis, trends in therapy, and associated
changes in patient survival.  
•  Promote studies designed to identify factors
amenable to cancer control interventions,
such as (a) environmental, occupational,
socioeconomic, dietary, and health-related
exposures; (b) screening practices, early
detection, and treatment; and (c)
determinants of length and quality of patient
survival. 
• Promote research studies measuring
progress in cancer control and etiology,
including linkage of information from the
biomedical and social sciences. 
• Promote specialty training in epidemiology,
biostatistics, surveillance research, and
tumor registry methodology, operations,
and management.
• Develop new statistical methods, models,
and software for the analysis and
presentation of national and small-area
cancer statistics. 
The SEER Program is an authoritative source of
information on cancer incidence and survival in the
United States. Case ascertainment for SEER began
on January 1, 1973, in Connecticut, Hawaii, Iowa,
New Mexico, and Utah and in the metropolitan
areas of Detroit and San Francisco-Oakland. During
1974–1975, the metropolitan area of Atlanta and
the 13-county Seattle-Puget Sound area were
added. In 1978, 10 predominantly black rural
counties in Georgia were added, followed in 1980
by the addition of American Indians residing in
Arizona. Three other geographic areas participated
in the SEER Program but left the program prior to
1990: New Orleans, Louisiana (1974–1977); four
counties in New Jersey (1979–1989); and Puerto
Rico (1973–1989). The NCI also funds a cancer
registry that, with technical assistance from SEER,
collects information on cancer cases among Alaska
Natives residing in Alaska. In 1992, the SEER
Program was expanded to increase coverage of
minority populations, especially Hispanics, by
adding Los Angeles County and four counties in
the San José-Monterey area south of San Francisco.
In 2001, the SEER Program further expanded its
coverage by providing additional funds to the NPCR
registries in California, Kentucky, Louisiana, and
New Jersey (see Web site http://surveillance.
cancer.gov/expansion.html). Appendix F is a map 
of the United States that shows the location of
SEER registries. Appendix G shows the first
diagnosis year for which data were reported to 
NCI for each SEER area. 
The SEER Program currently collects and
publishes cancer incidence and survival data from
these population-based cancer registries and
supplemental registries. With its recent expansion
in 2001, SEER coverage increased from 14% to
26% of the U.S. population (from about 39 million
to nearly 74 million people). The 2001 expansion
increased SEER coverage to 23% of African
Americans, 40% of Hispanics (32% of non-Mexican
Hispanics), 45% of American Indians and Alaska
Natives, 53% of Asians, and 70% of Native
Hawaiians and Pacific Islanders. Information on
more than 3 million in situ and invasive cancer cases
is included in the SEER database, and approximately
170,000 new cases are accessioned each year within
SEER catchment areas. The SEER registries
routinely collect data on patient demographics,
primary tumor site, morphology, stage at diagnosis,
and first course of treatment. They also actively
follow all patients for information on vital status
(alive or dead). 
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For more information on the SEER Program, visit
its Web site at http://seer.cancer.gov.
National Program of Cancer 
Registries (NPCR) 
Recognizing the need for more complete local,
state, regional, and national cancer incidence data,
Congress established the National Program of
Cancer Registries (NPCR) by enacting the Cancer
Registries Amendment Act, Public Law 102-515, 
in 1992 and reauthorizing the program in 1998.17
Congress mandated the Centers for Disease
Control and Prevention (CDC) to provide funds 
to states and territories to improve or enhance
existing cancer registries; plan for and implement
registries where they did not exist; develop model
legislation and regulations for states and territories
to enhance the viability of registry operations; set
standards for data completeness, timeliness, and
quality; provide training for registry personnel; and
help establish a computerized reporting and data-
processing system. Federal funds are provided to
state and territorial health departments (or their
authorized agencies) at a ratio of 3:1 to match state
support for the central cancer registry.
NPCR’s goals are to rapidly establish and
standardize the reporting of cancer within and
among the states in order to build state and
national capacity to do the following:18
•  Monitor the cancer burden.
•  Identify cancer incidence variation for
ethnic groups and for regions within a state,
between states, and between regions.
• Provide data for research.
• Provide guidance for health resource
allocation.
• Respond to public concern and inquiries 
about cancer.
•  Improve planning for future health care
needs. 
•  Evaluate cancer prevention and control
activities.
NPCR registries routinely collect data on patient
demographics, primary site, morphology, stage at
diagnosis, and first course of treatment. They also
conduct passive follow-up for vital status (confirming
deaths through linkage with state and national death
records).
Before NPCR was established, 10 states had no
cancer registry and many states with a cancer
registry lacked the resources and legislative support
to collect needed data.19 In 1994, the first 37 states
received funding from CDC to participate in
NPCR; 5 additional states and the District of
Columbia joined in 1995, and 3 more states and 
3 territories joined in 1997.20 In 2002, CDC funds
a total of 49 statewide and territorial cancer
registries at two levels: planning for a new registry
or enhancement for an existing one. Two states
(South Dakota and Tennessee) and 2 territories
(Palau and the Virgin Islands) receive funds to plan
for and establish a registry; 43 states, 1 territory
(Puerto Rico), and the District of Columbia receive
funds to enhance their cancer registries (Appendix
F). NPCR registries cover 96% of the U.S.
population. NPCR registries whose data for the
1999 diagnosis year meet criteria for inclusion in
this report cover 73% of the U.S. population 
(73% of the white population, 69% of the black
population, and 72% of the Hispanic population).
In 2000, CDC began the NPCR–Cancer Surveillance
System (NPCR–CSS) to receive, evaluate, and
disseminate data from NPCR registries. NPCR–CSS
is designed to provide cancer incidence data to meet
CDC’s public health surveillance responsibilities and
to help monitor progress toward NPCR goals. In
January 2001, NPCR registries began annually
reporting their incidence data to CDC. NPCR
registries report incidence data to CDC from their
NPCR reference year forward. The “NPCR
reference year” is the first diagnosis year for which a
state or territorial cancer registry collected data with
the assistance of NPCR funds. The NPCR reference
year for each state and territory is shown in Appendix
G. Data from the SEER metropolitan areas and
SEER special population cancer registries operating
in Alaska, Arizona, California, Georgia, Michigan,
and Washington are reported to their respective
NPCR state cancer registry for inclusion in the state’s
incidence data and are transmitted to CDC as part 
of the state’s annual data submission. In January 2002,
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CDC received information on more than 5.3 million
invasive cancer cases diagnosed during 1995–1999,
including more than 1.1 million invasive cancer cases
diagnosed in 1999.  
For more information on NPCR, visit its Web site
at http://www.cdc.gov/cancer/npcr/.
Collaborating Partner
North American Association of
Central Cancer Registries (NAACCR)
Both the SEER Program and NPCR work closely
with the North American Association of Central
Cancer Registries (NAACCR) to promote standards
for cancer surveillance in the United States and
Canada. Established in 1987, NAACCR is an
umbrella organization for population-based cancer
registries, governmental agencies, professional
associations, and private groups in North America
interested in improving the quality and use of cancer
registry data. The mission of NAACCR is to support
and coordinate the development, enhancement, and
application of cancer registration techniques in
population-based groups in a consistent manner, 
so that quality data may be used for cancer control
and epidemiologic research, public health programs,
and patient care to reduce the burden of cancer 
in North America. For more information, see
http://www.naaccr.org/about/index.html. All state
and metropolitan area registries participating in
SEER and NPCR are members of NAACCR. 
In 1997, NAACCR began voluntary annual reviews
of member registries to determine their ability to
produce complete, accurate, and timely data.
Registries report their data to NAACCR in early
December each year. NAACCR evaluates the data
using standard, objective measures and then
recognizes those registries that meet the highest
standards for data quality.21,22 For more information
on the certification program, visit the Web site:
http://www.naaccr.org/Certification/index.html. 
In 1997, when NAACCR began its registry
certification program with an evaluation of 1995
incidence data, 9 NPCR registries and all 10 SEER
registries were certified. In 2002, after NAACCR
evaluated the 1999 incidence data, 32 NPCR
registries and all 10 SEER registries were certified.
(Data from San Francisco-Oakland and San José-
Monterey are combined and evaluated as the
Greater Bay Area.)
For more information on NAACCR, visit its Web
site at http://www.naaccr.org.
Registry Eligibility Criteria 
Data included in this report are from statewide 
or metropolitan area cancer registries that have
high quality cancer incidence data for 1999 as
demonstrated by meeting the following data quality
criteria for all cancer sites combined:
• Case ascertainment is 90% or more complete. 
The registry data include at least 90% of 
the expected, unduplicated cases where the
expected cases are estimated by using methods
developed by NAACCR.5,21–23 Because some
cancer patients receive diagnostic or treatment
services at more than one reporting facility,
cancer registries perform a procedure known
as “unduplication” to ensure that each cancer
case is counted only once.24
• No more than 5% of cases are ascertained solely on
the basis of a death certificate. The proportion
of cases ascertained solely on the basis of a
death certificate, with no other information
on the case available after the registry has
completed a routine procedure known as
“death clearance and followback,”24–26 is 
one measure of the completeness of case
ascertainment. 
• No more than 3% of cases are missing
information on sex. 
• No more than 3% of cases are missing
information on age.
• No more than 5% of cases are missing
information on race. 
• At least 97% of the registry’s records passed a set
of single-field and inter-field computerized edits.
Computerized edits are computer programs
that test the validity and logic of data
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components. For example, if (a) a patient
received a diagnosis of cancer in 1999, (b)
the patient’s age was reported as 80 years,
and (c) the patient’s year of birth was reported
as 1942, a computerized edit could, without
human intervention, identify these components
as incompatible. The computerized edits
applied to the data in this report were designed
by the SEER Program for use by SEER
registries. During the 1990s, these edits
were expanded and incorporated into
NAACCR standards (http://www.naaccr.
org/standards) and into editing software
designed and maintained by CDC (http://
www.cdc.gov/cancer/edits/edits.htm).
Data from 37 state cancer registries (32 NPCR and
5 SEER), the District of Columbia (NPCR), and 
6 SEER metropolitan areas (Atlanta, Detroit, 
Los Angeles, San Francisco-Oakland, San José-
Monterey, and Seattle-Puget Sound) are included
in this report. In total, these registries cover 78% of
the U.S. population (Figure 1) (78% of the U.S.
white population, 72% of the U.S. black population,
and 77% of the U.S. Hispanic population). Appendix
H shows state-specific measures for the data quality
criteria used to determine which registries’ data
were eligible for inclusion in this report. NPCR
registries whose data are not included in this report
were allowed to choose whether to have their data
quality information listed in Appendix H. 
Data Sources 
Incidence Data 
Data from registries in the SEER Program were
reported to NCI as of November 1, 2001, and made
available through the SEER Program public use
data file, released in April 2002 (http://www.seer.
cancer.gov/publicdata/). Data from the registries
participating in NPCR were reported to CDC as 
of January 31, 2002. For this report, data from
California, Kentucky, Louisiana, and New Jersey
are as reported to CDC as of January 31, 2002.
SEER and NPCR cancer registries consider as
reportable all incident cases with a behavior code of
2 (in situ, non-invasive) or 3 (malignant or invasive,
primary site only) in the International Classification
of Diseases for Oncology, 2nd edition (ICD–O–2),27
with the exception of in situ cancer of the cervix.
Basal and squamous cell carcinomas of the skin are
also excluded, with the exception of those on the
skin of the genital organs.28
Both SEER and NPCR data were collected and
reported by using uniform data items and codes as
documented by NAACCR, which provides for
comparability of data items collected by the two
federal programs.14,28 All information on primary
cancer sites was coded according to the ICD–O–2,27
and cancer sites listed in this publication were
defined according to SEER recodes, which define
standard groupings of primary cancer sites (Appendix
I).4 In situ bladder cancers were recoded to invasive
bladder cases because the data for distinguishing
between in situ and invasive bladder cases are not
always available or reliable. Case counts and rates
were calculated for invasive cancers. The report also
includes counts and rates for in situ breast cancer
cases in females; these are reported separately and are
not included in counts or rates for the “all sites”
category. Case counts and rates for leukemias were
calculated for acute and chronic lymphocytic
leukemia, acute and chronic myeloid leukemia, and
other leukemias. The “other leukemias” category
includes other lymphocytic leukemias, other myeloid
leukemias, all monocytic leukemias, and all other
leukemias. Non-reportable cancers and cancers in
patients of unknown sex or age were omitted from all
calculations, but cases in patients of unknown race
were included in the “all races” category. Counts of
cases used in this report are in Appendices D and E. 
Of the cases included in this report, 93.8% were
confirmed by positive microscopic findings
(histology, cytology, or unspecified microscopy
method) indicative of cancer.28 Other methods used
to confirm the diagnosis of cancer were positive
laboratory test results or markers indicative of
cancer (0.3%), direct visualization (0.2%),
radiography or other imaging techniques (2.1%),
and clinical diagnosis only (0.6%). For 3% of the
cases, it was unknown whether the diagnosis was
microscopically confirmed. 
Population Data 
The population estimates for the denominators of
incidence rates are race- (all races, white, black) and
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sex-specific county population estimates aggregated
to the state or metropolitan area level. The county
population estimates incorporated into NCI’s
SEER*Stat software to calculate cancer incidence
and mortality rates are available at http://www.seer.
cancer.gov. The SEER*Stat population estimates 
are a slight modification of the annual time series of
July 1 county population estimates (by age, sex, race,
and Hispanic origin) produced by the Population
Estimates Program of the U.S. Bureau of the Census
(Census Bureau) with support from NCI through an
interagency agreement. The Census Bureau’s
population estimates are available on its Web site at
http://eire.census.gov/popest/data/counties.php. 
The procedures used by the Census Bureau to
produce its county estimates are documented at
http://www.census.gov/population/estimates/county/
casrh_doc.txt. The 1999 race- and sex-specific
population estimates from the U.S. Bureau of the
Census, as available from SEER*Stat, are projected
estimates and did not reflect results from the
enumerated 2000 census. 
Specific documentation regarding modifications
made by NCI to Census Bureau estimates is given at
http://www.seer.cancer.gov. Briefly, the modification
affects only population estimates for Hawaii and is
based on information from the Epidemiology
Program of the Hawaii Cancer Research Center.
The modified population estimates were obtained by
SEER using survey data collected by the Hawaii
Department of Health to address concerns that the
Native Hawaiian population had been undercounted
in previous censuses. The “Hawaii-adjustment” 
to Census Bureau estimates has the net result of
reducing the estimated white population and
increasing the estimated Asian and Pacific Islander
population in the state. Census Bureau estimates for
the total population, black population, and American
Indian and Alaska Native populations in Hawaii are
unaffected. 
NCI recently made an additional modification to
its use of Census Bureau estimates in order to
calculate the age-specific rates needed for age-
adjustment according to the 2000 U.S. standard
population.1,2 Prior to implementing the use of the
2000 U.S. standard population, NCI used a single
age category for 0- to 4-year-olds for age adjustment.
NCI currently uses Census Bureau estimates to
subdivide this age group into younger than 1 year
and 1–4 years of age. Population estimates for all ages
combined, by state and SEER metropolitan area,
race and sex, for 1999, are shown in Appendix J.
Statistical Methods
Incidence Rates
Crude and age-adjusted incidence rates are per
100,000 population. Incidence rates are for invasive
cancers and in situ female breast cancer, unless
otherwise specified. An exception is the incidence
rate for cancer of the urinary bladder, which
includes both in situ and invasive cancers. Cancer
incidence rates include multiple primary cancers
that occur in single patients; for example, if a
patient has more than one primary cancer, each
cancer is counted as a separate case according to
standard rules for counting multiple primary
cancers.14 For cancers that occur only in one sex,
such as cancers of the prostate or uterine cervix, the
population denominators used to calculate
incidence rates are for the specific sex only.
Crude Incidence Rates
The crude incidence rates presented in this report
are the total number of new cancer cases diagnosed
in 1999 in a population category of interest divided
by the at-risk population for that category,
multiplied by 100,000.  
Age-Adjusted Incidence Rates
Because the occurrence of many cancers increases
with age and because the age distribution of a
population (i.e., the number of people in particular
age categories) can change over time and can be
different for different populations, researchers must
age-adjust incidence rates so that they can make a
valid comparison between one year’s rates and those
of another year or between one geographic area’s
rates and those of another area. Age-adjusting the
rates ensures that any differences in incidence from
one year to another or from one geographic area to
another are not actually due to differences in age
distribution. 
The standard used to age-adjust the rates for this
report was the 2000 U.S. standard population, in
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accordance with a 1998 Department of Health and
Human Services recommendation.1,2 The 2000 U.S.
standard population is based on the proportion of
the population in specific age groups (e.g., younger
than 1 year, 1–4 years, 5–9 years, 10–14 years, 
15–19 years, . . . 85 years or older) in 2000. The
proportions of the population in these age groups
serve as weights for calculating age-adjusted
incidence rates. The weights for the 2000 U.S.
standard population are in Appendix K. Note that
the 2000 U.S. standard population weights are not
race- or sex-specific, so they do not adjust for
differences in race or sex between geographic areas
or among population groups. They do, however,
provide the basis for adjustment for differences in
the age distributions across groups defined by sex,
race, geography, or other categories. 
The 2000 U.S. standard population weights used 
for this report are the estimated age distribution of
the U.S. population across 5-year age categories.29
These standard weights are used to compute age-
adjusted incidence rates by the method of direct
standardization as implemented in NCI SEER*Stat
software and described as follows:3 If Ij is the
number of incident cases diagnosed in 1999 in age
category j, and Pj is the population size at risk in age
category j, then the incidence rate Rj in age category
j is defined as
If wj is the 2000 U.S. standard population weight
for age category j, then the age-adjusted (directly
standardized) incidence rate Radj is computed as
Note from the multiplier in the formula that
incidence rates are expressed as cases per 100,000
population.
Confidence Intervals
Cancer registries have data included in this report if the
registry’s case ascertainment for cancers diagnosed in 1999
among residents of the state or metropolitan area is at
least 90% complete.5,21–23 However, even if all the
registries were able to collect data on 100% of diagnosed
cancer cases, there would still be some uncertainty in
computed cancer statistics such as crude and age-adjusted
incidence rates. This uncertainty arises because many
factors contribute to a cancer incidence rate in any given
year or state, and some of these factors exhibit random
behavior. For example, there is uncertainty about whether
cancer will develop in an individual in any given year.
Chance also plays a role in determining when a cancer is
detected and diagnosed, and when the data on that cancer
are included in the registry. When large numbers of a
particular cancer are diagnosed in any given year, the
effects of chance are small relative to the large incidence
rate. With rare cancers, however, the incidence rates are
small and the chance occurrence of more or fewer cases in
a given year can markedly affect the rate. 
To estimate the extent of this uncertainty, a statistical
framework known as superpopulation sampling is
applied. Under this framework, the observed cancer
cases are but one outcome among many outcomes
that could have occurred as a result of an underlying
random process. In general, in superpopulation
modeling, certain features of the mechanism thought
to have generated the observed data are specified.30
The standard superpopulation model used for rates
for vital statistics is the Poisson process,31 which
assigns to rare events more uncertainty relative to 
the size of the rate than it does to common events.
The population risk profile is posited to influence
the underlying Poisson process from which rates
arise, and only a single realization of that process 
is observed. Parameters are estimated for the
underlying disease process. In the current report, 
a single parameter is estimated to represent the
incidence rate and its variability. However, the
Poisson model is capable of estimating separate
parameters that represent contributions to the rate
from various population risk factors, the effects of
cancer control interventions, and other attributes
of the population risk profile in any particular year. 
The range of plausible underlying disease rates that
may have generated the observed rate is expressed
through a confidence interval. For this report, we used
confidence intervals that are expected to include the
true underlying rate 95% of the time. Confidence
intervals in this report were computed by using
SEER*Stat Version 4.2 software and are based on 
the gamma method.32 These gamma intervals are
approximations to exact Poisson confidence intervals.
The gamma method performs better than other
methods, especially for small incidence rates or for






Radj = ∑ wj Rj   x 100,000
j
standard age distribution. Various factors such as
population heterogeneity can sometimes lead to
“extra-Poisson” variation in which the rates are more
variable than would be predicted by a Poisson model.
No attempt was made to correct for this. In addition,
as discussed in “Interpreting the Data,” the confidence
intervals do not account for systematic 
(i.e., non-random) biases in the incidence rates. 
Users of this report who want to know if the
differences between the incidence rates of various
groups are statistically significant may consider
examining whether the confidence intervals overlap.
The use of overlapping confidence intervals to test
for statistically significant differences between two
incidence rates is not advised because the practice
more frequently fails to detect significant differences
than does standard hypothesis testing.33 Another
consideration when comparing differences between
rates is public health importance. For some rates in
this report, numerators and denominators are large
and standard errors are therefore small, with the
result that some statistically significant differences
may be so small as to lack importance, especially for
population-based public health program decisions.  
Suppression of Incidence Rates 
and Case Counts 
When the numbers of cases used to compute
incidence rates are small, those rates tend to 
have poor reliability.31 Therefore, to discourage
misinterpretation and misuse of rates or counts that
are unstable because of the small numbers of cases,
incidence rates and case counts are not shown in
tables and figures if the case counts are less than 
16. A case count of less than approximately 16
results in a standard error of the incidence rate 
that is approximately 25% or more as large as the
incidence rate itself. Equivalently, a case count of
less than approximately 16 results in the width of
the 95% confidence interval around the rate being
at least as large as the rate itself. These relationships
were derived under the assumption of a Poisson
process and with the standard population age
distribution close to the observed population age
distribution. 
Another important reason for employing a cell
suppression threshold value is to protect the
confidentiality of patients whose data are included
in a report by reducing or eliminating the risk 
of identity disclosure.34,35 The cell suppression
threshold value of 16, which was selected to reduce
misuse and misinterpretation of unstable rates and
counts in this report, is more than sufficient to
protect patient confidentiality given the low level
of geographic and clinical detail provided in the
report.36
Because the incidence rates shown in the state-,
sex-, and race-specific bar graphs in Figures 3.1
through 3.44 do not contain confidence intervals 
to indicate their reliability, we applied a data
suppression criterion in addition to the threshold
value of 16 cases: in these figures, incidence rates
are not ranked or shown for any population groups
of less than 50,000 persons.  
Inclusion of Incidence Rates 
and Counts for U.S. Census 
Regions and Divisions
Rates for U.S. census regions and divisions were
calculated by aggregating data reported from the
states in each region and division. Only data from
state registries that met the criteria for inclusion
in this report (see “Registry Eligibility Criteria”)
were included in calculations of rates for U.S.
census regions and divisions. There is a potential
for bias in the rates for census regions and
divisions where data for some states were
excluded. We considered the extent of potential
bias in regions or divisions with incomplete data
and made the following determination: in this
report, incidence rates for U.S. census regions and
divisions are reported only if (1) at least 78% of
the population is covered by cancer registries that
meet the criteria for inclusion in this report and
(2) 95% confidence intervals around the observed
age-adjusted region or division incidence rates for
each of four major cancer sites (female breast,
male prostate, male and female colorectal, male
and female lung and bronchus) for the region or
division include estimated “bias-corrected” region
or division rates (see Appendix L) for each of
those cancer sites. 
On the basis of these analyses, the observed rates
for the following census regions or divisions are
published in this report: the Northeast region and
the New England and Middle Atlantic divisions;
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the Midwest region and the West North Central
division; and the West region and the Pacific
division. 
Case counts for U.S. census regions and divisions
are in Appendix E if all state cancer registries in the
region or division met the criteria for inclusion in
this report, with the following exception: the region
or division count is suppressed if the count for
exactly one state in the region or division is
suppressed due to a count of less than 16.
Inclusion of Incidence Rates and
Counts for the United States
Cancer incidence rates for the United States, as
shown in Tables 1.1 through 1.4 and in one row of
Tables 2.2.2 through 2.25.2, are aggregate rates
based on more than 1 million cancer cases reported
from central cancer registries in 37 states, 6
metropolitan areas, and the District of Columbia,
geographic areas in which approximately 78% 
of the U.S. population resides. The U.S. rates in
this report did not meet the statistical criteria for
inclusion that were applied to rates and counts for
U.S. census regions and divisions (see “Inclusion
of Incidence Rates and Counts for U.S. Census
Regions and Divisions”). 
Case counts for the U.S. rates for all ages combined
are in Appendix D. The U.S. case counts are
provided only to allow readers the opportunity to
verify the crude rates by recalculation. Readers are
cautioned that the U.S. counts in this report are 
not estimates of the number of cancer cases that
occurred or that were reported during 1999 in the
entire United States. In addition, because the 22%
of the U.S. population that is not covered 
by registries whose data are in this report may 
differ in important ways from the 78% of the U.S.
population that is covered, it should not be assumed
that these counts represent 78% of the cancer cases
that occurred or were reported during 1999 
in the entire United States.  
Interpreting the Data
Both crude and age-adjusted incidence rates are
presented in this report. Crude rates are helpful 
in determining the need for services for a given
population, relative to another population,
regardless of size. Crude rates are influenced 
by the underlying age distribution of the state’s
population. Even if two states have the same age-
adjusted rates, the state with the relatively older
population (as demonstrated by having a higher
median age) will have higher crude rates because
incidence rates for most cancers increase with
increasing age. A table of the median age of each
state’s population is in Appendix M to help with the
interpretation of the crude rates. Ideally, crude,
age-adjusted, and age-specific rates are used in
planning for population-based cancer prevention
and control interventions.2
Published age-adjusted cancer incidence rates for
diagnosis years before 1999 were calculated by
using the 1970 U.S. standard population. Beginning
with the first publication of data for the 1999
diagnosis year, cancer incidence rates are age-
adjusted to the 2000 U.S. standard population.
This change conforms to Department of Health
and Human Services policy for reporting death 
and disease rates.1,2 This policy was motivated by 
a need to standardize age-adjustment procedures
across government agencies.1 The change from 
the 1970 to the 2000 U.S. standard updates the
calculation of age-adjusted rates to more closely
reflect the current age distribution of the U.S.
population and the current burden of cancer. Due
to the aging of the U.S. population, the 2000 U.S.
standard population gives more weight to older 
age categories than did the 1970 standard
population.2,9,37 Appendix K compares the
differences in age distributions between the 
1970 and the 2000 U.S. standard populations.
Because cancer incidence increases with age, the
change to the 2000 U.S. standard population
results in higher incidence rates for most cancers.
Therefore, caution should be used when comparing
the data published here with previously published
cancer incidence rates adjusted to standard
populations other than the 2000 U.S. standard
population. 
There are other reasons to use caution when
interpreting these data. Data quality is routinely
evaluated by the SEER Program and NPCR.20,38
This evaluation includes (1) re-abstracting and re-
coding studies and (2) casefinding studies, both of
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which are conducted with registries from time to
time to provide information on errors in the data
and data completeness. Even though the cancer
registries whose data are included in this report
met data quality criteria for all invasive sites
combined, the completeness and quality of site-
specific data may vary. The observed rates may
have been influenced by differences in the
timeliness, completeness, and accuracy of the data
from one registry to another, from one reporting
period to another, and from one primary cancer
site to another. 
Completeness and accuracy of the data may also
be affected by the time interval allowed for
reporting data to the two federal programs. For
this reason, the completeness and accuracy of
data on specific cancer sites may vary. For this
report of 1999 data, the SEER and NPCR time
interval for reporting data differed by 3 months.
NCI (SEER) allowed an interval of 22 months
after the close of the diagnosis year (data
submission November 1, 2001) and CDC
(NPCR) allowed an interval of 25 months after
the close of the diagnosis year (data submission
January 31, 2002).
Delays in reporting of cancer cases can affect
timely and accurate calculation of cancer incidence
rates.39 Cases are reported continuously to
statewide and metropolitan area cancer registries 
in accordance with statutory and contractual
reporting requirements. After the initial submission
of the most recent year’s data to the federal funding
agency, cancer registries continue to revise and
update their data on the basis of new information
received. Therefore, some 1999 cancer cases will
have been reported to statewide and metropolitan
area cancer registries after these registries
submitted their 1999 data to either NCI or CDC.
For this reason, incidence rates and case counts
reported directly by statewide or metropolitan area
cancer registries may differ from those included in
this publication. Reporting delays appear to be
more of a problem for cancers that are usually
diagnosed and treated in nonhospital settings 
such as physician offices (e.g., prostate cancer,
melanoma of the skin). Methods to adjust incidence
rates for reporting delay exist39 but were not
applied to the data in the current report. 
Incidence rates are also influenced by the choice of
population files. As described in “Population
Data,” the denominators for our incidence rates
were race- and sex-specific population estimates
that were projected from the 1990 census. Because
some state health departments use customized state
population projections in calculating incidence
rates, the rates published in this report may differ
slightly from those published by individual states. 
Rates in this report are for cancer cases diagnosed
in 1999, the year just before the 2000 decennial
census. When the final detailed race-specific data
from the enumerated 2000 census are available,
they will be used with the 1990 census data to
provide intercensal race-specific population
estimates for 1999 (expected in 2003), which will
be more accurate than the projected 1999
populations used in this report. Preliminary 2000
census results indicate that there are sizable
differences with some of the projected population
estimates. The problems appear to be more acute
for smaller geographic areas and populations with
limited numbers of people. Specifically, in some
metropolitan areas 
the projected 1999 black population varies
considerably from the enumerated 2000 census
counts. For example, the 1999 populations for
blacks in one SEER metropolitan area appear 
to differ from the 2000 census counts by more 
than 20%, and rates based on projected versus
preliminary local intercensal (incorporating 2000
census data) estimates differed by approximately
19%. We anticipate that cancer incidence rates,
and in fact all population-based data that used race-
specific 1999 projected estimates for population
denominators, may need to be adjusted after 
the 2000 census data are final. The adjustments
may result not only in different rates but also in
different relationships between rates in geographic
areas and among different populations. 
There is yet another reason for caution when
interpreting incidence rates based on projected
1999 population counts. For the 2000 census,
respondents for the first time were given the
opportunity to identify themselves as being of more
than one race. Studies are in progress to determine
the appropriate corrections needed to adjust for
this change in procedures for collecting census data
on race.40
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Rates for populations according to Hispanic
ethnicity and racial populations other than black
and white are not included in this report. States
with a high proportion of Hispanics may have
different incidence patterns than states with a 
low proportion of Hispanics. Data collection
procedures for identifying specific racial and ethnic
populations vary widely from registry to registry.41
Further study of the quality of data on race and
ethnicity is ongoing; we expect that future United
States Cancer Statistics reports will have cancer
statistics on Hispanics and other ethnic and racial
populations.
Rates for a census region or division, or the
country as a whole, may not have met the
statistical criteria for inclusion due to bias. 
This bias arises if, within the region, division, 
or country, the sub-area for which data are
available has rates that are substantially different
from the rates in the sub-area for which data are
not available. Merely increasing the coverage may
not reduce bias unless the covered area is similar
to the missing area in terms of cancer rates or
proportions. It is possible to have some bias even 
if the percentage of coverage is high and millions
of cases are recorded. As the proportion of the
U.S. population covered by cancer registries with
high quality data approaches 100% and the
covered area becomes more representative of the
entire country, the reported U.S. rate is expected
to move closer to a true U.S. rate.
Geographic variation in cancer incidence rates may
be the result of regional differences in the exposure
of the population to known or unknown risk
factors.42–44 A comparison of incidence rates based
on data from all SEER registries combined and
from all NPCR registries combined revealed that
the two federal programs had different cancer
incidence rates. NPCR reported higher incidence
rates for tobacco-related cancers and for colon
cancer than did SEER. The relationship was
reversed for melanoma, prostate cancer, female
breast cancer, and cancers that are more common
among Asian and Pacific Islander populations (e.g.,
stomach cancer and cancer of the liver and
intrahepatic bile duct). The rates for cancer sites
classified as ill-defined were higher in NPCR than
in SEER. These registry program differences may
arise from differences in socio-demographic
population characteristics (e.g., age, race and
ethnicity, geographic region, urban or rural
residence), screening use, health behaviors (e.g.,
using tobacco, eating poorly, not engaging in
regular physical activity), exposure to cancer-
causing agents, or registry operations factors (e.g.,
completeness, timeliness, specificity in coding
cancer site). Methodologic work is under way to
investigate variability associated with known factors
that affect cancer rates and risks by using model-
based statistical techniques and other approaches
for surveillance research. Studies are also in
progress to evaluate differences in registry
operations. Work continues to ensure the reporting
of high-quality data.  
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Table 1.1: Invasive Cancer Incidence Rates by Primary Site and Race (All Races, White, Black),
United States: SEER and NPCR Registries That Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Primary Site Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
All Sites 552.3 (550.8-553.9) 498.2 (496.9-499.6) 542.0 (540.4-543.6) 519.5 (518.0-521.0) 617.4 (611.6-623.3) 389.4 (385.9-393.0)
Oral Cavity and Pharynx 15.8 ( 15.5- 16.0) 14.6 ( 14.4- 14.8) 15.2 ( 15.0- 15.5) 14.9 ( 14.6- 15.1) 19.2 ( 18.3- 20.2) 13.6 ( 12.9- 14.2)
Lip 1.6 ( 1.5- 1.6) 1.4 ( 1.3- 1.5) 1.7 ( 1.6- 1.8) 1.6 ( 1.5- 1.7) ∼ ∼
Tongue 3.8 ( 3.7- 3.9) 3.5 ( 3.4- 3.7) 3.8 ( 3.7- 3.9) 3.7 ( 3.6- 3.8) 4.0 ( 3.6- 4.5) 2.9 ( 2.6- 3.2)
Salivary Gland 1.5 ( 1.4- 1.6) 1.4 ( 1.3- 1.4) 1.5 ( 1.5- 1.6) 1.5 ( 1.4- 1.5) 1.2 ( 0.9- 1.4) 0.8 ( 0.6- 1.0)
Floor of Mouth 1.2 ( 1.1- 1.2) 1.1 ( 1.0- 1.2) 1.1 ( 1.1- 1.2) 1.1 ( 1.1- 1.2) 1.7 ( 1.4- 2.0) 1.2 ( 1.0- 1.4)
Gum and Other Mouth 2.1 ( 2.0- 2.2) 1.9 ( 1.8- 2.0) 2.0 ( 1.9- 2.1) 1.9 ( 1.8- 2.0) 2.9 ( 2.5- 3.3) 2.0 ( 1.8- 2.3)
Nasopharynx 0.8 ( 0.8- 0.9) 0.8 ( 0.8- 0.9) 0.6 ( 0.6- 0.7) 0.6 ( 0.6- 0.7) 1.0 ( 0.8- 1.3) 0.8 ( 0.7- 1.0)
Tonsil 2.1 ( 2.0- 2.2) 2.0 ( 1.9- 2.1) 2.1 ( 2.0- 2.2) 2.1 ( 2.0- 2.2) 2.9 ( 2.6- 3.3) 2.1 ( 1.8- 2.4)
Oropharynx 0.6 ( 0.6- 0.7) 0.6 ( 0.5- 0.6) 0.6 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 1.5 ( 1.2- 1.8) 1.0 ( 0.8- 1.2)
Hypopharynx 1.5 ( 1.4- 1.6) 1.4 ( 1.3- 1.4) 1.3 ( 1.3- 1.4) 1.3 ( 1.2- 1.4) 2.9 ( 2.5- 3.3) 1.9 ( 1.7- 2.2)
Other Oral Cavity and Pharynx 0.6 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 1.1 ( 0.9- 1.4) 0.7 ( 0.6- 0.9)
Digestive System 112.0 (111.3-112.7) 99.3 ( 98.7- 99.9) 108.9 (108.2-109.6) 102.9 (102.2-103.6) 130.6 (127.9-133.3) 80.3 ( 78.7- 81.9)
Esophagus 8.8 ( 8.6- 8.9) 7.9 ( 7.8- 8.1) 8.4 ( 8.2- 8.6) 8.1 ( 7.9- 8.3) 13.0 ( 12.2- 13.9) 8.3 ( 7.8- 8.8)
Stomach 11.0 ( 10.8- 11.3) 9.7 ( 9.5- 9.9) 10.0 ( 9.8- 10.2) 9.4 ( 9.2- 9.6) 17.5 ( 16.5- 18.6) 10.3 ( 9.7- 10.9)
Small Intestine 2.0 ( 1.9- 2.1) 1.8 ( 1.7- 1.9) 1.9 ( 1.8- 2.0) 1.8 ( 1.7- 1.9) 3.0 ( 2.6- 3.5) 1.9 ( 1.6- 2.1)
Colon and Rectum 66.4 ( 65.9- 66.9) 58.6 ( 58.1- 59.0) 66.0 ( 65.4- 66.5) 62.1 ( 61.6- 62.6) 67.9 ( 65.9- 69.9) 41.2 ( 40.0- 42.3)
Colon excluding Rectum 46.9 ( 46.4- 47.3) 41.0 ( 40.6- 41.4) 46.3 ( 45.8- 46.8) 43.3 ( 42.8- 43.7) 52.0 ( 50.2- 53.7) 31.0 ( 30.0- 32.0)
Rectum and Rectosigmoid Junction 19.5 ( 19.2- 19.8) 17.6 ( 17.3- 17.8) 19.6 ( 19.3- 20.0) 18.8 ( 18.5- 19.1) 15.9 ( 15.0- 16.9) 10.2 ( 9.6- 10.8)
Anus, Anal Canal and Anorectum 1.2 ( 1.1- 1.2) 1.1 ( 1.0- 1.1) 1.2 ( 1.1- 1.2) 1.1 ( 1.0- 1.2) 1.3 ( 1.1- 1.6) 1.0 ( 0.8- 1.2)
Liver and Intrahepatic Bile Duct 7.0 ( 6.9- 7.2) 6.4 ( 6.3- 6.6) 6.1 ( 5.9- 6.3) 5.9 ( 5.7- 6.0) 9.6 ( 8.9- 10.4) 6.5 ( 6.1- 7.0)
Gallbladder 0.8 ( 0.7- 0.9) 0.7 ( 0.6- 0.7) 0.8 ( 0.7- 0.8) 0.7 ( 0.7- 0.8) 0.9 ( 0.7- 1.2) 0.5 ( 0.4- 0.6)
Other Biliary 1.6 ( 1.5- 1.6) 1.4 ( 1.3- 1.4) 1.6 ( 1.5- 1.6) 1.4 ( 1.4- 1.5) 1.2 ( 1.0- 1.5) 0.8 ( 0.6- 0.9)
Pancreas 12.3 ( 12.0- 12.5) 10.9 ( 10.7- 11.1) 12.1 ( 11.8- 12.3) 11.4 ( 11.2- 11.7) 15.2 ( 14.3- 16.2) 9.4 ( 8.8- 9.9)
Retroperitoneum 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.4 ( 0.3- 0.6) 0.3 ( 0.2- 0.4)
Peritoneum, Omentum and Mesentery 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) ∼ ∼
Other Digestive Organs 0.3 ( 0.3- 0.4) 0.3 ( 0.2- 0.3) 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.3) 0.3 ( 0.2- 0.5) 0.2 ( 0.1- 0.3)
Respiratory System 100.0 ( 99.3-100.6) 90.0 ( 89.4- 90.5) 98.5 ( 97.8- 99.1) 94.5 ( 93.8- 95.1) 125.0 (122.3-127.6) 78.0 ( 76.5- 79.6)
Nose, Nasal Cavity and Middle Ear 0.8 ( 0.8- 0.9) 0.8 ( 0.7- 0.8) 0.8 ( 0.8- 0.9) 0.8 ( 0.7- 0.9) 1.0 ( 0.7- 1.2) 0.7 ( 0.5- 0.8)
Larynx 7.9 ( 7.7- 8.1) 7.3 ( 7.1- 7.4) 7.6 ( 7.4- 7.8) 7.4 ( 7.2- 7.6) 12.1 ( 11.3- 12.9) 7.9 ( 7.4- 8.4)
Lung and Bronchus 89.1 ( 88.5- 89.7) 80.0 ( 79.5- 80.6) 87.8 ( 87.2- 88.5) 84.2 ( 83.6- 84.8) 110.7 (108.3-113.3) 68.7 ( 67.2- 70.2)
Pleura 1.8 ( 1.7- 1.9) 1.6 ( 1.5- 1.7) 1.9 ( 1.8- 2.0) 1.8 ( 1.7- 1.9) 0.8 ( 0.6- 1.1) 0.5 ( 0.4- 0.6)
Trachea and Other Respiratory Organs 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.4 ( 0.2- 0.5) 0.3 ( 0.2- 0.4)
Bones and Joints 1.1 ( 1.0- 1.1) 1.0 ( 1.0- 1.1) 1.1 ( 1.0- 1.2) 1.1 ( 1.0- 1.1) 0.8 ( 0.6- 1.0) 0.8 ( 0.6- 1.0)
Soft Tissue including Heart 3.3 ( 3.2- 3.5) 3.1 ( 3.0- 3.2) 3.3 ( 3.1- 3.4) 3.2 ( 3.0- 3.3) 3.6 ( 3.2- 4.0) 2.8 ( 2.5- 3.1)
Skin excluding Basal and Squamous 21.5 ( 21.2- 21.8) 19.8 ( 19.5- 20.1) 22.8 ( 22.5- 23.2) 22.1 ( 21.8- 22.4) 4.1 ( 3.7- 4.5) 3.3 ( 3.0- 3.6)
Melanomas of the Skin 19.0 ( 18.7- 19.3) 17.6 ( 17.3- 17.8) 20.5 ( 20.2- 20.8) 19.9 ( 19.6- 20.2) 1.2 ( 1.0- 1.5) 0.8 ( 0.6- 1.0)
Other Non-Epithelial Skin 2.5 ( 2.4- 2.6) 2.3 ( 2.2- 2.4) 2.3 ( 2.2- 2.4) 2.2 ( 2.1- 2.3) 2.9 ( 2.5- 3.3) 2.5 ( 2.2- 2.8)
Breast 1.5 ( 1.4- 1.6) 1.4 ( 1.3- 1.4) 1.5 ( 1.4- 1.5) 1.4 ( 1.3- 1.5) 2.1 ( 1.8- 2.5) 1.3 ( 1.1- 1.5)
Male Genital System 168.6 (167.7-169.4) 153.1 (152.3-153.8) 159.6 (158.7-160.4) 154.4 (153.6-155.3) 231.6 (228.0-235.2) 142.5 (140.4-144.7)
Prostate 162.0 (161.2-162.8) 146.5 (145.8-147.2) 152.3 (151.5-153.2) 147.1 (146.3-148.0) 229.3 (225.7-232.9) 140.6 (138.5-142.7)
Testis 5.5 ( 5.3- 5.6) 5.6 ( 5.5- 5.8) 6.2 ( 6.0- 6.3) 6.3 ( 6.1- 6.5) 1.4 ( 1.1- 1.6) 1.3 ( 1.1- 1.5)
Penis 0.9 ( 0.8- 0.9) 0.8 ( 0.7- 0.8) 0.8 ( 0.8- 0.9) 0.8 ( 0.7- 0.9) 0.7 ( 0.5- 0.9) 0.4 ( 0.3- 0.6)








Table 1.1: Invasive Cancer Incidence Rates by Primary Site and Race (All Races, White, Black),
United States: SEER and NPCR Registries That Meet Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Primary Site Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
Urinary System 55.7 ( 55.2- 56.2) 49.4 ( 48.9- 49.8) 57.7 ( 57.2- 58.3) 54.7 ( 54.2- 55.2) 35.0 ( 33.6- 36.5) 21.3 ( 20.5- 22.2)
Urinary Bladder‖ 38.3 ( 37.9- 38.7) 33.5 ( 33.2- 33.9) 40.2 ( 39.8- 40.7) 37.7 ( 37.3- 38.1) 17.9 ( 16.9- 19.0) 10.0 ( 9.5- 10.6)
Kidney and Renal Pelvis 16.0 ( 15.8- 16.3) 14.7 ( 14.5- 14.9) 16.1 ( 15.8- 16.4) 15.6 ( 15.4- 15.9) 16.3 ( 15.4- 17.3) 10.9 ( 10.3- 11.5)
Ureter 0.9 ( 0.8- 0.9) 0.8 ( 0.7- 0.8) 0.9 ( 0.8- 1.0) 0.9 ( 0.8- 0.9) 0.3 ( 0.2- 0.4) 0.2 ( 0.1- 0.2)
Other Urinary Organs 0.5 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.5 ( 0.3- 0.7) 0.3 ( 0.2- 0.4)
Eye and Orbit 0.9 ( 0.8- 0.9) 0.8 ( 0.7- 0.9) 0.9 ( 0.8- 1.0) 0.9 ( 0.8- 0.9) 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4)
Brain and Other Nervous System 7.9 ( 7.7- 8.1) 7.5 ( 7.3- 7.7) 8.3 ( 8.1- 8.5) 8.2 ( 8.0- 8.4) 4.5 ( 4.1- 5.0) 3.8 ( 3.4- 4.1)
Brain 7.5 ( 7.3- 7.6) 7.1 ( 6.9- 7.3) 7.9 ( 7.7- 8.1) 7.8 ( 7.6- 7.9) 4.2 ( 3.7- 4.6) 3.5 ( 3.1- 3.8)
Cranial Nerves and Other Nervous System 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.4 ( 0.3- 0.6) 0.3 ( 0.2- 0.4)
Endocrine System 4.3 ( 4.2- 4.4) 4.2 ( 4.1- 4.3) 4.5 ( 4.3- 4.6) 4.4 ( 4.3- 4.6) 2.5 ( 2.2- 2.9) 2.0 ( 1.7- 2.3)
Thyroid 3.6 ( 3.5- 3.7) 3.5 ( 3.4- 3.6) 3.8 ( 3.6- 3.9) 3.8 ( 3.6- 3.9) 1.8 ( 1.5- 2.1) 1.3 ( 1.1- 1.5)
Other Endocrine including Thymus 0.7 ( 0.6- 0.8) 0.7 ( 0.6- 0.7) 0.7 ( 0.6- 0.7) 0.7 ( 0.6- 0.7) 0.8 ( 0.6- 1.0) 0.7 ( 0.5- 0.8)
Lymphomas 25.1 ( 24.8- 25.4) 23.2 ( 22.9- 23.5) 25.4 ( 25.0- 25.7) 24.5 ( 24.2- 24.8) 19.6 ( 18.6- 20.6) 15.0 ( 14.4- 15.8)
Hodgkin Lymphoma 3.2 ( 3.1- 3.3) 3.1 ( 3.0- 3.2) 3.2 ( 3.1- 3.4) 3.2 ( 3.1- 3.4) 2.9 ( 2.6- 3.2) 2.7 ( 2.4- 3.0)
Non-Hodgkin Lymphoma 22.0 ( 21.7- 22.3) 20.0 ( 19.7- 20.3) 22.1 ( 21.8- 22.5) 21.3 ( 21.0- 21.6) 16.7 ( 15.8- 17.6) 12.4 ( 11.7- 13.0)
Multiple Myeloma 6.0 ( 5.8- 6.2) 5.3 ( 5.2- 5.5) 5.6 ( 5.4- 5.7) 5.3 ( 5.1- 5.4) 10.8 ( 10.0- 11.6) 6.6 ( 6.2- 7.1)
Leukemias 14.5 ( 14.3- 14.8) 13.0 ( 12.8- 13.3) 14.8 ( 14.5- 15.1) 14.0 ( 13.8- 14.3) 10.5 ( 9.8- 11.3) 7.2 ( 6.7- 7.7)
Acute Lymphocytic 1.5 ( 1.5- 1.6) 1.5 ( 1.5- 1.6) 1.6 ( 1.5- 1.7) 1.6 ( 1.5- 1.7) 0.9 ( 0.7- 1.1) 0.9 ( 0.8- 1.1)
Chronic Lymphocytic 4.2 ( 4.1- 4.3) 3.7 ( 3.5- 3.8) 4.3 ( 4.1- 4.4) 4.0 ( 3.9- 4.1) 3.1 ( 2.7- 3.5) 1.8 ( 1.5- 2.0)
Acute Myeloid 4.4 ( 4.3- 4.6) 4.0 ( 3.9- 4.1) 4.5 ( 4.3- 4.6) 4.3 ( 4.1- 4.4) 3.3 ( 2.9- 3.8) 2.3 ( 2.0- 2.6)
Chronic Myeloid 1.8 ( 1.7- 1.9) 1.6 ( 1.6- 1.7) 1.8 ( 1.7- 1.9) 1.7 ( 1.6- 1.8) 1.5 ( 1.2- 1.8) 1.0 ( 0.9- 1.2)
Other Leukemias 2.6 ( 2.5- 2.7) 2.2 ( 2.1- 2.3) 2.6 ( 2.5- 2.7) 2.4 ( 2.3- 2.5) 1.8 ( 1.5- 2.1) 1.1 ( 0.9- 1.3)
Miscellaneous 14.4 ( 14.1- 14.6) 12.6 ( 12.4- 12.8) 14.1 ( 13.8- 14.3) 13.1 ( 12.9- 13.4) 17.2 ( 16.3- 18.3) 10.6 ( 10.1- 11.2)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. Rates cover approximately 78% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
‖ Includes invasive and in situ.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific site-race category.
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Table 1.2: Invasive Cancer Incidence Rates by Primary Site and Race (All Races, White, Black),
United States: SEER and NPCR Registries that Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Primary Site Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
All Sites 420.1 (418.9-421.2) 457.9 (456.7-459.2) 423.8 (422.5-425.1) 487.4 (486.0-488.9) 381.7 (378.0-385.4) 313.2 (310.2-316.3)
Oral Cavity and Pharynx 6.3 ( 6.2- 6.5) 6.9 ( 6.7- 7.0) 6.2 ( 6.0- 6.3) 7.1 ( 7.0- 7.3) 6.3 ( 5.8- 6.8) 5.3 ( 4.9- 5.7)
Lip 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.4 ( 0.4- 0.5) ∼ ∼
Tongue 1.6 ( 1.5- 1.6) 1.7 ( 1.6- 1.8) 1.5 ( 1.5- 1.6) 1.8 ( 1.7- 1.9) 1.2 ( 1.0- 1.5) 1.0 ( 0.9- 1.2)
Salivary Gland 0.9 ( 0.8- 0.9) 0.9 ( 0.9- 1.0) 0.9 ( 0.8- 0.9) 1.0 ( 0.9- 1.1) 0.8 ( 0.6- 0.9) 0.6 ( 0.5- 0.8)
Floor of Mouth 0.5 ( 0.4- 0.5) 0.5 ( 0.5- 0.6) 0.5 ( 0.4- 0.5) 0.6 ( 0.5- 0.6) 0.5 ( 0.4- 0.7) 0.4 ( 0.3- 0.6)
Gum and Other Mouth 1.4 ( 1.3- 1.5) 1.5 ( 1.5- 1.6) 1.4 ( 1.3- 1.4) 1.6 ( 1.5- 1.7) 1.3 ( 1.1- 1.5) 1.1 ( 0.9- 1.2)
Nasopharynx 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.3 ( 0.2- 0.3) 0.3 ( 0.3- 0.3) 0.5 ( 0.4- 0.6) 0.4 ( 0.3- 0.6)
Tonsil 0.6 ( 0.6- 0.6) 0.6 ( 0.6- 0.7) 0.6 ( 0.5- 0.6) 0.7 ( 0.6- 0.7) 0.8 ( 0.6- 1.0) 0.7 ( 0.5- 0.8)
Oropharynx 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.4)
Hypopharynx 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.4 ( 0.4- 0.4) 0.5 ( 0.4- 0.7) 0.4 ( 0.3- 0.5)
Other Oral Cavity and Pharynx 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) 0.2 ( 0.1- 0.3)
Digestive System 75.0 ( 74.5- 75.5) 85.4 ( 84.9- 86.0) 72.7 ( 72.2- 73.2) 89.0 ( 88.4- 89.6) 90.3 ( 88.5- 92.2) 70.9 ( 69.4- 72.3)
Esophagus 2.2 ( 2.1- 2.2) 2.5 ( 2.4- 2.5) 2.0 ( 1.9- 2.1) 2.5 ( 2.4- 2.6) 3.6 ( 3.2- 4.0) 2.9 ( 2.6- 3.2)
Stomach 5.1 ( 5.0- 5.2) 5.9 ( 5.7- 6.0) 4.4 ( 4.3- 4.6) 5.5 ( 5.3- 5.7) 9.1 ( 8.5- 9.7) 7.0 ( 6.6- 7.5)
Small Intestine 1.4 ( 1.3- 1.5) 1.5 ( 1.5- 1.6) 1.3 ( 1.3- 1.4) 1.6 ( 1.5- 1.6) 2.2 ( 1.9- 2.5) 1.7 ( 1.5- 2.0)
Colon and Rectum 48.5 ( 48.1- 48.9) 55.3 ( 54.9- 55.7) 47.6 ( 47.2- 48.0) 58.4 ( 57.9- 58.9) 54.0 ( 52.6- 55.4) 42.5 ( 41.4- 43.6)
Colon excluding Rectum 36.5 ( 36.1- 36.8) 41.9 ( 41.5- 42.3) 35.6 ( 35.2- 36.0) 44.1 ( 43.7- 44.6) 43.2 ( 41.9- 44.5) 33.9 ( 32.9- 34.9)
Rectum and Rectosigmoid Junction 12.0 ( 11.8- 12.2) 13.4 ( 13.2- 13.6) 12.0 ( 11.8- 12.2) 14.3 ( 14.1- 14.5) 10.8 ( 10.2- 11.4) 8.6 ( 8.1- 9.1)
Anus, Anal Canal and Anorectum 1.5 ( 1.4- 1.5) 1.6 ( 1.5- 1.7) 1.5 ( 1.4- 1.6) 1.7 ( 1.6- 1.8) 1.3 ( 1.1- 1.5) 1.1 ( 0.9- 1.3)
Liver and Intrahepatic Bile Duct 2.8 ( 2.7- 2.9) 3.2 ( 3.1- 3.3) 2.5 ( 2.4- 2.6) 3.1 ( 2.9- 3.2) 3.5 ( 3.1- 3.9) 2.8 ( 2.5- 3.1)
Gallbladder 1.5 ( 1.4- 1.6) 1.7 ( 1.6- 1.8) 1.5 ( 1.4- 1.5) 1.8 ( 1.7- 1.9) 1.6 ( 1.3- 1.9) 1.2 ( 1.0- 1.4)
Other Biliary 1.1 ( 1.1- 1.2) 1.3 ( 1.2- 1.4) 1.1 ( 1.0- 1.2) 1.4 ( 1.3- 1.5) 1.0 ( 0.8- 1.2) 0.7 ( 0.6- 0.9)
Pancreas 9.6 ( 9.4- 9.7) 11.0 ( 10.8- 11.2) 9.2 ( 9.0- 9.4) 11.4 ( 11.2- 11.6) 13.1 ( 12.4- 13.8) 10.1 ( 9.5- 10.6)
Retroperitoneum 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.4 ( 0.4- 0.4) 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.5)
Peritoneum, Omentum and Mesentery 0.8 ( 0.7- 0.8) 0.8 ( 0.8- 0.9) 0.8 ( 0.8- 0.9) 1.0 ( 0.9- 1.0) 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.4)
Other Digestive Organs 0.3 ( 0.2- 0.3) 0.3 ( 0.3- 0.3) 0.3 ( 0.2- 0.3) 0.3 ( 0.3- 0.4) 0.2 ( 0.2- 0.4) 0.2 ( 0.1- 0.3)
Respiratory System 56.1 ( 55.7- 56.5) 62.0 ( 61.5- 62.5) 57.2 ( 56.7- 57.6) 67.2 ( 66.6- 67.7) 53.4 ( 52.0- 54.8) 42.7 ( 41.6- 43.8)
Nose, Nasal Cavity and Middle Ear 0.5 ( 0.5- 0.6) 0.6 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 0.6 ( 0.6- 0.7) 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.5)
Larynx 1.7 ( 1.7- 1.8) 1.9 ( 1.8- 1.9) 1.7 ( 1.6- 1.8) 1.9 ( 1.8- 2.0) 2.4 ( 2.2- 2.8) 2.0 ( 1.8- 2.3)
Lung and Bronchus 53.4 ( 52.9- 53.8) 59.0 ( 58.6- 59.5) 54.4 ( 54.0- 54.9) 64.1 ( 63.5- 64.6) 50.3 ( 48.9- 51.7) 40.1 ( 39.0- 41.2)
Pleura 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.4 ( 0.4- 0.5) 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.2)
Trachea and Other Respiratory Organs 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) ∼ ∼
Bones and Joints 0.8 ( 0.7- 0.9) 0.8 ( 0.8- 0.9) 0.8 ( 0.8- 0.9) 0.9 ( 0.8- 0.9) 0.6 ( 0.5- 0.8) 0.6 ( 0.5- 0.8)
Soft Tissue including Heart 2.4 ( 2.3- 2.5) 2.6 ( 2.5- 2.7) 2.4 ( 2.3- 2.5) 2.7 ( 2.6- 2.8) 2.3 ( 2.0- 2.6) 2.1 ( 1.8- 2.3)
Skin excluding Basal and Squamous 13.2 ( 13.0- 13.4) 13.9 ( 13.7- 14.2) 14.4 ( 14.2- 14.7) 15.6 ( 15.4- 15.9) 2.0 ( 1.8- 2.3) 1.8 ( 1.6- 2.0)
Melanomas of the Skin 12.1 ( 11.9- 12.3) 12.7 ( 12.5- 12.9) 13.4 ( 13.1- 13.6) 14.4 ( 14.2- 14.7) 0.9 ( 0.7- 1.1) 0.7 ( 0.6- 0.9)
Other Non-Epithelial Skin 1.1 ( 1.1- 1.2) 1.2 ( 1.2- 1.3) 1.1 ( 1.0- 1.1) 1.2 ( 1.2- 1.3) 1.2 ( 1.0- 1.4) 1.1 ( 0.9- 1.3)
Breast 134.1 (133.4-134.8) 143.2 (142.5-143.9) 136.3 (135.5-137.0) 152.7 (151.9-153.5) 112.7 (110.7-114.7) 94.9 ( 93.3- 96.6)
Female Genital System 53.9 ( 53.5- 54.3) 57.4 ( 56.9- 57.9) 54.6 ( 54.1- 55.0) 60.7 ( 60.2- 61.3) 46.5 ( 45.3- 47.8) 39.1 ( 38.1- 40.2)
Cervix 9.5 ( 9.3- 9.6) 9.7 ( 9.5- 9.9) 8.8 ( 8.6- 9.0) 9.2 ( 9.0- 9.4) 13.9 ( 13.2- 14.6) 12.3 ( 11.8- 13.0)
Corpus 23.9 ( 23.6- 24.2) 25.6 ( 25.3- 25.9) 24.6 ( 24.3- 25.0) 27.7 ( 27.4- 28.1) 17.3 ( 16.5- 18.1) 14.0 ( 13.4- 14.7)
Uterus, NOS 0.7 ( 0.7- 0.8) 0.8 ( 0.7- 0.9) 0.7 ( 0.6- 0.7) 0.8 ( 0.7- 0.8) 1.4 ( 1.1- 1.6) 1.1 ( 0.9- 1.3)
Ovary 16.2 ( 15.9- 16.4) 17.2 ( 17.0- 17.5) 16.8 ( 16.6- 17.1) 18.8 ( 18.5- 19.1) 10.6 ( 10.0- 11.3) 8.9 ( 8.4- 9.4)
Vagina 0.7 ( 0.6- 0.7) 0.8 ( 0.7- 0.8) 0.6 ( 0.6- 0.7) 0.7 ( 0.7- 0.8) 1.2 ( 1.0- 1.4) 1.0 ( 0.8- 1.1)
Vulva 2.3 ( 2.2- 2.4) 2.6 ( 2.5- 2.7) 2.4 ( 2.3- 2.5) 2.9 ( 2.7- 3.0) 1.6 ( 1.3- 1.8) 1.3 ( 1.1- 1.5)








Table 1.2: Invasive Cancer Incidence Rates by Primary Site and Race (All Races, White, Black),
United States: SEER and NPCR Registries that Meet Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Primary Site Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
Urinary System 19.0 ( 18.8- 19.3) 21.3 ( 21.0- 21.5) 19.5 ( 19.2- 19.7) 23.2 ( 22.9- 23.5) 16.3 ( 15.5- 17.1) 13.0 ( 12.4- 13.6)
Urinary Bladder‖ 10.0 ( 9.8- 10.2) 11.4 ( 11.2- 11.6) 10.4 ( 10.2- 10.6) 12.7 ( 12.4- 12.9) 7.1 ( 6.6- 7.7) 5.4 ( 5.0- 5.8)
Kidney and Renal Pelvis 8.4 ( 8.2- 8.5) 9.1 ( 9.0- 9.3) 8.4 ( 8.2- 8.6) 9.7 ( 9.5- 9.9) 8.7 ( 8.2- 9.3) 7.2 ( 6.7- 7.7)
Ureter 0.5 ( 0.4- 0.5) 0.5 ( 0.5- 0.6) 0.5 ( 0.4- 0.5) 0.6 ( 0.5- 0.6) 0.2 ( 0.1- 0.3) 0.1 ( 0.1- 0.2)
Other Urinary Organs 0.2 ( 0.1- 0.2) 0.2 ( 0.2- 0.2) 0.1 ( 0.1- 0.2) 0.2 ( 0.2- 0.2) 0.3 ( 0.2- 0.4) 0.2 ( 0.2- 0.3)
Eye and Orbit 0.6 ( 0.6- 0.7) 0.7 ( 0.6- 0.7) 0.7 ( 0.6- 0.7) 0.7 ( 0.7- 0.8) 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.3)
Brain and Other Nervous System 5.7 ( 5.5- 5.8) 6.0 ( 5.8- 6.1) 6.0 ( 5.8- 6.1) 6.5 ( 6.4- 6.7) 3.6 ( 3.3- 4.0) 3.2 ( 2.9- 3.5)
Brain 5.3 ( 5.1- 5.4) 5.6 ( 5.4- 5.7) 5.6 ( 5.5- 5.8) 6.1 ( 6.0- 6.3) 3.2 ( 2.9- 3.6) 2.9 ( 2.6- 3.2)
Cranial Nerves and Other Nervous System 0.4 ( 0.3- 0.4) 0.4 ( 0.4- 0.4) 0.4 ( 0.3- 0.4) 0.4 ( 0.4- 0.5) 0.4 ( 0.3- 0.5) 0.3 ( 0.2- 0.4)
Endocrine System 10.4 ( 10.2- 10.6) 10.6 ( 10.4- 10.8) 10.7 ( 10.5- 10.9) 11.0 ( 10.8- 11.2) 6.5 ( 6.0- 7.0) 6.0 ( 5.6- 6.4)
Thyroid 9.9 ( 9.7- 10.1) 10.0 ( 9.8- 10.2) 10.2 ( 10.0- 10.4) 10.4 ( 10.2- 10.7) 5.9 ( 5.5- 6.4) 5.4 ( 5.0- 5.8)
Other Endocrine including Thymus 0.5 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 0.6 ( 0.5- 0.8) 0.5 ( 0.4- 0.7)
Lymphomas 18.3 ( 18.0- 18.5) 19.9 ( 19.7- 20.2) 18.8 ( 18.5- 19.0) 21.6 ( 21.3- 21.9) 12.7 ( 12.1- 13.4) 11.1 ( 10.5- 11.7)
Hodgkin Lymphoma 2.5 ( 2.4- 2.6) 2.6 ( 2.5- 2.7) 2.7 ( 2.6- 2.8) 2.7 ( 2.6- 2.8) 1.9 ( 1.7- 2.2) 1.9 ( 1.7- 2.2)
Non-Hodgkin Lymphoma 15.7 ( 15.5- 16.0) 17.4 ( 17.1- 17.6) 16.1 ( 15.8- 16.3) 18.9 ( 18.6- 19.1) 10.8 ( 10.2- 11.4) 9.2 ( 8.7- 9.7)
Multiple Myeloma 4.1 ( 4.0- 4.3) 4.6 ( 4.5- 4.8) 3.7 ( 3.6- 3.8) 4.5 ( 4.3- 4.6) 8.2 ( 7.7- 8.8) 6.4 ( 6.0- 6.9)
Leukemias 8.8 ( 8.6- 8.9) 9.6 ( 9.5- 9.8) 8.9 ( 8.7- 9.1) 10.3 ( 10.1- 10.5) 7.0 ( 6.5- 7.5) 5.9 ( 5.5- 6.3)
Acute Lymphocytic 1.2 ( 1.1- 1.2) 1.2 ( 1.1- 1.2) 1.2 ( 1.2- 1.3) 1.2 ( 1.1- 1.3) 0.7 ( 0.6- 0.9) 0.7 ( 0.6- 0.9)
Chronic Lymphocytic 2.1 ( 2.0- 2.2) 2.4 ( 2.3- 2.5) 2.1 ( 2.0- 2.2) 2.6 ( 2.5- 2.7) 1.5 ( 1.2- 1.7) 1.1 ( 0.9- 1.3)
Acute Myeloid 3.1 ( 3.0- 3.2) 3.4 ( 3.2- 3.5) 3.1 ( 3.0- 3.2) 3.6 ( 3.5- 3.7) 2.6 ( 2.3- 3.0) 2.2 ( 2.0- 2.5)
Chronic Myeloid 1.1 ( 1.0- 1.1) 1.2 ( 1.1- 1.3) 1.1 ( 1.0- 1.1) 1.2 ( 1.2- 1.3) 1.0 ( 0.8- 1.2) 0.8 ( 0.7- 1.0)
Other Leukemias 1.3 ( 1.3- 1.4) 1.5 ( 1.5- 1.6) 1.4 ( 1.3- 1.4) 1.7 ( 1.6- 1.8) 1.2 ( 1.0- 1.4) 1.0 ( 0.8- 1.1)
Miscellaneous 11.3 ( 11.1- 11.5) 13.0 ( 12.8- 13.3) 11.1 ( 10.9- 11.3) 13.8 ( 13.5- 14.0) 12.9 ( 12.2- 13.6) 10.1 ( 9.5- 10.6)
Breast, in situ ¶ 28.8 ( 28.5- 29.1) 30.1 ( 29.8- 30.4) 29.3 ( 28.9- 29.6) 31.7 ( 31.4- 32.1) 22.5 ( 21.6- 23.4) 18.8 ( 18.1- 19.6)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. Rates cover approximately 78% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
‖ Includes invasive and in situ.
¶ Rates for in situ female breast cancer are listed separately and are not included in rates for the "all sites" category.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific site-race category.
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Table 1.3: All Cancer Sites Combined. Invasive Cancer Incidence Rates by Age and




Age at Diagnosis (Years) All Races White Black
<1 26.2 ( 23.6- 28.9) 27.4 ( 24.4- 30.5) 17.9 ( 12.7- 24.6)
1-4 20.2 ( 19.1- 21.4) 21.2 ( 19.9- 22.5) 13.1 ( 10.7- 15.8)
5-9 12.0 ( 11.3- 12.8) 12.1 ( 11.3- 13.0) 11.0 ( 9.2- 13.1)
10-14 12.3 ( 11.6- 13.1) 12.9 ( 12.0- 13.8) 9.2 ( 7.5- 11.1)
15-19 20.7 ( 19.7- 21.7) 21.0 ( 19.9- 22.2) 18.4 ( 16.0- 21.1)
20-24 31.8 ( 30.5- 33.1) 33.7 ( 32.2- 35.3) 17.0 ( 14.5- 19.8)
25-29 48.0 ( 46.4- 49.6) 50.9 ( 49.0- 52.8) 28.9 ( 25.5- 32.6)
30-34 65.4 ( 63.6- 67.3) 67.2 ( 65.1- 69.2) 50.6 ( 46.1- 55.4)
35-39 87.3 ( 85.4- 89.3) 87.7 ( 85.5- 89.8) 79.5 ( 74.1- 85.3)
40-44 143.4 ( 140.9- 146.0) 140.2 ( 137.5- 143.0) 160.4 ( 152.4- 168.8)
45-49 271.5 ( 267.8- 275.3) 259.6 ( 255.7- 263.7) 369.0 ( 355.3- 383.1)
50-54 531.0 ( 525.3- 536.7) 507.2 ( 501.1- 513.2) 761.8 ( 739.0- 785.1)
55-59 975.0 ( 966.2- 983.9) 938.7 ( 929.4- 948.0) 1343.1 (1308.2-1378.8)
60-64 1583.8 (1571.3-1596.5) 1536.9 (1523.6-1550.2) 2031.1 (1982.9-2080.2)
65-69 2327.2 (2311.0-2343.4) 2294.5 (2277.3-2311.7) 2509.9 (2453.1-2567.8)
70-74 2864.5 (2845.6-2883.5) 2826.5 (2806.6-2846.4) 2967.5 (2896.7-3039.5)
75-79 3068.3 (3046.4-3090.3) 3016.1 (2993.4-3039.0) 3245.2 (3156.9-3335.4)
80-84 3152.7 (3124.1-3181.5) 3107.8 (3078.1-3137.7) 3188.1 (3067.3-3312.5)
85+ 3065.5 (3031.3-3099.9) 3049.7 (3014.0-3085.8) 2866.0 (2735.7-3000.9)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria: case ascertainment is at
least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. Rates cover
approximately 78% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except
urinary bladder.
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999







Table 1.4: All Cancer Sites Combined. Invasive Cancer Incidence Rates by Age and




Age at Diagnosis (Years) All Races White Black
<1 19.5 ( 17.3- 22.0) 19.6 ( 17.1- 22.3) 15.2 ( 10.3- 21.5)
1-4 17.9 ( 16.9- 19.1) 18.7 ( 17.4- 20.0) 13.6 ( 11.2- 16.4)
5-9 9.7 ( 9.0- 10.4) 9.8 ( 9.0- 10.6) 7.6 ( 6.1- 9.4)
10-14 12.4 ( 11.6- 13.2) 12.5 ( 11.6- 13.5) 11.0 ( 9.1- 13.1)
15-19 19.0 ( 18.0- 20.0) 19.6 ( 18.5- 20.8) 13.9 ( 11.8- 16.4)
20-24 34.6 ( 33.3- 36.1) 35.8 ( 34.2- 37.4) 25.1 ( 22.0- 28.5)
25-29 63.2 ( 61.3- 65.0) 65.7 ( 63.6- 67.9) 47.3 ( 43.1- 51.8)
30-34 102.4 ( 100.2- 104.7) 102.9 ( 100.4- 105.5) 93.5 ( 87.7- 99.6)
35-39 162.8 ( 160.2- 165.5) 163.3 ( 160.4- 166.3) 151.5 ( 144.4- 158.9)
40-44 265.7 ( 262.3- 269.1) 264.8 ( 261.0- 268.5) 252.8 ( 243.3- 262.6)
45-49 410.9 ( 406.4- 415.4) 412.0 ( 407.1- 417.1) 383.1 ( 370.3- 396.2)
50-54 605.9 ( 599.9- 611.8) 609.1 ( 602.6- 615.6) 566.9 ( 549.3- 585.0)
55-59 833.4 ( 825.6- 841.3) 846.2 ( 837.6- 854.8) 737.0 ( 714.2- 760.3)
60-64 1104.3 (1094.4-1114.3) 1121.2 (1110.4-1132.1) 1003.1 ( 973.9-1033.0)
65-69 1385.0 (1373.5-1396.5) 1413.5 (1401.0-1426.1) 1181.5 (1147.8-1215.9)
70-74 1677.2 (1664.3-1690.1) 1694.8 (1681.1-1708.6) 1527.9 (1485.3-1571.5)
75-79 1888.2 (1873.7-1902.9) 1897.3 (1881.9-1912.8) 1755.1 (1703.1-1808.2)
80-84 1998.5 (1980.7-2016.4) 2002.4 (1983.8-2021.2) 1823.5 (1756.3-1892.6)
85+ 1873.1 (1855.7-1890.7) 1871.6 (1853.4-1890.0) 1762.1 (1695.6-1830.5)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria: case ascertainment is at
least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. Rates cover
approximately 78% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except
urinary bladder.
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999
population size. Caution should be used in interpreting rates based on these projected populations.
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Table 2.1.1: All Cancer Sites Combined. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 552.3 (550.8- 553.9) 498.2 (496.9-499.6) 542.0 (540.4- 543.6) 519.5 (518.0-521.0) 617.4 (611.6- 623.3) 389.4 (385.9-393.0)
Northeast 573.0 (569.9- 576.1) 545.8 (542.9-548.8) 564.9 (561.6- 568.2) 574.3 (570.9-577.6) 595.6 (584.5- 607.0) 395.1 (388.0-402.3)
New England 586.4 (579.8- 593.0) 548.3 (542.2-554.5) 578.9 (572.3- 585.7) 568.7 (562.2-575.3) 615.9 (579.7- 654.4) 329.7 (311.5-348.7)
Connecticut 580.6 (568.6- 592.9) 558.8 (547.2-570.5) 570.1 (557.7- 582.7) 579.9 (567.4-592.7) 623.0 (568.0- 683.1) 362.7 (332.5-394.9)
Maine
Massachusetts 588.6 (579.5- 597.7) 547.9 (539.5-556.4) 579.7 (570.5- 589.1) 570.5 (561.5-579.7) 613.6 (562.5- 669.5) 312.0 (287.8-337.7)
New Hampshire 534.1 (513.8- 555.0) 457.2 (440.1-474.7) 533.0 (512.7- 554.0) 461.4 (444.1-479.3) ∼ ∼
Rhode Island 644.7 (621.7- 668.4) 628.8 (606.5-651.8) 650.0 (626.4- 674.4) 663.8 (639.9-688.4) 654.1 (506.6- 844.6) 305.8 (241.3-382.2)
Vermont
Middle Atlantic 569.1 (565.6- 572.6) 545.1 (541.7-548.5) 560.4 (556.6- 564.2) 576.1 (572.3-580.0) 593.6 (581.9- 605.5) 404.4 (396.7-412.2)
New Jersey 606.9 (598.9- 615.0) 565.6 (558.2-573.1) 609.0 (600.4- 617.7) 615.9 (607.2-624.6) 669.4 (641.9- 698.2) 436.3 (419.3-453.8)
New York 537.9 (532.8- 543.0) 495.0 (490.4-499.7) 531.0 (525.5- 536.6) 530.2 (524.7-535.7) 517.6 (503.0- 532.5) 352.2 (342.8-361.8)
Pennsylvania 587.4 (581.3- 593.7) 607.2 (600.9-613.6) 567.7 (561.4- 574.1) 612.1 (605.4-618.9) 718.2 (691.5- 745.9) 514.4 (495.6-533.7)
Midwest
East North Central
Illinois 558.8 (552.2- 565.4) 479.8 (474.2-485.4) 539.8 (532.9- 546.8) 492.4 (486.1-498.7) 631.0 (609.3- 653.4) 395.2 (382.1-408.6)
Indiana
Michigan 607.8 (600.3- 615.4) 534.3 (527.8-540.9) 588.2 (580.3- 596.1) 542.7 (535.5-549.9) 713.1 (688.2- 738.8) 484.1 (467.5-501.2)
Detroit 633.1 (621.1- 645.3) 560.5 (550.1-571.1) 607.5 (594.3- 621.0) 572.7 (560.5-585.2) 736.1 (707.1- 766.1) 541.5 (520.4-563.3)
Ohio 555.4 (548.8- 562.1) 509.8 (503.8-515.9) 531.8 (525.0- 538.7) 506.1 (499.7-512.5) 623.4 (599.1- 648.6) 432.5 (416.2-449.3)
Wisconsin 540.9 (531.5- 550.5) 493.3 (484.8-502.0) 532.7 (523.2- 542.4) 508.7 (499.7-517.9) 726.8 (653.8- 808.8) 316.7 (288.2-347.3)
West North Central 548.4 (543.3- 553.5) 506.0 (501.4-510.8) 536.2 (531.0- 541.4) 514.5 (509.6-519.5) 657.5 (627.1- 689.1) 375.3 (358.7-392.6)
Iowa 554.4 (542.0- 566.9) 552.0 (539.8-564.5) 545.1 (532.7- 557.6) 554.8 (542.3-567.5) 724.2 (584.6- 894.7) 356.3 (291.7-430.9)
Kansas 553.4 (540.0- 567.0) 499.9 (487.8-512.1) 534.1 (520.6- 547.8) 501.0 (488.4-513.8) 729.9 (649.2- 819.0) 406.7 (363.2-454.0)
Minnesota 561.5 (551.2- 571.9) 487.8 (478.9-496.8) 550.5 (540.2- 561.0) 499.6 (490.3-509.1) 609.3 (513.3- 725.4) 248.5 (214.4-286.5)
Missouri 533.4 (524.3- 542.7) 497.9 (489.4-506.5) 522.4 (513.0- 532.0) 510.3 (501.2-519.6) 647.8 (610.6- 687.1) 412.9 (389.8-437.0)
Nebraska 545.5 (529.0- 562.4) 509.0 (493.6-524.7) 525.3 (508.9- 542.2) 506.7 (490.9-522.9) 545.2 (438.7- 676.7) 304.4 (247.9-369.8)




Delaware 568.3 (542.7- 595.0) 523.3 (500.1-547.2) 550.8 (523.6- 579.4) 554.1 (527.1-582.0) 688.7 (608.7- 779.0) 420.9 (374.4-471.5)
District of Columbia 667.1 (634.0- 701.5) 636.9 (605.6-669.3) 453.9 (407.4- 506.0) 408.6 (367.8-452.8) 758.7 (714.5- 805.3) 759.5 (715.5-805.5)
Florida 587.5 (582.3- 592.7) 688.2 (682.3-694.3) 582.1 (576.7- 587.5) 753.3 (746.4-760.2) 627.3 (606.4- 648.9) 359.4 (348.3-370.7)
Georgia
Atlanta 532.6 (515.7- 550.0) 334.7 (324.8-344.7) 479.0 (460.9- 497.7) 347.2 (334.8-359.9) 748.1 (701.3- 797.9) 316.9 (299.6-334.9)
Maryland 567.3 (557.0- 577.9) 475.2 (466.7-483.8) 542.2 (530.7- 553.8) 509.4 (498.8-520.1) 592.3 (567.6- 618.2) 364.7 (350.5-379.3)
North Carolina 499.5 (491.7- 507.4) 439.0 (432.3-445.8) 490.0 (481.5- 498.7) 468.8 (460.8-476.8) 551.5 (530.7- 573.1) 357.9 (344.8-371.4)
South Carolina 578.3 (566.4- 590.5) 508.2 (498.1-518.5) 557.5 (544.3- 571.0) 546.2 (533.6-559.0) 642.7 (615.4- 671.0) 414.7 (397.7-432.3)
Virginia
West Virginia 579.5 (563.7- 595.7) 600.0 (583.8-616.5) 570.5 (554.6- 586.8) 595.8 (579.4-612.6) 630.8 (529.6- 746.3) 510.7 (429.0-603.4)
East South Central
Alabama













Table 2.1.1: All Cancer Sites Combined. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 579.6 (568.1- 591.3) 480.7 (471.3-490.1) 556.9 (544.0- 570.2) 520.4 (508.6-532.5) 670.7 (645.1- 697.1) 414.0 (398.6-429.8)
Oklahoma
Texas
West 509.4 (506.5- 512.3) 416.7 (414.4-419.0) 507.4 (504.4- 510.5) 432.7 (430.1-435.3) 557.6 (542.3- 573.3) 340.6 (331.7-349.7)
Mountain
Arizona 458.9 (449.8- 468.1) 421.6 (413.3-429.9) 465.0 (455.6- 474.5) 453.0 (443.9-462.2) 457.9 (390.6- 536.5) 238.7 (207.7-273.0)
Colorado 503.1 (491.8- 514.7) 396.4 (387.7-405.1) 505.1 (493.4- 517.0) 407.1 (398.0-416.4) 424.6 (366.4- 492.3) 257.0 (225.0-292.4)
Idaho 503.6 (484.5- 523.3) 428.4 (412.3-444.9) 506.5 (487.2- 526.4) 436.8 (420.3-453.7) ∼ ∼
Montana 507.2 (485.9- 529.2) 495.5 (474.9-516.7) 487.8 (466.6- 509.7) 497.9 (476.5-520.1) ∼ ∼
Nevada
New Mexico 466.6 (450.9- 482.7) 402.7 (389.3-416.3) 478.9 (462.4- 495.9) 442.2 (427.1-457.6) 345.6 (259.2- 457.9) 241.5 (182.9-312.8)
Utah 490.7 (474.3- 507.6) 330.9 (320.1-342.1) 496.6 (479.9- 513.8) 341.6 (330.3-353.2) ∼ ∼
Wyoming 542.1 (510.5- 575.4) 475.7 (448.6-504.0) 543.8 (511.8- 577.4) 486.2 (458.2-515.5) ∼ ∼
Pacific 519.1 (515.7- 522.4) 420.2 (417.5-422.9) 516.2 (512.6- 519.9) 435.4 (432.4-438.5) 577.4 (560.8- 594.4) 356.7 (346.9-366.7)
Alaska 526.8 (489.5- 567.5) 306.2 (287.5-325.9) 501.8 (461.8- 545.8) 318.8 (297.0-341.8) 771.0 (484.9-1252.5) 260.9 (179.6-366.4)
California 506.3 (502.4- 510.2) 399.0 (395.9-402.0) 500.4 (496.2- 504.7) 412.5 (409.1-416.0) 577.2 (559.8- 595.1) 365.6 (355.0-376.4)
San Francisco-Oakland 521.1 (510.3- 532.0) 457.2 (447.8-466.7) 516.2 (503.6- 529.0) 484.9 (473.1-496.8) 554.0 (518.6- 591.5) 409.7 (384.3-436.4)
San Jose-Monterey 490.6 (475.8- 505.8) 366.3 (355.4-377.4) 480.4 (464.3- 497.0) 379.9 (367.3-392.8) 551.1 (440.2- 693.6) 229.6 (189.0-276.2)
Los Angeles 497.1 (489.5- 504.7) 367.8 (362.2-373.3) 490.1 (481.6- 498.7) 369.1 (362.8-375.5) 597.5 (571.7- 624.4) 433.9 (415.7-452.7)
Hawaii 478.0 (460.2- 496.3) 463.6 (446.4-481.3) 635.8 (593.2- 680.8) 506.0 (472.7-541.1) 297.3 (178.6- 478.4) 115.6 ( 72.4-175.0)
Oregon 556.5 (544.8- 568.5) 525.2 (514.2-536.5) 551.5 (539.6- 563.7) 535.8 (524.3-547.5) 617.8 (499.3- 761.7) 338.5 (278.0-408.3)
Washington 574.9 (565.3- 584.6) 486.8 (478.8-495.0) 565.0 (555.1- 575.0) 500.7 (492.0-509.5) 592.8 (526.6- 667.5) 313.2 (280.4-348.7)
Seattle-Puget Sound 590.9 (579.0- 603.0) 491.2 (481.4-501.1) 596.6 (584.1- 609.3) 523.7 (512.9-534.7) 630.9 (557.2- 714.4) 330.4 (294.5-369.5)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.1.2: All Cancer Sites Combined. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 420.1 (418.9- 421.2) 457.9 (456.7-459.2) 423.8 (422.5- 425.1) 487.4 (486.0-488.9) 381.7 (378.0- 385.4) 313.2 (310.2-316.3)
Northeast 438.6 (436.2- 441.0) 509.3 (506.6-512.1) 442.3 (439.7- 444.9) 543.5 (540.4-546.7) 367.9 (361.0- 375.0) 320.8 (314.8-326.9)
New England 454.3 (449.2- 459.4) 518.4 (512.7-524.2) 453.4 (448.1- 458.7) 540.2 (534.0-546.4) 361.0 (338.7- 384.5) 259.6 (244.0-275.9)
Connecticut 458.0 (448.4- 467.7) 532.3 (521.3-543.4) 457.1 (447.1- 467.3) 558.5 (546.5-570.7) 388.6 (354.3- 425.6) 306.9 (280.5-335.1)
Maine
Massachusetts 451.5 (444.5- 458.6) 516.0 (508.1-523.9) 449.6 (442.4- 456.9) 539.3 (530.9-547.9) 342.1 (311.2- 375.5) 230.7 (210.5-252.3)
New Hampshire 427.7 (411.5- 444.4) 437.1 (420.6-454.0) 424.7 (408.4- 441.4) 437.6 (420.9-454.7) ∼ ∼
Rhode Island 487.0 (469.2- 505.4) 584.3 (563.6-605.6) 495.7 (477.3- 514.8) 617.1 (594.9-639.9) 400.1 (294.7- 540.5) 229.0 (174.3-295.3)
Vermont
Middle Atlantic 434.1 (431.4- 436.8) 506.6 (503.5-509.7) 438.7 (435.7- 441.7) 544.7 (541.0-548.3) 368.7 (361.3- 376.1) 329.0 (322.5-335.6)
New Jersey 450.0 (444.0- 456.1) 513.3 (506.5-520.2) 463.3 (456.6- 470.0) 568.2 (560.1-576.4) 402.0 (384.8- 420.0) 335.0 (320.9-349.6)
New York 423.9 (419.9- 427.8) 479.0 (474.6-483.4) 431.5 (427.1- 436.0) 523.8 (518.5-529.1) 332.0 (322.9- 341.4) 297.8 (289.7-306.1)
Pennsylvania 438.5 (433.8- 443.3) 544.1 (538.3-549.9) 433.2 (428.2- 438.2) 557.7 (551.4-564.0) 436.5 (419.7- 453.9) 409.6 (393.9-425.9)
Midwest
East North Central
Illinois 426.2 (421.2- 431.2) 455.6 (450.3-460.9) 424.7 (419.3- 430.2) 480.4 (474.4-486.5) 415.5 (401.4- 430.0) 340.1 (328.7-351.9)
Indiana
Michigan 432.6 (427.1- 438.3) 459.5 (453.6-465.4) 431.0 (425.1- 437.1) 480.0 (473.4-486.7) 432.1 (415.9- 448.8) 361.4 (347.9-375.2)
Detroit 436.1 (427.6- 444.7) 472.7 (463.5-482.1) 435.7 (426.0- 445.6) 509.3 (498.0-520.8) 439.7 (421.1- 458.9) 388.2 (371.8-405.0)
Ohio 422.8 (417.8- 427.9) 472.3 (466.7-477.9) 417.8 (412.5- 423.1) 483.3 (477.2-489.4) 390.1 (374.4- 406.4) 337.6 (324.1-351.7)
Wisconsin 405.3 (398.0- 412.8) 443.6 (435.6-451.6) 403.3 (395.8- 411.0) 460.1 (451.6-468.7) 449.9 (403.9- 500.6) 264.3 (239.2-291.4)
West North Central 413.6 (409.6- 417.6) 460.6 (456.3-465.0) 409.5 (405.4- 413.6) 471.9 (467.3-476.6) 409.5 (390.0- 429.9) 308.1 (293.5-323.2)
Iowa 417.6 (407.9- 427.5) 499.5 (488.1-511.0) 415.3 (405.5- 425.3) 506.1 (494.5-517.9) 428.3 (339.2- 535.3) 291.3 (231.7-361.6)
Kansas 416.4 (406.0- 427.1) 460.8 (449.4-472.4) 411.6 (400.9- 422.5) 470.2 (458.2-482.5) 381.1 (333.0- 434.6) 292.2 (255.6-332.5)
Minnesota 422.8 (414.7- 430.9) 443.0 (434.7-451.5) 416.4 (408.3- 424.7) 454.0 (445.2-462.9) 405.0 (337.0- 485.0) 203.9 (172.3-239.6)
Missouri 410.6 (403.5- 417.8) 461.2 (453.3-469.2) 408.2 (400.7- 415.8) 477.7 (469.1-486.4) 421.4 (397.1- 446.8) 346.7 (326.9-367.4)
Nebraska 406.0 (393.1- 419.2) 456.8 (442.6-471.4) 398.2 (385.2- 411.6) 460.4 (445.6-475.5) 321.3 (252.2- 405.7) 222.9 (176.2-278.2)




Delaware 457.5 (437.0- 478.7) 489.3 (467.5-511.9) 459.3 (436.9- 482.7) 534.4 (508.5-561.3) 443.9 (390.0- 503.9) 329.7 (290.7-372.4)
District of Columbia 422.0 (399.7- 445.4) 495.6 (469.7-522.5) 392.5 (353.5- 436.9) 416.7 (376.3-460.3) 422.5 (395.1- 451.9) 525.9 (492.4-561.1)
Florida 441.6 (437.4- 445.8) 577.3 (572.0-582.7) 449.1 (444.6- 453.7) 639.7 (633.5-645.9) 377.0 (364.0- 390.4) 277.0 (267.7-286.5)
Georgia
Atlanta 405.1 (393.3- 417.3) 331.4 (321.9-341.2) 392.2 (378.7- 406.1) 369.0 (356.4-382.0) 452.1 (425.2- 480.6) 266.5 (251.6-282.0)
Maryland 415.2 (407.6- 423.0) 424.9 (417.1-432.9) 423.2 (414.2- 432.3) 482.4 (472.2-492.8) 382.7 (366.8- 399.2) 300.1 (288.0-312.6)
North Carolina 374.3 (368.5- 380.2) 403.5 (397.2-409.8) 383.1 (376.5- 389.8) 443.0 (435.5-450.7) 338.8 (325.9- 352.0) 294.5 (283.4-306.0)
South Carolina 377.8 (369.6- 386.2) 401.9 (393.2-410.8) 381.5 (371.9- 391.3) 444.6 (433.5-456.0) 358.7 (342.6- 375.4) 304.7 (291.1-318.8)
Virginia
West Virginia 432.5 (420.4- 444.8) 535.9 (521.2-551.0) 429.2 (417.0- 441.7) 534.5 (519.5-549.8) 419.2 (351.1- 497.8) 470.0 (395.7-554.3)
East South Central
Alabama












Table 2.1.2: All Cancer Sites Combined. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 391.0 (382.9- 399.1) 398.5 (390.4-406.8) 396.4 (386.8- 406.1) 450.7 (439.9-461.6) 382.1 (366.6- 398.1) 309.9 (297.5-322.7)
Oklahoma
Texas
West 405.0 (402.7- 407.3) 400.2 (397.9-402.4) 414.4 (411.9- 417.0) 424.1 (421.5-426.7) 368.2 (357.5- 379.2) 284.8 (276.6-293.1)
Mountain
Arizona 375.0 (367.5- 382.6) 396.0 (388.1-404.1) 385.4 (377.5- 393.5) 427.5 (418.7-436.3) 260.5 (218.8- 308.8) 173.2 (146.5-203.4)
Colorado 391.6 (383.0- 400.4) 382.2 (373.8-390.8) 394.2 (385.3- 403.4) 393.7 (384.7-402.7) 311.9 (268.2- 361.8) 230.4 (199.5-264.6)
Idaho 397.1 (381.5- 413.2) 393.8 (378.5-409.7) 400.3 (384.6- 416.7) 402.0 (386.2-418.3) ∼ ∼
Montana 385.4 (368.3- 403.3) 434.2 (415.1-454.1) 379.3 (361.9- 397.5) 444.1 (423.9-464.9) ∼ ∼
Nevada
New Mexico 361.4 (349.0- 374.3) 359.2 (346.8-371.9) 377.5 (364.2- 391.3) 395.9 (381.9-410.3) 157.8 (102.9- 233.7) 120.8 ( 79.6-175.7)
Utah 349.6 (337.1- 362.4) 278.2 (268.3-288.3) 354.2 (341.4- 367.4) 286.4 (276.2-297.0) ∼ ∼
Wyoming 387.8 (363.6- 413.5) 401.7 (376.7-428.0) 387.9 (363.4- 414.0) 408.7 (382.9-435.8) ∼ ∼
Pacific 414.8 (412.1- 417.6) 409.3 (406.7-412.0) 426.9 (423.9- 430.0) 436.6 (433.5-439.7) 381.7 (370.1- 393.6) 299.7 (290.7-308.9)
Alaska 437.5 (407.3- 469.9) 308.1 (288.4-328.8) 428.4 (394.3- 465.3) 316.3 (293.1-340.8) 255.0 (134.8- 498.2) 149.5 ( 87.1-239.3)
California 405.3 (402.2- 408.4) 392.9 (389.9-395.9) 418.8 (415.3- 422.3) 421.7 (418.2-425.2) 382.5 (370.4- 394.9) 307.8 (298.1-317.7)
San Francisco-Oakland 414.1 (405.6- 422.7) 447.3 (438.2-456.6) 444.7 (434.1- 455.4) 513.2 (501.2-525.5) 366.1 (341.0- 392.5) 322.8 (301.0-345.9)
San Jose-Monterey 398.3 (386.5- 410.3) 378.2 (367.0-389.6) 408.8 (395.5- 422.4) 408.0 (394.8-421.5) 302.1 (229.6- 393.4) 171.3 (133.6-216.5)
Los Angeles 385.9 (380.1- 391.8) 362.0 (356.6-367.5) 403.5 (396.6- 410.4) 384.2 (377.8-390.8) 376.7 (359.6- 394.3) 336.6 (321.4-352.3)
Hawaii 392.1 (376.9- 407.7) 430.9 (414.3-448.0) 444.0 (410.8- 479.5) 443.1 (410.3-477.9) 252.0 (147.1- 411.1) 148.2 ( 92.9-224.4)
Oregon 442.9 (433.3- 452.6) 493.5 (482.9-504.3) 445.3 (435.6- 455.3) 509.3 (498.2-520.6) 398.3 (314.7- 498.0) 268.3 (212.8-333.9)
Washington 455.2 (447.5- 463.0) 460.6 (452.8-468.5) 455.1 (447.0- 463.3) 478.6 (470.2-487.2) 383.2 (334.0- 438.7) 245.9 (215.6-279.2)
Seattle-Puget Sound 466.0 (456.6- 475.6) 469.3 (459.8-478.9) 476.7 (466.6- 486.9) 502.7 (492.1-513.5) 390.8 (337.4- 451.5) 244.8 (212.8-280.1)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.2.1: Cancer of the Oral Cavity and Pharynx. Invasive Cancer Incidence Rates by U.S. Census Region and
Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 15.8 ( 15.5- 16.0) 14.6 ( 14.4- 14.8) 15.2 ( 15.0- 15.5) 14.9 ( 14.6- 15.1) 19.2 ( 18.3- 20.2) 13.6 ( 12.9- 14.2)
Northeast 15.4 ( 14.9- 15.9) 14.9 ( 14.4- 15.4) 14.7 ( 14.1- 15.2) 15.0 ( 14.4- 15.5) 17.6 ( 15.9- 19.6) 12.8 ( 11.6- 14.2)
New England 16.0 ( 15.0- 17.2) 15.2 ( 14.2- 16.2) 15.6 ( 14.6- 16.8) 15.5 ( 14.4- 16.6) 20.8 ( 15.0- 29.0) 12.3 ( 9.0- 16.4)
Connecticut 16.0 ( 14.1- 18.1) 15.5 ( 13.6- 17.6) 15.4 ( 13.4- 17.6) 15.7 ( 13.7- 17.9) 23.0 ( 14.5- 37.0) 15.7 ( 10.0- 23.6)
Maine
Massachusetts 16.2 ( 14.7- 17.8) 15.3 ( 13.9- 16.8) 15.8 ( 14.3- 17.4) 15.7 ( 14.2- 17.3) 19.8 ( 11.7- 33.7) 10.2 ( 6.2- 15.7)
New Hampshire 15.2 ( 12.0- 19.2) 13.5 ( 10.7- 16.8) 15.1 ( 11.9- 19.1) 13.5 ( 10.7- 16.9) ∼ ∼
Rhode Island 16.1 ( 12.6- 20.2) 15.5 ( 12.2- 19.5) 16.1 ( 12.6- 20.5) 16.2 ( 12.7- 20.5) ∼ ∼
Vermont
Middle Atlantic 15.2 ( 14.6- 15.7) 14.8 ( 14.2- 15.4) 14.3 ( 13.7- 14.9) 14.8 ( 14.2- 15.4) 17.3 ( 15.5- 19.4) 12.9 ( 11.6- 14.4)
New Jersey 14.3 ( 13.1- 15.6) 13.7 ( 12.6- 14.9) 14.0 ( 12.8- 15.4) 14.3 ( 13.0- 15.7) 15.9 ( 12.3- 20.7) 12.1 ( 9.4- 15.4)
New York 15.3 ( 14.4- 16.2) 14.5 ( 13.7- 15.3) 14.4 ( 13.5- 15.3) 14.5 ( 13.6- 15.5) 15.2 ( 12.9- 17.8) 11.6 ( 9.9- 13.4)
Pennsylvania 15.5 ( 14.6- 16.6) 16.0 ( 14.9- 17.0) 14.5 ( 13.5- 15.6) 15.4 ( 14.4- 16.5) 23.9 ( 19.3- 29.5) 17.3 ( 14.0- 21.2)
Midwest
East North Central
Illinois 16.0 ( 15.0- 17.1) 14.4 ( 13.5- 15.4) 15.2 ( 14.1- 16.4) 14.3 ( 13.3- 15.4) 21.5 ( 18.0- 25.8) 15.6 ( 13.1- 18.4)
Indiana
Michigan 15.4 ( 14.2- 16.6) 14.1 ( 13.1- 15.2) 14.7 ( 13.5- 16.0) 14.0 ( 12.9- 15.2) 21.0 ( 17.1- 25.6) 15.7 ( 12.8- 19.1)
Detroit 16.3 ( 14.5- 18.4) 15.1 ( 13.4- 16.9) 14.3 ( 12.3- 16.5) 13.8 ( 12.0- 15.9) 25.1 ( 20.1- 31.1) 19.6 ( 15.8- 24.1)
Ohio 13.0 ( 12.0- 14.1) 12.2 ( 11.3- 13.2) 12.5 ( 11.5- 13.5) 12.1 ( 11.2- 13.2) 15.5 ( 12.0- 19.9) 11.3 ( 8.8- 14.2)
Wisconsin 17.2 ( 15.6- 19.0) 16.3 ( 14.7- 17.9) 16.5 ( 14.9- 18.2) 16.2 ( 14.6- 17.9) 43.4 ( 26.2- 71.6) 18.2 ( 11.9- 26.7)
West North Central 16.2 ( 15.3- 17.1) 15.2 ( 14.4- 16.0) 15.7 ( 14.9- 16.6) 15.3 ( 14.4- 16.2) 18.0 ( 13.6- 23.7) 11.8 ( 9.0- 15.2)
Iowa 16.7 ( 14.6- 19.0) 16.7 ( 14.6- 18.9) 16.6 ( 14.5- 18.9) 16.9 ( 14.7- 19.2) ∼ ∼
Kansas 16.4 ( 14.2- 18.9) 15.0 ( 13.0- 17.3) 15.5 ( 13.3- 18.0) 14.7 ( 12.6- 17.0) ∼ ∼
Minnesota 16.9 ( 15.2- 18.7) 15.1 ( 13.5- 16.7) 16.6 ( 14.9- 18.5) 15.5 ( 13.9- 17.2) ∼ ∼
Missouri 15.4 ( 13.9- 17.1) 14.8 ( 13.4- 16.3) 14.9 ( 13.3- 16.6) 14.8 ( 13.3- 16.5) 18.3 ( 12.9- 25.9) 13.2 ( 9.3- 18.1)
Nebraska 15.1 ( 12.4- 18.1) 14.2 ( 11.8- 17.1) 14.4 ( 11.8- 17.4) 14.0 ( 11.5- 16.9) ∼ ∼




Delaware 17.5 ( 13.3- 22.8) 16.6 ( 12.7- 21.4) 16.1 ( 11.8- 21.8) 16.4 ( 12.0- 21.8) ∼ ∼
District of Columbia 24.5 ( 18.7- 31.9) 24.6 ( 18.8- 31.7) ∼ ∼ 29.1 ( 21.1- 39.6) 29.4 ( 21.3- 39.6)
Florida 20.0 ( 19.1- 21.0) 22.3 ( 21.2- 23.4) 19.7 ( 18.7- 20.8) 23.9 ( 22.7- 25.2) 20.3 ( 16.9- 24.4) 12.7 ( 10.7- 15.0)
Georgia
Atlanta 13.4 ( 11.1- 16.3) 10.2 ( 8.5- 12.1) 11.4 ( 9.0- 14.6) 9.7 ( 7.7- 12.0) 20.3 ( 14.1- 29.8) 11.8 ( 8.7- 15.7)
Maryland 16.4 ( 14.8- 18.2) 14.8 ( 13.3- 16.4) 15.7 ( 13.8- 17.7) 15.4 ( 13.6- 17.4) 18.0 ( 14.3- 22.7) 13.3 ( 10.7- 16.3)
North Carolina 16.0 ( 14.6- 17.5) 14.5 ( 13.3- 15.7) 14.5 ( 13.1- 16.1) 14.1 ( 12.7- 15.5) 22.7 ( 19.0- 27.2) 16.9 ( 14.1- 20.0)
South Carolina 19.9 ( 17.9- 22.3) 18.6 ( 16.7- 20.6) 18.6 ( 16.4- 21.2) 19.2 ( 16.9- 21.7) 23.7 ( 19.0- 29.6) 17.1 ( 13.8- 20.9)
Virginia
West Virginia 16.3 ( 13.8- 19.2) 17.8 ( 15.1- 20.8) 15.5 ( 13.1- 18.4) 17.2 ( 14.5- 20.2) ∼ ∼
East South Central
Alabama












Table 2.2.1: Cancer of the Oral Cavity and Pharynx. Invasive Cancer Incidence Rates by U.S. Census Region and
Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 20.2 ( 18.2- 22.4) 17.8 ( 16.1- 19.7) 19.1 ( 16.8- 21.7) 18.6 ( 16.4- 21.0) 24.3 ( 19.9- 29.5) 17.0 ( 14.0- 20.4)
Oklahoma
Texas
West 14.4 ( 13.9- 14.9) 12.2 ( 11.8- 12.6) 14.6 ( 14.0- 15.1) 12.8 ( 12.3- 13.2) 13.6 ( 11.3- 16.2) 8.9 ( 7.5- 10.5)
Mountain
Arizona 12.1 ( 10.7- 13.7) 11.2 ( 9.9- 12.7) 12.3 ( 10.9- 14.0) 12.0 ( 10.6- 13.6) ∼ ∼
Colorado 11.2 ( 9.6- 13.1) 9.4 ( 8.1- 10.8) 11.4 ( 9.7- 13.3) 9.8 ( 8.4- 11.3) ∼ ∼
Idaho 14.5 ( 11.5- 18.1) 13.0 ( 10.3- 16.1) 14.5 ( 11.5- 18.2) 13.2 ( 10.5- 16.4) ∼ ∼
Montana 12.4 ( 9.4- 16.3) 13.0 ( 9.8- 16.8) 12.4 ( 9.3- 16.3) 13.5 ( 10.2- 17.6) ∼ ∼
Nevada
New Mexico 14.0 ( 11.4- 17.0) 12.5 ( 10.2- 15.1) 14.7 ( 12.0- 17.9) 13.9 ( 11.4- 16.9) ∼ ∼
Utah 10.5 ( 8.3- 13.3) 7.4 ( 5.8- 9.2) 10.7 ( 8.4- 13.6) 7.6 ( 6.0- 9.5) ∼ ∼
Wyoming 13.9 ( 9.2- 20.4) 12.4 ( 8.4- 17.8) 13.3 ( 8.7- 19.8) 12.1 ( 8.0- 17.5) ∼ ∼
Pacific 15.2 ( 14.6- 15.8) 12.8 ( 12.3- 13.3) 15.5 ( 14.8- 16.1) 13.4 ( 12.9- 14.0) 14.6 ( 12.2- 17.6) 9.7 ( 8.1- 11.4)
Alaska 17.4 ( 11.6- 27.1) 12.6 ( 9.0- 17.1) 12.5 ( 7.2- 23.1) 10.5 ( 6.8- 15.4) ∼ ∼
California 15.3 ( 14.6- 16.0) 12.5 ( 12.0- 13.1) 15.6 ( 14.8- 16.3) 13.1 ( 12.5- 13.7) 15.4 ( 12.8- 18.6) 10.5 ( 8.8- 12.5)
San Francisco-Oakland 16.3 ( 14.5- 18.3) 14.9 ( 13.2- 16.7) 16.4 ( 14.3- 18.9) 15.8 ( 13.8- 18.1) 14.2 ( 9.1- 21.8) 10.6 ( 6.9- 15.7)
San Jose-Monterey 14.0 ( 11.7- 16.8) 11.2 ( 9.3- 13.2) 13.6 ( 11.0- 16.6) 11.1 ( 9.1- 13.5) ∼ ∼
Los Angeles 13.9 ( 12.7- 15.2) 10.7 ( 9.8- 11.7) 14.1 ( 12.7- 15.6) 10.8 ( 9.7- 11.9) 16.4 ( 12.6- 21.3) 13.2 ( 10.2- 16.8)
Hawaii 13.7 ( 10.9- 17.2) 13.6 ( 10.7- 16.9) 16.8 ( 10.7- 25.4) 14.8 ( 9.6- 21.8) ∼ ∼
Oregon 16.4 ( 14.5- 18.6) 16.0 ( 14.1- 18.1) 16.7 ( 14.7- 18.9) 16.7 ( 14.7- 18.9) ∼ ∼
Washington 14.1 ( 12.7- 15.7) 12.5 ( 11.2- 13.9) 14.3 ( 12.8- 15.9) 13.2 ( 11.9- 14.7) ∼ ∼
Seattle-Puget Sound 14.5 ( 12.7- 16.4) 12.8 ( 11.3- 14.5) 15.2 ( 13.3- 17.3) 14.1 ( 12.4- 16.1) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.2.2: Cancer of the Oral Cavity and Pharynx. Invasive Cancer Incidence Rates by U.S. Census Region and
Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 6.3 ( 6.2- 6.5) 6.9 ( 6.7- 7.0) 6.2 ( 6.0- 6.3) 7.1 ( 7.0- 7.3) 6.3 ( 5.8- 6.8) 5.3 ( 4.9- 5.7)
Northeast 6.3 ( 6.0- 6.6) 7.3 ( 7.0- 7.7) 6.1 ( 5.8- 6.4) 7.6 ( 7.2- 7.9) 6.2 ( 5.3- 7.2) 5.5 ( 4.7- 6.3)
New England 7.1 ( 6.5- 7.8) 8.1 ( 7.4- 8.9) 7.1 ( 6.4- 7.8) 8.3 ( 7.6- 9.1) ∼ ∼
Connecticut 6.6 ( 5.5- 7.9) 7.9 ( 6.6- 9.3) 6.6 ( 5.5- 8.0) 8.2 ( 6.8- 9.8) ∼ ∼
Maine
Massachusetts 7.4 ( 6.6- 8.4) 8.4 ( 7.4- 9.5) 7.3 ( 6.4- 8.3) 8.7 ( 7.6- 9.8) ∼ ∼
New Hampshire 6.8 ( 4.9- 9.3) 6.7 ( 4.8- 9.1) 6.9 ( 4.9- 9.4) 6.9 ( 4.9- 9.3) ∼ ∼
Rhode Island 7.3 ( 5.3- 10.0) 8.7 ( 6.4- 11.7) 7.1 ( 5.1- 10.0) 8.7 ( 6.2- 11.8) ∼ ∼
Vermont
Middle Atlantic 6.1 ( 5.7- 6.4) 7.1 ( 6.7- 7.5) 5.8 ( 5.5- 6.2) 7.3 ( 6.9- 7.7) 6.3 ( 5.4- 7.3) 5.7 ( 4.9- 6.6)
New Jersey 7.1 ( 6.3- 7.9) 8.1 ( 7.2- 9.0) 6.9 ( 6.1- 7.8) 8.6 ( 7.6- 9.6) 7.7 ( 5.6- 10.5) 6.8 ( 5.0- 9.2)
New York 5.7 ( 5.3- 6.2) 6.4 ( 5.9- 7.0) 5.5 ( 5.0- 6.0) 6.7 ( 6.1- 7.3) 5.4 ( 4.3- 6.7) 4.8 ( 3.8- 6.0)
Pennsylvania 5.9 ( 5.4- 6.5) 7.5 ( 6.8- 8.2) 5.5 ( 5.0- 6.1) 7.3 ( 6.6- 8.1) 7.4 ( 5.3- 10.0) 6.9 ( 5.0- 9.3)
Midwest
East North Central
Illinois 6.5 ( 5.9- 7.1) 6.8 ( 6.2- 7.5) 6.3 ( 5.7- 7.1) 7.0 ( 6.3- 7.8) 6.8 ( 5.1- 8.8) 5.8 ( 4.4- 7.5)
Indiana
Michigan 6.6 ( 5.9- 7.3) 7.0 ( 6.3- 7.8) 6.5 ( 5.8- 7.3) 7.2 ( 6.5- 8.1) 6.2 ( 4.4- 8.5) 5.2 ( 3.7- 7.1)
Detroit 6.8 ( 5.7- 7.9) 7.3 ( 6.2- 8.5) 6.7 ( 5.5- 8.0) 7.9 ( 6.5- 9.4) 6.1 ( 4.1- 8.8) 5.5 ( 3.7- 7.8)
Ohio 5.9 ( 5.3- 6.5) 6.6 ( 6.0- 7.3) 5.8 ( 5.2- 6.4) 6.7 ( 6.0- 7.4) 6.1 ( 4.3- 8.5) 5.4 ( 3.8- 7.4)
Wisconsin 6.2 ( 5.3- 7.2) 6.7 ( 5.8- 7.8) 6.2 ( 5.3- 7.2) 7.0 ( 6.0- 8.1) ∼ ∼
West North Central 5.6 ( 5.1- 6.1) 6.3 ( 5.8- 6.8) 5.5 ( 5.0- 6.0) 6.4 ( 5.9- 7.0) 5.4 ( 3.4- 8.2) 4.2 ( 2.7- 6.3)
Iowa 5.0 ( 4.0- 6.2) 6.1 ( 4.9- 7.5) 5.0 ( 4.0- 6.2) 6.2 ( 5.0- 7.6) ∼ ∼
Kansas 5.4 ( 4.3- 6.7) 6.3 ( 5.0- 7.8) 5.3 ( 4.2- 6.7) 6.5 ( 5.1- 8.1) ∼ ∼
Minnesota 6.1 ( 5.2- 7.2) 6.4 ( 5.4- 7.4) 5.8 ( 4.9- 6.9) 6.3 ( 5.3- 7.4) ∼ ∼
Missouri 5.5 ( 4.7- 6.4) 6.1 ( 5.2- 7.1) 5.4 ( 4.6- 6.4) 6.3 ( 5.4- 7.4) ∼ ∼
Nebraska 6.3 ( 4.8- 8.2) 7.3 ( 5.6- 9.3) 6.2 ( 4.7- 8.1) 7.3 ( 5.5- 9.4) ∼ ∼




Delaware 5.8 ( 3.7- 8.8) 5.9 ( 3.8- 8.9) 6.5 ( 4.0- 10.1) 7.0 ( 4.3- 10.7) ∼ ∼
District of Columbia 6.4 ( 3.9- 10.2) 7.6 ( 4.7- 11.6) ∼ ∼ ∼ ∼
Florida 7.9 ( 7.4- 8.5) 10.3 ( 9.6- 11.0) 8.0 ( 7.4- 8.6) 11.3 ( 10.5- 12.2) 6.0 ( 4.5- 7.9) 4.8 ( 3.6- 6.2)
Georgia
Atlanta 6.2 ( 4.8- 7.9) 4.9 ( 3.8- 6.2) 6.4 ( 4.7- 8.4) 5.7 ( 4.2- 7.5) 5.0 ( 2.7- 9.0) 3.5 ( 2.0- 5.8)
Maryland 6.2 ( 5.3- 7.2) 6.3 ( 5.4- 7.3) 5.7 ( 4.7- 6.9) 6.5 ( 5.4- 7.9) 6.8 ( 4.8- 9.3) 5.3 ( 3.8- 7.2)
North Carolina 5.9 ( 5.2- 6.7) 6.4 ( 5.6- 7.2) 5.8 ( 5.0- 6.7) 6.8 ( 5.9- 7.8) 6.3 ( 4.6- 8.3) 5.5 ( 4.0- 7.2)
South Carolina 6.8 ( 5.7- 8.0) 7.2 ( 6.1- 8.5) 6.5 ( 5.3- 7.9) 7.7 ( 6.3- 9.3) 7.2 ( 5.1- 9.9) 6.3 ( 4.5- 8.6)
Virginia
West Virginia 5.8 ( 4.5- 7.4) 7.4 ( 5.7- 9.3) 5.9 ( 4.6- 7.6) 7.6 ( 5.9- 9.6) ∼ ∼
East South Central
Alabama













Table 2.2.2: Cancer of the Oral Cavity and Pharynx. Invasive Cancer Incidence Rates by U.S. Census Region and
Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 7.2 ( 6.2- 8.4) 7.4 ( 6.3- 8.6) 7.1 ( 5.9- 8.5) 8.1 ( 6.7- 9.7) 7.6 ( 5.6- 10.2) 6.4 ( 4.7- 8.4)
Oklahoma
Texas
West 6.1 ( 5.8- 6.4) 6.0 ( 5.8- 6.3) 6.0 ( 5.7- 6.3) 6.1 ( 5.8- 6.4) 6.1 ( 4.8- 7.7) 4.9 ( 3.9- 6.2)
Mountain
Arizona 5.7 ( 4.8- 6.8) 6.1 ( 5.1- 7.1) 5.9 ( 5.0- 7.0) 6.5 ( 5.5- 7.7) ∼ ∼
Colorado 4.5 ( 3.6- 5.5) 4.4 ( 3.5- 5.4) 4.3 ( 3.4- 5.4) 4.3 ( 3.4- 5.3) ∼ ∼
Idaho 5.2 ( 3.6- 7.3) 5.3 ( 3.6- 7.4) 5.3 ( 3.6- 7.5) 5.4 ( 3.7- 7.6) ∼ ∼
Montana 6.1 ( 4.2- 8.8) 7.2 ( 4.9- 10.2) 6.0 ( 4.0- 8.8) 7.3 ( 4.9- 10.4) ∼ ∼
Nevada
New Mexico 4.4 ( 3.1- 6.0) 4.4 ( 3.1- 6.0) 4.7 ( 3.3- 6.5) 5.0 ( 3.5- 6.8) ∼ ∼
Utah 4.8 ( 3.4- 6.5) 3.8 ( 2.7- 5.2) 4.8 ( 3.4- 6.6) 3.9 ( 2.8- 5.3) ∼ ∼
Wyoming 6.4 ( 3.7- 10.7) 6.7 ( 3.8- 10.9) ∼ ∼ ∼ ∼
Pacific 6.4 ( 6.1- 6.8) 6.3 ( 6.0- 6.7) 6.3 ( 5.9- 6.6) 6.4 ( 6.1- 6.8) 6.1 ( 4.7- 7.7) 5.0 ( 3.9- 6.3)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 6.3 ( 5.9- 6.7) 6.1 ( 5.7- 6.5) 6.2 ( 5.8- 6.6) 6.3 ( 5.8- 6.7) 6.2 ( 4.8- 8.0) 5.3 ( 4.1- 6.7)
San Francisco-Oakland 7.0 ( 5.9- 8.2) 7.6 ( 6.4- 8.9) 6.5 ( 5.3- 8.0) 7.5 ( 6.1- 9.1) ∼ ∼
San Jose-Monterey 5.0 ( 3.8- 6.6) 4.8 ( 3.6- 6.2) 4.6 ( 3.3- 6.3) 4.7 ( 3.4- 6.4) ∼ ∼
Los Angeles 5.9 ( 5.2- 6.6) 5.5 ( 4.9- 6.2) 5.7 ( 5.0- 6.6) 5.5 ( 4.8- 6.3) 6.4 ( 4.4- 9.1) 6.0 ( 4.1- 8.4)
Hawaii 8.8 ( 6.6- 11.4) 9.7 ( 7.3- 12.5) 12.7 ( 7.6- 20.2) 12.5 ( 7.5- 19.5) ∼ ∼
Oregon 6.5 ( 5.4- 7.8) 7.4 ( 6.2- 8.8) 6.4 ( 5.3- 7.7) 7.5 ( 6.2- 9.0) ∼ ∼
Washington 6.5 ( 5.6- 7.5) 6.6 ( 5.7- 7.6) 6.3 ( 5.3- 7.3) 6.6 ( 5.6- 7.7) ∼ ∼
Seattle-Puget Sound 6.5 ( 5.4- 7.7) 6.6 ( 5.5- 7.8) 6.4 ( 5.3- 7.7) 6.8 ( 5.6- 8.2) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.3.1: Cancer of the Esophagus. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 8.8 ( 8.6- 8.9) 7.9 ( 7.8- 8.1) 8.4 ( 8.2- 8.6) 8.1 ( 7.9- 8.3) 13.0 ( 12.2- 13.9) 8.3 ( 7.8- 8.8)
Northeast 9.2 ( 8.8- 9.6) 8.8 ( 8.4- 9.1) 8.8 ( 8.4- 9.2) 9.0 ( 8.6- 9.4) 13.2 ( 11.6- 15.1) 8.7 ( 7.6- 9.8)
New England 10.1 ( 9.3- 11.0) 9.5 ( 8.7- 10.3) 10.0 ( 9.1- 10.9) 9.8 ( 9.0- 10.8) 15.9 ( 10.4- 24.2) 7.8 ( 5.2- 11.2)
Connecticut 9.3 ( 7.8- 11.0) 9.0 ( 7.6- 10.6) 9.1 ( 7.6- 10.8) 9.3 ( 7.8- 11.1) ∼ ∼
Maine
Massachusetts 10.8 ( 9.6- 12.2) 10.1 ( 9.0- 11.3) 10.7 ( 9.5- 12.1) 10.5 ( 9.3- 11.8) ∼ ∼
New Hampshire 9.4 ( 6.9- 12.7) 8.1 ( 6.0- 10.8) 9.4 ( 6.8- 12.6) 8.1 ( 6.0- 10.8) ∼ ∼
Rhode Island 9.2 ( 6.7- 12.5) 9.2 ( 6.7- 12.4) 9.2 ( 6.6- 12.5) 9.6 ( 6.9- 13.0) ∼ ∼
Vermont
Middle Atlantic 8.9 ( 8.5- 9.3) 8.5 ( 8.1- 9.0) 8.5 ( 8.0- 8.9) 8.7 ( 8.2- 9.2) 13.0 ( 11.3- 14.9) 8.8 ( 7.7- 10.0)
New Jersey 8.6 ( 7.6- 9.6) 8.0 ( 7.2- 9.0) 8.5 ( 7.5- 9.5) 8.6 ( 7.6- 9.7) 12.2 ( 8.6- 17.0) 7.7 ( 5.6- 10.4)
New York 8.5 ( 7.9- 9.2) 7.9 ( 7.3- 8.5) 8.0 ( 7.3- 8.7) 8.0 ( 7.3- 8.7) 12.5 ( 10.3- 15.0) 8.6 ( 7.2- 10.2)
Pennsylvania 9.6 ( 8.8- 10.4) 9.8 ( 9.0- 10.7) 9.0 ( 8.3- 9.9) 9.7 ( 8.9- 10.6) 14.9 ( 11.2- 19.6) 10.4 ( 7.9- 13.5)
Midwest
East North Central
Illinois 10.1 ( 9.2- 11.0) 8.7 ( 8.0- 9.5) 9.4 ( 8.5- 10.3) 8.6 ( 7.8- 9.5) 16.2 ( 12.9- 20.2) 10.2 ( 8.2- 12.5)
Indiana
Michigan 10.3 ( 9.3- 11.3) 9.1 ( 8.3- 10.0) 10.2 ( 9.2- 11.3) 9.5 ( 8.6- 10.5) 11.8 ( 8.8- 15.6) 8.2 ( 6.1- 10.7)
Detroit 8.7 ( 7.3- 10.2) 7.8 ( 6.6- 9.2) 8.5 ( 7.0- 10.2) 8.1 ( 6.7- 9.7) 10.3 ( 7.2- 14.5) 7.9 ( 5.5- 10.9)
Ohio 10.2 ( 9.3- 11.1) 9.4 ( 8.6- 10.3) 9.9 ( 9.0- 10.9) 9.6 ( 8.8- 10.6) 12.2 ( 8.9- 16.6) 7.8 ( 5.8- 10.4)
Wisconsin 9.5 ( 8.3- 10.9) 8.7 ( 7.6- 9.9) 9.2 ( 8.0- 10.5) 8.8 ( 7.6- 10.0) ∼ ∼
West North Central 8.1 ( 7.5- 8.7) 7.5 ( 6.9- 8.1) 8.0 ( 7.3- 8.6) 7.7 ( 7.1- 8.3) 11.5 ( 7.9- 16.5) 6.9 ( 4.8- 9.6)
Iowa 8.6 ( 7.1- 10.3) 8.6 ( 7.1- 10.3) 8.3 ( 6.8- 10.0) 8.5 ( 7.0- 10.2) ∼ ∼
Kansas 6.9 ( 5.5- 8.6) 6.4 ( 5.1- 7.9) 6.4 ( 5.0- 8.0) 6.0 ( 4.7- 7.6) ∼ ∼
Minnesota 8.8 ( 7.6- 10.3) 7.7 ( 6.6- 8.9) 8.9 ( 7.7- 10.4) 8.1 ( 7.0- 9.4) ∼ ∼
Missouri 7.9 ( 6.8- 9.1) 7.4 ( 6.4- 8.5) 7.8 ( 6.7- 9.1) 7.6 ( 6.5- 8.8) 8.9 ( 5.1- 14.9) 5.9 ( 3.4- 9.4)
Nebraska 8.3 ( 6.4- 10.7) 7.9 ( 6.0- 10.0) 8.3 ( 6.4- 10.7) 8.1 ( 6.2- 10.4) ∼ ∼




Delaware 7.9 ( 5.3- 11.9) 7.6 ( 5.1- 11.0) 7.9 ( 5.0- 12.2) 8.4 ( 5.4- 12.5) ∼ ∼
District of Columbia 13.8 ( 9.5- 19.6) 13.5 ( 9.3- 19.0) ∼ ∼ 20.7 ( 14.0- 29.8) 21.2 ( 14.4- 30.1)
Florida 9.9 ( 9.2- 10.6) 11.4 ( 10.7- 12.2) 9.5 ( 8.8- 10.2) 12.2 ( 11.3- 13.1) 13.3 ( 10.5- 16.9) 7.8 ( 6.2- 9.6)
Georgia
Atlanta 8.0 ( 6.1- 10.6) 5.0 ( 3.9- 6.4) 5.9 ( 4.0- 8.5) 4.2 ( 3.0- 5.8) 16.8 ( 10.3- 26.9) 6.8 ( 4.5- 9.9)
Maryland 10.3 ( 9.0- 11.8) 8.7 ( 7.6- 9.9) 9.6 ( 8.2- 11.3) 9.1 ( 7.7- 10.6) 13.2 ( 9.9- 17.7) 8.5 ( 6.4- 11.0)
North Carolina 7.3 ( 6.4- 8.3) 6.4 ( 5.6- 7.3) 6.5 ( 5.5- 7.6) 6.2 ( 5.3- 7.2) 11.6 ( 8.8- 15.3) 7.6 ( 5.8- 9.8)
South Carolina 11.5 ( 9.9- 13.3) 10.5 ( 9.0- 12.0) 8.6 ( 7.0- 10.5) 8.4 ( 6.9- 10.2) 22.1 ( 17.6- 27.8) 15.8 ( 12.6- 19.5)
Virginia
West Virginia 7.8 ( 6.1- 10.0) 8.0 ( 6.3- 10.1) 7.6 ( 5.9- 9.8) 7.9 ( 6.1- 10.0) ∼ ∼
East South Central
Alabama













Table 2.3.1: Cancer of the Esophagus. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 9.7 ( 8.2- 11.3) 8.0 ( 6.9- 9.3) 8.3 ( 6.8- 10.1) 7.8 ( 6.4- 9.4) 14.3 ( 10.8- 18.8) 9.0 ( 6.8- 11.5)
Oklahoma
Texas
West 7.3 ( 6.9- 7.6) 5.9 ( 5.6- 6.2) 7.4 ( 7.1- 7.8) 6.3 ( 6.0- 6.6) 7.6 ( 5.9- 9.8) 4.4 ( 3.5- 5.6)
Mountain
Arizona 6.9 ( 5.8- 8.1) 6.3 ( 5.3- 7.4) 7.0 ( 5.9- 8.3) 6.8 ( 5.7- 8.0) ∼ ∼
Colorado 6.9 ( 5.6- 8.5) 5.0 ( 4.0- 6.0) 6.9 ( 5.5- 8.5) 5.1 ( 4.1- 6.3) ∼ ∼
Idaho 6.0 ( 4.1- 8.5) 5.3 ( 3.6- 7.4) 6.1 ( 4.2- 8.7) 5.4 ( 3.7- 7.6) ∼ ∼
Montana 12.4 ( 9.3- 16.3) 12.3 ( 9.2- 16.0) 12.0 ( 8.9- 16.0) 12.5 ( 9.3- 16.5) ∼ ∼
Nevada
New Mexico 7.7 ( 5.8- 10.1) 6.7 ( 5.0- 8.6) 8.2 ( 6.1- 10.7) 7.6 ( 5.7- 9.8) ∼ ∼
Utah 5.6 ( 4.0- 7.8) 3.9 ( 2.8- 5.2) 5.7 ( 4.0- 7.8) 4.0 ( 2.8- 5.4) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 7.4 ( 7.0- 7.8) 5.9 ( 5.6- 6.3) 7.6 ( 7.2- 8.1) 6.4 ( 6.0- 6.7) 7.7 ( 5.8- 10.0) 4.5 ( 3.4- 5.7)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 7.0 ( 6.6- 7.5) 5.5 ( 5.1- 5.8) 7.2 ( 6.7- 7.8) 5.9 ( 5.5- 6.3) 7.8 ( 5.8- 10.3) 4.6 ( 3.5- 6.0)
San Francisco-Oakland 7.8 ( 6.5- 9.3) 6.7 ( 5.6- 8.0) 8.1 ( 6.6- 9.9) 7.4 ( 6.0- 9.0) ∼ ∼
San Jose-Monterey 7.4 ( 5.7- 9.6) 5.4 ( 4.1- 6.9) 8.7 ( 6.6- 11.3) 6.7 ( 5.1- 8.6) ∼ ∼
Los Angeles 6.3 ( 5.5- 7.2) 4.6 ( 4.0- 5.2) 6.2 ( 5.3- 7.3) 4.6 ( 4.0- 5.4) 6.5 ( 4.0- 10.3) 4.5 ( 2.8- 6.7)
Hawaii 7.3 ( 5.3- 9.9) 7.1 ( 5.1- 9.6) ∼ ∼ ∼ ∼
Oregon 7.9 ( 6.5- 9.4) 7.3 ( 6.1- 8.8) 7.9 ( 6.5- 9.5) 7.6 ( 6.3- 9.1) ∼ ∼
Washington 9.1 ( 7.9- 10.4) 7.8 ( 6.8- 8.9) 9.2 ( 8.0- 10.6) 8.3 ( 7.2- 9.5) ∼ ∼
Seattle-Puget Sound 9.4 ( 8.0- 11.1) 8.0 ( 6.8- 9.4) 9.8 ( 8.3- 11.5) 8.8 ( 7.4- 10.3) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.3.2: Cancer of the Esophagus. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 2.2 ( 2.1- 2.2) 2.5 ( 2.4- 2.5) 2.0 ( 1.9- 2.1) 2.5 ( 2.4- 2.6) 3.6 ( 3.2- 4.0) 2.9 ( 2.6- 3.2)
Northeast 2.3 ( 2.1- 2.5) 2.8 ( 2.6- 3.0) 2.1 ( 1.9- 2.3) 2.8 ( 2.6- 3.0) 3.7 ( 3.1- 4.5) 3.3 ( 2.7- 4.0)
New England 2.5 ( 2.2- 3.0) 3.0 ( 2.6- 3.5) 2.3 ( 1.9- 2.7) 2.9 ( 2.5- 3.4) 5.4 ( 3.1- 9.2) 4.0 ( 2.3- 6.5)
Connecticut 3.1 ( 2.4- 4.0) 3.6 ( 2.8- 4.6) 2.5 ( 1.9- 3.4) 3.2 ( 2.4- 4.3) ∼ ∼
Maine
Massachusetts 2.2 ( 1.7- 2.7) 2.6 ( 2.1- 3.3) 1.9 ( 1.5- 2.5) 2.6 ( 2.0- 3.2) ∼ ∼
New Hampshire 2.6 ( 1.5- 4.3) 2.6 ( 1.5- 4.3) 2.6 ( 1.5- 4.3) 2.7 ( 1.5- 4.4) ∼ ∼
Rhode Island 3.2 ( 1.9- 5.1) 4.1 ( 2.5- 6.2) 3.1 ( 1.8- 5.1) 4.2 ( 2.6- 6.5) ∼ ∼
Vermont
Middle Atlantic 2.2 ( 2.1- 2.4) 2.8 ( 2.5- 3.0) 2.0 ( 1.9- 2.2) 2.8 ( 2.5- 3.0) 3.5 ( 2.8- 4.3) 3.2 ( 2.6- 3.9)
New Jersey 2.5 ( 2.1- 3.0) 3.0 ( 2.5- 3.6) 2.4 ( 1.9- 2.9) 3.2 ( 2.6- 3.9) 3.6 ( 2.2- 5.8) 3.0 ( 1.8- 4.7)
New York 2.4 ( 2.1- 2.7) 2.8 ( 2.5- 3.1) 2.1 ( 1.8- 2.4) 2.8 ( 2.4- 3.2) 3.6 ( 2.7- 4.7) 3.3 ( 2.5- 4.3)
Pennsylvania 1.9 ( 1.7- 2.3) 2.6 ( 2.2- 3.0) 1.8 ( 1.5- 2.2) 2.5 ( 2.1- 3.0) 3.2 ( 1.9- 5.1) 3.1 ( 1.8- 4.8)
Midwest
East North Central
Illinois 2.0 ( 1.7- 2.4) 2.2 ( 1.9- 2.6) 1.8 ( 1.5- 2.2) 2.1 ( 1.8- 2.6) 3.7 ( 2.5- 5.4) 2.9 ( 1.9- 4.1)
Indiana
Michigan 2.1 ( 1.7- 2.5) 2.3 ( 1.9- 2.7) 1.9 ( 1.5- 2.3) 2.2 ( 1.8- 2.7) 3.5 ( 2.2- 5.4) 2.8 ( 1.7- 4.3)
Detroit 2.1 ( 1.6- 2.8) 2.4 ( 1.7- 3.1) 1.8 ( 1.2- 2.5) 2.2 ( 1.5- 3.0) 3.6 ( 2.1- 5.9) 3.1 ( 1.8- 5.0)
Ohio 2.3 ( 2.0- 2.7) 2.7 ( 2.3- 3.2) 2.1 ( 1.7- 2.5) 2.5 ( 2.1- 3.0) 3.9 ( 2.4- 5.9) 3.2 ( 2.0- 4.8)
Wisconsin 2.3 ( 1.8- 2.9) 2.7 ( 2.1- 3.4) 2.2 ( 1.7- 2.8) 2.7 ( 2.0- 3.4) ∼ ∼
West North Central 1.8 ( 1.5- 2.0) 2.1 ( 1.8- 2.4) 1.7 ( 1.5- 2.0) 2.1 ( 1.8- 2.5) ∼ ∼
Iowa 1.6 ( 1.1- 2.4) 2.2 ( 1.5- 3.1) 1.7 ( 1.1- 2.4) 2.3 ( 1.5- 3.2) ∼ ∼
Kansas 1.5 ( 1.0- 2.3) 1.8 ( 1.1- 2.6) 1.6 ( 1.0- 2.4) 1.9 ( 1.2- 2.9) ∼ ∼
Minnesota 2.0 ( 1.5- 2.6) 2.3 ( 1.7- 3.0) 2.0 ( 1.5- 2.6) 2.4 ( 1.8- 3.1) ∼ ∼
Missouri 1.9 ( 1.4- 2.4) 2.2 ( 1.7- 2.8) 1.6 ( 1.2- 2.1) 2.0 ( 1.5- 2.6) ∼ ∼
Nebraska 1.5 ( 0.9- 2.5) 1.9 ( 1.1- 3.1) 1.6 ( 0.9- 2.6) 2.0 ( 1.1- 3.3) ∼ ∼




Delaware ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼
Florida 2.5 ( 2.2- 2.9) 3.6 ( 3.2- 4.0) 2.4 ( 2.1- 2.7) 3.8 ( 3.3- 4.3) 3.8 ( 2.6- 5.5) 2.6 ( 1.8- 3.7)
Georgia
Atlanta 2.5 ( 1.6- 3.7) 1.9 ( 1.2- 2.8) ∼ ∼ ∼ ∼
Maryland 2.5 ( 1.9- 3.1) 2.5 ( 2.0- 3.2) 2.3 ( 1.7- 3.0) 2.7 ( 1.9- 3.5) 3.3 ( 1.9- 5.3) 2.3 ( 1.4- 3.7)
North Carolina 1.8 ( 1.4- 2.3) 2.0 ( 1.6- 2.5) 1.5 ( 1.1- 2.0) 1.8 ( 1.4- 2.4) 3.2 ( 2.0- 4.8) 2.7 ( 1.7- 4.0)
South Carolina 2.7 ( 2.0- 3.5) 2.9 ( 2.2- 3.7) 1.5 ( 1.0- 2.3) 1.9 ( 1.2- 2.8) 6.1 ( 4.1- 8.7) 5.0 ( 3.4- 7.1)
Virginia
West Virginia 2.0 ( 1.3- 3.1) 2.6 ( 1.6- 3.8) 2.0 ( 1.3- 3.2) 2.6 ( 1.6- 3.8) ∼ ∼
East South Central
Alabama













Table 2.3.2: Cancer of the Esophagus. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 2.2 ( 1.6- 2.9) 2.2 ( 1.7- 3.0) 2.3 ( 1.6- 3.2) 2.7 ( 1.9- 3.7) ∼ ∼
Oklahoma
Texas
West 2.0 ( 1.8- 2.2) 2.0 ( 1.8- 2.2) 2.0 ( 1.9- 2.2) 2.2 ( 2.0- 2.3) 3.2 ( 2.3- 4.5) 2.4 ( 1.7- 3.2)
Mountain
Arizona 1.6 ( 1.2- 2.2) 1.8 ( 1.3- 2.4) 1.7 ( 1.2- 2.3) 2.0 ( 1.4- 2.7) ∼ ∼
Colorado 1.8 ( 1.2- 2.5) 1.7 ( 1.2- 2.4) 1.7 ( 1.2- 2.4) 1.7 ( 1.2- 2.4) ∼ ∼
Idaho ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼
Nevada
New Mexico ∼ ∼ ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 2.2 ( 2.0- 2.4) 2.2 ( 2.0- 2.4) 2.2 ( 2.0- 2.5) 2.4 ( 2.1- 2.6) 3.4 ( 2.3- 4.7) 2.5 ( 1.7- 3.5)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 2.2 ( 2.0- 2.4) 2.1 ( 1.9- 2.4) 2.2 ( 2.0- 2.5) 2.3 ( 2.1- 2.6) 3.6 ( 2.5- 5.1) 2.8 ( 1.9- 3.9)
San Francisco-Oakland 2.4 ( 1.8- 3.2) 2.6 ( 2.0- 3.4) 2.4 ( 1.7- 3.4) 3.0 ( 2.1- 4.0) ∼ ∼
San Jose-Monterey 2.4 ( 1.5- 3.5) 2.3 ( 1.5- 3.3) 2.5 ( 1.6- 3.8) 2.6 ( 1.6- 3.9) ∼ ∼
Los Angeles 1.8 ( 1.5- 2.3) 1.8 ( 1.4- 2.2) 1.9 ( 1.4- 2.4) 1.9 ( 1.5- 2.4) 3.3 ( 1.9- 5.5) 2.9 ( 1.7- 4.7)
Hawaii ∼ ∼ ∼ ∼ ∼ ∼
Oregon 2.4 ( 1.8- 3.2) 2.7 ( 2.0- 3.7) 2.4 ( 1.8- 3.3) 2.9 ( 2.1- 3.8) ∼ ∼
Washington 2.2 ( 1.7- 2.8) 2.2 ( 1.7- 2.8) 2.4 ( 1.8- 3.0) 2.5 ( 1.9- 3.2) ∼ ∼
Seattle-Puget Sound 2.4 ( 1.7- 3.1) 2.4 ( 1.7- 3.1) 2.6 ( 1.9- 3.5) 2.8 ( 2.0- 3.7) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.4.1: Cancer of the Stomach. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 11.0 ( 10.8- 11.3) 9.7 ( 9.5- 9.9) 10.0 ( 9.8- 10.2) 9.4 ( 9.2- 9.6) 17.5 ( 16.5- 18.6) 10.3 ( 9.7- 10.9)
Northeast 13.5 ( 13.0- 14.0) 12.6 ( 12.1- 13.0) 12.6 ( 12.1- 13.1) 12.5 ( 12.0- 13.0) 19.0 ( 16.9- 21.3) 11.5 ( 10.3- 12.8)
New England 12.2 ( 11.2- 13.2) 11.1 ( 10.2- 12.0) 11.6 ( 10.6- 12.6) 11.1 ( 10.2- 12.0) 20.9 ( 14.5- 30.0) 10.5 ( 7.4- 14.3)
Connecticut 13.0 ( 11.2- 15.0) 12.4 ( 10.7- 14.2) 12.4 ( 10.7- 14.5) 12.6 ( 10.8- 14.6) ∼ ∼
Maine
Massachusetts 12.1 ( 10.8- 13.5) 10.8 ( 9.7- 12.1) 11.2 ( 9.9- 12.6) 10.6 ( 9.4- 11.9) 25.7 ( 15.7- 41.5) 12.2 ( 7.8- 18.1)
New Hampshire 9.0 ( 6.6- 12.3) 7.8 ( 5.7- 10.4) 9.2 ( 6.7- 12.4) 8.0 ( 5.8- 10.6) ∼ ∼
Rhode Island 13.0 ( 9.9- 16.8) 12.6 ( 9.6- 16.2) 13.0 ( 9.8- 16.9) 13.3 ( 10.1- 17.2) ∼ ∼
Vermont
Middle Atlantic 13.9 ( 13.4- 14.5) 13.0 ( 12.5- 13.6) 12.9 ( 12.3- 13.5) 13.0 ( 12.4- 13.6) 18.8 ( 16.6- 21.2) 11.7 ( 10.4- 13.1)
New Jersey 14.9 ( 13.7- 16.3) 13.6 ( 12.4- 14.8) 14.5 ( 13.2- 15.9) 14.4 ( 13.1- 15.8) 20.2 ( 15.4- 26.4) 11.6 ( 9.0- 14.8)
New York 14.8 ( 13.9- 15.6) 13.2 ( 12.5- 14.0) 13.5 ( 12.6- 14.4) 13.1 ( 12.3- 14.0) 16.9 ( 14.2- 20.0) 10.4 ( 8.8- 12.1)
Pennsylvania 12.2 ( 11.3- 13.2) 12.4 ( 11.5- 13.3) 11.3 ( 10.4- 12.3) 12.0 ( 11.1- 13.0) 22.4 ( 17.8- 28.0) 15.3 ( 12.2- 19.0)
Midwest
East North Central
Illinois 11.1 ( 10.2- 12.1) 9.4 ( 8.6- 10.2) 10.1 ( 9.2- 11.1) 9.0 ( 8.2- 9.9) 16.1 ( 12.8- 20.2) 10.0 ( 8.0- 12.3)
Indiana
Michigan 10.9 ( 9.9- 12.0) 9.2 ( 8.3- 10.1) 10.1 ( 9.1- 11.3) 9.0 ( 8.1- 10.0) 15.6 ( 12.0- 20.1) 9.8 ( 7.6- 12.5)
Detroit 13.7 ( 11.9- 15.7) 11.4 ( 10.0- 13.0) 13.0 ( 11.1- 15.2) 11.7 ( 10.0- 13.6) 15.7 ( 11.5- 20.9) 10.9 ( 8.1- 14.4)
Ohio 9.3 ( 8.5- 10.3) 8.4 ( 7.6- 9.2) 8.2 ( 7.4- 9.2) 7.7 ( 6.9- 8.5) 18.1 ( 14.1- 23.2) 12.1 ( 9.5- 15.2)
Wisconsin 9.9 ( 8.7- 11.3) 8.9 ( 7.8- 10.2) 9.6 ( 8.4- 11.0) 9.1 ( 7.9- 10.4) ∼ ∼
West North Central 9.1 ( 8.4- 9.8) 8.3 ( 7.7- 8.9) 8.6 ( 8.0- 9.3) 8.2 ( 7.5- 8.8) 17.4 ( 12.5- 23.7) 9.0 ( 6.6- 12.1)
Iowa 9.2 ( 7.6- 10.9) 9.1 ( 7.6- 10.8) 9.2 ( 7.6- 10.9) 9.3 ( 7.7- 11.1) ∼ ∼
Kansas 9.6 ( 7.9- 11.6) 8.6 ( 7.1- 10.3) 9.0 ( 7.3- 11.0) 8.4 ( 6.8- 10.2) ∼ ∼
Minnesota 10.2 ( 8.9- 11.8) 8.7 ( 7.6- 10.0) 9.8 ( 8.4- 11.3) 8.7 ( 7.5- 10.0) ∼ ∼
Missouri 8.5 ( 7.4- 9.8) 7.8 ( 6.7- 8.9) 7.7 ( 6.6- 9.0) 7.4 ( 6.3- 8.6) 17.5 ( 11.7- 25.5) 10.7 ( 7.3- 15.3)
Nebraska 6.2 ( 4.5- 8.2) 5.8 ( 4.2- 7.7) 5.7 ( 4.1- 7.7) 5.5 ( 4.0- 7.4) ∼ ∼




Delaware 10.0 ( 6.9- 14.4) 9.3 ( 6.4- 13.0) 8.6 ( 5.5- 13.3) 8.7 ( 5.6- 12.9) ∼ ∼
District of Columbia 15.7 ( 10.9- 22.1) 14.3 ( 10.0- 19.9) ∼ ∼ 17.3 ( 11.1- 26.0) 17.1 ( 11.1- 25.2)
Florida 10.8 ( 10.1- 11.6) 12.6 ( 11.8- 13.4) 10.0 ( 9.3- 10.8) 12.9 ( 12.0- 13.8) 19.3 ( 15.7- 23.8) 10.2 ( 8.4- 12.3)
Georgia
Atlanta 9.2 ( 7.1- 11.9) 5.8 ( 4.6- 7.3) 6.3 ( 4.3- 9.1) 4.4 ( 3.1- 6.1) 15.1 ( 8.8- 25.2) 6.0 ( 3.9- 9.0)
Maryland 10.5 ( 9.1- 12.1) 8.3 ( 7.3- 9.6) 8.4 ( 7.0- 10.0) 7.8 ( 6.5- 9.2) 18.3 ( 13.7- 24.2) 9.2 ( 7.1- 11.8)
North Carolina 9.0 ( 8.0- 10.2) 7.6 ( 6.7- 8.5) 6.6 ( 5.7- 7.8) 6.2 ( 5.3- 7.2) 21.0 ( 16.9- 25.9) 12.7 ( 10.3- 15.4)
South Carolina 10.8 ( 9.2- 12.7) 9.2 ( 7.9- 10.7) 8.5 ( 6.9- 10.5) 7.9 ( 6.5- 9.6) 19.2 ( 14.8- 24.9) 12.4 ( 9.6- 15.8)
Virginia
West Virginia 8.1 ( 6.2- 10.3) 7.9 ( 6.2- 10.0) 8.1 ( 6.2- 10.4) 8.0 ( 6.2- 10.1) ∼ ∼
East South Central
Alabama













Table 2.4.1: Cancer of the Stomach. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 10.6 ( 9.1- 12.3) 8.6 ( 7.4- 9.9) 8.5 ( 7.0- 10.3) 7.9 ( 6.5- 9.5) 17.2 ( 13.2- 22.2) 10.0 ( 7.7- 12.7)
Oklahoma
Texas
West 10.6 ( 10.2- 11.0) 8.5 ( 8.1- 8.8) 9.4 ( 9.0- 9.9) 7.9 ( 7.5- 8.2) 13.9 ( 11.5- 16.9) 7.6 ( 6.3- 9.0)
Mountain
Arizona 8.5 ( 7.3- 9.9) 7.8 ( 6.7- 9.0) 8.4 ( 7.2- 9.8) 8.2 ( 7.0- 9.5) ∼ ∼
Colorado 7.9 ( 6.5- 9.6) 6.0 ( 4.9- 7.1) 7.6 ( 6.1- 9.2) 5.8 ( 4.8- 7.0) ∼ ∼
Idaho 7.6 ( 5.4- 10.6) 6.1 ( 4.3- 8.3) 7.3 ( 5.1- 10.3) 5.9 ( 4.2- 8.2) ∼ ∼
Montana 8.4 ( 5.9- 11.8) 8.2 ( 5.7- 11.3) 8.2 ( 5.7- 11.6) 8.3 ( 5.8- 11.7) ∼ ∼
Nevada
New Mexico 8.6 ( 6.6- 11.2) 7.2 ( 5.6- 9.3) 7.8 ( 5.8- 10.3) 7.0 ( 5.3- 9.2) ∼ ∼
Utah 8.0 ( 6.0- 10.6) 5.1 ( 3.8- 6.6) 7.9 ( 5.9- 10.5) 5.2 ( 3.8- 6.8) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 11.5 ( 11.0- 12.0) 9.1 ( 8.7- 9.5) 10.1 ( 9.6- 10.6) 8.4 ( 7.9- 8.8) 14.0 ( 11.4- 17.1) 7.9 ( 6.5- 9.5)
Alaska 13.4 ( 7.5- 23.8) 6.8 ( 4.2- 10.2) ∼ ∼ ∼ ∼
California 11.6 ( 11.0- 12.3) 9.0 ( 8.5- 9.4) 10.4 ( 9.8- 11.1) 8.5 ( 8.0- 9.0) 14.6 ( 11.8- 17.9) 8.6 ( 7.0- 10.4)
San Francisco-Oakland 12.3 ( 10.7- 14.1) 10.6 ( 9.2- 12.1) 10.0 ( 8.3- 11.9) 9.3 ( 7.7- 11.0) 20.4 ( 13.8- 29.6) 13.6 ( 9.3- 19.2)
San Jose-Monterey 11.6 ( 9.4- 14.2) 8.3 ( 6.8- 10.2) 8.4 ( 6.4- 11.0) 6.5 ( 4.9- 8.4) ∼ ∼
Los Angeles 14.8 ( 13.5- 16.2) 10.7 ( 9.8- 11.7) 13.4 ( 12.0- 14.9) 9.9 ( 8.9- 11.0) 12.6 ( 9.2- 17.3) 9.3 ( 6.8- 12.4)
Hawaii 21.0 ( 17.3- 25.1) 20.2 ( 16.7- 24.1) 13.9 ( 8.1- 22.4) 10.6 ( 6.3- 16.8) ∼ ∼
Oregon 8.6 ( 7.2- 10.3) 8.0 ( 6.7- 9.5) 8.1 ( 6.7- 9.8) 7.8 ( 6.4- 9.3) ∼ ∼
Washington 10.0 ( 8.8- 11.4) 8.4 ( 7.3- 9.5) 9.5 ( 8.3- 10.9) 8.4 ( 7.3- 9.6) ∼ ∼
Seattle-Puget Sound 11.2 ( 9.6- 13.0) 9.1 ( 7.8- 10.5) 10.3 ( 8.7- 12.1) 8.9 ( 7.5- 10.4) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.4.2: Cancer of the Stomach. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 5.1 ( 5.0- 5.2) 5.9 ( 5.7- 6.0) 4.4 ( 4.3- 4.6) 5.5 ( 5.3- 5.7) 9.1 ( 8.5- 9.7) 7.0 ( 6.6- 7.5)
Northeast 5.9 ( 5.6- 6.2) 7.4 ( 7.1- 7.7) 5.3 ( 5.1- 5.6) 7.3 ( 6.9- 7.6) 9.0 ( 8.0- 10.3) 7.5 ( 6.6- 8.5)
New England 5.3 ( 4.8- 5.8) 6.6 ( 6.0- 7.3) 5.1 ( 4.5- 5.6) 6.8 ( 6.1- 7.5) 7.7 ( 4.7- 12.2) 5.0 ( 3.1- 7.7)
Connecticut 6.2 ( 5.2- 7.4) 7.9 ( 6.6- 9.4) 6.0 ( 4.9- 7.2) 8.2 ( 6.8- 9.8) ∼ ∼
Maine
Massachusetts 4.8 ( 4.1- 5.5) 6.0 ( 5.2- 6.9) 4.6 ( 3.9- 5.3) 6.1 ( 5.2- 7.1) ∼ ∼
New Hampshire 4.0 ( 2.6- 5.9) 4.4 ( 2.9- 6.5) 3.9 ( 2.5- 5.8) 4.4 ( 2.9- 6.4) ∼ ∼
Rhode Island 6.6 ( 4.8- 9.0) 8.9 ( 6.5- 11.9) 6.4 ( 4.6- 9.0) 9.1 ( 6.6- 12.2) ∼ ∼
Vermont
Middle Atlantic 6.1 ( 5.8- 6.4) 7.6 ( 7.3- 8.0) 5.4 ( 5.1- 5.7) 7.4 ( 7.0- 7.9) 9.2 ( 8.0- 10.5) 7.8 ( 6.8- 8.9)
New Jersey 6.6 ( 5.9- 7.3) 8.0 ( 7.1- 8.9) 5.9 ( 5.2- 6.7) 8.0 ( 7.1- 9.1) 9.0 ( 6.5- 12.2) 7.2 ( 5.2- 9.6)
New York 6.6 ( 6.1- 7.1) 7.8 ( 7.3- 8.4) 5.7 ( 5.2- 6.2) 7.6 ( 7.0- 8.2) 9.0 ( 7.5- 10.7) 7.6 ( 6.4- 9.0)
Pennsylvania 5.2 ( 4.7- 5.7) 7.1 ( 6.5- 7.8) 4.8 ( 4.3- 5.3) 6.8 ( 6.2- 7.6) 9.5 ( 7.2- 12.4) 9.0 ( 6.8- 11.7)
Midwest
East North Central
Illinois 5.1 ( 4.6- 5.7) 5.8 ( 5.2- 6.4) 4.5 ( 4.0- 5.1) 5.5 ( 4.9- 6.2) 8.4 ( 6.5- 10.9) 6.4 ( 4.9- 8.2)
Indiana
Michigan 5.3 ( 4.7- 5.9) 5.8 ( 5.2- 6.6) 4.5 ( 3.9- 5.1) 5.3 ( 4.6- 6.1) 11.0 ( 8.5- 14.0) 8.8 ( 6.8- 11.2)
Detroit 6.7 ( 5.7- 7.8) 7.5 ( 6.4- 8.8) 5.7 ( 4.7- 6.9) 7.2 ( 5.9- 8.6) 10.0 ( 7.4- 13.4) 8.6 ( 6.3- 11.4)
Ohio 4.6 ( 4.1- 5.1) 5.4 ( 4.8- 6.1) 4.0 ( 3.6- 4.6) 5.1 ( 4.5- 5.7) 9.2 ( 6.9- 12.1) 7.6 ( 5.6- 9.9)
Wisconsin 3.5 ( 2.9- 4.3) 4.2 ( 3.4- 5.0) 3.4 ( 2.7- 4.1) 4.2 ( 3.4- 5.1) ∼ ∼
West North Central 3.5 ( 3.1- 3.8) 4.3 ( 3.9- 4.7) 3.3 ( 2.9- 3.6) 4.2 ( 3.8- 4.7) 4.9 ( 3.0- 7.7) 3.7 ( 2.2- 5.7)
Iowa 3.2 ( 2.4- 4.2) 4.1 ( 3.2- 5.3) 3.1 ( 2.4- 4.1) 4.2 ( 3.2- 5.4) ∼ ∼
Kansas 3.3 ( 2.5- 4.3) 4.0 ( 3.0- 5.2) 3.2 ( 2.3- 4.2) 4.0 ( 2.9- 5.3) ∼ ∼
Minnesota 4.1 ( 3.4- 4.9) 4.8 ( 4.0- 5.7) 4.0 ( 3.3- 4.9) 5.0 ( 4.1- 6.0) ∼ ∼
Missouri 3.2 ( 2.6- 3.9) 3.8 ( 3.1- 4.6) 2.8 ( 2.2- 3.5) 3.6 ( 2.8- 4.4) ∼ ∼
Nebraska 3.6 ( 2.5- 5.0) 4.7 ( 3.4- 6.4) 3.1 ( 2.1- 4.5) 4.3 ( 3.0- 6.0) ∼ ∼




Delaware 6.5 ( 4.3- 9.5) 7.2 ( 4.8- 10.5) 5.4 ( 3.3- 8.5) 6.7 ( 4.1- 10.3) ∼ ∼
District of Columbia 10.7 ( 7.5- 15.3) 13.4 ( 9.4- 18.4) ∼ ∼ 10.9 ( 7.1- 16.9) 14.9 ( 9.8- 21.9)
Florida 4.9 ( 4.5- 5.3) 6.9 ( 6.4- 7.5) 4.4 ( 3.9- 4.8) 6.9 ( 6.2- 7.5) 10.7 ( 8.5- 13.3) 7.0 ( 5.6- 8.7)
Georgia
Atlanta 5.5 ( 4.2- 7.2) 4.1 ( 3.1- 5.3) 4.4 ( 3.0- 6.2) 3.9 ( 2.7- 5.4) 8.9 ( 5.4- 14.1) 4.6 ( 2.9- 7.1)
Maryland 4.3 ( 3.5- 5.1) 4.4 ( 3.7- 5.3) 3.3 ( 2.5- 4.2) 4.0 ( 3.1- 5.0) 6.9 ( 4.9- 9.6) 5.1 ( 3.6- 6.9)
North Carolina 4.3 ( 3.7- 5.0) 4.7 ( 4.1- 5.5) 3.5 ( 2.9- 4.2) 4.2 ( 3.5- 5.0) 8.0 ( 6.1- 10.3) 6.8 ( 5.2- 8.8)
South Carolina 4.5 ( 3.7- 5.5) 4.9 ( 4.0- 5.9) 3.8 ( 2.9- 4.9) 4.5 ( 3.5- 5.8) 7.1 ( 4.9- 9.8) 5.8 ( 4.1- 8.1)
Virginia
West Virginia 3.5 ( 2.5- 4.8) 4.6 ( 3.3- 6.2) 3.5 ( 2.5- 4.8) 4.6 ( 3.3- 6.2) ∼ ∼
East South Central
Alabama













Table 2.4.2: Cancer of the Stomach. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 5.7 ( 4.8- 6.8) 5.9 ( 5.0- 7.0) 3.8 ( 2.9- 4.8) 4.5 ( 3.5- 5.7) 11.5 ( 8.9- 14.6) 8.9 ( 6.9- 11.3)
Oklahoma
Texas
West 5.4 ( 5.1- 5.6) 5.4 ( 5.1- 5.7) 4.5 ( 4.3- 4.8) 4.8 ( 4.5- 5.0) 10.2 ( 8.4- 12.2) 7.3 ( 6.0- 8.7)
Mountain
Arizona 3.8 ( 3.1- 4.6) 4.1 ( 3.4- 5.0) 3.5 ( 2.8- 4.3) 4.1 ( 3.3- 5.0) ∼ ∼
Colorado 4.5 ( 3.6- 5.5) 4.3 ( 3.4- 5.2) 4.2 ( 3.3- 5.2) 4.1 ( 3.2- 5.1) ∼ ∼
Idaho 3.7 ( 2.4- 5.6) 3.8 ( 2.5- 5.7) 3.8 ( 2.4- 5.7) 4.0 ( 2.5- 5.9) ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼
Nevada
New Mexico 6.0 ( 4.5- 7.9) 5.9 ( 4.4- 7.7) 5.4 ( 3.9- 7.3) 5.6 ( 4.1- 7.6) ∼ ∼
Utah 4.6 ( 3.3- 6.3) 3.6 ( 2.6- 5.0) 4.8 ( 3.4- 6.5) 3.8 ( 2.7- 5.2) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 5.8 ( 5.5- 6.1) 5.8 ( 5.5- 6.2) 4.7 ( 4.4- 5.1) 5.0 ( 4.7- 5.4) 10.3 ( 8.5- 12.6) 7.5 ( 6.2- 9.1)
Alaska 7.4 ( 4.0- 13.4) 5.4 ( 3.1- 8.8) ∼ ∼ ∼ ∼
California 6.1 ( 5.7- 6.5) 6.0 ( 5.7- 6.4) 5.2 ( 4.8- 5.6) 5.4 ( 5.0- 5.8) 10.5 ( 8.5- 12.9) 7.9 ( 6.4- 9.6)
San Francisco-Oakland 7.6 ( 6.5- 8.8) 8.4 ( 7.2- 9.8) 6.0 ( 4.9- 7.4) 7.4 ( 6.0- 9.0) 11.7 ( 7.5- 17.5) 10.0 ( 6.5- 14.7)
San Jose-Monterey 6.9 ( 5.5- 8.7) 6.6 ( 5.2- 8.3) 6.0 ( 4.5- 7.9) 6.2 ( 4.7- 8.1) ∼ ∼
Los Angeles 7.4 ( 6.6- 8.2) 7.1 ( 6.3- 7.9) 6.2 ( 5.4- 7.1) 6.1 ( 5.3- 7.0) 10.8 ( 8.0- 14.2) 9.1 ( 6.7- 12.0)
Hawaii 11.3 ( 8.9- 14.2) 12.7 ( 10.0- 15.9) ∼ ∼ ∼ ∼
Oregon 2.9 ( 2.2- 3.7) 3.3 ( 2.5- 4.3) 2.7 ( 2.0- 3.5) 3.3 ( 2.4- 4.3) ∼ ∼
Washington 4.6 ( 3.8- 5.4) 4.7 ( 3.9- 5.6) 3.8 ( 3.1- 4.6) 4.1 ( 3.4- 5.0) ∼ ∼
Seattle-Puget Sound 4.5 ( 3.6- 5.6) 4.6 ( 3.7- 5.7) 3.7 ( 2.9- 4.7) 4.0 ( 3.1- 5.1) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.5.1: Cancer of the Colon and Rectum. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 66.4 ( 65.9- 66.9) 58.6 ( 58.1- 59.0) 66.0 ( 65.4- 66.5) 62.1 ( 61.6- 62.6) 67.9 ( 65.9- 69.9) 41.2 ( 40.0- 42.3)
Northeast 72.6 ( 71.5- 73.7) 67.8 ( 66.8- 68.9) 72.8 ( 71.6- 74.0) 73.1 ( 71.9- 74.3) 63.1 ( 59.5- 67.0) 40.7 ( 38.4- 43.0)
New England 70.2 ( 67.9- 72.5) 64.4 ( 62.3- 66.5) 70.1 ( 67.8- 72.5) 67.9 ( 65.6- 70.2) 55.0 ( 44.4- 68.0) 28.9 ( 23.7- 35.0)
Connecticut 72.1 ( 67.9- 76.5) 68.4 ( 64.4- 72.6) 72.2 ( 67.9- 76.9) 72.9 ( 68.5- 77.5) 56.9 ( 40.8- 78.5) 31.5 ( 23.0- 42.0)
Maine
Massachusetts 70.0 ( 66.9- 73.3) 63.9 ( 61.0- 66.8) 69.7 ( 66.5- 73.0) 67.5 ( 64.5- 70.7) 56.9 ( 41.8- 77.4) 29.0 ( 21.9- 37.5)
New Hampshire 58.3 ( 51.6- 65.8) 47.4 ( 42.0- 53.3) 58.2 ( 51.4- 65.7) 47.8 ( 42.3- 53.8) ∼ ∼
Rhode Island 76.8 ( 69.0- 85.4) 74.7 ( 67.1- 82.8) 78.7 ( 70.6- 87.5) 80.3 ( 72.1- 89.2) ∼ ∼
Vermont
Middle Atlantic 73.3 ( 72.0- 74.6) 68.9 ( 67.7- 70.1) 73.7 ( 72.3- 75.1) 74.8 ( 73.4- 76.2) 64.0 ( 60.1- 68.1) 42.3 ( 39.9- 44.9)
New Jersey 77.0 ( 74.2- 80.0) 70.1 ( 67.5- 72.7) 78.3 ( 75.2- 81.5) 77.9 ( 74.8- 81.0) 73.0 ( 64.0- 83.2) 46.8 ( 41.3- 52.8)
New York 70.7 ( 68.8- 72.6) 63.5 ( 61.8- 65.1) 71.3 ( 69.3- 73.4) 70.2 ( 68.2- 72.2) 55.8 ( 51.0- 61.1) 36.2 ( 33.3- 39.4)
Pennsylvania 74.6 ( 72.4- 76.8) 76.3 ( 74.1- 78.6) 73.8 ( 71.5- 76.2) 79.1 ( 76.6- 81.5) 76.7 ( 68.1- 86.3) 54.4 ( 48.4- 60.9)
Midwest
East North Central
Illinois 71.3 ( 68.9- 73.7) 59.5 ( 57.5- 61.5) 70.6 ( 68.1- 73.2) 62.9 ( 60.6- 65.1) 72.7 ( 65.3- 80.9) 43.4 ( 39.1- 48.0)
Indiana
Michigan 62.5 ( 60.1- 65.1) 53.7 ( 51.7- 55.8) 61.5 ( 58.9- 64.1) 55.5 ( 53.3- 57.9) 71.1 ( 63.3- 79.7) 46.6 ( 41.5- 52.1)
Detroit 64.3 ( 60.5- 68.4) 55.6 ( 52.4- 59.0) 62.2 ( 57.9- 66.7) 57.3 ( 53.5- 61.4) 74.2 ( 65.0- 84.3) 53.3 ( 46.8- 60.4)
Ohio 70.8 ( 68.4- 73.2) 63.4 ( 61.3- 65.6) 69.3 ( 66.8- 71.8) 64.5 ( 62.2- 66.8) 69.5 ( 61.5- 78.5) 47.3 ( 42.0- 53.1)
Wisconsin 70.6 ( 67.2- 74.2) 63.6 ( 60.6- 66.8) 69.9 ( 66.5- 73.5) 66.1 ( 62.9- 69.4) 69.1 ( 47.5- 101.0) 28.0 ( 20.0- 38.2)
West North Central 68.9 ( 67.1- 70.8) 62.7 ( 61.1- 64.4) 68.3 ( 66.4- 70.1) 64.7 ( 62.9- 66.5) 77.4 ( 67.1- 89.1) 42.5 ( 37.0- 48.6)
Iowa 76.6 ( 72.1- 81.4) 75.9 ( 71.4- 80.6) 76.8 ( 72.2- 81.6) 77.8 ( 73.2- 82.7) ∼ ∼
Kansas 67.2 ( 62.6- 72.1) 60.3 ( 56.1- 64.6) 65.9 ( 61.2- 70.9) 61.4 ( 57.1- 66.0) 85.3 ( 58.8- 121.0) 44.8 ( 31.2- 62.3)
Minnesota 63.1 ( 59.7- 66.7) 53.8 ( 50.9- 56.8) 62.8 ( 59.4- 66.5) 56.1 ( 53.0- 59.3) ∼ ∼
Missouri 69.2 ( 65.9- 72.6) 63.2 ( 60.2- 66.3) 68.1 ( 64.7- 71.7) 65.3 ( 62.0- 68.6) 79.6 ( 66.9- 94.5) 49.9 ( 42.1- 58.8)
Nebraska 71.8 ( 65.8- 78.1) 66.1 ( 60.7- 71.9) 70.2 ( 64.2- 76.6) 67.1 ( 61.4- 73.1) ∼ ∼




Delaware 66.4 ( 57.6- 76.5) 58.4 ( 50.8- 66.8) 62.5 ( 53.3- 73.2) 60.3 ( 51.7- 70.0) 96.4 ( 67.0- 137.5) 55.1 ( 39.2- 75.3)
District of Columbia 66.1 ( 55.8- 77.9) 61.1 ( 51.7- 71.7) 50.7 ( 35.6- 72.2) 42.5 ( 30.1- 58.4) 75.6 ( 62.0- 91.6) 74.5 ( 61.2- 89.9)
Florida 72.9 ( 71.1- 74.8) 85.5 ( 83.4- 87.6) 72.1 ( 70.2- 74.0) 94.2 ( 91.7- 96.7) 77.8 ( 70.4- 85.9) 43.0 ( 39.2- 47.0)
Georgia
Atlanta 57.4 ( 51.7- 63.7) 33.0 ( 30.0- 36.3) 52.5 ( 46.4- 59.3) 35.6 ( 31.7- 39.8) 83.5 ( 67.3- 103.1) 30.5 ( 25.3- 36.4)
Maryland 63.2 ( 59.7- 66.9) 51.2 ( 48.5- 54.1) 61.3 ( 57.4- 65.4) 56.0 ( 52.5- 59.6) 65.4 ( 57.1- 74.8) 38.3 ( 33.8- 43.2)
North Carolina 53.4 ( 50.8- 56.1) 45.8 ( 43.7- 48.0) 52.7 ( 49.9- 55.6) 49.2 ( 46.6- 51.8) 57.6 ( 51.0- 65.1) 36.7 ( 32.6- 41.2)
South Carolina 64.3 ( 60.2- 68.5) 55.0 ( 51.7- 58.5) 62.2 ( 57.7- 67.0) 59.4 ( 55.3- 63.7) 68.2 ( 59.4- 78.2) 43.4 ( 38.0- 49.4)
Virginia
West Virginia 73.3 ( 67.6- 79.3) 73.8 ( 68.2- 79.7) 72.3 ( 66.6- 78.4) 73.8 ( 68.1- 79.8) ∼ ∼
East South Central
Alabama













Table 2.5.1: Cancer of the Colon and Rectum. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 70.5 ( 66.5- 74.7) 57.1 ( 53.9- 60.4) 69.1 ( 64.5- 73.9) 63.4 ( 59.3- 67.7) 77.3 ( 68.6- 86.9) 45.7 ( 40.6- 51.1)
Oklahoma
Texas
West 57.1 ( 56.1- 58.1) 45.4 ( 44.6- 46.2) 56.7 ( 55.7- 57.8) 47.1 ( 46.2- 47.9) 60.9 ( 55.7- 66.4) 35.4 ( 32.6- 38.4)
Mountain
Arizona 54.7 ( 51.6- 58.0) 49.4 ( 46.6- 52.3) 55.6 ( 52.3- 59.0) 53.4 ( 50.3- 56.6) 56.6 ( 33.0- 93.8) 26.9 ( 17.2- 40.0)
Colorado 54.8 ( 51.0- 58.9) 41.2 ( 38.4- 44.1) 54.8 ( 50.8- 58.9) 42.1 ( 39.2- 45.2) 39.3 ( 24.1- 65.3) 26.7 ( 17.1- 39.7)
Idaho 52.2 ( 46.1- 58.9) 43.3 ( 38.3- 48.8) 52.3 ( 46.1- 59.1) 44.1 ( 38.9- 49.7) ∼ ∼
Montana 63.3 ( 55.9- 71.6) 60.5 ( 53.5- 68.3) 59.7 ( 52.3- 67.9) 59.4 ( 52.2- 67.4) ∼ ∼
Nevada
New Mexico 53.5 ( 48.2- 59.2) 45.5 ( 41.1- 50.2) 54.9 ( 49.4- 61.0) 50.2 ( 45.2- 55.5) ∼ ∼
Utah 50.7 ( 45.4- 56.4) 32.9 ( 29.5- 36.5) 51.2 ( 45.8- 57.0) 33.9 ( 30.4- 37.7) ∼ ∼
Wyoming 65.9 ( 55.1- 78.5) 56.4 ( 47.3- 66.7) 67.1 ( 56.1- 80.0) 58.7 ( 49.2- 69.4) ∼ ∼
Pacific 58.0 ( 56.8- 59.1) 45.6 ( 44.7- 46.5) 57.4 ( 56.2- 58.7) 47.1 ( 46.1- 48.2) 62.9 ( 57.4- 68.9) 36.9 ( 33.8- 40.2)
Alaska 67.3 ( 54.0- 84.3) 36.0 ( 29.8- 43.1) 53.5 ( 40.6- 71.1) 31.0 ( 24.5- 38.8) ∼ ∼
California 57.1 ( 55.8- 58.4) 43.6 ( 42.6- 44.6) 56.8 ( 55.4- 58.3) 45.5 ( 44.4- 46.7) 64.0 ( 58.2- 70.5) 38.4 ( 35.1- 42.1)
San Francisco-Oakland 60.0 ( 56.3- 63.9) 51.0 ( 47.9- 54.2) 60.2 ( 55.9- 64.8) 55.4 ( 51.5- 59.5) 52.6 ( 41.6- 66.1) 35.6 ( 28.4- 44.1)
San Jose-Monterey 54.1 ( 49.2- 59.5) 39.1 ( 35.6- 42.8) 54.4 ( 49.0- 60.4) 41.2 ( 37.1- 45.6) 85.4 ( 44.6- 164.4) 36.9 ( 21.9- 58.3)
Los Angeles 56.8 ( 54.2- 59.4) 40.5 ( 38.7- 42.4) 55.6 ( 52.7- 58.6) 40.4 ( 38.4- 42.6) 68.5 ( 59.7- 78.5) 47.4 ( 41.5- 53.9)
Hawaii 61.8 ( 55.5- 68.7) 59.5 ( 53.4- 66.0) 59.3 ( 46.8- 74.4) 46.6 ( 36.9- 58.1) ∼ ∼
Oregon 56.7 ( 53.0- 60.7) 52.8 ( 49.3- 56.4) 56.3 ( 52.5- 60.3) 54.0 ( 50.3- 57.8) ∼ ∼
Washington 62.1 ( 58.9- 65.4) 51.1 ( 48.5- 53.8) 61.5 ( 58.2- 64.9) 53.1 ( 50.3- 56.0) 47.9 ( 31.2- 74.0) 27.4 ( 18.3- 39.3)
Seattle-Puget Sound 61.0 ( 57.2- 65.1) 49.2 ( 46.2- 52.4) 61.4 ( 57.3- 65.6) 52.4 ( 49.0- 55.9) 52.7 ( 34.0- 82.6) 30.1 ( 20.0- 43.5)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.5.2: Cancer of the Colon and Rectum. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 48.5 ( 48.1- 48.9) 55.3 ( 54.9- 55.7) 47.6 ( 47.2- 48.0) 58.4 ( 57.9- 58.9) 54.0 ( 52.6- 55.4) 42.5 ( 41.4- 43.6)
Northeast 53.2 ( 52.4- 54.0) 65.9 ( 64.9- 66.9) 52.6 ( 51.7- 53.4) 70.5 ( 69.4- 71.6) 53.2 ( 50.5- 56.0) 44.7 ( 42.5- 47.0)
New England 52.7 ( 51.0- 54.4) 64.7 ( 62.7- 66.7) 52.1 ( 50.3- 53.8) 67.7 ( 65.5- 69.9) 56.0 ( 47.2- 66.2) 37.3 ( 31.6- 43.8)
Connecticut 54.2 ( 51.1- 57.5) 68.0 ( 64.1- 72.0) 52.8 ( 49.6- 56.2) 71.1 ( 66.9- 75.5) 68.5 ( 54.2- 85.8) 50.7 ( 40.4- 63.0)
Maine
Massachusetts 51.2 ( 49.0- 53.6) 63.1 ( 60.4- 65.9) 50.8 ( 48.5- 53.2) 66.7 ( 63.7- 69.8) 47.3 ( 35.9- 61.5) 29.4 ( 22.5- 37.7)
New Hampshire 47.4 ( 42.2- 53.2) 50.2 ( 44.8- 56.2) 46.7 ( 41.5- 52.5) 50.0 ( 44.5- 56.0) ∼ ∼
Rhode Island 61.8 ( 55.8- 68.4) 80.9 ( 73.3- 89.0) 62.3 ( 56.2- 69.1) 85.6 ( 77.4- 94.3) ∼ ∼
Vermont
Middle Atlantic 53.3 ( 52.4- 54.3) 66.2 ( 65.1- 67.4) 52.7 ( 51.7- 53.7) 71.4 ( 70.1- 72.7) 52.9 ( 50.1- 55.8) 45.7 ( 43.3- 48.2)
New Jersey 52.6 ( 50.6- 54.6) 63.1 ( 60.8- 65.6) 52.7 ( 50.5- 54.9) 70.1 ( 67.3- 73.0) 55.9 ( 49.4- 63.1) 44.4 ( 39.3- 49.9)
New York 53.5 ( 52.1- 54.9) 63.5 ( 61.9- 65.1) 52.7 ( 51.2- 54.2) 69.2 ( 67.3- 71.2) 49.8 ( 46.2- 53.5) 43.1 ( 40.0- 46.3)
Pennsylvania 53.5 ( 51.9- 55.1) 72.6 ( 70.5- 74.7) 52.7 ( 51.1- 54.4) 75.1 ( 72.8- 77.4) 58.0 ( 51.9- 64.6) 54.2 ( 48.6- 60.4)
Midwest
East North Central
Illinois 50.4 ( 48.7- 52.1) 56.4 ( 54.6- 58.3) 48.9 ( 47.1- 50.7) 59.5 ( 57.3- 61.6) 57.2 ( 51.9- 62.8) 45.3 ( 41.2- 49.7)
Indiana
Michigan 47.2 ( 45.4- 49.0) 51.8 ( 49.9- 53.9) 45.8 ( 43.9- 47.7) 53.6 ( 51.5- 55.9) 54.1 ( 48.5- 60.3) 44.6 ( 40.0- 49.7)
Detroit 47.9 ( 45.1- 50.8) 53.4 ( 50.3- 56.6) 45.4 ( 42.4- 48.6) 56.1 ( 52.4- 60.0) 56.6 ( 50.0- 63.9) 49.4 ( 43.7- 55.6)
Ohio 50.0 ( 48.3- 51.7) 58.6 ( 56.7- 60.6) 48.3 ( 46.6- 50.1) 59.3 ( 57.2- 61.4) 55.5 ( 49.6- 61.9) 46.9 ( 41.9- 52.3)
Wisconsin 47.3 ( 44.8- 49.8) 55.1 ( 52.3- 58.0) 46.3 ( 43.9- 48.9) 56.9 ( 53.9- 60.0) 67.7 ( 49.6- 91.1) 34.0 ( 25.4- 44.6)
West North Central 48.9 ( 47.6- 50.3) 58.5 ( 56.9- 60.1) 48.3 ( 47.0- 49.7) 60.3 ( 58.7- 62.0) 55.1 ( 47.9- 63.0) 39.7 ( 34.5- 45.3)
Iowa 55.0 ( 51.7- 58.5) 72.6 ( 68.3- 77.1) 55.1 ( 51.7- 58.7) 74.3 ( 69.9- 78.9) ∼ ∼
Kansas 48.0 ( 44.6- 51.6) 57.0 ( 53.1- 61.2) 46.9 ( 43.4- 50.5) 58.1 ( 53.9- 62.5) 58.6 ( 40.5- 82.5) 43.2 ( 29.9- 60.4)
Minnesota 45.5 ( 43.0- 48.2) 50.6 ( 47.8- 53.5) 44.6 ( 42.1- 47.3) 52.1 ( 49.2- 55.2) 64.2 ( 38.0- 103.9) 27.7 ( 16.9- 42.8)
Missouri 48.9 ( 46.6- 51.4) 58.4 ( 55.6- 61.3) 48.3 ( 45.8- 50.8) 60.8 ( 57.7- 63.9) 54.6 ( 46.0- 64.4) 43.8 ( 36.9- 51.6)
Nebraska 50.7 ( 46.4- 55.4) 61.6 ( 56.4- 67.1) 50.5 ( 46.0- 55.2) 63.3 ( 57.9- 69.1) ∼ ∼




Delaware 54.4 ( 47.6- 62.0) 59.7 ( 52.3- 67.9) 51.6 ( 44.4- 59.7) 62.6 ( 53.9- 72.2) 79.9 ( 57.3- 109.1) 54.9 ( 39.8- 74.0)
District of Columbia 55.3 ( 47.7- 64.2) 68.6 ( 59.2- 79.1) 34.3 ( 23.8- 51.0) 39.7 ( 28.0- 54.8) 66.1 ( 55.9- 78.4) 86.1 ( 72.9-101.1)
Florida 53.0 ( 51.6- 54.4) 75.3 ( 73.4- 77.3) 52.1 ( 50.6- 53.5) 82.7 ( 80.5- 85.0) 58.1 ( 52.9- 63.7) 40.1 ( 36.6- 43.8)
Georgia
Atlanta 43.5 ( 39.6- 47.7) 33.4 ( 30.4- 36.6) 38.4 ( 34.2- 43.0) 35.1 ( 31.3- 39.2) 65.5 ( 55.0- 77.6) 33.2 ( 28.1- 39.0)
Maryland 45.6 ( 43.1- 48.2) 47.3 ( 44.7- 49.9) 42.6 ( 39.9- 45.5) 51.9 ( 48.6- 55.4) 50.1 ( 44.2- 56.5) 36.1 ( 32.0- 40.6)
North Carolina 42.1 ( 40.2- 44.1) 46.6 ( 44.5- 48.7) 41.0 ( 38.9- 43.2) 49.5 ( 46.9- 52.1) 47.5 ( 42.7- 52.6) 40.6 ( 36.5- 44.9)
South Carolina 44.1 ( 41.3- 47.0) 47.5 ( 44.5- 50.6) 41.2 ( 38.1- 44.4) 49.6 ( 45.9- 53.4) 51.4 ( 45.4- 58.1) 42.6 ( 37.6- 48.1)
Virginia
West Virginia 52.2 ( 48.2- 56.5) 68.4 ( 63.2- 73.9) 52.0 ( 47.9- 56.4) 68.6 ( 63.3- 74.2) 61.0 ( 36.7- 96.8) 66.7 ( 40.7-103.0)
East South Central
Alabama













Table 2.5.2: Cancer of the Colon and Rectum. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 47.5 ( 44.8- 50.4) 49.1 ( 46.2- 52.0) 46.5 ( 43.3- 49.9) 54.6 ( 50.9- 58.5) 50.6 ( 45.0- 56.8) 39.8 ( 35.4- 44.5)
Oklahoma
Texas
West 42.5 ( 41.7- 43.2) 42.7 ( 41.9- 43.4) 41.8 ( 41.1- 42.6) 44.3 ( 43.4- 45.1) 52.7 ( 48.5- 57.1) 37.8 ( 34.9- 40.9)
Mountain
Arizona 40.0 ( 37.6- 42.5) 43.7 ( 41.1- 46.4) 41.0 ( 38.5- 43.6) 47.6 ( 44.7- 50.6) 33.6 ( 19.2- 55.5) 19.8 ( 11.5- 31.6)
Colorado 39.4 ( 36.6- 42.3) 37.5 ( 34.9- 40.3) 39.0 ( 36.2- 41.9) 38.3 ( 35.5- 41.2) 45.3 ( 29.1- 68.3) 31.1 ( 20.5- 45.2)
Idaho 38.7 ( 34.0- 43.9) 39.9 ( 35.1- 45.2) 38.7 ( 34.0- 43.9) 40.5 ( 35.6- 45.9) ∼ ∼
Montana 41.9 ( 36.4- 48.0) 49.1 ( 42.8- 56.1) 40.0 ( 34.6- 46.1) 49.2 ( 42.7- 56.5) ∼ ∼
Nevada
New Mexico 32.3 ( 28.7- 36.3) 32.1 ( 28.5- 36.1) 34.2 ( 30.3- 38.5) 36.2 ( 32.1- 40.8) ∼ ∼
Utah 35.4 ( 31.5- 39.7) 27.7 ( 24.6- 31.0) 35.6 ( 31.6- 39.9) 28.4 ( 25.3- 31.9) ∼ ∼
Wyoming 48.4 ( 40.1- 58.1) 50.7 ( 42.1- 60.6) 48.1 ( 39.8- 57.9) 51.6 ( 42.7- 61.8) ∼ ∼
Pacific 43.8 ( 42.9- 44.7) 44.0 ( 43.2- 44.9) 43.0 ( 42.0- 43.9) 45.7 ( 44.7- 46.7) 54.7 ( 50.2- 59.5) 40.0 ( 36.7- 43.4)
Alaska 49.6 ( 39.0- 62.5) 29.6 ( 23.7- 36.5) 38.6 ( 27.8- 52.8) 22.4 ( 16.6- 29.7) ∼ ∼
California 42.9 ( 41.9- 43.9) 42.4 ( 41.4- 43.4) 42.3 ( 41.2- 43.4) 44.3 ( 43.2- 45.5) 55.2 ( 50.5- 60.2) 41.7 ( 38.2- 45.4)
San Francisco-Oakland 45.9 ( 43.2- 48.8) 51.3 ( 48.2- 54.5) 44.8 ( 41.6- 48.2) 55.5 ( 51.6- 59.6) 55.4 ( 45.8- 66.6) 46.7 ( 38.7- 56.0)
San Jose-Monterey 38.4 ( 34.8- 42.3) 36.5 ( 33.1- 40.2) 38.8 ( 34.8- 43.1) 39.6 ( 35.6- 44.0) ∼ ∼
Los Angeles 42.2 ( 40.3- 44.1) 40.1 ( 38.3- 41.9) 40.9 ( 38.8- 43.2) 40.6 ( 38.5- 42.7) 52.5 ( 46.1- 59.4) 45.4 ( 40.0- 51.4)
Hawaii 48.0 ( 42.9- 53.6) 54.0 ( 48.3- 60.3) 43.5 ( 33.7- 55.6) 44.1 ( 34.2- 56.0) ∼ ∼
Oregon 48.4 ( 45.3- 51.6) 56.5 ( 52.9- 60.2) 48.1 ( 45.0- 51.3) 58.1 ( 54.4- 62.0) ∼ ∼
Washington 44.3 ( 42.0- 46.8) 45.9 ( 43.4- 48.4) 43.2 ( 40.8- 45.7) 47.1 ( 44.5- 49.8) 53.0 ( 34.6- 78.5) 27.9 ( 18.4- 40.6)
Seattle-Puget Sound 45.7 ( 42.8- 48.7) 46.7 ( 43.7- 49.8) 45.4 ( 42.4- 48.6) 49.5 ( 46.2- 52.9) 59.8 ( 39.0- 88.9) 31.3 ( 20.6- 45.6)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.6.1: Cancer of the Liver and Intrahepatic Bile Duct. Invasive Cancer Incidence Rates by U.S. Census Region
and Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 7.0 ( 6.9- 7.2) 6.4 ( 6.3- 6.6) 6.1 ( 5.9- 6.3) 5.9 ( 5.7- 6.0) 9.6 ( 8.9- 10.4) 6.5 ( 6.1- 7.0)
Northeast 7.8 ( 7.4- 8.2) 7.5 ( 7.2- 7.9) 6.8 ( 6.5- 7.2) 6.9 ( 6.6- 7.3) 11.1 ( 9.7- 12.7) 7.9 ( 6.9- 9.0)
New England 6.9 ( 6.2- 7.7) 6.5 ( 5.9- 7.2) 6.3 ( 5.7- 7.1) 6.2 ( 5.6- 7.0) 13.0 ( 8.5- 20.2) 7.5 ( 5.0- 10.8)
Connecticut 7.5 ( 6.2- 9.1) 7.3 ( 6.0- 8.7) 6.8 ( 5.5- 8.3) 6.9 ( 5.6- 8.4) ∼ ∼
Maine
Massachusetts 6.8 ( 5.8- 7.8) 6.4 ( 5.5- 7.3) 6.2 ( 5.3- 7.3) 6.2 ( 5.3- 7.2) ∼ ∼
New Hampshire 6.1 ( 4.2- 8.8) 5.4 ( 3.7- 7.6) 6.0 ( 4.1- 8.7) 5.4 ( 3.6- 7.6) ∼ ∼
Rhode Island 6.5 ( 4.4- 9.4) 6.3 ( 4.2- 9.0) 5.7 ( 3.7- 8.6) 5.7 ( 3.7- 8.4) ∼ ∼
Vermont
Middle Atlantic 8.1 ( 7.7- 8.5) 7.8 ( 7.4- 8.2) 7.0 ( 6.5- 7.4) 7.2 ( 6.7- 7.6) 10.9 ( 9.4- 12.6) 8.0 ( 6.9- 9.1)
New Jersey 7.0 ( 6.1- 7.9) 6.5 ( 5.7- 7.3) 6.4 ( 5.5- 7.4) 6.4 ( 5.5- 7.3) 9.8 ( 6.8- 14.0) 6.9 ( 4.9- 9.4)
New York 9.2 ( 8.5- 9.8) 8.6 ( 7.9- 9.2) 8.1 ( 7.4- 8.8) 8.1 ( 7.4- 8.8) 9.3 ( 7.5- 11.5) 6.7 ( 5.5- 8.2)
Pennsylvania 7.3 ( 6.6- 8.0) 7.6 ( 6.9- 8.3) 5.9 ( 5.3- 6.6) 6.4 ( 5.7- 7.1) 16.6 ( 12.9- 21.3) 12.6 ( 9.8- 15.9)
Midwest
East North Central
Illinois 7.4 ( 6.7- 8.2) 6.5 ( 5.8- 7.2) 6.3 ( 5.6- 7.1) 5.8 ( 5.2- 6.6) 12.5 ( 9.6- 16.1) 7.8 ( 6.0- 9.9)
Indiana
Michigan 8.1 ( 7.2- 9.0) 7.2 ( 6.4- 8.0) 7.6 ( 6.7- 8.5) 7.0 ( 6.2- 7.9) 10.4 ( 7.6- 14.0) 7.3 ( 5.4- 9.6)
Detroit 8.9 ( 7.6- 10.5) 8.0 ( 6.8- 9.3) 8.3 ( 6.8- 10.0) 7.8 ( 6.4- 9.4) 10.7 ( 7.5- 15.0) 8.1 ( 5.7- 11.1)
Ohio 5.6 ( 4.9- 6.3) 5.1 ( 4.5- 5.7) 4.7 ( 4.1- 5.4) 4.4 ( 3.8- 5.1) 11.8 ( 8.8- 15.9) 8.5 ( 6.3- 11.1)
Wisconsin 5.9 ( 5.0- 7.0) 5.5 ( 4.6- 6.4) 5.9 ( 4.9- 7.0) 5.6 ( 4.7- 6.7) ∼ ∼
West North Central 5.1 ( 4.6- 5.6) 4.7 ( 4.3- 5.2) 4.5 ( 4.0- 5.0) 4.4 ( 3.9- 4.8) 12.0 ( 8.4- 17.0) 7.7 ( 5.5- 10.5)
Iowa 5.3 ( 4.1- 6.7) 5.2 ( 4.1- 6.6) 4.9 ( 3.8- 6.3) 5.0 ( 3.9- 6.3) ∼ ∼
Kansas 4.7 ( 3.5- 6.1) 4.3 ( 3.2- 5.6) 4.4 ( 3.3- 5.9) 4.2 ( 3.1- 5.5) ∼ ∼
Minnesota 5.1 ( 4.2- 6.2) 4.6 ( 3.8- 5.6) 4.3 ( 3.4- 5.3) 4.0 ( 3.2- 4.9) ∼ ∼
Missouri 5.3 ( 4.4- 6.3) 5.0 ( 4.2- 5.9) 4.5 ( 3.7- 5.5) 4.4 ( 3.6- 5.4) 12.4 ( 7.9- 19.2) 8.3 ( 5.3- 12.4)
Nebraska 4.8 ( 3.4- 6.6) 4.5 ( 3.2- 6.3) 4.5 ( 3.1- 6.4) 4.5 ( 3.1- 6.2) ∼ ∼




Delaware 4.8 ( 2.7- 8.3) 4.4 ( 2.5- 7.1) ∼ ∼ ∼ ∼
District of Columbia 11.9 ( 7.9- 17.4) 11.9 ( 8.0- 17.1) ∼ ∼ 14.7 ( 9.2- 22.8) 15.0 ( 9.4- 22.8)
Florida 7.1 ( 6.5- 7.7) 8.1 ( 7.5- 8.8) 6.6 ( 6.0- 7.2) 8.4 ( 7.7- 9.1) 9.7 ( 7.4- 12.9) 6.1 ( 4.7- 7.7)
Georgia
Atlanta 5.9 ( 4.2- 8.1) 3.7 ( 2.8- 5.0) 4.1 ( 2.5- 6.5) 2.7 ( 1.7- 4.0) ∼ ∼
Maryland 6.0 ( 4.9- 7.2) 4.9 ( 4.1- 5.9) 5.0 ( 3.9- 6.3) 4.5 ( 3.5- 5.6) 7.4 ( 5.0- 11.0) 5.0 ( 3.4- 6.9)
North Carolina 4.2 ( 3.5- 5.0) 3.8 ( 3.2- 4.5) 4.0 ( 3.3- 4.9) 3.9 ( 3.2- 4.7) 4.5 ( 2.9- 7.0) 3.3 ( 2.2- 4.8)
South Carolina 5.3 ( 4.3- 6.7) 4.7 ( 3.8- 5.8) 5.1 ( 3.9- 6.6) 5.0 ( 3.9- 6.4) 5.5 ( 3.3- 8.9) 3.9 ( 2.4- 6.0)
Virginia
West Virginia 5.5 ( 4.1- 7.4) 5.5 ( 4.1- 7.3) 5.1 ( 3.7- 7.0) 5.1 ( 3.7- 6.9) ∼ ∼
East South Central
Alabama













Table 2.6.1: Cancer of the Liver and Intrahepatic Bile Duct. Invasive Cancer Incidence Rates by U.S. Census Region
and Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 7.6 ( 6.4- 9.1) 6.3 ( 5.3- 7.4) 7.7 ( 6.2- 9.5) 6.8 ( 5.5- 8.3) 7.0 ( 4.8- 10.2) 4.9 ( 3.3- 6.9)
Oklahoma
Texas
West 7.9 ( 7.6- 8.3) 6.7 ( 6.4- 7.0) 6.5 ( 6.1- 6.8) 5.6 ( 5.3- 5.9) 9.6 ( 7.8- 11.9) 6.3 ( 5.2- 7.7)
Mountain
Arizona 5.9 ( 4.9- 7.1) 5.4 ( 4.5- 6.4) 6.0 ( 4.9- 7.2) 5.8 ( 4.8- 6.9) ∼ ∼
Colorado 6.1 ( 4.9- 7.6) 5.0 ( 4.0- 6.0) 5.9 ( 4.7- 7.4) 4.9 ( 3.9- 6.0) ∼ ∼
Idaho 3.6 ( 2.2- 5.7) 3.2 ( 2.0- 4.9) 3.7 ( 2.3- 5.8) 3.3 ( 2.0- 5.1) ∼ ∼
Montana 5.1 ( 3.1- 7.9) 4.8 ( 3.0- 7.3) 4.8 ( 2.9- 7.6) 4.7 ( 2.8- 7.3) ∼ ∼
Nevada
New Mexico 8.1 ( 6.2- 10.6) 7.0 ( 5.4- 9.0) 7.7 ( 5.7- 10.2) 7.0 ( 5.3- 9.2) ∼ ∼
Utah 4.4 ( 2.9- 6.4) 2.9 ( 2.0- 4.1) 4.3 ( 2.8- 6.3) 2.9 ( 1.9- 4.1) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 8.7 ( 8.3- 9.2) 7.3 ( 7.0- 7.7) 6.8 ( 6.4- 7.2) 5.9 ( 5.5- 6.2) 10.6 ( 8.5- 13.1) 7.0 ( 5.7- 8.6)
Alaska 9.3 ( 5.1- 17.7) 5.8 ( 3.5- 9.1) ∼ ∼ ∼ ∼
California 9.3 ( 8.8- 9.8) 7.5 ( 7.1- 7.9) 7.2 ( 6.7- 7.7) 6.0 ( 5.6- 6.4) 10.4 ( 8.3- 13.0) 7.2 ( 5.8- 8.9)
San Francisco-Oakland 12.3 ( 10.7- 14.0) 11.3 ( 9.9- 12.9) 8.7 ( 7.1- 10.5) 8.4 ( 6.9- 10.1) 12.7 ( 8.2- 19.6) 10.6 ( 6.9- 15.7)
San Jose-Monterey 11.1 ( 9.0- 13.6) 8.7 ( 7.1- 10.5) 7.2 ( 5.4- 9.6) 5.8 ( 4.4- 7.6) ∼ ∼
Los Angeles 10.2 ( 9.1- 11.3) 7.6 ( 6.9- 8.5) 8.2 ( 7.2- 9.4) 6.2 ( 5.4- 7.1) 8.8 ( 6.0- 12.7) 6.7 ( 4.6- 9.4)
Hawaii 12.0 ( 9.4- 15.2) 11.9 ( 9.2- 15.0) ∼ ∼ ∼ ∼
Oregon 5.7 ( 4.6- 7.0) 5.5 ( 4.4- 6.8) 5.3 ( 4.2- 6.6) 5.2 ( 4.1- 6.5) ∼ ∼
Washington 7.2 ( 6.2- 8.4) 6.4 ( 5.5- 7.4) 6.1 ( 5.2- 7.3) 5.6 ( 4.7- 6.6) ∼ ∼
Seattle-Puget Sound 8.2 ( 6.8- 9.7) 7.1 ( 6.0- 8.4) 6.7 ( 5.5- 8.2) 6.1 ( 5.0- 7.4) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.6.2: Cancer of the Liver and Intrahepatic Bile Duct. Invasive Cancer Incidence Rates by U.S. Census Region
and Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 2.8 ( 2.7- 2.9) 3.2 ( 3.1- 3.3) 2.5 ( 2.4- 2.6) 3.1 ( 2.9- 3.2) 3.5 ( 3.1- 3.9) 2.8 ( 2.5- 3.1)
Northeast 2.9 ( 2.7- 3.1) 3.5 ( 3.3- 3.7) 2.6 ( 2.4- 2.8) 3.4 ( 3.2- 3.7) 4.0 ( 3.3- 4.9) 3.4 ( 2.8- 4.1)
New England 2.5 ( 2.1- 2.9) 2.9 ( 2.5- 3.4) 2.3 ( 2.0- 2.7) 3.0 ( 2.5- 3.5) ∼ ∼
Connecticut 2.6 ( 2.0- 3.5) 3.2 ( 2.4- 4.2) 2.8 ( 2.1- 3.7) 3.6 ( 2.7- 4.7) ∼ ∼
Maine
Massachusetts 2.6 ( 2.1- 3.2) 3.1 ( 2.5- 3.7) 2.3 ( 1.8- 2.8) 2.9 ( 2.3- 3.6) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼ ∼ ∼
Vermont
Middle Atlantic 3.0 ( 2.8- 3.2) 3.7 ( 3.4- 4.0) 2.6 ( 2.4- 2.9) 3.5 ( 3.3- 3.8) 4.3 ( 3.5- 5.1) 3.7 ( 3.0- 4.4)
New Jersey 2.7 ( 2.3- 3.3) 3.3 ( 2.7- 3.9) 2.6 ( 2.2- 3.2) 3.5 ( 2.9- 4.2) ∼ ∼
New York 3.6 ( 3.3- 4.0) 4.3 ( 3.9- 4.7) 3.1 ( 2.7- 3.5) 4.1 ( 3.6- 4.6) 4.6 ( 3.6- 5.9) 4.0 ( 3.1- 5.1)
Pennsylvania 2.3 ( 2.0- 2.7) 3.1 ( 2.7- 3.6) 2.1 ( 1.8- 2.5) 2.9 ( 2.5- 3.4) 4.5 ( 2.9- 6.6) 4.2 ( 2.7- 6.1)
Midwest
East North Central
Illinois 3.5 ( 3.0- 3.9) 3.8 ( 3.3- 4.3) 3.2 ( 2.7- 3.7) 3.7 ( 3.2- 4.3) 4.6 ( 3.2- 6.5) 3.7 ( 2.6- 5.1)
Indiana
Michigan 2.7 ( 2.3- 3.2) 2.9 ( 2.5- 3.5) 2.5 ( 2.1- 3.0) 2.9 ( 2.4- 3.5) 3.9 ( 2.5- 5.8) 3.2 ( 2.0- 4.7)
Detroit 3.3 ( 2.6- 4.1) 3.6 ( 2.9- 4.5) 2.8 ( 2.1- 3.7) 3.5 ( 2.6- 4.6) 4.6 ( 2.9- 7.1) 4.0 ( 2.5- 6.1)
Ohio 2.4 ( 2.1- 2.9) 2.8 ( 2.4- 3.3) 2.3 ( 1.9- 2.7) 2.8 ( 2.3- 3.3) 3.9 ( 2.5- 5.9) 3.3 ( 2.1- 5.0)
Wisconsin 2.4 ( 1.9- 3.0) 2.7 ( 2.1- 3.4) 2.3 ( 1.8- 3.0) 2.7 ( 2.1- 3.5) ∼ ∼
West North Central 2.2 ( 1.9- 2.5) 2.5 ( 2.2- 2.9) 2.0 ( 1.7- 2.3) 2.4 ( 2.1- 2.8) 4.2 ( 2.4- 6.9) 2.9 ( 1.7- 4.8)
Iowa 2.2 ( 1.5- 3.0) 2.9 ( 2.1- 3.9) 2.1 ( 1.5- 2.9) 2.8 ( 2.0- 3.8) ∼ ∼
Kansas 2.9 ( 2.1- 3.9) 3.3 ( 2.4- 4.5) 2.8 ( 2.0- 3.9) 3.4 ( 2.5- 4.6) ∼ ∼
Minnesota 2.1 ( 1.6- 2.7) 2.2 ( 1.7- 2.9) 1.9 ( 1.4- 2.6) 2.2 ( 1.6- 2.9) ∼ ∼
Missouri 2.2 ( 1.7- 2.8) 2.5 ( 2.0- 3.2) 1.9 ( 1.4- 2.5) 2.2 ( 1.7- 2.9) ∼ ∼
Nebraska ∼ ∼ ∼ ∼ ∼ ∼




Delaware ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 6.0 ( 3.6- 9.7) 7.2 ( 4.4- 11.1) ∼ ∼ 8.5 ( 5.1- 14.3) 10.9 ( 6.6- 17.0)
Florida 3.0 ( 2.6- 3.3) 4.1 ( 3.6- 4.5) 2.9 ( 2.5- 3.3) 4.4 ( 3.9- 5.0) 2.9 ( 1.9- 4.3) 2.3 ( 1.5- 3.3)
Georgia
Atlanta 2.8 ( 1.9- 4.0) 2.2 ( 1.5- 3.1) ∼ ∼ ∼ ∼
Maryland 2.4 ( 1.9- 3.1) 2.5 ( 2.0- 3.2) 2.2 ( 1.6- 3.0) 2.7 ( 2.0- 3.6) ∼ ∼
North Carolina 1.7 ( 1.4- 2.2) 1.9 ( 1.5- 2.4) 1.7 ( 1.3- 2.2) 2.0 ( 1.5- 2.6) ∼ ∼
South Carolina 1.8 ( 1.3- 2.5) 2.0 ( 1.4- 2.7) 1.8 ( 1.2- 2.6) 2.1 ( 1.4- 3.0) ∼ ∼
Virginia
West Virginia 2.2 ( 1.5- 3.3) 3.0 ( 2.0- 4.3) 2.2 ( 1.4- 3.3) 3.0 ( 2.0- 4.4) ∼ ∼
East South Central
Alabama













Table 2.6.2: Cancer of the Liver and Intrahepatic Bile Duct. Invasive Cancer Incidence Rates by U.S. Census Region
and Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 2.7 ( 2.1- 3.5) 2.8 ( 2.1- 3.6) 2.9 ( 2.1- 3.8) 3.4 ( 2.5- 4.5) ∼ ∼
Oklahoma
Texas
West 3.2 ( 3.0- 3.5) 3.2 ( 3.0- 3.4) 2.7 ( 2.5- 2.9) 2.9 ( 2.7- 3.1) 3.3 ( 2.3- 4.5) 2.4 ( 1.7- 3.3)
Mountain
Arizona 2.2 ( 1.7- 2.9) 2.4 ( 1.8- 3.1) 2.1 ( 1.6- 2.8) 2.4 ( 1.8- 3.2) ∼ ∼
Colorado 2.4 ( 1.8- 3.2) 2.3 ( 1.7- 3.1) 2.3 ( 1.7- 3.1) 2.3 ( 1.6- 3.1) ∼ ∼
Idaho 2.6 ( 1.5- 4.2) 2.7 ( 1.6- 4.3) 2.6 ( 1.5- 4.3) 2.8 ( 1.6- 4.5) ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼
Nevada
New Mexico 3.3 ( 2.2- 4.8) 3.3 ( 2.2- 4.7) 3.2 ( 2.1- 4.7) 3.4 ( 2.2- 5.0) ∼ ∼
Utah 2.7 ( 1.7- 4.1) 2.1 ( 1.4- 3.2) 2.7 ( 1.7- 4.1) 2.2 ( 1.4- 3.3) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 3.5 ( 3.3- 3.8) 3.5 ( 3.3- 3.8) 2.9 ( 2.7- 3.2) 3.0 ( 2.8- 3.3) 3.5 ( 2.5- 4.9) 2.6 ( 1.9- 3.6)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 3.6 ( 3.3- 3.9) 3.5 ( 3.3- 3.8) 3.0 ( 2.7- 3.3) 3.1 ( 2.8- 3.4) 3.4 ( 2.4- 4.9) 2.6 ( 1.8- 3.7)
San Francisco-Oakland 3.7 ( 2.9- 4.6) 4.0 ( 3.2- 5.0) 2.4 ( 1.7- 3.3) 2.8 ( 2.0- 3.9) ∼ ∼
San Jose-Monterey 3.4 ( 2.3- 4.7) 3.1 ( 2.2- 4.3) 2.0 ( 1.2- 3.2) 2.0 ( 1.2- 3.2) ∼ ∼
Los Angeles 4.5 ( 3.9- 5.1) 4.2 ( 3.6- 4.8) 4.1 ( 3.4- 4.8) 4.0 ( 3.3- 4.7) 3.6 ( 2.1- 5.7) 3.1 ( 1.8- 4.9)
Hawaii 4.3 ( 2.9- 6.3) 4.9 ( 3.3- 7.1) ∼ ∼ ∼ ∼
Oregon 2.8 ( 2.1- 3.6) 3.1 ( 2.3- 4.1) 2.5 ( 1.8- 3.3) 2.9 ( 2.1- 3.8) ∼ ∼
Washington 3.3 ( 2.7- 4.0) 3.4 ( 2.7- 4.1) 2.6 ( 2.0- 3.3) 2.9 ( 2.2- 3.6) ∼ ∼
Seattle-Puget Sound 3.7 ( 2.9- 4.7) 3.8 ( 3.0- 4.7) 3.0 ( 2.2- 3.9) 3.2 ( 2.4- 4.2) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.7.1: Cancer of the Pancreas. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 12.3 ( 12.0- 12.5) 10.9 ( 10.7- 11.1) 12.1 ( 11.8- 12.3) 11.4 ( 11.2- 11.7) 15.2 ( 14.3- 16.2) 9.4 ( 8.8- 9.9)
Northeast 13.5 ( 13.0- 14.0) 12.7 ( 12.2- 13.1) 13.3 ( 12.8- 13.8) 13.3 ( 12.8- 13.8) 15.7 ( 13.9- 17.7) 10.1 ( 9.0- 11.3)
New England 13.2 ( 12.2- 14.3) 12.1 ( 11.2- 13.1) 13.1 ( 12.1- 14.2) 12.7 ( 11.7- 13.7) 14.0 ( 9.1- 21.6) 7.8 ( 5.2- 11.2)
Connecticut 13.3 ( 11.6- 15.4) 12.6 ( 10.9- 14.5) 13.1 ( 11.3- 15.2) 13.2 ( 11.4- 15.2) 19.4 ( 10.6- 34.3) 10.9 ( 6.3- 17.8)
Maine
Massachusetts 13.3 ( 12.0- 14.8) 12.2 ( 11.0- 13.5) 13.2 ( 11.9- 14.7) 12.8 ( 11.5- 14.3) ∼ ∼
New Hampshire 12.9 ( 9.9- 16.7) 10.8 ( 8.3- 13.8) 12.9 ( 9.9- 16.7) 10.9 ( 8.4- 14.0) ∼ ∼
Rhode Island 12.4 ( 9.3- 16.2) 11.7 ( 8.9- 15.3) 12.6 ( 9.5- 16.6) 12.6 ( 9.5- 16.4) ∼ ∼
Vermont
Middle Atlantic 13.6 ( 13.0- 14.1) 12.8 ( 12.3- 13.3) 13.3 ( 12.7- 13.9) 13.6 ( 13.0- 14.2) 15.9 ( 14.0- 18.0) 10.4 ( 9.2- 11.7)
New Jersey 13.8 ( 12.6- 15.1) 12.6 ( 11.5- 13.7) 13.2 ( 11.9- 14.5) 13.1 ( 11.9- 14.4) 19.1 ( 14.6- 25.0) 11.6 ( 9.0- 14.8)
New York 13.7 ( 12.9- 14.6) 12.4 ( 11.7- 13.1) 13.9 ( 13.0- 14.9) 13.7 ( 12.9- 14.7) 13.4 ( 11.1- 16.2) 8.4 ( 7.0- 10.0)
Pennsylvania 13.3 ( 12.3- 14.2) 13.7 ( 12.7- 14.7) 12.6 ( 11.7- 13.6) 13.6 ( 12.6- 14.6) 19.7 ( 15.6- 24.9) 14.4 ( 11.4- 18.0)
Midwest
East North Central
Illinois 13.2 ( 12.2- 14.3) 11.2 ( 10.4- 12.1) 12.7 ( 11.6- 13.8) 11.5 ( 10.6- 12.5) 16.6 ( 13.2- 20.8) 10.1 ( 8.1- 12.4)
Indiana
Michigan 12.1 ( 11.1- 13.2) 10.6 ( 9.7- 11.6) 11.4 ( 10.4- 12.6) 10.5 ( 9.5- 11.6) 18.4 ( 14.6- 23.0) 12.7 ( 10.1- 15.7)
Detroit 12.2 ( 10.6- 14.0) 10.8 ( 9.4- 12.4) 10.9 ( 9.2- 12.9) 10.3 ( 8.7- 12.1) 18.2 ( 13.9- 23.6) 13.5 ( 10.4- 17.3)
Ohio 11.4 ( 10.4- 12.4) 10.4 ( 9.6- 11.3) 11.4 ( 10.4- 12.4) 10.8 ( 9.9- 11.8) 11.5 ( 8.4- 15.6) 7.8 ( 5.8- 10.4)
Wisconsin 11.9 ( 10.6- 13.4) 10.8 ( 9.6- 12.2) 11.7 ( 10.4- 13.3) 11.2 ( 9.9- 12.6) ∼ ∼
West North Central 11.6 ( 10.8- 12.3) 10.6 ( 9.9- 11.3) 11.3 ( 10.5- 12.1) 10.8 ( 10.1- 11.5) 19.5 ( 14.6- 26.0) 10.8 ( 8.2- 14.1)
Iowa 10.7 ( 9.0- 12.6) 10.6 ( 8.9- 12.4) 10.4 ( 8.8- 12.3) 10.5 ( 8.9- 12.4) ∼ ∼
Kansas 13.4 ( 11.4- 15.7) 11.9 ( 10.1- 13.9) 12.9 ( 10.8- 15.2) 11.8 ( 9.9- 13.9) ∼ ∼
Minnesota 10.4 ( 9.0- 11.9) 9.0 ( 7.9- 10.3) 10.2 ( 8.8- 11.7) 9.3 ( 8.0- 10.7) ∼ ∼
Missouri 12.7 ( 11.3- 14.2) 11.8 ( 10.5- 13.2) 12.5 ( 11.1- 14.1) 12.1 ( 10.8- 13.7) 14.6 ( 9.6- 21.9) 9.4 ( 6.2- 13.6)
Nebraska 11.6 ( 9.3- 14.3) 10.8 ( 8.7- 13.3) 11.1 ( 8.8- 13.8) 10.7 ( 8.5- 13.3) ∼ ∼




Delaware 12.6 ( 9.0- 17.5) 11.2 ( 8.0- 15.2) 12.4 ( 8.6- 17.8) 12.2 ( 8.5- 17.0) ∼ ∼
District of Columbia 17.2 ( 12.2- 23.6) 16.4 ( 11.7- 22.3) ∼ ∼ 19.3 ( 12.8- 28.3) 19.1 ( 12.7- 27.7)
Florida 13.1 ( 12.3- 13.9) 15.3 ( 14.4- 16.2) 12.9 ( 12.1- 13.7) 16.7 ( 15.7- 17.7) 16.4 ( 13.2- 20.5) 9.0 ( 7.4- 11.0)
Georgia
Atlanta 12.8 ( 10.2- 16.0) 7.6 ( 6.2- 9.3) 10.8 ( 8.2- 14.3) 7.5 ( 5.8- 9.6) 22.0 ( 14.2- 33.3) 8.6 ( 5.9- 12.0)
Maryland 11.3 ( 9.9- 12.9) 9.5 ( 8.3- 10.7) 10.9 ( 9.3- 12.7) 10.2 ( 8.8- 11.9) 12.8 ( 9.5- 17.3) 8.2 ( 6.2- 10.6)
North Carolina 12.2 ( 11.0- 13.5) 10.4 ( 9.4- 11.5) 12.2 ( 10.8- 13.7) 11.3 ( 10.1- 12.6) 12.5 ( 9.6- 16.3) 8.1 ( 6.2- 10.4)
South Carolina 12.5 ( 10.8- 14.6) 10.3 ( 8.9- 11.9) 12.7 ( 10.6- 15.0) 11.6 ( 9.8- 13.6) 12.4 ( 8.9- 17.2) 7.8 ( 5.6- 10.5)
Virginia
West Virginia 10.6 ( 8.6- 13.1) 11.0 ( 8.9- 13.5) 10.4 ( 8.4- 12.9) 10.8 ( 8.7- 13.3) ∼ ∼
East South Central
Alabama













Table 2.7.1: Cancer of the Pancreas. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 13.1 ( 11.3- 15.0) 10.4 ( 9.1- 11.9) 11.6 ( 9.7- 13.7) 10.4 ( 8.8- 12.3) 18.9 ( 14.7- 24.1) 10.9 ( 8.5- 13.8)
Oklahoma
Texas
West 11.2 ( 10.8- 11.6) 9.0 ( 8.6- 9.3) 11.3 ( 10.8- 11.8) 9.4 ( 9.1- 9.8) 11.7 ( 9.6- 14.3) 7.2 ( 5.9- 8.6)
Mountain
Arizona 9.8 ( 8.5- 11.2) 8.9 ( 7.8- 10.2) 10.0 ( 8.6- 11.5) 9.7 ( 8.4- 11.1) ∼ ∼
Colorado 11.3 ( 9.6- 13.2) 8.3 ( 7.1- 9.7) 11.2 ( 9.4- 13.2) 8.4 ( 7.1- 9.8) ∼ ∼
Idaho 9.4 ( 7.0- 12.5) 8.2 ( 6.1- 10.7) 9.6 ( 7.1- 12.7) 8.4 ( 6.3- 11.1) ∼ ∼
Montana 12.8 ( 9.6- 16.9) 12.1 ( 9.0- 15.8) 12.9 ( 9.6- 17.1) 12.8 ( 9.5- 16.7) ∼ ∼
Nevada
New Mexico 13.5 ( 11.0- 16.5) 11.8 ( 9.6- 14.3) 13.0 ( 10.4- 16.1) 12.2 ( 9.8- 15.0) ∼ ∼
Utah 11.2 ( 8.8- 14.1) 7.2 ( 5.6- 9.0) 11.4 ( 8.9- 14.4) 7.4 ( 5.8- 9.3) ∼ ∼
Wyoming 16.4 ( 11.3- 23.5) 14.5 ( 10.1- 20.2) 16.0 ( 10.9- 23.0) 14.2 ( 9.8- 20.0) ∼ ∼
Pacific 11.2 ( 10.7- 11.7) 8.9 ( 8.5- 9.3) 11.4 ( 10.8- 11.9) 9.4 ( 9.0- 9.9) 12.2 ( 9.9- 15.0) 7.5 ( 6.1- 9.0)
Alaska 10.6 ( 5.6- 19.9) 5.8 ( 3.5- 9.1) ∼ ∼ ∼ ∼
California 11.0 ( 10.4- 11.6) 8.4 ( 8.0- 8.9) 11.1 ( 10.5- 11.8) 9.0 ( 8.5- 9.5) 12.3 ( 9.9- 15.3) 7.8 ( 6.4- 9.6)
San Francisco-Oakland 10.7 ( 9.2- 12.4) 9.4 ( 8.1- 10.8) 10.1 ( 8.4- 12.1) 9.6 ( 8.0- 11.4) 14.8 ( 9.6- 22.5) 11.0 ( 7.2- 16.2)
San Jose-Monterey 12.6 ( 10.2- 15.3) 8.9 ( 7.3- 10.8) 11.7 ( 9.3- 14.6) 8.9 ( 7.1- 11.1) ∼ ∼
Los Angeles 10.8 ( 9.7- 12.1) 7.7 ( 7.0- 8.6) 11.5 ( 10.2- 12.9) 8.3 ( 7.4- 9.3) 11.0 ( 7.8- 15.4) 8.3 ( 6.0- 11.3)
Hawaii 10.8 ( 8.3- 13.9) 10.3 ( 7.9- 13.3) 13.5 ( 7.9- 21.9) 10.0 ( 5.8- 16.1) ∼ ∼
Oregon 12.3 ( 10.7- 14.3) 11.7 ( 10.1- 13.4) 12.1 ( 10.4- 14.1) 11.8 ( 10.2- 13.7) ∼ ∼
Washington 12.2 ( 10.8- 13.7) 10.2 ( 9.1- 11.4) 12.2 ( 10.8- 13.8) 10.7 ( 9.5- 12.1) ∼ ∼
Seattle-Puget Sound 13.0 ( 11.2- 14.9) 10.6 ( 9.2- 12.1) 13.1 ( 11.3- 15.1) 11.4 ( 9.8- 13.1) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.7.2: Cancer of the Pancreas. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 9.6 ( 9.4- 9.7) 11.0 ( 10.8- 11.2) 9.2 ( 9.0- 9.4) 11.4 ( 11.2- 11.6) 13.1 ( 12.4- 13.8) 10.1 ( 9.5- 10.6)
Northeast 10.4 ( 10.1- 10.8) 13.0 ( 12.6- 13.5) 10.2 ( 9.8- 10.6) 13.7 ( 13.2- 14.2) 12.9 ( 11.6- 14.3) 10.5 ( 9.4- 11.7)
New England 9.9 ( 9.1- 10.6) 12.1 ( 11.2- 13.0) 9.9 ( 9.1- 10.7) 12.8 ( 11.9- 13.8) 10.1 ( 6.4- 15.1) 6.3 ( 4.1- 9.2)
Connecticut 10.1 ( 8.8- 11.6) 12.8 ( 11.2- 14.7) 10.2 ( 8.8- 11.8) 13.9 ( 12.0- 15.9) ∼ ∼
Maine
Massachusetts 9.8 ( 8.9- 10.9) 12.1 ( 10.9- 13.3) 9.9 ( 8.9- 11.0) 12.9 ( 11.6- 14.3) ∼ ∼
New Hampshire 9.4 ( 7.2- 12.2) 9.9 ( 7.5- 12.7) 9.4 ( 7.1- 12.2) 9.9 ( 7.5- 12.8) ∼ ∼
Rhode Island 9.1 ( 7.0- 11.9) 12.4 ( 9.6- 15.9) 9.2 ( 6.9- 12.1) 13.1 ( 10.0- 16.8) ∼ ∼
Vermont
Middle Atlantic 10.6 ( 10.2- 11.0) 13.3 ( 12.8- 13.8) 10.3 ( 9.9- 10.7) 14.0 ( 13.4- 14.6) 13.2 ( 11.8- 14.7) 11.1 ( 9.9- 12.3)
New Jersey 11.0 ( 10.1- 12.0) 13.4 ( 12.3- 14.5) 10.9 ( 10.0- 12.0) 14.6 ( 13.3- 15.9) 14.5 ( 11.1- 18.6) 10.3 ( 8.0- 13.2)
New York 11.3 ( 10.7- 12.0) 13.6 ( 12.8- 14.3) 11.0 ( 10.3- 11.7) 14.6 ( 13.7- 15.5) 13.0 ( 11.2- 15.0) 11.0 ( 9.5- 12.7)
Pennsylvania 9.5 ( 8.8- 10.2) 12.8 ( 11.9- 13.7) 9.1 ( 8.4- 9.8) 12.9 ( 12.0- 13.9) 13.0 ( 10.2- 16.3) 12.1 ( 9.5- 15.2)
Midwest
East North Central
Illinois 10.1 ( 9.4- 10.9) 11.4 ( 10.5- 12.2) 9.6 ( 8.8- 10.4) 11.7 ( 10.8- 12.7) 13.5 ( 11.0- 16.4) 10.3 ( 8.4- 12.5)
Indiana
Michigan 10.8 ( 9.9- 11.7) 11.9 ( 10.9- 12.9) 9.9 ( 9.1- 10.9) 11.7 ( 10.6- 12.7) 17.4 ( 14.3- 21.2) 14.0 ( 11.4- 16.9)
Detroit 11.7 ( 10.3- 13.1) 13.0 ( 11.6- 14.7) 10.3 ( 8.9- 11.9) 12.8 ( 11.1- 14.7) 17.6 ( 14.0- 21.8) 15.0 ( 11.9- 18.6)
Ohio 8.8 ( 8.1- 9.5) 10.4 ( 9.6- 11.3) 8.4 ( 7.7- 9.2) 10.4 ( 9.6- 11.4) 12.9 ( 10.1- 16.2) 10.9 ( 8.6- 13.7)
Wisconsin 10.0 ( 8.9- 11.2) 11.8 ( 10.5- 13.1) 9.4 ( 8.4- 10.6) 11.8 ( 10.4- 13.2) 28.6 ( 17.1- 45.7) 13.7 ( 8.5- 21.0)
West North Central 8.5 ( 8.0- 9.1) 10.1 ( 9.5- 10.8) 8.2 ( 7.6- 8.7) 10.2 ( 9.5- 10.9) 16.0 ( 12.3- 20.5) 11.6 ( 8.9- 14.8)
Iowa 7.7 ( 6.5- 9.1) 10.3 ( 8.7- 12.0) 7.4 ( 6.2- 8.8) 10.2 ( 8.6- 12.0) ∼ ∼
Kansas 8.8 ( 7.4- 10.4) 10.5 ( 8.9- 12.4) 8.7 ( 7.2- 10.3) 10.8 ( 9.0- 12.8) ∼ ∼
Minnesota 6.9 ( 5.9- 8.0) 7.5 ( 6.4- 8.6) 6.7 ( 5.7- 7.8) 7.6 ( 6.5- 8.9) ∼ ∼
Missouri 10.2 ( 9.2- 11.4) 12.3 ( 11.1- 13.7) 9.6 ( 8.5- 10.8) 12.2 ( 10.8- 13.6) 17.2 ( 12.6- 23.1) 14.0 ( 10.2- 18.7)
Nebraska 8.1 ( 6.4- 10.1) 9.8 ( 7.8- 12.1) 7.9 ( 6.2- 10.0) 9.9 ( 7.9- 12.4) ∼ ∼




Delaware 12.1 ( 9.0- 16.0) 13.2 ( 9.8- 17.3) 12.4 ( 9.0- 16.8) 15.1 ( 11.0- 20.1) ∼ ∼
District of Columbia 10.7 ( 7.5- 15.2) 13.4 ( 9.4- 18.4) ∼ ∼ 12.2 ( 8.1- 18.6) 16.1 ( 10.7- 23.2)
Florida 10.2 ( 9.6- 10.8) 14.5 ( 13.7- 15.4) 10.0 ( 9.4- 10.7) 15.9 ( 14.9- 16.9) 12.5 ( 10.1- 15.3) 8.5 ( 6.9- 10.3)
Georgia
Atlanta 9.1 ( 7.3- 11.2) 6.7 ( 5.4- 8.3) 7.0 ( 5.3- 9.1) 6.3 ( 4.7- 8.2) 17.6 ( 12.2- 24.8) 8.0 ( 5.6- 11.0)
Maryland 9.1 ( 8.0- 10.3) 9.4 ( 8.3- 10.6) 8.6 ( 7.4- 9.9) 10.4 ( 8.9- 12.0) 11.7 ( 8.9- 15.1) 7.9 ( 6.1- 10.2)
North Carolina 9.2 ( 8.3- 10.1) 10.4 ( 9.4- 11.4) 8.5 ( 7.6- 9.5) 10.5 ( 9.4- 11.8) 12.6 ( 10.2- 15.4) 10.6 ( 8.6- 13.0)
South Carolina 9.4 ( 8.1- 10.8) 10.1 ( 8.8- 11.6) 8.2 ( 6.8- 9.7) 9.8 ( 8.2- 11.6) 13.7 ( 10.7- 17.4) 11.2 ( 8.7- 14.1)
Virginia
West Virginia 6.5 ( 5.1- 8.2) 8.5 ( 6.8- 10.6) 6.6 ( 5.2- 8.3) 8.7 ( 6.9- 10.8) ∼ ∼
East South Central
Alabama













Table 2.7.2: Cancer of the Pancreas. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 10.0 ( 8.8- 11.4) 10.4 ( 9.1- 11.8) 9.2 ( 7.9- 10.8) 11.0 ( 9.4- 12.9) 12.5 ( 9.8- 15.7) 9.7 ( 7.6- 12.2)
Oklahoma
Texas
West 8.8 ( 8.5- 9.2) 8.9 ( 8.5- 9.2) 8.8 ( 8.4- 9.1) 9.3 ( 8.9- 9.7) 10.7 ( 8.9- 12.8) 7.7 ( 6.4- 9.1)
Mountain
Arizona 8.3 ( 7.3- 9.5) 9.2 ( 8.0- 10.5) 8.3 ( 7.2- 9.5) 9.7 ( 8.4- 11.1) ∼ ∼
Colorado 8.3 ( 7.1- 9.7) 7.9 ( 6.7- 9.2) 8.3 ( 7.0- 9.7) 8.1 ( 6.9- 9.5) ∼ ∼
Idaho 12.7 ( 10.1- 15.8) 13.1 ( 10.4- 16.2) 12.9 ( 10.2- 16.1) 13.5 ( 10.7- 16.8) ∼ ∼
Montana 7.4 ( 5.3- 10.3) 9.0 ( 6.4- 12.3) 7.4 ( 5.3- 10.4) 9.5 ( 6.8- 13.0) ∼ ∼
Nevada
New Mexico 8.5 ( 6.7- 10.7) 8.5 ( 6.7- 10.6) 8.9 ( 7.0- 11.2) 9.5 ( 7.4- 11.9) ∼ ∼
Utah 6.4 ( 4.8- 8.4) 5.0 ( 3.8- 6.6) 6.4 ( 4.8- 8.4) 5.1 ( 3.8- 6.7) ∼ ∼
Wyoming 6.3 ( 3.6- 10.6) 6.7 ( 3.8- 10.9) ∼ ∼ ∼ ∼
Pacific 9.0 ( 8.6- 9.4) 9.1 ( 8.7- 9.5) 8.9 ( 8.5- 9.3) 9.5 ( 9.0- 9.9) 10.6 ( 8.7- 12.8) 7.8 ( 6.4- 9.4)
Alaska 13.0 ( 7.8- 21.0) 7.1 ( 4.4- 10.9) 13.2 ( 7.5- 22.5) 7.8 ( 4.5- 12.5) ∼ ∼
California 8.6 ( 8.2- 9.1) 8.5 ( 8.1- 9.0) 8.6 ( 8.2- 9.2) 9.1 ( 8.6- 9.6) 10.5 ( 8.5- 12.8) 8.0 ( 6.5- 9.7)
San Francisco-Oakland 8.3 ( 7.1- 9.5) 9.3 ( 8.0- 10.7) 8.3 ( 7.0- 9.9) 10.6 ( 9.0- 12.5) 8.5 ( 5.0- 13.6) 7.2 ( 4.3- 11.4)
San Jose-Monterey 8.6 ( 6.9- 10.5) 8.1 ( 6.5- 9.9) 8.5 ( 6.7- 10.7) 8.6 ( 6.7- 10.7) ∼ ∼
Los Angeles 8.1 ( 7.3- 9.0) 7.7 ( 7.0- 8.6) 8.3 ( 7.4- 9.4) 8.2 ( 7.3- 9.2) 8.4 ( 6.0- 11.5) 7.3 ( 5.2- 9.9)
Hawaii 11.6 ( 9.1- 14.6) 13.0 ( 10.3- 16.3) ∼ ∼ ∼ ∼
Oregon 10.4 ( 9.0- 12.0) 12.2 ( 10.6- 14.0) 10.3 ( 8.9- 11.9) 12.6 ( 10.9- 14.5) ∼ ∼
Washington 9.2 ( 8.2- 10.4) 9.5 ( 8.4- 10.7) 9.1 ( 8.0- 10.3) 9.9 ( 8.7- 11.1) ∼ ∼
Seattle-Puget Sound 10.7 ( 9.3- 12.2) 10.9 ( 9.5- 12.4) 10.6 ( 9.2- 12.2) 11.5 ( 10.0- 13.3) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.8.1: Cancer of the Larynx. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 7.9 ( 7.7- 8.1) 7.3 ( 7.1- 7.4) 7.6 ( 7.4- 7.8) 7.4 ( 7.2- 7.6) 12.1 ( 11.3- 12.9) 7.9 ( 7.4- 8.4)
Northeast 8.3 ( 7.9- 8.6) 8.0 ( 7.6- 8.4) 8.0 ( 7.6- 8.4) 8.3 ( 7.9- 8.7) 10.8 ( 9.3- 12.4) 7.3 ( 6.4- 8.4)
New England 8.6 ( 7.8- 9.4) 8.2 ( 7.4- 9.0) 8.4 ( 7.7- 9.3) 8.4 ( 7.6- 9.2) 13.5 ( 8.7- 20.9) 7.2 ( 4.8- 10.5)
Connecticut 8.3 ( 6.9- 9.9) 8.2 ( 6.8- 9.7) 8.1 ( 6.7- 9.8) 8.4 ( 7.0- 10.1) ∼ ∼
Maine
Massachusetts 8.5 ( 7.5- 9.7) 8.1 ( 7.1- 9.1) 8.3 ( 7.2- 9.5) 8.3 ( 7.2- 9.4) 16.2 ( 9.1- 29.2) 8.1 ( 4.6- 13.2)
New Hampshire 8.5 ( 6.2- 11.6) 7.4 ( 5.4- 10.0) 8.6 ( 6.3- 11.8) 7.6 ( 5.5- 10.2) ∼ ∼
Rhode Island 10.3 ( 7.5- 13.8) 9.9 ( 7.2- 13.1) 10.0 ( 7.3- 13.6) 10.1 ( 7.3- 13.5) ∼ ∼
Vermont
Middle Atlantic 8.1 ( 7.7- 8.6) 7.9 ( 7.5- 8.4) 7.9 ( 7.4- 8.3) 8.2 ( 7.8- 8.7) 10.5 ( 9.0- 12.2) 7.3 ( 6.3- 8.4)
New Jersey 7.5 ( 6.7- 8.5) 7.1 ( 6.3- 8.0) 7.1 ( 6.2- 8.2) 7.3 ( 6.4- 8.3) 12.0 ( 8.7- 16.5) 8.4 ( 6.2- 11.2)
New York 8.0 ( 7.4- 8.7) 7.6 ( 7.0- 8.2) 8.0 ( 7.3- 8.7) 8.1 ( 7.5- 8.8) 8.6 ( 6.9- 10.8) 6.0 ( 4.8- 7.4)
Pennsylvania 8.7 ( 7.9- 9.4) 9.0 ( 8.2- 9.8) 8.2 ( 7.4- 9.0) 8.9 ( 8.1- 9.7) 13.5 ( 10.1- 17.9) 9.8 ( 7.4- 12.9)
Midwest
East North Central
Illinois 9.1 ( 8.3- 9.9) 8.0 ( 7.3- 8.8) 8.3 ( 7.4- 9.2) 7.7 ( 6.9- 8.5) 14.7 ( 11.8- 18.4) 10.2 ( 8.2- 12.5)
Indiana
Michigan 8.0 ( 7.2- 8.9) 7.2 ( 6.5- 8.0) 7.4 ( 6.6- 8.3) 7.0 ( 6.2- 7.9) 13.8 ( 10.5- 17.9) 9.4 ( 7.2- 12.0)
Detroit 7.3 ( 6.1- 8.7) 6.7 ( 5.6- 8.0) 6.0 ( 4.8- 7.4) 5.9 ( 4.8- 7.3) 13.4 ( 9.8- 18.0) 10.0 ( 7.4- 13.4)
Ohio 8.3 ( 7.5- 9.2) 7.8 ( 7.1- 8.6) 8.1 ( 7.3- 9.0) 7.9 ( 7.1- 8.7) 9.3 ( 6.7- 12.9) 6.8 ( 4.9- 9.3)
Wisconsin 6.7 ( 5.7- 7.9) 6.3 ( 5.3- 7.3) 6.4 ( 5.4- 7.5) 6.2 ( 5.3- 7.3) ∼ ∼
West North Central 7.6 ( 7.0- 8.2) 7.1 ( 6.6- 7.7) 7.4 ( 6.8- 8.0) 7.2 ( 6.6- 7.8) 13.2 ( 9.3- 18.4) 7.9 ( 5.6- 10.7)
Iowa 8.0 ( 6.6- 9.7) 8.1 ( 6.7- 9.7) 8.0 ( 6.5- 9.6) 8.2 ( 6.7- 9.8) ∼ ∼
Kansas 7.2 ( 5.7- 8.9) 6.6 ( 5.3- 8.1) 6.8 ( 5.3- 8.5) 6.5 ( 5.1- 8.1) ∼ ∼
Minnesota 6.7 ( 5.7- 8.0) 5.9 ( 5.0- 7.0) 6.7 ( 5.7- 8.0) 6.2 ( 5.2- 7.3) ∼ ∼
Missouri 8.9 ( 7.8- 10.2) 8.5 ( 7.4- 9.6) 8.5 ( 7.3- 9.8) 8.4 ( 7.3- 9.7) 14.0 ( 9.1- 21.1) 9.4 ( 6.2- 13.6)
Nebraska 6.6 ( 5.0- 8.8) 6.4 ( 4.8- 8.4) 6.6 ( 4.9- 8.8) 6.6 ( 4.9- 8.6) ∼ ∼




Delaware 10.5 ( 7.4- 14.8) 10.1 ( 7.1- 13.9) 10.1 ( 6.8- 14.8) 10.5 ( 7.1- 14.9) ∼ ∼
District of Columbia 14.2 ( 9.8- 20.1) 13.9 ( 9.6- 19.5) ∼ ∼ 17.5 ( 11.4- 26.0) 17.8 ( 11.6- 26.0)
Florida 10.0 ( 9.3- 10.7) 11.5 ( 10.7- 12.3) 9.8 ( 9.1- 10.5) 12.4 ( 11.5- 13.3) 11.9 ( 9.2- 15.6) 6.7 ( 5.3- 8.4)
Georgia
Atlanta 7.0 ( 5.2- 9.3) 4.5 ( 3.4- 5.8) 6.2 ( 4.4- 8.7) 4.8 ( 3.4- 6.5) 11.7 ( 6.1- 21.2) 4.5 ( 2.7- 7.2)
Maryland 8.8 ( 7.6- 10.2) 7.8 ( 6.7- 8.9) 7.9 ( 6.6- 9.4) 7.7 ( 6.4- 9.1) 13.1 ( 9.8- 17.6) 8.3 ( 6.3- 10.8)
North Carolina 9.1 ( 8.1- 10.2) 8.3 ( 7.4- 9.3) 8.3 ( 7.3- 9.5) 8.3 ( 7.2- 9.4) 13.5 ( 10.5- 17.3) 9.0 ( 7.0- 11.3)
South Carolina 9.1 ( 7.7- 10.8) 8.3 ( 7.1- 9.7) 8.3 ( 6.8- 10.1) 8.4 ( 6.9- 10.1) 12.3 ( 8.9- 16.8) 8.5 ( 6.2- 11.4)
Virginia
West Virginia 10.4 ( 8.5- 12.8) 11.4 ( 9.2- 13.8) 10.1 ( 8.1- 12.5) 11.1 ( 8.9- 13.6) ∼ ∼
East South Central
Alabama













Table 2.8.1: Cancer of the Larynx. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 10.3 ( 8.9- 11.9) 9.2 ( 8.0- 10.6) 9.1 ( 7.6- 10.9) 9.2 ( 7.7- 10.9) 14.6 ( 11.2- 18.8) 9.7 ( 7.5- 12.4)
Oklahoma
Texas
West 5.9 ( 5.6- 6.2) 4.9 ( 4.6- 5.1) 5.9 ( 5.6- 6.2) 5.1 ( 4.8- 5.4) 10.2 ( 8.2- 12.5) 6.5 ( 5.3- 7.8)
Mountain
Arizona 5.7 ( 4.7- 6.9) 5.2 ( 4.4- 6.3) 5.6 ( 4.6- 6.8) 5.5 ( 4.5- 6.6) ∼ ∼
Colorado 5.3 ( 4.2- 6.6) 4.3 ( 3.5- 5.3) 5.4 ( 4.3- 6.8) 4.5 ( 3.6- 5.6) ∼ ∼
Idaho 7.6 ( 5.4- 10.4) 6.6 ( 4.7- 8.9) 7.7 ( 5.5- 10.6) 6.8 ( 4.9- 9.2) ∼ ∼
Montana 6.3 ( 4.1- 9.2) 6.4 ( 4.2- 9.2) 5.8 ( 3.8- 8.8) 6.1 ( 4.0- 9.1) ∼ ∼
Nevada
New Mexico 6.5 ( 4.8- 8.7) 5.7 ( 4.2- 7.6) 6.7 ( 4.9- 9.1) 6.4 ( 4.7- 8.5) ∼ ∼
Utah 3.5 ( 2.3- 5.3) 2.4 ( 1.5- 3.5) 3.6 ( 2.3- 5.5) 2.5 ( 1.6- 3.7) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 6.0 ( 5.7- 6.4) 4.9 ( 4.6- 5.2) 6.0 ( 5.6- 6.4) 5.1 ( 4.8- 5.4) 10.8 ( 8.7- 13.4) 6.8 ( 5.5- 8.3)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 5.9 ( 5.5- 6.4) 4.7 ( 4.4- 5.0) 5.8 ( 5.4- 6.3) 4.8 ( 4.4- 5.2) 11.1 ( 8.8- 13.8) 7.1 ( 5.7- 8.8)
San Francisco-Oakland 7.2 ( 6.0- 8.6) 6.5 ( 5.4- 7.7) 7.3 ( 5.9- 9.0) 6.9 ( 5.6- 8.5) 13.2 ( 8.3- 20.6) 9.8 ( 6.2- 14.6)
San Jose-Monterey 5.4 ( 4.0- 7.3) 4.0 ( 2.9- 5.3) 5.8 ( 4.1- 8.0) 4.5 ( 3.2- 6.1) ∼ ∼
Los Angeles 6.5 ( 5.6- 7.4) 4.8 ( 4.2- 5.4) 6.2 ( 5.3- 7.3) 4.6 ( 4.0- 5.4) 10.5 ( 7.4- 14.8) 7.9 ( 5.6- 10.8)
Hawaii 5.9 ( 4.1- 8.3) 5.8 ( 4.0- 8.1) 14.3 ( 8.5- 22.8) 11.2 ( 6.8- 17.5) ∼ ∼
Oregon 6.1 ( 4.9- 7.5) 5.9 ( 4.7- 7.2) 6.1 ( 4.9- 7.5) 6.0 ( 4.8- 7.4) ∼ ∼
Washington 6.6 ( 5.6- 7.7) 5.6 ( 4.8- 6.5) 6.5 ( 5.5- 7.7) 5.8 ( 4.9- 6.8) ∼ ∼
Seattle-Puget Sound 6.0 ( 4.9- 7.4) 5.0 ( 4.1- 6.1) 6.1 ( 4.9- 7.5) 5.4 ( 4.3- 6.6) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.8.2: Cancer of the Larynx. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 1.7 ( 1.7- 1.8) 1.9 ( 1.8- 1.9) 1.7 ( 1.6- 1.8) 1.9 ( 1.8- 2.0) 2.4 ( 2.2- 2.8) 2.0 ( 1.8- 2.3)
Northeast 1.8 ( 1.6- 1.9) 2.0 ( 1.8- 2.2) 1.7 ( 1.5- 1.9) 2.0 ( 1.9- 2.2) 2.4 ( 1.9- 3.1) 2.2 ( 1.7- 2.7)
New England 2.0 ( 1.7- 2.4) 2.3 ( 1.9- 2.7) 2.0 ( 1.7- 2.4) 2.3 ( 1.9- 2.8) ∼ ∼
Connecticut 2.5 ( 1.9- 3.4) 2.9 ( 2.1- 3.8) 2.6 ( 1.9- 3.5) 3.1 ( 2.3- 4.1) ∼ ∼
Maine
Massachusetts 1.8 ( 1.4- 2.3) 2.0 ( 1.5- 2.5) 1.7 ( 1.2- 2.2) 2.0 ( 1.5- 2.5) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼ ∼ ∼
Vermont
Middle Atlantic 1.7 ( 1.5- 1.9) 1.9 ( 1.7- 2.1) 1.6 ( 1.4- 1.8) 1.9 ( 1.7- 2.2) 2.5 ( 1.9- 3.1) 2.3 ( 1.7- 2.9)
New Jersey 1.6 ( 1.2- 2.0) 1.8 ( 1.4- 2.2) 1.5 ( 1.2- 2.0) 1.8 ( 1.4- 2.4) ∼ ∼
New York 1.8 ( 1.5- 2.1) 2.0 ( 1.7- 2.3) 1.8 ( 1.5- 2.1) 2.1 ( 1.8- 2.4) 2.0 ( 1.4- 2.9) 1.9 ( 1.3- 2.6)
Pennsylvania 1.7 ( 1.4- 2.0) 2.0 ( 1.7- 2.4) 1.5 ( 1.2- 1.8) 1.8 ( 1.5- 2.2) 3.7 ( 2.3- 5.7) 3.6 ( 2.2- 5.4)
Midwest
East North Central
Illinois 1.5 ( 1.3- 1.9) 1.6 ( 1.3- 1.9) 1.4 ( 1.1- 1.8) 1.5 ( 1.2- 1.9) 2.4 ( 1.4- 3.7) 2.0 ( 1.2- 3.1)
Indiana
Michigan 2.7 ( 2.3- 3.2) 2.8 ( 2.4- 3.3) 2.2 ( 1.8- 2.7) 2.4 ( 2.0- 3.0) 5.9 ( 4.2- 8.2) 5.0 ( 3.6- 6.9)
Detroit 3.3 ( 2.6- 4.1) 3.5 ( 2.7- 4.4) 2.5 ( 1.9- 3.4) 3.0 ( 2.2- 4.0) 5.9 ( 3.9- 8.5) 5.3 ( 3.6- 7.6)
Ohio 1.5 ( 1.3- 1.9) 1.7 ( 1.4- 2.0) 1.4 ( 1.1- 1.7) 1.5 ( 1.2- 1.9) 2.6 ( 1.5- 4.2) 2.3 ( 1.3- 3.8)
Wisconsin 2.0 ( 1.5- 2.6) 2.1 ( 1.6- 2.7) 1.9 ( 1.4- 2.5) 2.1 ( 1.6- 2.8) ∼ ∼
West North Central 1.5 ( 1.3- 1.8) 1.7 ( 1.4- 1.9) 1.5 ( 1.3- 1.8) 1.7 ( 1.4- 2.0) ∼ ∼
Iowa 1.7 ( 1.1- 2.4) 2.0 ( 1.3- 2.8) 1.6 ( 1.1- 2.4) 2.0 ( 1.3- 2.8) ∼ ∼
Kansas 1.2 ( 0.7- 2.0) 1.3 ( 0.8- 2.1) 1.2 ( 0.7- 2.0) 1.4 ( 0.8- 2.2) ∼ ∼
Minnesota 1.2 ( 0.8- 1.8) 1.2 ( 0.8- 1.8) 1.3 ( 0.9- 1.8) 1.3 ( 0.9- 1.9) ∼ ∼
Missouri 1.8 ( 1.4- 2.4) 2.0 ( 1.5- 2.6) 1.8 ( 1.3- 2.4) 2.0 ( 1.5- 2.7) ∼ ∼
Nebraska ∼ ∼ ∼ ∼ ∼ ∼




Delaware ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼
Florida 2.3 ( 2.0- 2.6) 2.9 ( 2.6- 3.3) 2.4 ( 2.0- 2.7) 3.2 ( 2.8- 3.7) 1.9 ( 1.1- 3.1) 1.4 ( 0.8- 2.2)
Georgia
Atlanta 1.8 ( 1.1- 2.9) 1.4 ( 0.9- 2.2) ∼ ∼ ∼ ∼
Maryland 1.8 ( 1.3- 2.4) 1.8 ( 1.3- 2.4) 1.9 ( 1.3- 2.6) 2.1 ( 1.5- 2.9) ∼ ∼
North Carolina 1.6 ( 1.2- 2.0) 1.7 ( 1.3- 2.2) 1.6 ( 1.2- 2.1) 1.9 ( 1.4- 2.5) ∼ ∼
South Carolina 2.2 ( 1.6- 2.9) 2.3 ( 1.7- 3.1) 2.3 ( 1.6- 3.3) 2.6 ( 1.8- 3.6) ∼ ∼
Virginia
West Virginia 2.4 ( 1.6- 3.6) 2.9 ( 1.9- 4.2) 2.5 ( 1.6- 3.7) 3.0 ( 2.0- 4.4) ∼ ∼
East South Central
Alabama













Table 2.8.2: Cancer of the Larynx. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 2.5 ( 1.9- 3.3) 2.6 ( 1.9- 3.3) 2.5 ( 1.8- 3.4) 2.8 ( 2.0- 3.8) 2.8 ( 1.6- 4.5) 2.3 ( 1.3- 3.6)
Oklahoma
Texas
West 1.3 ( 1.2- 1.5) 1.3 ( 1.2- 1.4) 1.4 ( 1.2- 1.5) 1.4 ( 1.2- 1.5) 2.1 ( 1.4- 3.2) 1.6 ( 1.1- 2.4)
Mountain
Arizona 1.7 ( 1.2- 2.3) 1.8 ( 1.3- 2.4) 1.8 ( 1.3- 2.4) 2.0 ( 1.4- 2.7) ∼ ∼
Colorado 1.3 ( 0.8- 1.9) 1.2 ( 0.8- 1.8) 1.3 ( 0.8- 1.9) 1.3 ( 0.8- 1.9) ∼ ∼
Idaho ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼
Nevada
New Mexico ∼ ∼ ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 1.3 ( 1.2- 1.5) 1.3 ( 1.1- 1.4) 1.4 ( 1.2- 1.6) 1.4 ( 1.2- 1.6) 2.3 ( 1.5- 3.5) 1.8 ( 1.2- 2.6)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 1.2 ( 1.1- 1.4) 1.2 ( 1.0- 1.3) 1.3 ( 1.1- 1.5) 1.3 ( 1.1- 1.5) 2.1 ( 1.3- 3.3) 1.6 ( 1.0- 2.5)
San Francisco-Oakland 1.1 ( 0.7- 1.7) 1.2 ( 0.8- 1.7) 1.3 ( 0.8- 2.1) 1.5 ( 0.9- 2.3) ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼ ∼ ∼
Los Angeles 1.1 ( 0.8- 1.4) 1.0 ( 0.7- 1.3) 1.1 ( 0.7- 1.5) 1.0 ( 0.7- 1.4) ∼ ∼
Hawaii ∼ ∼ ∼ ∼ ∼ ∼
Oregon 1.5 ( 1.0- 2.2) 1.7 ( 1.1- 2.4) 1.6 ( 1.1- 2.3) 1.8 ( 1.2- 2.6) ∼ ∼
Washington 1.6 ( 1.2- 2.2) 1.6 ( 1.2- 2.2) 1.6 ( 1.2- 2.2) 1.6 ( 1.2- 2.2) ∼ ∼
Seattle-Puget Sound 1.5 ( 1.0- 2.1) 1.5 ( 1.0- 2.1) 1.3 ( 0.9- 2.0) 1.4 ( 0.9- 2.1) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.9.1: Cancer of the Lung and Bronchus. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 89.1 ( 88.5- 89.7) 80.0 ( 79.5- 80.6) 87.8 ( 87.2- 88.5) 84.2 ( 83.6- 84.8) 110.7 (108.3- 113.3) 68.7 ( 67.2- 70.2)
Northeast 86.8 ( 85.6- 88.0) 82.7 ( 81.6- 83.9) 86.0 ( 84.7- 87.3) 87.9 ( 86.6- 89.2) 97.2 ( 92.7- 101.9) 63.1 ( 60.3- 66.0)
New England 88.2 ( 85.7- 90.8) 82.3 ( 80.0- 84.7) 87.9 ( 85.3- 90.5) 86.5 ( 84.0- 89.1) 93.8 ( 79.9- 110.0) 48.5 ( 41.7- 56.1)
Connecticut 84.5 ( 79.9- 89.2) 81.1 ( 76.8- 85.7) 83.8 ( 79.1- 88.7) 85.4 ( 80.7- 90.4) 95.5 ( 74.8- 121.5) 55.4 ( 44.0- 68.9)
Maine
Massachusetts 88.1 ( 84.6- 91.7) 81.9 ( 78.6- 85.2) 87.7 ( 84.2- 91.4) 86.5 ( 83.0- 90.1) 85.7 ( 67.3- 109.3) 42.2 ( 33.6- 52.3)
New Hampshire 83.5 ( 75.7- 92.1) 70.9 ( 64.3- 78.0) 83.7 ( 75.7- 92.3) 71.9 ( 65.2- 79.2) ∼ ∼
Rhode Island 105.0 ( 95.9- 114.8) 103.4 ( 94.5-113.0) 105.4 ( 96.0- 115.4) 108.9 ( 99.3-119.2) ∼ ∼
Vermont
Middle Atlantic 86.4 ( 85.1- 87.8) 82.8 ( 81.5- 84.1) 85.4 ( 84.0- 86.9) 88.4 ( 86.9- 89.9) 97.6 ( 92.9- 102.6) 65.1 ( 62.1- 68.3)
New Jersey 86.1 ( 83.1- 89.2) 80.1 ( 77.3- 82.9) 85.1 ( 81.9- 88.4) 86.4 ( 83.1- 89.7) 107.4 ( 96.5- 119.4) 69.1 ( 62.5- 76.3)
New York 80.7 ( 78.7- 82.7) 73.9 ( 72.1- 75.7) 81.8 ( 79.7- 84.0) 81.9 ( 79.7- 84.1) 74.1 ( 68.6- 79.9) 49.7 ( 46.2- 53.4)
Pennsylvania 94.2 ( 91.8- 96.8) 98.3 ( 95.7-100.9) 89.9 ( 87.4- 92.5) 98.2 ( 95.5-100.9) 147.2 (135.1- 160.2) 103.2 ( 94.9-112.1)
Midwest
East North Central
Illinois 95.8 ( 93.1- 98.6) 81.7 ( 79.4- 84.0) 92.4 ( 89.6- 95.4) 83.9 ( 81.4- 86.6) 126.3 (116.7- 136.6) 78.3 ( 72.5- 84.4)
Indiana
Michigan 94.6 ( 91.6- 97.6) 82.7 ( 80.2- 85.3) 90.9 ( 87.8- 94.0) 83.5 ( 80.7- 86.3) 127.6 (117.2- 138.8) 86.3 ( 79.4- 93.7)
Detroit 100.5 ( 95.7- 105.4) 88.6 ( 84.5- 92.8) 93.5 ( 88.3- 98.9) 88.0 ( 83.2- 92.9) 133.4 (121.2- 146.6) 98.0 ( 89.1-107.5)
Ohio 102.5 ( 99.7- 105.4) 94.3 ( 91.7- 96.9) 99.7 ( 96.7- 102.6) 95.3 ( 92.5- 98.1) 123.3 (112.6- 135.0) 84.2 ( 77.0- 91.7)
Wisconsin 83.0 ( 79.3- 86.7) 75.5 ( 72.2- 78.9) 81.5 ( 77.8- 85.3) 77.8 ( 74.3- 81.5) 135.0 (104.4- 175.4) 57.5 ( 45.7- 71.3)
West North Central 88.8 ( 86.8- 90.9) 82.0 ( 80.1- 83.9) 86.8 ( 84.8- 88.9) 83.5 ( 81.5- 85.5) 134.8 (121.4- 149.5) 77.1 ( 69.7- 85.1)
Iowa 88.0 ( 83.1- 93.0) 88.1 ( 83.2- 93.1) 87.6 ( 82.8- 92.8) 89.8 ( 84.8- 95.0) 148.1 ( 86.9- 244.5) 67.2 ( 41.1-103.8)
Kansas 91.9 ( 86.5- 97.5) 82.6 ( 77.8- 87.7) 90.4 ( 84.9- 96.2) 84.7 ( 79.6- 90.1) 131.4 ( 98.7- 172.9) 72.9 ( 55.2- 94.5)
Minnesota 74.4 ( 70.7- 78.3) 64.3 ( 61.1- 67.6) 73.2 ( 69.5- 77.1) 66.2 ( 62.8- 69.7) 123.5 ( 85.2- 183.4) 49.7 ( 35.2- 68.2)
Missouri 105.2 (101.2- 109.4) 98.5 ( 94.7-102.3) 102.4 ( 98.2- 106.7) 100.5 ( 96.4-104.6) 136.0 (119.4- 154.5) 87.7 ( 77.2- 99.2)
Nebraska 78.3 ( 72.1- 84.9) 73.1 ( 67.4- 79.2) 75.6 ( 69.5- 82.2) 73.1 ( 67.2- 79.4) 130.3 ( 81.9- 206.0) 72.3 ( 46.3-107.6)




Delaware 109.9 ( 98.7- 122.2) 100.4 ( 90.4-111.2) 107.8 ( 96.0- 121.0) 108.4 ( 96.7-121.2) 130.9 ( 96.4- 176.8) 74.9 ( 56.1- 97.9)
District of Columbia 111.4 ( 98.2- 126.2) 105.7 ( 93.2-119.5) 63.7 ( 46.7- 87.0) 53.7 ( 39.6- 71.2) 134.6 (116.4- 155.2) 134.7 (116.5-154.8)
Florida 101.8 ( 99.6- 103.9) 120.7 (118.2-123.2) 101.3 ( 99.1- 103.6) 133.5 (130.6-136.4) 110.4 (101.7- 119.8) 61.6 ( 57.1- 66.4)
Georgia
Atlanta 89.1 ( 82.1- 96.7) 51.6 ( 47.7- 55.6) 80.8 ( 73.3- 89.1) 54.1 ( 49.2- 59.2) 123.2 (104.3- 145.4) 50.1 ( 43.4- 57.6)
Maryland 92.1 ( 87.9- 96.5) 75.7 ( 72.3- 79.2) 90.0 ( 85.4- 94.9) 83.7 ( 79.4- 88.1) 104.5 ( 94.2- 115.9) 62.5 ( 56.7- 68.7)
North Carolina 103.2 ( 99.7- 106.9) 89.8 ( 86.8- 92.9) 101.9 ( 98.0- 105.9) 97.1 ( 93.5-100.8) 111.8 (102.4- 121.9) 70.6 ( 64.8- 76.7)
South Carolina 109.5 (104.4- 114.9) 97.1 ( 92.7-101.6) 108.9 (103.2- 115.0) 108.0 (102.4-113.7) 110.8 ( 99.8- 122.9) 72.7 ( 65.7- 80.3)
Virginia
West Virginia 126.3 (119.1- 134.0) 133.6 (126.0-141.5) 126.4 (119.0- 134.1) 134.8 (127.1-142.9) 96.2 ( 59.5- 148.0) 77.7 ( 48.1-118.8)
East South Central
Alabama













Table 2.9.1: Cancer of the Lung and Bronchus. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 114.9 (109.9- 120.2) 95.3 ( 91.2- 99.6) 107.5 (101.9- 113.4) 100.7 ( 95.5-106.1) 142.1 (130.5- 154.6) 87.7 ( 80.7- 95.1)
Oklahoma
Texas
West 72.1 ( 71.0- 73.2) 57.7 ( 56.9- 58.6) 72.3 ( 71.1- 73.4) 60.5 ( 59.5- 61.5) 91.8 ( 85.6- 98.5) 54.3 ( 50.7- 58.0)
Mountain
Arizona 75.8 ( 72.2- 79.6) 69.5 ( 66.2- 73.0) 76.8 ( 73.0- 80.7) 75.0 ( 71.3- 78.8) 88.6 ( 61.9- 127.2) 47.1 ( 33.9- 63.6)
Colorado 63.2 ( 59.1- 67.5) 47.3 ( 44.4- 50.4) 63.5 ( 59.3- 68.0) 48.8 ( 45.7- 52.1) 53.8 ( 34.1- 84.4) 30.0 ( 19.8- 43.7)
Idaho 69.0 ( 62.0- 76.6) 57.7 ( 51.9- 64.0) 69.5 ( 62.4- 77.2) 59.1 ( 53.1- 65.5) ∼ ∼
Montana 76.6 ( 68.5- 85.5) 74.4 ( 66.6- 82.9) 74.0 ( 65.9- 82.9) 75.4 ( 67.2- 84.3) ∼ ∼
Nevada
New Mexico 60.5 ( 54.9- 66.6) 50.8 ( 46.2- 55.9) 62.0 ( 56.1- 68.4) 56.1 ( 50.8- 61.8) ∼ ∼
Utah 44.3 ( 39.4- 49.6) 28.8 ( 25.7- 32.3) 43.7 ( 38.8- 49.1) 29.1 ( 25.9- 32.7) ∼ ∼
Wyoming 68.9 ( 57.9- 81.7) 59.7 ( 50.4- 70.3) 69.4 ( 58.2- 82.3) 61.3 ( 51.6- 72.2) ∼ ∼
Pacific 74.1 ( 72.8- 75.4) 58.7 ( 57.7- 59.7) 74.6 ( 73.2- 76.0) 61.7 ( 60.5- 62.9) 95.4 ( 88.7- 102.6) 57.0 ( 53.1- 61.1)
Alaska 77.3 ( 63.7- 94.3) 43.0 ( 36.2- 50.8) 74.5 ( 59.9- 93.6) 45.5 ( 37.5- 54.8) ∼ ∼
California 70.5 ( 69.1- 72.0) 54.3 ( 53.1- 55.4) 70.3 ( 68.8- 72.0) 56.8 ( 55.6- 58.1) 94.3 ( 87.3- 101.9) 57.8 ( 53.6- 62.2)
San Francisco-Oakland 68.9 ( 65.0- 73.0) 58.9 ( 55.6- 62.4) 63.8 ( 59.4- 68.5) 58.7 ( 54.6- 62.9) 88.3 ( 74.4- 104.4) 64.0 ( 54.2- 75.1)
San Jose-Monterey 62.5 ( 57.2- 68.3) 44.4 ( 40.6- 48.3) 62.2 ( 56.4- 68.6) 46.9 ( 42.6- 51.6) 110.6 ( 61.1- 198.3) 38.9 ( 23.4- 60.8)
Los Angeles 64.1 ( 61.4- 66.9) 46.1 ( 44.2- 48.1) 60.4 ( 57.4- 63.5) 44.3 ( 42.1- 46.5) 98.0 ( 87.4- 109.6) 68.3 ( 61.2- 76.0)
Hawaii 69.1 ( 62.5- 76.3) 67.3 ( 60.8- 74.2) 90.5 ( 74.8- 108.9) 69.7 ( 57.7- 83.4) ∼ ∼
Oregon 86.1 ( 81.5- 90.9) 80.5 ( 76.3- 85.0) 85.5 ( 80.8- 90.4) 82.6 ( 78.1- 87.3) 132.4 ( 80.5- 212.2) 68.3 ( 42.8-103.4)
Washington 86.6 ( 82.9- 90.5) 72.0 ( 68.9- 75.1) 86.6 ( 82.7- 90.6) 75.4 ( 72.1- 78.9) 112.0 ( 84.9- 148.0) 58.5 ( 44.8- 75.0)
Seattle-Puget Sound 90.3 ( 85.7- 95.2) 73.2 ( 69.5- 77.1) 90.9 ( 86.0- 96.0) 78.1 ( 73.9- 82.4) 118.7 ( 88.5- 159.5) 60.3 ( 45.5- 78.3)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for




ancer Statistics: 1999 Incidence
58
Table 2.9.2: Cancer of the Lung and Bronchus. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 53.4 ( 52.9- 53.8) 59.0 ( 58.6- 59.5) 54.4 ( 54.0- 54.9) 64.1 ( 63.5- 64.6) 50.3 ( 48.9- 51.7) 40.1 ( 39.0- 41.2)
Northeast 53.7 ( 52.9- 54.6) 63.7 ( 62.8- 64.7) 54.8 ( 53.9- 55.7) 69.4 ( 68.3- 70.5) 45.8 ( 43.3- 48.3) 39.3 ( 37.2- 41.5)
New England 58.3 ( 56.5- 60.2) 67.3 ( 65.3- 69.4) 58.7 ( 56.8- 60.6) 71.0 ( 68.8- 73.3) 49.3 ( 41.1- 58.7) 33.6 ( 28.1- 39.8)
Connecticut 54.3 ( 51.0- 57.7) 63.9 ( 60.1- 67.8) 54.7 ( 51.4- 58.3) 68.2 ( 64.1- 72.5) 50.2 ( 38.3- 65.1) 38.4 ( 29.4- 49.2)
Maine
Massachusetts 59.0 ( 56.5- 61.6) 68.4 ( 65.5- 71.3) 59.0 ( 56.5- 61.7) 72.1 ( 69.1- 75.3) 51.3 ( 39.4- 66.0) 31.8 ( 24.6- 40.4)
New Hampshire 61.0 ( 54.9- 67.6) 61.6 ( 55.5- 68.1) 61.0 ( 54.9- 67.6) 62.1 ( 55.9- 68.8) ∼ ∼
Rhode Island 65.2 ( 58.9- 72.1) 78.9 ( 71.4- 87.0) 66.6 ( 60.0- 73.8) 84.1 ( 76.0- 92.8) ∼ ∼
Vermont
Middle Atlantic 52.4 ( 51.5- 53.4) 62.6 ( 61.6- 63.8) 53.6 ( 52.6- 54.6) 68.8 ( 67.5- 70.1) 45.4 ( 42.9- 48.1) 40.1 ( 37.8- 42.4)
New Jersey 55.5 ( 53.4- 57.6) 64.5 ( 62.1- 67.0) 57.2 ( 54.9- 59.6) 72.6 ( 69.7- 75.5) 51.5 ( 45.4- 58.3) 42.0 ( 37.1- 47.4)
New York 51.5 ( 50.1- 52.9) 59.2 ( 57.6- 60.7) 54.4 ( 52.8- 56.0) 67.8 ( 65.9- 69.8) 36.6 ( 33.6- 39.8) 32.3 ( 29.7- 35.1)
Pennsylvania 51.9 ( 50.3- 53.5) 66.7 ( 64.7- 68.7) 50.6 ( 49.0- 52.3) 67.8 ( 65.7- 70.1) 63.7 ( 57.3- 70.5) 59.7 ( 53.8- 66.1)
Midwest
East North Central
Illinois 54.8 ( 53.0- 56.6) 58.8 ( 56.9- 60.8) 54.0 ( 52.1- 56.0) 62.0 ( 59.8- 64.2) 62.0 ( 56.5- 67.8) 49.9 ( 45.5- 54.5)
Indiana
Michigan 57.4 ( 55.4- 59.5) 61.2 ( 59.1- 63.4) 56.5 ( 54.3- 58.7) 63.5 ( 61.1- 66.0) 66.8 ( 60.5- 73.7) 54.5 ( 49.3- 60.0)
Detroit 59.6 ( 56.5- 62.8) 65.3 ( 61.9- 68.9) 59.0 ( 55.5- 62.7) 70.5 ( 66.4- 74.9) 63.8 ( 56.8- 71.5) 55.1 ( 49.0- 61.6)
Ohio 56.1 ( 54.3- 58.0) 63.9 ( 61.8- 66.0) 55.3 ( 53.5- 57.3) 65.5 ( 63.3- 67.8) 60.8 ( 54.7- 67.5) 52.3 ( 47.0- 58.0)
Wisconsin 46.9 ( 44.4- 49.5) 51.2 ( 48.5- 54.0) 46.3 ( 43.8- 49.0) 53.0 ( 50.2- 56.0) 65.0 ( 48.1- 87.0) 36.0 ( 27.1- 46.8)
West North Central 50.6 ( 49.3- 52.0) 56.7 ( 55.1- 58.2) 50.0 ( 48.6- 51.5) 58.1 ( 56.5- 59.8) 61.8 ( 54.2- 70.1) 44.8 ( 39.4- 50.8)
Iowa 46.2 ( 43.0- 49.5) 56.1 ( 52.4- 60.1) 46.1 ( 42.9- 49.4) 57.0 ( 53.2- 61.1) ∼ ∼
Kansas 52.8 ( 49.1- 56.7) 58.4 ( 54.4- 62.6) 53.3 ( 49.5- 57.4) 61.1 ( 56.8- 65.6) 48.1 ( 31.9- 69.9) 35.6 ( 23.6- 51.4)
Minnesota 45.8 ( 43.2- 48.6) 47.4 ( 44.7- 50.2) 45.0 ( 42.4- 47.8) 48.7 ( 45.8- 51.6) 87.4 ( 57.1- 130.6) 40.2 ( 26.9- 57.8)
Missouri 59.2 ( 56.6- 62.0) 67.2 ( 64.2- 70.3) 58.9 ( 56.1- 61.8) 69.9 ( 66.6- 73.3) 61.9 ( 52.8- 72.2) 49.9 ( 42.5- 58.1)
Nebraska 44.4 ( 40.2- 48.8) 51.3 ( 46.6- 56.3) 43.1 ( 39.0- 47.6) 51.5 ( 46.6- 56.7) ∼ ∼




Delaware 65.8 ( 58.2- 74.1) 70.8 ( 62.7- 79.7) 66.0 ( 57.7- 75.2) 78.3 ( 68.6- 89.0) 65.4 ( 45.5- 91.8) 46.0 ( 32.2- 63.7)
District of Columbia 50.8 ( 43.3- 59.4) 60.6 ( 51.8- 70.5) 39.6 ( 27.9- 57.5) 41.9 ( 29.8- 57.3) 55.4 ( 46.0- 66.8) 71.8 ( 59.7- 85.5)
Florida 62.9 ( 61.4- 64.5) 87.0 ( 84.9- 89.1) 65.5 ( 63.8- 67.2) 99.8 ( 97.3-102.2) 39.1 ( 34.9- 43.6) 28.0 ( 25.1- 31.2)
Georgia
Atlanta 55.1 ( 50.6- 59.8) 41.4 ( 38.0- 44.9) 55.6 ( 50.5- 61.2) 49.6 ( 45.0- 54.5) 52.7 ( 43.6- 63.4) 27.9 ( 23.2- 33.2)
Maryland 57.0 ( 54.1- 59.9) 58.0 ( 55.2- 61.0) 58.7 ( 55.4- 62.2) 68.3 ( 64.5- 72.2) 55.2 ( 49.1- 61.9) 40.0 ( 35.7- 44.8)
North Carolina 51.0 ( 48.9- 53.2) 56.1 ( 53.8- 58.5) 53.8 ( 51.4- 56.3) 64.4 ( 61.5- 67.4) 38.3 ( 34.0- 43.0) 32.3 ( 28.7- 36.2)
South Carolina 46.2 ( 43.4- 49.2) 49.9 ( 46.9- 53.1) 50.4 ( 47.0- 54.0) 60.7 ( 56.7- 65.0) 32.9 ( 28.1- 38.3) 27.1 ( 23.1- 31.5)
Virginia
West Virginia 67.5 ( 63.0- 72.4) 87.3 ( 81.4- 93.5) 67.0 ( 62.3- 71.9) 87.0 ( 81.0- 93.3) 82.5 ( 54.2- 121.8) 93.3 ( 62.0-134.9)
East South Central
Alabama













Table 2.9.2: Cancer of the Lung and Bronchus. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 52.4 ( 49.5- 55.4) 53.9 ( 50.9- 57.0) 54.3 ( 50.9- 58.0) 63.3 ( 59.3- 67.5) 47.4 ( 42.0- 53.4) 37.4 ( 33.2- 42.0)
Oklahoma
Texas
West 48.4 ( 47.6- 49.2) 47.8 ( 47.0- 48.6) 50.4 ( 49.6- 51.3) 52.0 ( 51.1- 52.9) 51.8 ( 47.7- 56.1) 38.1 ( 35.2- 41.2)
Mountain
Arizona 47.7 ( 45.1- 50.4) 52.0 ( 49.2- 55.0) 49.1 ( 46.4- 52.0) 56.8 ( 53.7- 60.1) 29.7 ( 16.7- 50.0) 18.6 ( 10.6- 30.2)
Colorado 40.7 ( 37.9- 43.7) 38.4 ( 35.7- 41.2) 40.9 ( 38.0- 43.9) 39.7 ( 36.9- 42.6) 48.0 ( 30.6- 72.4) 28.8 ( 18.6- 42.5)
Idaho 42.0 ( 37.0- 47.5) 41.5 ( 36.6- 46.9) 42.2 ( 37.2- 47.8) 42.3 ( 37.3- 47.8) ∼ ∼
Montana 48.5 ( 42.6- 55.0) 55.7 ( 48.9- 63.1) 47.0 ( 41.1- 53.6) 56.3 ( 49.3- 64.0) ∼ ∼
Nevada
New Mexico 36.3 ( 32.5- 40.6) 36.2 ( 32.4- 40.4) 38.6 ( 34.4- 43.2) 41.1 ( 36.7- 45.9) ∼ ∼
Utah 22.4 ( 19.2- 25.8) 17.2 ( 14.9- 19.9) 22.5 ( 19.4- 26.1) 17.8 ( 15.3- 20.5) ∼ ∼
Wyoming 46.5 ( 38.4- 56.0) 48.6 ( 40.2- 58.3) 45.9 ( 37.8- 55.6) 49.0 ( 40.4- 59.0) ∼ ∼
Pacific 50.9 ( 50.0- 51.9) 50.1 ( 49.2- 51.1) 53.9 ( 52.8- 54.9) 55.4 ( 54.3- 56.5) 54.1 ( 49.7- 58.7) 40.6 ( 37.4- 44.1)
Alaska 69.3 ( 57.0- 83.9) 42.5 ( 35.3- 50.6) 73.0 ( 58.7- 90.4) 46.7 ( 38.1- 56.7) ∼ ∼
California 48.8 ( 47.7- 49.9) 47.2 ( 46.1- 48.2) 51.4 ( 50.1- 52.6) 52.2 ( 51.0- 53.5) 54.6 ( 50.0- 59.5) 42.3 ( 38.8- 46.1)
San Francisco-Oakland 49.6 ( 46.7- 52.6) 53.9 ( 50.7- 57.2) 54.4 ( 50.7- 58.2) 64.1 ( 59.9- 68.5) 55.7 ( 46.2- 66.9) 47.9 ( 39.8- 57.3)
San Jose-Monterey 44.5 ( 40.6- 48.7) 41.8 ( 38.2- 45.7) 45.8 ( 41.5- 50.5) 46.1 ( 41.8- 50.8) ∼ ∼
Los Angeles 41.5 ( 39.6- 43.4) 38.7 ( 37.0- 40.5) 42.8 ( 40.6- 45.1) 41.1 ( 39.0- 43.3) 51.9 ( 45.6- 58.8) 45.4 ( 40.0- 51.4)
Hawaii 39.5 ( 34.9- 44.7) 44.9 ( 39.6- 50.6) 56.6 ( 44.9- 70.6) 54.0 ( 42.9- 67.0) ∼ ∼
Oregon 60.8 ( 57.3- 64.4) 68.2 ( 64.3- 72.3) 61.6 ( 58.0- 65.4) 71.3 ( 67.2- 75.6) ∼ ∼
Washington 58.5 ( 55.7- 61.3) 58.5 ( 55.7- 61.3) 60.1 ( 57.2- 63.1) 62.9 ( 59.9- 66.1) 52.8 ( 34.9- 77.7) 28.9 ( 19.2- 41.8)
Seattle-Puget Sound 63.3 ( 59.9- 67.0) 62.8 ( 59.4- 66.4) 66.3 ( 62.5- 70.2) 69.5 ( 65.6- 73.6) 54.2 ( 34.8- 81.9) 29.0 ( 18.8- 42.8)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.10.1: Melanomas of the Skin. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 19.0 ( 18.7- 19.3) 17.6 ( 17.3- 17.8) 20.5 ( 20.2- 20.8) 19.9 ( 19.6- 20.2) 1.2 ( 1.0- 1.5) 0.8 ( 0.6- 1.0)
Northeast 16.7 ( 16.2- 17.2) 16.1 ( 15.6- 16.7) 18.3 ( 17.7- 18.9) 18.7 ( 18.1- 19.3) ∼ ∼
New England 22.3 ( 21.0- 23.6) 21.4 ( 20.2- 22.6) 22.9 ( 21.6- 24.2) 22.8 ( 21.5- 24.2) ∼ ∼
Connecticut 25.6 ( 23.1- 28.2) 25.1 ( 22.7- 27.7) 26.2 ( 23.6- 29.0) 26.8 ( 24.2- 29.7) ∼ ∼
Maine
Massachusetts 19.7 ( 18.1- 21.4) 18.9 ( 17.4- 20.6) 20.2 ( 18.6- 22.0) 20.4 ( 18.7- 22.2) ∼ ∼
New Hampshire 23.2 ( 19.2- 28.0) 20.8 ( 17.3- 24.8) 23.6 ( 19.5- 28.4) 21.3 ( 17.7- 25.4) ∼ ∼
Rhode Island 25.6 ( 21.2- 30.8) 24.8 ( 20.5- 29.6) 26.8 ( 22.1- 32.2) 27.0 ( 22.3- 32.3) ∼ ∼
Vermont
Middle Atlantic 15.0 ( 14.5- 15.6) 14.6 ( 14.0- 15.1) 16.8 ( 16.1- 17.5) 17.2 ( 16.6- 17.9) ∼ ∼
New Jersey 19.1 ( 17.7- 20.6) 18.2 ( 16.9- 19.6) 22.3 ( 20.7- 24.0) 22.8 ( 21.2- 24.5) ∼ ∼
New York 11.8 ( 11.1- 12.6) 11.1 ( 10.4- 11.8) 13.8 ( 12.9- 14.7) 13.9 ( 13.0- 14.8) ∼ ∼
Pennsylvania 17.0 ( 15.9- 18.1) 17.3 ( 16.2- 18.4) 17.3 ( 16.2- 18.5) 18.3 ( 17.1- 19.5) ∼ ∼
Midwest
East North Central
Illinois 14.9 ( 13.9- 16.0) 13.4 ( 12.5- 14.3) 16.3 ( 15.1- 17.5) 15.4 ( 14.3- 16.5) ∼ ∼
Indiana
Michigan 22.3 ( 20.9- 23.7) 20.2 ( 18.9- 21.5) 23.5 ( 22.0- 25.1) 22.3 ( 20.9- 23.8) ∼ ∼
Detroit 20.6 ( 18.5- 22.9) 18.6 ( 16.7- 20.6) 25.2 ( 22.6- 28.1) 24.3 ( 21.8- 26.9) ∼ ∼
Ohio 16.6 ( 15.4- 17.7) 15.5 ( 14.5- 16.6) 16.4 ( 15.2- 17.6) 15.9 ( 14.8- 17.1) ∼ ∼
Wisconsin 13.0 ( 11.6- 14.5) 12.3 ( 11.0- 13.7) 13.4 ( 12.0- 15.0) 13.2 ( 11.7- 14.7) ∼ ∼
West North Central 17.1 ( 16.2- 18.0) 16.0 ( 15.2- 16.9) 16.6 ( 15.8- 17.6) 16.1 ( 15.3- 17.0) ∼ ∼
Iowa 20.1 ( 17.8- 22.6) 19.9 ( 17.6- 22.3) 18.9 ( 16.7- 21.4) 19.1 ( 16.8- 21.6) ∼ ∼
Kansas 21.8 ( 19.2- 24.6) 20.0 ( 17.6- 22.6) 20.3 ( 17.8- 23.2) 19.2 ( 16.8- 21.8) ∼ ∼
Minnesota 19.7 ( 17.8- 21.7) 18.0 ( 16.4- 19.8) 19.4 ( 17.6- 21.4) 18.4 ( 16.7- 20.3) ∼ ∼
Missouri 12.4 ( 11.0- 13.8) 11.7 ( 10.4- 13.0) 13.3 ( 11.8- 14.9) 13.0 ( 11.6- 14.6) ∼ ∼
Nebraska 14.6 ( 12.0- 17.6) 13.9 ( 11.4- 16.7) 11.4 ( 9.1- 14.2) 11.0 ( 8.8- 13.6) ∼ ∼




Delaware 16.0 ( 12.0- 21.2) 15.0 ( 11.3- 19.5) 18.1 ( 13.5- 24.1) 18.5 ( 13.8- 24.2) ∼ ∼
District of Columbia 10.8 ( 7.1- 16.0) 11.1 ( 7.3- 16.1) 19.8 ( 11.4- 34.9) 19.0 ( 11.1- 30.5) ∼ ∼
Florida 21.9 ( 20.8- 22.9) 24.6 ( 23.5- 25.8) 23.2 ( 22.1- 24.4) 28.3 ( 27.0- 29.7) ∼ ∼
Georgia
Atlanta 21.8 ( 18.6- 25.5) 15.6 ( 13.5- 17.9) 26.0 ( 22.1- 30.5) 21.5 ( 18.5- 24.9) ∼ ∼
Maryland 22.1 ( 20.1- 24.2) 19.3 ( 17.6- 21.1) 28.4 ( 25.8- 31.1) 27.4 ( 25.0- 30.0) ∼ ∼
North Carolina 17.1 ( 15.7- 18.6) 15.5 ( 14.2- 16.8) 20.7 ( 19.0- 22.5) 20.1 ( 18.5- 21.8) ∼ ∼
South Carolina 21.7 ( 19.5- 24.2) 19.6 ( 17.7- 21.7) 27.5 ( 24.7- 30.7) 27.3 ( 24.6- 30.3) ∼ ∼
Virginia
West Virginia 19.2 ( 16.4- 22.3) 20.0 ( 17.1- 23.2) 17.5 ( 14.9- 20.6) 18.6 ( 15.8- 21.8) ∼ ∼
East South Central
Alabama













Table 2.10.1: Melanomas of the Skin. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 12.1 ( 10.5- 13.9) 10.2 ( 8.9- 11.6) 15.2 ( 13.1- 17.5) 14.4 ( 12.4- 16.5) ∼ ∼
Oklahoma
Texas
West 22.1 ( 21.5- 22.7) 19.0 ( 18.5- 19.5) 24.1 ( 23.5- 24.8) 21.4 ( 20.9- 22.0) ∼ ∼
Mountain
Arizona 20.1 ( 18.2- 22.1) 18.4 ( 16.7- 20.2) 20.9 ( 19.0- 23.1) 20.1 ( 18.2- 22.1) ∼ ∼
Colorado 24.4 ( 22.0- 27.0) 21.1 ( 19.1- 23.2) 25.7 ( 23.2- 28.4) 22.7 ( 20.6- 25.0) ∼ ∼
Idaho 24.0 ( 20.1- 28.6) 21.4 ( 18.0- 25.4) 24.5 ( 20.5- 29.2) 22.1 ( 18.5- 26.2) ∼ ∼
Montana 13.3 ( 10.0- 17.4) 12.7 ( 9.6- 16.6) 11.8 ( 8.7- 15.9) 11.8 ( 8.7- 15.6) ∼ ∼
Nevada
New Mexico 17.7 ( 14.8- 21.1) 15.8 ( 13.2- 18.7) 19.3 ( 16.1- 23.0) 18.3 ( 15.3- 21.6) ∼ ∼
Utah 28.4 ( 24.6- 32.6) 20.4 ( 17.7- 23.3) 29.4 ( 25.5- 33.7) 21.4 ( 18.6- 24.5) ∼ ∼
Wyoming 28.1 ( 21.4- 36.5) 25.7 ( 19.7- 33.0) 28.7 ( 21.8- 37.3) 26.7 ( 20.5- 34.3) ∼ ∼
Pacific 22.2 ( 21.5- 22.9) 18.9 ( 18.4- 19.5) 24.6 ( 23.8- 25.4) 21.7 ( 21.0- 22.4) ∼ ∼
Alaska 14.4 ( 8.3- 24.6) 8.3 ( 5.5- 12.1) 15.2 ( 8.8- 27.0) 10.1 ( 6.5- 14.9) ∼ ∼
California 22.1 ( 21.3- 22.9) 18.3 ( 17.7- 19.0) 24.4 ( 23.4- 25.3) 20.9 ( 20.1- 21.7) ∼ ∼
San Francisco-Oakland 19.0 ( 17.0- 21.2) 17.5 ( 15.7- 19.4) 24.9 ( 22.2- 27.8) 24.3 ( 21.8- 27.1) ∼ ∼
San Jose-Monterey 20.3 ( 17.5- 23.5) 16.7 ( 14.4- 19.2) 20.5 ( 17.3- 24.1) 17.4 ( 14.8- 20.3) ∼ ∼
Los Angeles 17.4 ( 16.0- 18.9) 13.5 ( 12.5- 14.6) 21.4 ( 19.7- 23.3) 16.8 ( 15.4- 18.2) ∼ ∼
Hawaii 19.6 ( 16.2- 23.6) 19.1 ( 15.8- 23.0) 55.2 ( 43.4- 69.4) 47.2 ( 37.5- 58.8) ∼ ∼
Oregon 23.7 ( 21.4- 26.3) 23.2 ( 20.9- 25.7) 24.4 ( 21.9- 27.0) 24.4 ( 22.0- 27.0) ∼ ∼
Washington 23.3 ( 21.5- 25.3) 21.2 ( 19.6- 23.0) 25.3 ( 23.3- 27.4) 23.8 ( 21.9- 25.8) ∼ ∼
Seattle-Puget Sound 23.4 ( 21.2- 25.9) 21.3 ( 19.3- 23.4) 25.7 ( 23.3- 28.4) 24.4 ( 22.1- 26.9) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.10.2: Melanomas of the Skin. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 12.1 ( 11.9- 12.3) 12.7 ( 12.5- 12.9) 13.4 ( 13.1- 13.6) 14.4 ( 14.2- 14.7) 0.9 ( 0.7- 1.1) 0.7 ( 0.6- 0.9)
Northeast 10.4 ( 10.0- 10.7) 11.5 ( 11.0- 11.9) 11.6 ( 11.1- 12.0) 13.2 ( 12.8- 13.7) ∼ ∼
New England 14.9 ( 14.0- 15.9) 16.2 ( 15.2- 17.2) 15.3 ( 14.3- 16.3) 17.0 ( 16.0- 18.2) ∼ ∼
Connecticut 15.9 ( 14.1- 17.9) 17.3 ( 15.4- 19.4) 16.1 ( 14.2- 18.2) 18.0 ( 15.9- 20.3) ∼ ∼
Maine
Massachusetts 13.9 ( 12.6- 15.2) 15.1 ( 13.8- 16.5) 14.3 ( 13.0- 15.7) 16.1 ( 14.7- 17.6) ∼ ∼
New Hampshire 19.0 ( 15.7- 22.8) 19.7 ( 16.3- 23.6) 19.1 ( 15.8- 23.0) 20.0 ( 16.5- 23.9) ∼ ∼
Rhode Island 12.9 ( 10.1- 16.3) 15.0 ( 11.8- 18.7) 13.6 ( 10.7- 17.3) 16.3 ( 12.8- 20.3) ∼ ∼
Vermont
Middle Atlantic 9.0 ( 8.6- 9.4) 10.0 ( 9.6- 10.5) 10.3 ( 9.9- 10.8) 11.9 ( 11.4- 12.5) ∼ ∼
New Jersey 11.5 ( 10.6- 12.6) 12.8 ( 11.7- 13.9) 13.8 ( 12.6- 15.0) 15.9 ( 14.6- 17.3) ∼ ∼
New York 7.3 ( 6.8- 7.8) 8.0 ( 7.4- 8.6) 8.8 ( 8.1- 9.4) 10.0 ( 9.3- 10.8) ∼ ∼
Pennsylvania 9.9 ( 9.2- 10.7) 11.3 ( 10.5- 12.2) 10.3 ( 9.5- 11.1) 12.0 ( 11.1- 13.0) ∼ ∼
Midwest
East North Central
Illinois 8.7 ( 8.0- 9.4) 9.0 ( 8.3- 9.8) 9.9 ( 9.1- 10.8) 10.6 ( 9.7- 11.6) ∼ ∼
Indiana
Michigan 15.3 ( 14.2- 16.4) 15.7 ( 14.6- 16.8) 16.7 ( 15.5- 17.9) 17.6 ( 16.3- 18.9) ∼ ∼
Detroit 13.3 ( 11.8- 14.9) 13.9 ( 12.4- 15.6) 17.1 ( 15.1- 19.2) 18.6 ( 16.5- 20.9) ∼ ∼
Ohio 11.0 ( 10.2- 11.9) 11.6 ( 10.8- 12.6) 11.3 ( 10.4- 12.2) 12.1 ( 11.2- 13.1) ∼ ∼
Wisconsin 9.1 ( 8.0- 10.3) 9.4 ( 8.3- 10.6) 9.4 ( 8.2- 10.6) 9.9 ( 8.7- 11.3) ∼ ∼
West North Central 11.9 ( 11.2- 12.6) 12.5 ( 11.8- 13.3) 11.6 ( 10.9- 12.4) 12.5 ( 11.7- 13.2) ∼ ∼
Iowa 14.2 ( 12.4- 16.2) 15.5 ( 13.5- 17.6) 13.4 ( 11.7- 15.5) 14.9 ( 13.0- 17.1) ∼ ∼
Kansas 12.4 ( 10.6- 14.4) 13.1 ( 11.3- 15.2) 11.2 ( 9.5- 13.2) 12.2 ( 10.3- 14.3) ∼ ∼
Minnesota 15.6 ( 14.1- 17.3) 15.9 ( 14.4- 17.6) 15.4 ( 13.9- 17.1) 16.0 ( 14.4- 17.8) ∼ ∼
Missouri 7.4 ( 6.5- 8.5) 8.0 ( 7.0- 9.1) 7.9 ( 6.9- 9.1) 8.8 ( 7.7- 10.0) ∼ ∼
Nebraska 13.9 ( 11.5- 16.7) 14.0 ( 11.6- 16.7) 11.5 ( 9.2- 14.1) 11.7 ( 9.4- 14.3) ∼ ∼




Delaware 10.7 ( 7.7- 14.5) 11.1 ( 8.0- 15.0) 12.2 ( 8.7- 16.8) 13.4 ( 9.6- 18.2) ∼ ∼
District of Columbia 5.9 ( 3.6- 9.7) 7.2 ( 4.4- 11.1) ∼ ∼ ∼ ∼
Florida 12.3 ( 11.6- 13.1) 14.6 ( 13.7- 15.4) 13.5 ( 12.7- 14.4) 16.7 ( 15.7- 17.8) ∼ ∼
Georgia
Atlanta 10.9 ( 9.1- 13.0) 10.2 ( 8.6- 12.0) 14.1 ( 11.8- 16.9) 14.4 ( 12.0- 17.1) ∼ ∼
Maryland 14.4 ( 13.1- 16.0) 14.9 ( 13.5- 16.5) 20.0 ( 18.0- 22.1) 21.7 ( 19.6- 24.0) ∼ ∼
North Carolina 11.3 ( 10.3- 12.3) 11.7 ( 10.7- 12.8) 14.0 ( 12.7- 15.4) 15.2 ( 13.8- 16.6) ∼ ∼
South Carolina 13.2 ( 11.7- 14.8) 13.7 ( 12.1- 15.4) 17.5 ( 15.5- 19.9) 19.0 ( 16.8- 21.5) ∼ ∼
Virginia
West Virginia 11.5 ( 9.5- 13.9) 12.8 ( 10.6- 15.3) 10.4 ( 8.5- 12.7) 11.7 ( 9.5- 14.1) ∼ ∼
East South Central
Alabama













Table 2.10.2: Melanomas of the Skin. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 6.5 ( 5.5- 7.7) 6.6 ( 5.6- 7.7) 9.1 ( 7.7- 10.7) 9.8 ( 8.3- 11.5) ∼ ∼
Oklahoma
Texas
West 14.4 ( 14.0- 14.9) 14.3 ( 13.8- 14.7) 15.8 ( 15.4- 16.3) 15.9 ( 15.4- 16.4) 1.3 ( 0.8- 2.1) 1.2 ( 0.7- 1.8)
Mountain
Arizona 12.4 ( 11.0- 13.9) 12.5 ( 11.1- 14.0) 13.6 ( 12.0- 15.2) 14.0 ( 12.5- 15.7) ∼ ∼
Colorado 16.9 ( 15.2- 18.8) 17.0 ( 15.3- 18.9) 18.0 ( 16.1- 20.0) 18.3 ( 16.4- 20.3) ∼ ∼
Idaho 15.8 ( 12.8- 19.4) 15.3 ( 12.4- 18.7) 16.3 ( 13.2- 19.9) 15.8 ( 12.8- 19.3) ∼ ∼
Montana 9.5 ( 6.8- 12.9) 9.7 ( 7.0- 13.1) 8.9 ( 6.2- 12.4) 9.3 ( 6.6- 12.7) ∼ ∼
Nevada
New Mexico 9.8 ( 7.8- 12.1) 9.6 ( 7.7- 11.9) 10.6 ( 8.5- 13.3) 10.8 ( 8.6- 13.4) ∼ ∼
Utah 17.5 ( 14.8- 20.5) 14.6 ( 12.4- 17.1) 18.3 ( 15.5- 21.4) 15.4 ( 13.1- 18.0) ∼ ∼
Wyoming 12.5 ( 8.4- 18.0) 13.0 ( 8.8- 18.5) 12.9 ( 8.7- 18.6) 13.6 ( 9.2- 19.3) ∼ ∼
Pacific 14.6 ( 14.1- 15.1) 14.4 ( 13.9- 15.0) 16.3 ( 15.7- 16.9) 16.3 ( 15.7- 16.9) 1.2 ( 0.7- 2.1) 1.1 ( 0.7- 1.8)
Alaska 7.2 ( 4.2- 12.5) 6.5 ( 3.9- 10.1) 9.1 ( 5.3- 16.0) 8.7 ( 5.2- 13.6) ∼ ∼
California 13.9 ( 13.3- 14.5) 13.5 ( 13.0- 14.1) 15.2 ( 14.5- 15.9) 15.1 ( 14.4- 15.8) ∼ ∼
San Francisco-Oakland 13.3 ( 11.8- 14.9) 14.2 ( 12.6- 15.9) 18.4 ( 16.3- 20.8) 20.2 ( 17.9- 22.8) ∼ ∼
San Jose-Monterey 14.5 ( 12.4- 17.0) 14.2 ( 12.1- 16.5) 13.6 ( 11.2- 16.2) 13.6 ( 11.3- 16.3) ∼ ∼
Los Angeles 11.0 ( 10.1- 12.0) 10.5 ( 9.6- 11.4) 13.8 ( 12.6- 15.2) 13.1 ( 11.9- 14.4) ∼ ∼
Hawaii 9.7 ( 7.4- 12.6) 10.3 ( 7.9- 13.3) 26.9 ( 19.3- 36.9) 27.7 ( 19.9- 37.4) ∼ ∼
Oregon 16.5 ( 14.7- 18.6) 17.4 ( 15.5- 19.5) 16.6 ( 14.7- 18.7) 17.7 ( 15.7- 19.9) ∼ ∼
Washington 19.4 ( 17.8- 21.0) 19.6 ( 18.0- 21.3) 21.3 ( 19.5- 23.1) 21.9 ( 20.2- 23.8) ∼ ∼
Seattle-Puget Sound 18.9 ( 17.0- 20.9) 19.2 ( 17.4- 21.3) 20.9 ( 18.9- 23.2) 21.9 ( 19.7- 24.2) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.11: Cancer of the Breast. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 134.1 (133.4- 134.8) 143.2 (142.5-143.9) 136.3 (135.5- 137.0) 152.7 (151.9-153.5) 112.7 (110.7- 114.7) 94.9 ( 93.3- 96.6)
Northeast 136.1 (134.8- 137.5) 153.6 (152.1-155.1) 138.5 (137.0- 140.0) 164.1 (162.4-165.8) 101.9 ( 98.3- 105.7) 90.9 ( 87.7- 94.2)
New England 145.1 (142.2- 148.1) 160.7 (157.5-163.9) 145.1 (142.1- 148.2) 167.0 (163.6-170.5) 107.3 ( 95.5- 120.2) 79.9 ( 71.4- 89.2)
Connecticut 150.1 (144.6- 155.8) 169.6 (163.5-176.0) 149.3 (143.5- 155.3) 176.3 (169.6-183.2) 121.8 (103.2- 143.2) 98.4 ( 83.7-114.9)
Maine
Massachusetts 144.7 (140.7- 148.7) 160.3 (156.0-164.8) 145.1 (141.0- 149.4) 168.1 (163.4-172.9) 94.4 ( 79.0- 112.4) 67.4 ( 56.7- 79.6)
New Hampshire 137.9 (128.7- 147.6) 138.6 (129.4-148.3) 136.3 (127.1- 146.1) 138.1 (128.9-147.9) ∼ ∼
Rhode Island 139.7 (130.1- 150.0) 159.6 (148.9-170.9) 142.1 (132.1- 152.8) 168.0 (156.5-180.1) 133.0 ( 76.9- 226.3) 77.6 ( 47.4-119.9)
Vermont
Middle Atlantic 133.5 (132.0- 135.1) 151.4 (149.7-153.1) 136.3 (134.7- 138.0) 163.1 (161.1-165.1) 101.4 ( 97.6- 105.3) 92.4 ( 88.9- 95.9)
New Jersey 139.6 (136.2- 143.0) 155.4 (151.7-159.2) 145.8 (142.0- 149.7) 172.6 (168.1-177.1) 109.0 (100.3- 118.4) 94.2 ( 86.7-102.1)
New York 128.7 (126.5- 130.9) 141.8 (139.5-144.3) 132.7 (130.2- 135.2) 155.1 (152.3-158.1) 90.1 ( 85.4- 94.9) 82.9 ( 78.7- 87.3)
Pennsylvania 136.2 (133.5- 138.9) 163.3 (160.1-166.5) 135.1 (132.3- 138.0) 167.7 (164.3-171.1) 125.1 (116.1- 134.6) 116.7 (108.3-125.5)
Midwest
East North Central
Illinois 136.6 (133.7- 139.5) 142.9 (140.0-145.9) 137.0 (133.9- 140.2) 150.6 (147.2-154.0) 122.2 (114.7- 130.1) 102.4 ( 96.1-108.9)
Indiana
Michigan 131.6 (128.5- 134.7) 137.8 (134.6-141.1) 132.8 (129.5- 136.2) 145.3 (141.7-149.0) 121.7 (113.3- 130.7) 103.4 ( 96.2-110.9)
Detroit 129.9 (125.3- 134.7) 139.0 (134.0-144.1) 131.8 (126.4- 137.3) 150.9 (144.8-157.2) 125.0 (115.2- 135.4) 111.6 (102.9-120.8)
Ohio 135.8 (132.9- 138.7) 148.5 (145.4-151.7) 134.3 (131.3- 137.4) 151.9 (148.5-155.3) 117.9 (109.4- 127.0) 103.4 ( 96.0-111.3)
Wisconsin 132.8 (128.6- 137.1) 142.3 (137.8-146.9) 132.2 (127.9- 136.7) 147.4 (142.6-152.3) 140.8 (116.7- 169.7) 89.0 ( 74.7-105.3)
West North Central 133.1 (130.8- 135.4) 144.1 (141.6-146.5) 132.9 (130.6- 135.3) 148.5 (145.9-151.2) 120.5 (110.1- 131.6) 92.7 ( 84.8-101.2)
Iowa 132.3 (126.8- 138.1) 153.2 (146.9-159.6) 132.8 (127.2- 138.6) 156.2 (149.8-162.8) 127.3 ( 81.7- 191.2) 88.8 ( 57.5-131.1)
Kansas 135.8 (129.8- 142.0) 145.7 (139.3-152.3) 134.6 (128.4- 141.0) 148.6 (141.8-155.5) 110.9 ( 86.1- 141.1) 87.7 ( 68.2-110.9)
Minnesota 140.1 (135.4- 144.9) 143.9 (139.2-148.8) 139.5 (134.8- 144.4) 148.9 (144.0-154.1) 107.0 ( 74.1- 152.4) 55.5 ( 39.6- 75.5)
Missouri 127.7 (123.7- 131.8) 138.9 (134.6-143.3) 127.5 (123.3- 131.8) 144.2 (139.5-149.1) 125.1 (112.2- 139.2) 104.3 ( 93.6-116.0)
Nebraska 130.4 (123.0- 138.1) 142.9 (135.0-151.2) 129.9 (122.4- 137.7) 146.2 (137.9-154.8) 112.9 ( 74.2- 167.2) 80.0 ( 53.2-115.6)




Delaware 138.0 (126.8- 150.0) 145.5 (133.8-158.1) 137.9 (125.6- 151.2) 157.3 (143.4-172.2) 127.8 (100.6- 161.1) 100.9 ( 79.9-125.8)
District of Columbia 138.0 (125.3- 152.0) 157.0 (142.6-172.5) 162.8 (137.9- 193.2) 167.5 (142.3-196.0) 126.3 (111.3- 143.4) 150.4 (132.7-169.8)
Florida 132.9 (130.5- 135.2) 166.3 (163.4-169.1) 136.5 (134.0- 139.1) 184.9 (181.6-188.2) 100.3 ( 93.8- 107.2) 76.4 ( 71.6- 81.5)
Georgia
Atlanta 141.3 (134.4- 148.4) 119.4 (113.7-125.3) 139.8 (131.9- 148.1) 133.8 (126.2-141.7) 144.2 (129.8- 159.9) 94.3 ( 85.5-103.7)
Maryland 137.0 (132.6- 141.5) 139.6 (135.2-144.2) 139.6 (134.4- 144.9) 155.3 (149.6-161.2) 127.7 (118.9- 137.1) 106.9 ( 99.7-114.4)
North Carolina 123.2 (119.8- 126.6) 131.0 (127.5-134.7) 125.8 (122.0- 129.7) 143.2 (138.9-147.6) 110.9 (103.6- 118.5) 97.4 ( 91.1-104.1)
South Carolina 125.6 (120.9- 130.5) 132.7 (127.7-137.8) 127.2 (121.7- 133.0) 147.2 (140.8-153.8) 114.9 (105.9- 124.4) 99.6 ( 91.9-107.8)
Virginia
West Virginia 123.5 (117.0- 130.3) 149.9 (142.1-157.9) 122.7 (116.1- 129.5) 149.8 (141.9-158.0) 116.5 ( 81.7- 162.5) 126.7 ( 89.6-173.9)
East South Central
Alabama













Table 2.11: Cancer of the Breast. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 123.1 (118.6- 127.8) 124.5 (120.0-129.2) 127.6 (122.2- 133.1) 143.4 (137.4-149.7) 111.8 (103.6- 120.6) 91.4 ( 84.7- 98.5)
Oklahoma
Texas
West 136.0 (134.7- 137.4) 133.1 (131.8-134.4) 140.5 (139.1- 142.0) 141.8 (140.3-143.3) 113.1 (107.3- 119.1) 91.1 ( 86.5- 95.8)
Mountain
Arizona 123.6 (119.3- 128.1) 128.5 (124.0-133.1) 126.9 (122.3- 131.6) 138.3 (133.3-143.4) 84.2 ( 62.0- 113.1) 59.3 ( 44.2- 78.0)
Colorado 139.4 (134.2- 144.6) 138.3 (133.2-143.5) 140.9 (135.6- 146.3) 142.8 (137.4-148.3) 91.5 ( 69.9- 119.2) 74.9 ( 57.8- 95.4)
Idaho 131.4 (122.5- 140.9) 128.8 (120.0-138.0) 132.3 (123.3- 141.9) 131.1 (122.2-140.6) ∼ ∼
Montana 122.2 (112.6- 132.6) 136.6 (125.9-147.9) 120.7 (111.0- 131.2) 140.1 (128.9-152.1) ∼ ∼
Nevada
New Mexico 122.8 (115.6- 130.4) 121.9 (114.7-129.4) 129.9 (122.0- 138.1) 135.7 (127.5-144.2) ∼ ∼
Utah 119.3 (112.0- 127.0) 92.7 ( 87.0- 98.6) 121.5 (114.0- 129.4) 95.9 ( 90.0-102.1) ∼ ∼
Wyoming 131.2 (117.3- 146.6) 136.3 (121.9-151.9) 133.0 (118.8- 148.7) 140.5 (125.5-156.7) ∼ ∼
Pacific 138.9 (137.3- 140.5) 135.5 (134.0-137.1) 144.6 (142.9- 146.4) 145.5 (143.7-147.3) 117.6 (111.3- 124.1) 95.8 ( 90.8-101.1)
Alaska 127.8 (112.7- 145.1) 99.9 ( 88.8-112.0) 136.2 (118.3- 156.8) 111.7 ( 98.1-126.6) ∼ ∼
California 135.1 (133.3- 136.9) 129.2 (127.5-131.0) 141.5 (139.4- 143.6) 139.6 (137.5-141.6) 118.0 (111.4- 124.9) 98.5 ( 93.1-104.2)
San Francisco-Oakland 143.8 (138.8- 148.9) 153.0 (147.7-158.4) 159.5 (153.1- 166.1) 179.3 (172.2-186.6) 110.9 ( 97.5- 125.8) 100.3 ( 88.3-113.5)
San Jose-Monterey 137.1 (130.2- 144.3) 128.9 (122.4-135.6) 146.4 (138.4- 154.7) 143.8 (136.0-151.9) 76.8 ( 45.4- 127.2) 53.9 ( 33.7- 81.5)
Los Angeles 125.5 (122.2- 128.9) 115.8 (112.8-118.9) 132.0 (128.1- 136.1) 122.3 (118.7-126.0) 115.6 (106.4- 125.5) 105.4 ( 97.0-114.3)
Hawaii 134.0 (125.2- 143.3) 147.2 (137.6-157.3) 155.5 (136.2- 177.0) 157.4 (138.0-178.6) ∼ ∼
Oregon 151.5 (145.9- 157.3) 166.5 (160.4-172.8) 153.0 (147.3- 159.0) 172.4 (166.0-179.0) 137.8 ( 91.0- 201.0) 93.9 ( 62.4-135.7)
Washington 153.8 (149.3- 158.4) 154.9 (150.4-159.5) 154.6 (150.0- 159.5) 161.5 (156.6-166.5) 107.7 ( 83.3- 138.4) 73.3 ( 57.3- 92.5)
Seattle-Puget Sound 156.1 (150.6- 161.7) 156.6 (151.1-162.2) 160.8 (155.0- 166.8) 168.5 (162.4-174.7) 106.7 ( 80.9- 139.9) 73.1 ( 56.2- 93.5)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.12: Cancer of the Breast. In Situ Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 28.8 ( 28.5- 29.1) 30.1 ( 29.8- 30.4) 29.3 ( 28.9- 29.6) 31.7 ( 31.4- 32.1) 22.5 ( 21.6- 23.4) 18.8 ( 18.1- 19.6)
Northeast 34.4 ( 33.7- 35.1) 37.4 ( 36.6- 38.1) 35.1 ( 34.4- 35.9) 39.5 ( 38.7- 40.4) 24.0 ( 22.3- 25.8) 21.4 ( 19.9- 23.0)
New England 43.1 ( 41.5- 44.8) 45.7 ( 44.0- 47.5) 43.0 ( 41.3- 44.7) 47.1 ( 45.3- 49.0) 27.0 ( 21.4- 33.8) 20.5 ( 16.3- 25.5)
Connecticut 40.2 ( 37.3- 43.3) 43.5 ( 40.4- 46.8) 40.1 ( 37.0- 43.3) 45.0 ( 41.7- 48.6) 30.9 ( 22.2- 42.5) 26.0 ( 18.7- 35.1)
Maine
Massachusetts 47.0 ( 44.7- 49.4) 49.7 ( 47.3- 52.2) 46.7 ( 44.3- 49.2) 51.2 ( 48.6- 53.9) 26.2 ( 18.4- 36.7) 18.3 ( 13.0- 25.1)
New Hampshire 36.4 ( 31.7- 41.5) 36.5 ( 31.8- 41.6) 36.3 ( 31.6- 41.5) 36.6 ( 31.9- 41.8) ∼ ∼
Rhode Island 35.8 ( 30.9- 41.2) 39.1 ( 33.9- 44.9) 37.1 ( 32.0- 43.0) 41.8 ( 36.2- 48.1) ∼ ∼
Vermont
Middle Atlantic 31.8 ( 31.1- 32.6) 34.8 ( 34.0- 35.7) 32.5 ( 31.7- 33.4) 37.0 ( 36.0- 37.9) 23.6 ( 21.8- 25.5) 21.5 ( 19.9- 23.3)
New Jersey 34.4 ( 32.7- 36.2) 37.0 ( 35.2- 38.9) 36.9 ( 35.0- 39.0) 41.6 ( 39.5- 43.9) 23.0 ( 19.2- 27.6) 20.2 ( 16.8- 24.0)
New York 31.2 ( 30.1- 32.3) 33.4 ( 32.2- 34.6) 32.1 ( 30.8- 33.4) 35.7 ( 34.3- 37.1) 20.4 ( 18.2- 22.8) 18.7 ( 16.7- 20.8)
Pennsylvania 31.0 ( 29.7- 32.3) 35.5 ( 34.0- 37.0) 30.4 ( 29.0- 31.8) 35.8 ( 34.2- 37.4) 33.1 ( 28.5- 38.1) 30.8 ( 26.6- 35.5)
Midwest
East North Central
Illinois 27.0 ( 25.7- 28.3) 27.6 ( 26.3- 28.9) 27.3 ( 25.9- 28.7) 29.0 ( 27.5- 30.5) 19.5 ( 16.6- 22.9) 16.3 ( 13.9- 19.0)
Indiana
Michigan 32.0 ( 30.5- 33.6) 32.8 ( 31.3- 34.5) 32.2 ( 30.5- 33.9) 34.2 ( 32.5- 36.1) 30.7 ( 26.5- 35.3) 26.0 ( 22.5- 30.0)
Detroit 39.4 ( 36.9- 42.1) 41.5 ( 38.8- 44.3) 40.6 ( 37.6- 43.8) 45.1 ( 41.8- 48.6) 34.4 ( 29.4- 40.1) 30.7 ( 26.3- 35.7)
Ohio 27.5 ( 26.2- 28.8) 29.4 ( 28.0- 30.8) 27.3 ( 26.0- 28.8) 30.0 ( 28.5- 31.5) 22.2 ( 18.5- 26.3) 19.3 ( 16.2- 22.9)
Wisconsin 26.9 ( 25.0- 28.9) 27.7 ( 25.8- 29.8) 27.0 ( 25.0- 29.1) 28.7 ( 26.6- 30.9) 26.5 ( 16.9- 41.1) 17.0 ( 11.1- 24.9)
West North Central 24.6 ( 23.7- 25.7) 25.7 ( 24.7- 26.8) 24.9 ( 23.9- 25.9) 26.8 ( 25.7- 27.9) 14.3 ( 10.9- 18.5) 11.0 ( 8.4- 14.2)
Iowa 25.8 ( 23.3- 28.4) 28.4 ( 25.7- 31.3) 26.2 ( 23.8- 28.9) 29.4 ( 26.6- 32.3) ∼ ∼
Kansas 23.1 ( 20.6- 25.8) 23.7 ( 21.1- 26.4) 22.4 ( 19.9- 25.2) 23.6 ( 21.0- 26.5) ∼ ∼
Minnesota 28.7 ( 26.6- 30.9) 28.6 ( 26.5- 30.8) 28.4 ( 26.3- 30.7) 29.4 ( 27.2- 31.7) ∼ ∼
Missouri 21.6 ( 20.0- 23.3) 23.1 ( 21.3- 24.9) 22.2 ( 20.5- 24.1) 24.5 ( 22.6- 26.6) 15.5 ( 11.2- 21.1) 13.1 ( 9.5- 17.6)
Nebraska 25.3 ( 22.1- 28.9) 26.2 ( 22.9- 29.9) 25.9 ( 22.5- 29.6) 27.4 ( 23.9- 31.3) ∼ ∼




Delaware 39.3 ( 33.4- 46.0) 40.6 ( 34.5- 47.5) 40.8 ( 34.1- 48.5) 44.8 ( 37.6- 53.1) 29.6 ( 17.6- 48.1) 24.3 ( 14.6- 37.9)
District of Columbia 29.0 ( 23.3- 36.0) 32.8 ( 26.4- 40.3) 36.5 ( 25.2- 54.1) 36.5 ( 25.3- 51.0) 23.1 ( 17.1- 31.3) 28.7 ( 21.3- 37.8)
Florida 27.3 ( 26.2- 28.4) 33.0 ( 31.7- 34.3) 28.3 ( 27.2- 29.6) 36.6 ( 35.1- 38.1) 18.8 ( 16.0- 21.9) 14.4 ( 12.4- 16.7)
Georgia
Atlanta 30.7 ( 27.5- 34.1) 25.9 ( 23.3- 28.8) 31.8 ( 28.0- 35.9) 30.4 ( 26.8- 34.3) 29.2 ( 22.9- 36.9) 18.8 ( 15.0- 23.3)
Maryland 32.8 ( 30.7- 35.0) 33.3 ( 31.1- 35.6) 33.0 ( 30.5- 35.7) 36.0 ( 33.3- 38.9) 29.8 ( 25.6- 34.6) 24.8 ( 21.4- 28.6)
North Carolina 25.4 ( 23.9- 27.0) 26.7 ( 25.1- 28.4) 26.6 ( 24.8- 28.4) 29.8 ( 27.8- 31.8) 20.8 ( 17.7- 24.3) 18.0 ( 15.3- 21.0)
South Carolina 23.4 ( 21.4- 25.6) 24.7 ( 22.6- 26.9) 24.2 ( 21.8- 26.8) 27.6 ( 24.8- 30.5) 21.6 ( 17.7- 26.0) 18.1 ( 14.9- 21.8)
Virginia
West Virginia 24.3 ( 21.5- 27.5) 28.8 ( 25.5- 32.5) 24.3 ( 21.4- 27.5) 29.1 ( 25.7- 32.9) ∼ ∼
East South Central
Alabama













Table 2.12: Cancer of the Breast. In Situ Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 21.0 ( 19.1- 22.9) 21.1 ( 19.3- 23.1) 21.4 ( 19.2- 23.8) 23.7 ( 21.3- 26.3) 19.7 ( 16.3- 23.6) 16.0 ( 13.3- 19.2)
Oklahoma
Texas
West 27.3 ( 26.7- 27.9) 26.4 ( 25.8- 27.0) 27.5 ( 26.8- 28.1) 27.4 ( 26.7- 28.0) 20.9 ( 18.4- 23.6) 16.4 ( 14.5- 18.5)
Mountain
Arizona 25.0 ( 23.0- 27.0) 25.4 ( 23.4- 27.5) 25.7 ( 23.6- 27.8) 27.2 ( 25.0- 29.5) ∼ ∼
Colorado 27.6 ( 25.4- 30.0) 27.8 ( 25.5- 30.1) 27.9 ( 25.6- 30.4) 28.6 ( 26.3- 31.1) ∼ ∼
Idaho 27.0 ( 23.0- 31.5) 26.0 ( 22.2- 30.3) 26.9 ( 22.9- 31.5) 26.2 ( 22.3- 30.6) ∼ ∼
Montana 26.4 ( 22.0- 31.5) 29.1 ( 24.3- 34.5) 26.5 ( 22.0- 31.7) 30.2 ( 25.1- 36.0) ∼ ∼
Nevada
New Mexico 21.4 ( 18.5- 24.7) 21.3 ( 18.3- 24.5) 23.0 ( 19.8- 26.7) 24.0 ( 20.7- 27.8) ∼ ∼
Utah 22.5 ( 19.3- 25.9) 17.3 ( 14.9- 20.0) 22.9 ( 19.7- 26.5) 18.0 ( 15.4- 20.7) ∼ ∼
Wyoming 23.4 ( 17.8- 30.5) 24.7 ( 18.8- 31.9) 23.7 ( 18.0- 30.9) 25.4 ( 19.3- 32.8) ∼ ∼
Pacific 28.0 ( 27.3- 28.7) 27.0 ( 26.4- 27.7) 28.2 ( 27.4- 29.0) 27.9 ( 27.1- 28.7) 22.0 ( 19.3- 24.9) 17.4 ( 15.3- 19.8)
Alaska 30.8 ( 23.8- 39.9) 25.1 ( 19.7- 31.6) 29.7 ( 21.9- 40.4) 25.6 ( 19.4- 33.3) ∼ ∼
California 26.6 ( 25.8- 27.4) 25.1 ( 24.4- 25.9) 27.3 ( 26.4- 28.2) 26.4 ( 25.5- 27.3) 21.5 ( 18.7- 24.6) 17.6 ( 15.3- 20.0)
San Francisco-Oakland 31.6 ( 29.2- 34.1) 33.2 ( 30.7- 35.8) 30.9 ( 28.1- 33.9) 33.9 ( 30.8- 37.1) 25.0 ( 18.8- 32.6) 22.4 ( 16.9- 29.1)
San Jose-Monterey 33.0 ( 29.7- 36.7) 31.0 ( 27.8- 34.4) 34.7 ( 30.9- 38.9) 33.5 ( 29.8- 37.6) ∼ ∼
Los Angeles 24.7 ( 23.2- 26.2) 22.4 ( 21.1- 23.8) 26.4 ( 24.6- 28.3) 23.9 ( 22.3- 25.5) 20.2 ( 16.4- 24.6) 18.2 ( 14.8- 22.1)
Hawaii 35.4 ( 30.9- 40.4) 38.6 ( 33.8- 44.0) 28.9 ( 21.0- 39.2) 29.6 ( 21.6- 39.6) ∼ ∼
Oregon 30.3 ( 27.9- 33.0) 33.0 ( 30.3- 35.9) 30.0 ( 27.5- 32.7) 33.4 ( 30.6- 36.4) ∼ ∼
Washington 32.3 ( 30.3- 34.4) 32.3 ( 30.2- 34.4) 31.3 ( 29.2- 33.5) 32.3 ( 30.2- 34.6) 24.9 ( 13.9- 42.6) 16.5 ( 9.4- 26.8)
Seattle-Puget Sound 34.0 ( 31.5- 36.7) 34.0 ( 31.5- 36.7) 34.0 ( 31.4- 36.9) 35.4 ( 32.6- 38.3) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† In situ cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.13: Cancer of the Cervix Uteri. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 9.5 ( 9.3- 9.6) 9.7 ( 9.5- 9.9) 8.8 ( 8.6- 9.0) 9.2 ( 9.0- 9.4) 13.9 ( 13.2- 14.6) 12.3 ( 11.8- 13.0)
Northeast 9.3 ( 8.9- 9.6) 9.9 ( 9.5- 10.3) 8.3 ( 7.9- 8.7) 9.0 ( 8.6- 9.4) 14.5 ( 13.2- 15.9) 13.4 ( 12.2- 14.7)
New England 7.4 ( 6.8- 8.1) 7.9 ( 7.2- 8.6) 6.8 ( 6.2- 7.5) 7.4 ( 6.7- 8.2) 12.1 ( 8.6- 16.9) 10.0 ( 7.2- 13.6)
Connecticut 8.3 ( 7.0- 9.7) 8.9 ( 7.6- 10.5) 7.8 ( 6.5- 9.3) 8.7 ( 7.2- 10.3) 11.1 ( 6.3- 19.1) 9.9 ( 5.7- 16.1)
Maine
Massachusetts 6.8 ( 6.0- 7.8) 7.2 ( 6.3- 8.2) 6.0 ( 5.2- 6.9) 6.5 ( 5.6- 7.5) 14.7 ( 9.2- 22.8) 11.6 ( 7.4- 17.2)
New Hampshire 6.5 ( 4.6- 8.8) 6.7 ( 4.8- 9.1) 6.2 ( 4.4- 8.6) 6.5 ( 4.7- 8.9) ∼ ∼
Rhode Island 9.6 ( 7.1- 12.7) 9.9 ( 7.4- 13.0) 9.8 ( 7.2- 13.1) 10.4 ( 7.7- 13.7) ∼ ∼
Vermont
Middle Atlantic 9.8 ( 9.4- 10.3) 10.5 ( 10.1- 11.0) 8.8 ( 8.4- 9.3) 9.6 ( 9.1- 10.0) 14.8 ( 13.4- 16.3) 13.8 ( 12.5- 15.2)
New Jersey 10.5 ( 9.6- 11.5) 11.2 ( 10.2- 12.3) 10.1 ( 9.1- 11.2) 11.0 ( 9.9- 12.2) 16.5 ( 13.3- 20.3) 15.0 ( 12.1- 18.3)
New York 9.9 ( 9.3- 10.6) 10.6 ( 9.9- 11.2) 8.4 ( 7.8- 9.1) 9.2 ( 8.5- 9.9) 14.0 ( 12.2- 15.9) 13.1 ( 11.5- 15.0)
Pennsylvania 9.3 ( 8.6- 10.1) 9.9 ( 9.1- 10.7) 8.5 ( 7.8- 9.3) 9.2 ( 8.4- 10.0) 15.5 ( 12.5- 19.0) 14.7 ( 11.8- 18.0)
Midwest
East North Central
Illinois 10.7 ( 10.0- 11.6) 10.9 ( 10.1- 11.8) 9.4 ( 8.5- 10.2) 9.7 ( 8.9- 10.6) 18.4 ( 15.7- 21.6) 16.2 ( 13.8- 18.9)
Indiana
Michigan 8.3 ( 7.5- 9.1) 8.5 ( 7.7- 9.3) 7.5 ( 6.8- 8.4) 7.8 ( 7.0- 8.7) 13.5 ( 10.8- 16.6) 11.8 ( 9.5- 14.6)
Detroit 9.0 ( 7.8- 10.4) 9.4 ( 8.2- 10.8) 7.0 ( 5.8- 8.4) 7.5 ( 6.2- 9.0) 15.5 ( 12.3- 19.4) 14.3 ( 11.3- 17.8)
Ohio 8.7 ( 8.0- 9.5) 9.0 ( 8.3- 9.8) 8.6 ( 7.9- 9.5) 9.0 ( 8.2- 9.9) 9.5 ( 7.2- 12.3) 8.6 ( 6.5- 11.1)
Wisconsin 9.8 ( 8.6- 11.1) 9.8 ( 8.6- 11.0) 8.9 ( 7.7- 10.2) 9.0 ( 7.8- 10.3) 20.2 ( 12.5- 32.8) 16.4 ( 10.6- 24.1)
West North Central 8.6 ( 8.0- 9.2) 8.7 ( 8.1- 9.3) 8.1 ( 7.5- 8.7) 8.3 ( 7.7- 9.0) 12.6 ( 9.6- 16.4) 11.0 ( 8.4- 14.2)
Iowa 10.2 ( 8.6- 12.0) 10.1 ( 8.6- 11.9) 9.5 ( 8.0- 11.3) 9.6 ( 8.0- 11.3) ∼ ∼
Kansas 9.3 ( 7.7- 11.1) 9.3 ( 7.7- 11.0) 8.8 ( 7.2- 10.7) 8.9 ( 7.3- 10.8) ∼ ∼
Minnesota 7.5 ( 6.4- 8.7) 7.6 ( 6.5- 8.8) 7.1 ( 6.1- 8.3) 7.4 ( 6.3- 8.6) ∼ ∼
Missouri 8.8 ( 7.7- 9.9) 9.1 ( 8.0- 10.2) 8.3 ( 7.2- 9.5) 8.7 ( 7.5- 9.9) 12.5 ( 8.8- 17.4) 11.3 ( 7.9- 15.5)
Nebraska 8.5 ( 6.6- 10.8) 8.3 ( 6.5- 10.5) 7.9 ( 6.1- 10.2) 7.8 ( 6.0- 10.0) ∼ ∼




Delaware 7.9 ( 5.4- 11.2) 8.5 ( 5.9- 12.0) 7.9 ( 5.1- 11.8) 8.7 ( 5.7- 12.7) ∼ ∼
District of Columbia 13.5 ( 9.6- 18.7) 14.8 ( 10.6- 20.1) ∼ ∼ 15.3 ( 10.2- 22.8) 16.6 ( 11.1- 23.9)
Florida 11.5 ( 10.8- 12.3) 12.2 ( 11.4- 13.0) 10.9 ( 10.1- 11.7) 11.7 ( 10.9- 12.6) 17.8 ( 15.2- 20.7) 14.5 ( 12.4- 16.8)
Georgia
Atlanta 10.5 ( 8.8- 12.5) 10.1 ( 8.5- 11.9) 7.6 ( 6.0- 9.7) 8.2 ( 6.4- 10.4) 17.8 ( 13.0- 24.2) 12.2 ( 9.2- 15.8)
Maryland 8.2 ( 7.2- 9.4) 8.5 ( 7.4- 9.7) 6.7 ( 5.6- 8.0) 7.3 ( 6.1- 8.7) 10.8 ( 8.4- 13.8) 9.5 ( 7.4- 11.9)
North Carolina 9.5 ( 8.6- 10.5) 9.9 ( 8.9- 10.9) 8.7 ( 7.7- 9.8) 9.3 ( 8.2- 10.5) 12.8 ( 10.4- 15.6) 11.5 ( 9.4- 14.0)
South Carolina 11.3 ( 9.9- 12.9) 11.7 ( 10.3- 13.3) 9.6 ( 8.1- 11.4) 10.2 ( 8.6- 12.1) 16.2 ( 13.0- 20.1) 14.3 ( 11.4- 17.6)
Virginia
West Virginia 13.4 ( 11.2- 16.0) 14.3 ( 12.0- 17.0) 13.5 ( 11.3- 16.2) 14.4 ( 12.1- 17.2) ∼ ∼
East South Central
Alabama













Table 2.13: Cancer of the Cervix Uteri. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 12.3 ( 10.9- 13.9) 12.1 ( 10.7- 13.6) 10.7 ( 9.1- 12.5) 11.0 ( 9.4- 12.9) 16.5 ( 13.5- 20.0) 14.2 ( 11.6- 17.1)
Oklahoma
Texas
West 8.9 ( 8.6- 9.3) 8.8 ( 8.5- 9.2) 8.9 ( 8.5- 9.3) 8.8 ( 8.5- 9.2) 9.2 ( 7.7- 11.0) 8.2 ( 6.8- 9.7)
Mountain
Arizona 7.7 ( 6.7- 9.0) 7.6 ( 6.5- 8.8) 8.0 ( 6.8- 9.3) 7.9 ( 6.8- 9.2) ∼ ∼
Colorado 6.6 ( 5.5- 7.8) 6.6 ( 5.5- 7.8) 6.5 ( 5.4- 7.7) 6.6 ( 5.5- 7.8) ∼ ∼
Idaho 6.2 ( 4.4- 8.6) 5.9 ( 4.2- 8.1) 6.4 ( 4.5- 8.9) 6.1 ( 4.3- 8.4) ∼ ∼
Montana 8.6 ( 6.1- 12.0) 8.6 ( 6.1- 11.8) 8.4 ( 5.8- 11.9) 8.5 ( 5.9- 11.9) ∼ ∼
Nevada
New Mexico 7.6 ( 5.8- 9.7) 7.4 ( 5.7- 9.4) 7.9 ( 6.0- 10.2) 7.9 ( 6.0- 10.1) ∼ ∼
Utah 6.2 ( 4.7- 8.1) 5.1 ( 3.9- 6.7) 6.2 ( 4.7- 8.2) 5.2 ( 3.9- 6.8) ∼ ∼
Wyoming 10.0 ( 6.3- 15.2) 9.6 ( 6.1- 14.5) 10.3 ( 6.5- 15.8) 10.1 ( 6.4- 15.1) ∼ ∼
Pacific 9.5 ( 9.1- 10.0) 9.5 ( 9.1- 9.9) 9.5 ( 9.1- 10.0) 9.5 ( 9.1- 10.0) 9.8 ( 8.1- 11.8) 8.7 ( 7.2- 10.4)
Alaska 7.3 ( 4.1- 12.9) 6.1 ( 3.6- 9.7) ∼ ∼ ∼ ∼
California 10.1 ( 9.6- 10.6) 9.9 ( 9.4- 10.4) 10.3 ( 9.7- 10.8) 10.1 ( 9.6- 10.7) 9.8 ( 8.1- 11.9) 8.9 ( 7.3- 10.7)
San Francisco-Oakland 6.7 ( 5.7- 7.9) 7.3 ( 6.2- 8.5) 6.8 ( 5.5- 8.3) 7.5 ( 6.1- 9.1) 7.7 ( 4.5- 12.4) 7.2 ( 4.3- 11.4)
San Jose-Monterey 7.6 ( 6.0- 9.4) 7.4 ( 5.9- 9.1) 6.9 ( 5.3- 8.9) 6.9 ( 5.3- 8.8) ∼ ∼
Los Angeles 12.7 ( 11.7- 13.8) 12.2 ( 11.2- 13.2) 13.9 ( 12.6- 15.2) 13.1 ( 12.0- 14.4) 10.2 ( 7.7- 13.4) 10.0 ( 7.5- 13.0)
Hawaii 9.6 ( 7.3- 12.4) 9.8 ( 7.5- 12.7) 11.4 ( 6.7- 18.5) 11.9 ( 7.0- 18.7) ∼ ∼
Oregon 8.5 ( 7.2- 10.0) 8.7 ( 7.4- 10.2) 8.5 ( 7.1- 10.0) 8.7 ( 7.3- 10.3) ∼ ∼
Washington 7.5 ( 6.6- 8.6) 7.7 ( 6.7- 8.8) 7.1 ( 6.1- 8.2) 7.3 ( 6.3- 8.5) ∼ ∼
Seattle-Puget Sound 6.1 ( 5.1- 7.3) 6.3 ( 5.3- 7.6) 6.1 ( 5.0- 7.4) 6.4 ( 5.3- 7.8) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for




ancer Statistics: 1999 Incidence
70
Table 2.14: Cancer of the Corpus Uteri. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 24.6 ( 24.3- 24.9) 26.4 ( 26.1- 26.7) 25.3 ( 25.0- 25.6) 28.5 ( 28.2- 28.9) 18.6 ( 17.8- 19.5) 15.1 ( 14.4- 15.8)
Northeast 28.3 ( 27.7- 28.9) 32.0 ( 31.3- 32.7) 29.1 ( 28.4- 29.8) 34.5 ( 33.7- 35.3) 19.8 ( 18.2- 21.5) 17.4 ( 16.0- 18.9)
New England 28.4 ( 27.1- 29.7) 31.1 ( 29.7- 32.5) 28.6 ( 27.3- 30.0) 32.6 ( 31.1- 34.2) 14.6 ( 10.5- 20.1) 10.5 ( 7.6- 14.2)
Connecticut 28.2 ( 25.8- 30.7) 31.7 ( 29.1- 34.5) 29.2 ( 26.7- 31.9) 34.2 ( 31.3- 37.3) 14.1 ( 8.3- 23.1) 11.1 ( 6.6- 17.6)
Maine
Massachusetts 28.8 ( 27.0- 30.7) 31.5 ( 29.6- 33.5) 28.7 ( 26.8- 30.6) 32.8 ( 30.7- 34.9) 14.9 ( 9.2- 23.5) 10.1 ( 6.3- 15.5)
New Hampshire 26.4 ( 22.4- 30.9) 25.9 ( 22.1- 30.3) 26.2 ( 22.3- 30.8) 26.0 ( 22.1- 30.4) ∼ ∼
Rhode Island 28.5 ( 24.2- 33.3) 32.7 ( 27.9- 38.0) 29.3 ( 24.9- 34.4) 34.9 ( 29.7- 40.6) ∼ ∼
Vermont
Middle Atlantic 28.3 ( 27.6- 29.0) 32.3 ( 31.5- 33.1) 29.2 ( 28.5- 30.0) 35.1 ( 34.2- 36.1) 20.4 ( 18.7- 22.2) 18.3 ( 16.8- 19.9)
New Jersey 29.8 ( 28.3- 31.4) 33.2 ( 31.5- 35.0) 31.6 ( 29.8- 33.4) 37.5 ( 35.4- 39.6) 22.0 ( 18.1- 26.5) 18.6 ( 15.4- 22.3)
New York 26.4 ( 25.5- 27.4) 29.4 ( 28.3- 30.5) 26.8 ( 25.7- 27.9) 31.7 ( 30.4- 33.0) 21.2 ( 18.9- 23.6) 19.1 ( 17.1- 21.2)
Pennsylvania 30.1 ( 28.8- 31.4) 36.0 ( 34.5- 37.5) 31.0 ( 29.7- 32.4) 38.2 ( 36.6- 39.9) 17.0 ( 13.8- 20.7) 16.0 ( 13.0- 19.5)
Midwest
East North Central
Illinois 24.2 ( 23.1- 25.5) 25.3 ( 24.1- 26.6) 25.1 ( 23.8- 26.5) 27.5 ( 26.1- 29.0) 17.1 ( 14.3- 20.3) 14.0 ( 11.7- 16.5)
Indiana
Michigan 26.8 ( 25.4- 28.2) 28.0 ( 26.6- 29.5) 28.2 ( 26.7- 29.8) 30.9 ( 29.2- 32.6) 16.9 ( 13.8- 20.5) 14.1 ( 11.5- 17.0)
Detroit 25.7 ( 23.7- 27.9) 27.6 ( 25.4- 29.9) 27.6 ( 25.2- 30.2) 31.8 ( 29.1- 34.8) 19.1 ( 15.4- 23.5) 16.8 ( 13.6- 20.6)
Ohio 26.9 ( 25.7- 28.3) 29.5 ( 28.2- 31.0) 27.3 ( 25.9- 28.7) 30.8 ( 29.3- 32.4) 18.2 ( 14.9- 22.1) 15.5 ( 12.7- 18.8)
Wisconsin 25.9 ( 24.1- 27.9) 27.5 ( 25.6- 29.6) 26.4 ( 24.5- 28.4) 29.1 ( 27.0- 31.3) ∼ ∼
West North Central 26.8 ( 25.8- 27.9) 29.3 ( 28.3- 30.5) 27.0 ( 26.0- 28.1) 30.5 ( 29.4- 31.7) 20.6 ( 16.3- 25.6) 15.2 ( 12.1- 18.9)
Iowa 28.6 ( 26.0- 31.3) 32.8 ( 30.0- 35.9) 28.6 ( 26.1- 31.4) 33.5 ( 30.6- 36.7) ∼ ∼
Kansas 26.2 ( 23.6- 29.0) 28.8 ( 26.0- 31.8) 26.3 ( 23.6- 29.2) 29.9 ( 26.9- 33.1) ∼ ∼
Minnesota 27.4 ( 25.4- 29.6) 28.1 ( 26.1- 30.3) 27.2 ( 25.2- 29.4) 29.1 ( 26.9- 31.4) ∼ ∼
Missouri 25.9 ( 24.2- 27.8) 28.8 ( 26.9- 30.9) 26.5 ( 24.6- 28.5) 30.5 ( 28.4- 32.8) 20.4 ( 15.4- 26.7) 16.7 ( 12.6- 21.8)
Nebraska 27.8 ( 24.5- 31.4) 30.8 ( 27.2- 34.8) 27.8 ( 24.4- 31.6) 31.6 ( 27.9- 35.8) ∼ ∼




Delaware 27.1 ( 22.3- 32.7) 28.7 ( 23.6- 34.6) 29.4 ( 23.9- 35.9) 33.8 ( 27.5- 41.1) ∼ ∼
District of Columbia 17.2 ( 13.0- 22.8) 20.2 ( 15.3- 26.2) 24.8 ( 15.6- 40.5) 24.7 ( 15.7- 37.1) 13.2 ( 8.8- 19.7) 17.2 ( 11.6- 24.6)
Florida 23.1 ( 22.1- 24.1) 29.9 ( 28.7- 31.1) 23.4 ( 22.3- 24.4) 32.7 ( 31.3- 34.1) 23.6 ( 20.4- 27.3) 16.7 ( 14.4- 19.1)
Georgia
Atlanta 18.1 ( 15.6- 20.8) 14.8 ( 12.8- 16.9) 18.7 ( 15.8- 21.9) 17.8 ( 15.1- 20.8) 17.5 ( 12.4- 24.2) 9.1 ( 6.5- 12.3)
Maryland 23.5 ( 21.7- 25.4) 23.7 ( 21.9- 25.7) 25.9 ( 23.7- 28.3) 28.8 ( 26.4- 31.4) 15.6 ( 12.4- 19.3) 11.6 ( 9.3- 14.2)
North Carolina 20.0 ( 18.7- 21.4) 21.6 ( 20.2- 23.1) 20.2 ( 18.7- 21.8) 23.3 ( 21.6- 25.1) 20.2 ( 17.1- 23.7) 17.1 ( 14.5- 20.0)
South Carolina 19.3 ( 17.5- 21.2) 20.6 ( 18.7- 22.7) 18.8 ( 16.7- 21.1) 22.0 ( 19.6- 24.6) 21.0 ( 17.3- 25.5) 17.5 ( 14.4- 21.1)
Virginia
West Virginia 26.2 ( 23.3- 29.4) 32.0 ( 28.5- 35.9) 26.3 ( 23.3- 29.6) 32.3 ( 28.7- 36.3) ∼ ∼
East South Central
Alabama













Table 2.14: Cancer of the Corpus Uteri. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 16.1 ( 14.5- 17.8) 16.4 ( 14.8- 18.1) 15.5 ( 13.7- 17.6) 17.5 ( 15.5- 19.8) 18.5 ( 15.2- 22.4) 14.7 ( 12.1- 17.7)
Oklahoma
Texas
West 22.3 ( 21.8- 22.9) 21.8 ( 21.3- 22.4) 23.0 ( 22.4- 23.6) 23.2 ( 22.6- 23.8) 15.9 ( 13.7- 18.3) 12.2 ( 10.6- 14.1)
Mountain
Arizona 18.2 ( 16.6- 19.9) 19.0 ( 17.3- 20.9) 18.9 ( 17.2- 20.8) 20.8 ( 18.9- 22.8) ∼ ∼
Colorado 19.4 ( 17.5- 21.4) 18.8 ( 17.0- 20.8) 19.7 ( 17.7- 21.8) 19.6 ( 17.6- 21.7) ∼ ∼
Idaho 25.1 ( 21.3- 29.4) 24.7 ( 21.0- 28.9) 25.6 ( 21.7- 30.0) 25.5 ( 21.7- 29.9) ∼ ∼
Montana 17.1 ( 13.6- 21.3) 18.9 ( 15.1- 23.4) 16.5 ( 13.0- 20.8) 19.0 ( 15.0- 23.7) ∼ ∼
Nevada
New Mexico 19.7 ( 16.8- 22.8) 19.6 ( 16.8- 22.7) 20.1 ( 17.1- 23.5) 21.1 ( 18.0- 24.7) ∼ ∼
Utah 25.1 ( 21.8- 28.7) 19.5 ( 16.9- 22.3) 25.3 ( 21.9- 29.0) 20.0 ( 17.4- 23.0) ∼ ∼
Wyoming 16.4 ( 11.7- 22.5) 17.2 ( 12.3- 23.3) 16.0 ( 11.3- 22.1) 17.1 ( 12.1- 23.3) ∼ ∼
Pacific 23.3 ( 22.6- 23.9) 22.6 ( 22.0- 23.3) 24.1 ( 23.4- 24.9) 24.2 ( 23.5- 25.0) 17.3 ( 14.9- 20.0) 13.4 ( 11.6- 15.5)
Alaska 17.8 ( 12.7- 25.2) 14.6 ( 10.6- 19.7) 20.3 ( 14.0- 29.6) 16.9 ( 11.9- 23.3) ∼ ∼
California 22.4 ( 21.6- 23.1) 21.3 ( 20.6- 22.0) 23.5 ( 22.6- 24.3) 23.1 ( 22.3- 24.0) 17.6 ( 15.1- 20.4) 14.1 ( 12.1- 16.4)
San Francisco-Oakland 23.2 ( 21.2- 25.4) 24.5 ( 22.4- 26.7) 25.6 ( 23.0- 28.3) 28.3 ( 25.5- 31.3) 16.9 ( 12.0- 23.5) 15.2 ( 10.7- 20.8)
San Jose-Monterey 22.6 ( 19.9- 25.7) 21.0 ( 18.5- 23.9) 23.8 ( 20.6- 27.3) 23.1 ( 20.0- 26.4) ∼ ∼
Los Angeles 22.0 ( 20.6- 23.5) 20.2 ( 18.9- 21.5) 23.7 ( 22.1- 25.5) 21.9 ( 20.4- 23.6) 19.2 ( 15.5- 23.6) 17.3 ( 14.0- 21.1)
Hawaii 27.0 ( 23.1- 31.4) 29.1 ( 24.9- 33.8) 29.6 ( 21.4- 40.2) 29.0 ( 21.0- 38.9) ∼ ∼
Oregon 24.2 ( 22.0- 26.6) 27.0 ( 24.5- 29.6) 24.3 ( 22.1- 26.8) 27.9 ( 25.3- 30.6) ∼ ∼
Washington 27.1 ( 25.3- 29.1) 27.2 ( 25.3- 29.1) 27.0 ( 25.1- 29.1) 28.1 ( 26.1- 30.2) ∼ ∼
Seattle-Puget Sound 27.0 ( 24.7- 29.3) 26.8 ( 24.6- 29.2) 27.6 ( 25.2- 30.2) 28.8 ( 26.3- 31.4) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.15: Cancer of the Ovary. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 16.2 ( 15.9- 16.4) 17.2 ( 17.0- 17.5) 16.8 ( 16.6- 17.1) 18.8 ( 18.5- 19.1) 10.6 ( 10.0- 11.3) 8.9 ( 8.4- 9.4)
Northeast 16.9 ( 16.4- 17.4) 19.0 ( 18.5- 19.5) 17.4 ( 16.9- 18.0) 20.5 ( 19.9- 21.1) 11.1 ( 10.0- 12.4) 9.8 ( 8.7- 10.9)
New England 15.8 ( 14.8- 16.8) 17.5 ( 16.5- 18.6) 15.9 ( 14.9- 17.0) 18.4 ( 17.2- 19.5) 5.6 ( 3.2- 9.4) 4.3 ( 2.5- 6.8)
Connecticut 15.7 ( 14.0- 17.6) 17.9 ( 16.0- 20.1) 16.1 ( 14.3- 18.2) 19.3 ( 17.2- 21.7) ∼ ∼
Maine
Massachusetts 16.0 ( 14.7- 17.4) 17.7 ( 16.3- 19.3) 16.0 ( 14.7- 17.5) 18.4 ( 16.9- 20.1) ∼ ∼
New Hampshire 14.1 ( 11.3- 17.4) 14.3 ( 11.4- 17.6) 14.3 ( 11.4- 17.7) 14.6 ( 11.7- 18.0) ∼ ∼
Rhode Island 16.2 ( 13.0- 20.0) 18.5 ( 14.9- 22.6) 16.7 ( 13.4- 20.7) 19.6 ( 15.9- 24.1) ∼ ∼
Vermont
Middle Atlantic 17.2 ( 16.7- 17.8) 19.4 ( 18.8- 20.1) 17.9 ( 17.3- 18.5) 21.2 ( 20.5- 21.9) 11.7 ( 10.4- 13.1) 10.5 ( 9.4- 11.7)
New Jersey 18.0 ( 16.8- 19.3) 20.0 ( 18.6- 21.4) 18.9 ( 17.5- 20.3) 22.2 ( 20.6- 23.8) 12.5 ( 9.6- 16.1) 10.5 ( 8.1- 13.4)
New York 16.4 ( 15.6- 17.2) 18.0 ( 17.2- 18.9) 17.2 ( 16.3- 18.1) 20.0 ( 18.9- 21.0) 11.2 ( 9.6- 13.1) 10.1 ( 8.6- 11.7)
Pennsylvania 18.0 ( 17.1- 19.1) 21.2 ( 20.1- 22.4) 18.3 ( 17.3- 19.4) 22.2 ( 21.0- 23.5) 12.5 ( 9.8- 15.8) 11.8 ( 9.2- 14.8)
Midwest
East North Central
Illinois 16.3 ( 15.4- 17.4) 17.1 ( 16.1- 18.1) 17.2 ( 16.1- 18.3) 18.8 ( 17.6- 20.0) 10.9 ( 8.7- 13.5) 9.2 ( 7.4- 11.3)
Indiana
Michigan 16.6 ( 15.5- 17.7) 17.4 ( 16.3- 18.6) 16.9 ( 15.8- 18.2) 18.5 ( 17.2- 19.9) 13.6 ( 10.9- 16.9) 11.7 ( 9.4- 14.4)
Detroit 16.6 ( 15.0- 18.4) 17.8 ( 16.0- 19.6) 17.3 ( 15.4- 19.4) 19.8 ( 17.6- 22.1) 15.0 ( 11.8- 18.9) 13.5 ( 10.6- 17.0)
Ohio 15.4 ( 14.5- 16.4) 16.8 ( 15.7- 17.8) 15.9 ( 14.9- 17.0) 17.8 ( 16.6- 19.0) 10.0 ( 7.6- 12.9) 8.9 ( 6.8- 11.4)
Wisconsin 13.9 ( 12.6- 15.4) 14.8 ( 13.4- 16.4) 14.2 ( 12.8- 15.7) 15.6 ( 14.1- 17.3) ∼ ∼
West North Central 16.6 ( 15.8- 17.4) 17.8 ( 17.0- 18.7) 16.7 ( 15.9- 17.5) 18.5 ( 17.6- 19.5) 9.8 ( 6.9- 13.4) 7.3 ( 5.2- 10.0)
Iowa 17.4 ( 15.4- 19.5) 20.0 ( 17.8- 22.5) 17.0 ( 15.1- 19.2) 20.1 ( 17.8- 22.5) ∼ ∼
Kansas 15.2 ( 13.2- 17.3) 16.3 ( 14.2- 18.6) 15.4 ( 13.4- 17.7) 17.0 ( 14.8- 19.5) ∼ ∼
Minnesota 17.9 ( 16.2- 19.6) 18.2 ( 16.6- 20.0) 17.5 ( 15.9- 19.3) 18.6 ( 16.8- 20.4) ∼ ∼
Missouri 15.5 ( 14.2- 17.0) 17.0 ( 15.5- 18.6) 16.1 ( 14.6- 17.7) 18.2 ( 16.6- 20.0) 10.5 ( 7.0- 15.3) 8.5 ( 5.7- 12.3)
Nebraska 17.4 ( 14.8- 20.4) 18.5 ( 15.7- 21.6) 17.6 ( 14.9- 20.7) 19.0 ( 16.1- 22.2) ∼ ∼




Delaware 15.5 ( 11.9- 19.9) 16.3 ( 12.5- 20.8) 17.0 ( 12.8- 22.2) 19.1 ( 14.4- 24.7) ∼ ∼
District of Columbia 10.0 ( 6.8- 14.6) 11.5 ( 7.9- 16.3) ∼ ∼ 7.5 ( 4.2- 13.1) 9.2 ( 5.3- 14.9)
Florida 17.7 ( 16.9- 18.6) 22.3 ( 21.2- 23.3) 18.6 ( 17.7- 19.6) 25.2 ( 24.0- 26.5) 11.9 ( 9.7- 14.5) 8.8 ( 7.2- 10.7)
Georgia
Atlanta 15.4 ( 13.2- 17.9) 12.7 ( 10.9- 14.7) 16.2 ( 13.5- 19.2) 15.3 ( 12.8- 18.1) 13.0 ( 8.8- 18.8) 7.5 ( 5.2- 10.5)
Maryland 13.2 ( 11.9- 14.7) 13.4 ( 12.0- 14.8) 14.9 ( 13.2- 16.7) 16.5 ( 14.7- 18.5) 8.6 ( 6.4- 11.5) 6.6 ( 4.9- 8.7)
North Carolina 15.1 ( 13.9- 16.3) 16.0 ( 14.8- 17.3) 16.7 ( 15.4- 18.2) 18.8 ( 17.3- 20.5) 8.9 ( 6.9- 11.3) 7.8 ( 6.1- 9.9)
South Carolina 12.8 ( 11.3- 14.4) 13.6 ( 12.1- 15.3) 13.4 ( 11.6- 15.3) 15.6 ( 13.5- 17.8) 11.0 ( 8.4- 14.3) 9.4 ( 7.1- 12.1)
Virginia
West Virginia 14.6 ( 12.4- 17.1) 17.6 ( 15.0- 20.5) 15.0 ( 12.8- 17.6) 18.2 ( 15.5- 21.2) ∼ ∼
East South Central
Alabama













Table 2.15: Cancer of the Ovary. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 12.9 ( 11.5- 14.5) 13.1 ( 11.6- 14.7) 13.8 ( 12.1- 15.8) 15.4 ( 13.4- 17.5) 11.2 ( 8.7- 14.2) 9.3 ( 7.2- 11.7)
Oklahoma
Texas
West 16.3 ( 15.8- 16.8) 16.0 ( 15.5- 16.5) 17.0 ( 16.5- 17.6) 17.2 ( 16.7- 17.7) 10.7 ( 9.0- 12.7) 8.7 ( 7.3- 10.2)
Mountain
Arizona 13.9 ( 12.5- 15.5) 14.3 ( 12.9- 15.9) 14.7 ( 13.1- 16.3) 15.7 ( 14.1- 17.5) ∼ ∼
Colorado 16.8 ( 15.1- 18.7) 16.6 ( 14.9- 18.5) 17.2 ( 15.4- 19.2) 17.3 ( 15.5- 19.3) ∼ ∼
Idaho 16.0 ( 13.0- 19.5) 15.8 ( 12.8- 19.2) 16.3 ( 13.2- 19.9) 16.3 ( 13.3- 19.9) ∼ ∼
Montana 16.7 ( 13.3- 20.9) 18.7 ( 14.9- 23.2) 17.1 ( 13.5- 21.4) 19.7 ( 15.7- 24.5) ∼ ∼
Nevada
New Mexico 17.1 ( 14.5- 20.1) 17.0 ( 14.4- 19.9) 17.3 ( 14.5- 20.5) 18.0 ( 15.1- 21.3) ∼ ∼
Utah 16.0 ( 13.5- 19.0) 13.1 ( 11.1- 15.5) 16.4 ( 13.8- 19.4) 13.6 ( 11.5- 16.1) ∼ ∼
Wyoming 12.9 ( 8.9- 18.5) 13.4 ( 9.2- 18.9) 12.0 ( 8.1- 17.6) 12.7 ( 8.5- 18.2) ∼ ∼
Pacific 16.6 ( 16.0- 17.1) 16.2 ( 15.7- 16.7) 17.4 ( 16.8- 18.1) 17.6 ( 16.9- 18.2) 11.3 ( 9.4- 13.5) 9.2 ( 7.7- 11.0)
Alaska 18.0 ( 12.3- 26.0) 12.9 ( 9.1- 17.7) 19.4 ( 12.8- 29.2) 15.1 ( 10.4- 21.2) ∼ ∼
California 16.2 ( 15.6- 16.8) 15.6 ( 15.0- 16.2) 17.1 ( 16.4- 17.9) 17.0 ( 16.3- 17.7) 11.7 ( 9.7- 14.0) 9.7 ( 8.1- 11.6)
San Francisco-Oakland 17.0 ( 15.3- 18.8) 18.1 ( 16.3- 20.0) 19.0 ( 16.8- 21.4) 21.3 ( 18.9- 23.9) 12.1 ( 8.0- 17.9) 10.8 ( 7.1- 15.7)
San Jose-Monterey 17.3 ( 14.9- 20.0) 16.7 ( 14.4- 19.2) 18.2 ( 15.5- 21.2) 18.1 ( 15.4- 21.1) ∼ ∼
Los Angeles 15.6 ( 14.5- 16.8) 14.6 ( 13.5- 15.7) 16.7 ( 15.3- 18.1) 15.5 ( 14.2- 16.9) 10.8 ( 8.1- 14.2) 9.8 ( 7.4- 12.8)
Hawaii 14.4 ( 11.6- 17.7) 15.4 ( 12.4- 18.9) 16.4 ( 10.5- 24.6) 16.5 ( 10.7- 24.3) ∼ ∼
Oregon 16.3 ( 14.5- 18.3) 17.9 ( 15.9- 20.0) 16.7 ( 14.8- 18.7) 18.7 ( 16.6- 21.0) ∼ ∼
Washington 19.2 ( 17.6- 20.8) 19.2 ( 17.6- 20.9) 19.4 ( 17.8- 21.2) 20.1 ( 18.4- 21.9) ∼ ∼
Seattle-Puget Sound 20.6 ( 18.7- 22.8) 20.7 ( 18.7- 22.8) 21.6 ( 19.5- 23.9) 22.6 ( 20.4- 24.9) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.16: Cancer of the Prostate. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 162.0 (161.2- 162.8) 146.5 (145.8-147.2) 152.3 (151.5- 153.2) 147.1 (146.3-148.0) 229.3 (225.7- 232.9) 140.6 (138.5-142.7)
Northeast 167.0 (165.3- 168.6) 160.3 (158.7-161.9) 158.0 (156.3- 159.7) 162.6 (160.8-164.4) 231.0 (224.1- 238.2) 150.2 (145.9-154.7)
New England 174.0 (170.4- 177.6) 162.8 (159.5-166.2) 167.5 (163.9- 171.1) 165.1 (161.6-168.7) 243.9 (221.3- 268.7) 126.8 (115.6-138.7)
Connecticut 166.5 (160.1- 173.1) 160.5 (154.4-166.9) 156.4 (150.0- 163.1) 159.9 (153.4-166.7) 232.1 (199.3- 270.1) 133.4 (115.4-153.6)
Maine
Massachusetts 180.1 (175.1- 185.2) 167.8 (163.2-172.5) 173.7 (168.7- 178.8) 171.6 (166.6-176.6) 259.8 (226.5- 298.1) 125.0 (109.9-141.6)
New Hampshire 151.7 (141.1- 163.1) 129.3 (120.3-138.8) 149.8 (139.1- 161.1) 129.3 (120.2-138.9) ∼ ∼
Rhode Island 185.1 (172.9- 198.0) 180.6 (168.7-193.1) 184.9 (172.4- 198.1) 189.5 (176.8-202.8) 233.5 (152.0- 360.5) 111.2 ( 73.9-160.7)
Vermont
Middle Atlantic 164.9 (163.0- 166.8) 159.6 (157.8-161.4) 155.0 (153.0- 157.0) 161.7 (159.7-163.8) 229.6 (222.3- 237.1) 153.6 (148.9-158.4)
New Jersey 188.4 (184.0- 192.9) 176.8 (172.7-181.0) 182.0 (177.4- 186.8) 186.6 (181.8-191.4) 273.1 (255.4- 292.0) 172.0 (161.4-183.2)
New York 151.1 (148.4- 153.8) 140.0 (137.5-142.5) 138.5 (135.7- 141.3) 140.0 (137.2-142.9) 210.1 (200.8- 219.7) 139.7 (133.8-145.8)
Pennsylvania 169.0 (165.7- 172.3) 177.5 (174.1-181.0) 159.4 (156.1- 162.7) 175.1 (171.5-178.8) 241.7 (226.4- 258.0) 172.6 (161.7-183.9)
Midwest
East North Central
Illinois 155.2 (151.8- 158.7) 132.9 (129.9-135.8) 143.7 (140.2- 147.3) 131.3 (128.1-134.6) 206.1 (193.7- 219.4) 124.1 (116.9-131.8)
Indiana
Michigan 202.2 (197.9- 206.6) 177.7 (173.9-181.5) 185.8 (181.4- 190.3) 172.1 (168.1-176.2) 290.3 (274.4- 306.9) 193.1 (182.6-203.9)
Detroit 219.0 (212.0- 226.2) 194.4 (188.2-200.6) 196.3 (188.8- 204.0) 186.7 (179.7-193.9) 299.4 (280.9- 318.9) 217.4 (204.1-231.3)
Ohio 153.6 (150.1- 157.1) 141.6 (138.5-144.8) 138.5 (135.1- 142.0) 132.6 (129.4-136.0) 222.1 (207.8- 237.3) 154.1 (144.4-164.3)
Wisconsin 161.2 (156.1- 166.4) 146.6 (142.0-151.3) 156.8 (151.7- 162.1) 149.9 (145.0-154.9) 278.5 (233.9- 332.6) 113.5 ( 96.7-132.4)
West North Central 162.3 (159.6- 165.1) 150.0 (147.5-152.6) 156.2 (153.4- 159.0) 150.7 (148.0-153.4) 220.0 (202.3- 239.1) 119.2 (109.9-129.1)
Iowa 154.4 (147.9- 161.0) 154.7 (148.2-161.3) 148.2 (141.8- 154.8) 152.1 (145.6-158.8) 311.2 (219.4- 436.2) 141.2 (101.7-190.8)
Kansas 169.4 (162.0- 177.0) 152.4 (145.7-159.2) 159.5 (152.2- 167.1) 149.6 (142.7-156.7) 264.7 (216.3- 321.8) 140.7 (115.6-169.6)
Minnesota 181.7 (175.8- 187.7) 155.7 (150.7-160.8) 177.1 (171.2- 183.1) 159.4 (154.2-164.8) 177.1 (123.9- 252.9) 56.2 ( 40.7- 75.8)
Missouri 139.9 (135.3- 144.6) 132.6 (128.3-137.1) 133.5 (128.8- 138.3) 133.0 (128.3-137.7) 214.4 (192.9- 237.9) 132.1 (119.1-146.0)
Nebraska 174.4 (165.1- 184.1) 163.0 (154.4-172.0) 164.4 (155.3- 174.0) 159.6 (150.7-168.8) 153.6 (100.2- 234.0) 87.4 ( 58.5-125.5)




Delaware 163.3 (149.9- 178.0) 152.5 (140.1-165.7) 149.7 (135.8- 164.9) 153.4 (139.4-168.4) 243.4 (197.4- 300.1) 148.3 (121.3-179.5)
District of Columbia 234.7 (215.2- 255.6) 222.1 (203.8-241.6) 144.0 (118.5- 175.4) 128.7 (106.3-154.5) 275.0 (248.7- 303.6) 276.9 (250.6-305.2)
Florida 155.5 (152.9- 158.1) 188.5 (185.3-191.6) 148.9 (146.3- 151.7) 201.1 (197.5-204.7) 228.5 (215.9- 241.9) 127.0 (120.4-133.7)
Georgia
Atlanta 172.4 (163.0- 182.3) 105.8 (100.3-111.5) 142.1 (132.5- 152.4) 102.6 ( 95.9-109.6) 301.4 (272.4- 333.6) 118.3 (107.8-129.5)
Maryland 184.7 (178.8- 190.7) 153.7 (148.9-158.6) 157.0 (150.9- 163.3) 148.5 (142.8-154.4) 225.6 (210.2- 242.1) 132.0 (123.6-140.9)
North Carolina 140.8 (136.7- 145.0) 124.7 (121.1-128.3) 129.8 (125.5- 134.2) 126.2 (122.1-130.4) 195.9 (183.6- 209.0) 124.4 (116.8-132.4)
South Carolina 176.1 (169.6- 182.9) 154.0 (148.5-159.8) 152.8 (146.0- 159.9) 151.7 (145.1-158.5) 255.8 (238.4- 274.4) 156.2 (145.9-167.2)
Virginia
West Virginia 144.8 (137.0- 153.0) 151.7 (143.6-160.1) 141.0 (133.2- 149.3) 149.1 (141.0-157.6) 213.0 (156.3- 284.4) 173.9 (127.8-231.3)
East South Central
Alabama













Table 2.16: Cancer of the Prostate. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State
and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet
Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 163.1 (157.0- 169.4) 133.9 (129.0-139.0) 147.5 (140.9- 154.4) 138.2 (132.1-144.5) 218.2 (203.5- 233.7) 130.0 (121.4-139.0)
Oklahoma
Texas
West 156.3 (154.7- 157.9) 126.5 (125.2-127.8) 150.8 (149.2- 152.5) 127.8 (126.4-129.2) 212.3 (202.9- 222.0) 127.8 (122.3-133.4)
Mountain
Arizona 114.4 (110.0- 119.1) 106.9 (102.7-111.1) 114.5 (110.0- 119.3) 113.9 (109.4-118.6) 140.9 (105.0- 188.7) 69.5 ( 53.3- 89.1)
Colorado 166.7 (160.2- 173.5) 130.3 (125.3-135.3) 167.4 (160.7- 174.3) 133.9 (128.7-139.3) 148.4 (116.7- 189.7) 94.6 ( 75.5-117.0)
Idaho 157.4 (146.8- 168.7) 132.4 (123.6-141.8) 158.6 (147.9- 170.0) 135.5 (126.4-145.1) ∼ ∼
Montana 157.1 (145.5- 169.5) 155.7 (144.2-167.8) 149.8 (138.3- 162.1) 155.9 (144.0-168.5) ∼ ∼
Nevada
New Mexico 148.2 (139.5- 157.5) 128.1 (120.6-135.9) 153.2 (144.0- 163.0) 142.8 (134.3-151.7) 122.5 ( 73.1- 199.8) 84.7 ( 51.7-130.8)
Utah 182.8 (172.8- 193.3) 119.6 (113.1-126.4) 185.3 (175.0- 196.0) 124.0 (117.3-131.1) ∼ ∼
Wyoming 172.0 (154.6- 191.1) 152.2 (137.0-168.6) 172.4 (154.8- 191.7) 155.7 (140.1-172.7) ∼ ∼
Pacific 159.7 (157.9- 161.6) 127.5 (126.0-129.0) 152.3 (150.3- 154.3) 127.1 (125.4-128.8) 222.4 (212.2- 233.0) 135.4 (129.4-141.6)
Alaska 155.8 (136.1- 179.0) 86.1 ( 76.3- 96.8) 160.6 (138.2- 187.3) 94.7 ( 83.0-107.6) 377.6 (201.8- 761.0) 134.4 ( 78.3-215.2)
California 154.7 (152.5- 156.9) 119.9 (118.3-121.6) 144.3 (142.0- 146.6) 117.5 (115.7-119.4) 222.6 (211.9- 233.8) 139.2 (132.7-145.9)
San Francisco-Oakland 162.1 (156.1- 168.3) 140.0 (134.8-145.3) 154.6 (147.7- 161.7) 143.1 (136.8-149.6) 204.5 (183.3- 227.9) 149.7 (134.5-166.2)
San Jose-Monterey 166.1 (157.5- 175.2) 120.3 (114.1-126.7) 156.8 (147.6- 166.5) 121.5 (114.5-128.9) 150.0 (102.9- 230.2) 71.7 ( 50.0- 99.8)
Los Angeles 156.6 (152.4- 160.9) 113.9 (110.8-117.0) 144.8 (140.2- 149.6) 107.0 (103.6-110.5) 236.9 (220.9- 254.1) 172.4 (161.0-184.4)
Hawaii 135.5 (126.1- 145.5) 131.2 (122.1-140.7) 183.8 (160.9- 209.3) 139.4 (122.1-158.3) ∼ ∼
Oregon 176.2 (169.6- 183.0) 165.8 (159.6-172.2) 173.1 (166.4- 179.9) 168.0 (161.6-174.7) 224.6 (156.2- 319.6) 121.1 ( 86.1-165.6)
Washington 182.4 (177.0- 187.9) 153.0 (148.5-157.6) 175.2 (169.7- 180.8) 154.5 (149.7-159.4) 207.9 (169.9- 254.8) 107.5 ( 88.7-129.2)
Seattle-Puget Sound 187.5 (180.8- 194.4) 154.3 (148.9-159.9) 189.4 (182.4- 196.6) 165.3 (159.2-171.5) 217.2 (175.5- 269.1) 111.9 ( 91.4-135.6)
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.17: Cancer of the Testis. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 5.5 ( 5.3- 5.6) 5.6 ( 5.5- 5.8) 6.2 ( 6.0- 6.3) 6.3 ( 6.1- 6.5) 1.4 ( 1.1- 1.6) 1.3 ( 1.1- 1.5)
Northeast 5.8 ( 5.5- 6.1) 5.9 ( 5.6- 6.2) 6.5 ( 6.2- 6.9) 6.7 ( 6.3- 7.0) 1.3 ( 0.9- 1.9) 1.3 ( 0.9- 1.7)
New England 6.2 ( 5.6- 6.9) 6.5 ( 5.9- 7.2) 6.7 ( 6.0- 7.5) 7.0 ( 6.3- 7.8) ∼ ∼
Connecticut 6.2 ( 5.0- 7.6) 6.2 ( 5.0- 7.6) 6.9 ( 5.6- 8.5) 6.8 ( 5.5- 8.4) ∼ ∼
Maine
Massachusetts 6.4 ( 5.6- 7.4) 6.9 ( 6.0- 7.9) 6.9 ( 5.9- 7.9) 7.4 ( 6.4- 8.5) ∼ ∼
New Hampshire 6.2 ( 4.4- 8.7) 6.6 ( 4.7- 9.0) 6.3 ( 4.4- 8.8) 6.6 ( 4.7- 9.0) ∼ ∼
Rhode Island 5.4 ( 3.5- 8.0) 5.5 ( 3.6- 8.0) 5.9 ( 3.8- 8.7) 5.9 ( 3.9- 8.7) ∼ ∼
Vermont
Middle Atlantic 5.6 ( 5.3- 6.0) 5.7 ( 5.4- 6.1) 6.5 ( 6.1- 6.9) 6.5 ( 6.1- 7.0) 1.4 ( 0.9- 2.0) 1.3 ( 0.9- 1.9)
New Jersey 5.8 ( 5.1- 6.6) 5.9 ( 5.2- 6.8) 6.9 ( 6.0- 7.9) 7.0 ( 6.1- 8.0) ∼ ∼
New York 5.5 ( 5.0- 6.0) 5.7 ( 5.2- 6.2) 6.5 ( 5.9- 7.1) 6.6 ( 6.0- 7.3) 1.2 ( 0.7- 2.1) 1.2 ( 0.7- 1.9)
Pennsylvania 5.6 ( 5.1- 6.3) 5.7 ( 5.1- 6.3) 6.1 ( 5.5- 6.8) 6.1 ( 5.5- 6.9) ∼ ∼
Midwest
East North Central
Illinois 5.2 ( 4.7- 5.9) 5.4 ( 4.8- 6.0) 5.7 ( 5.1- 6.4) 5.9 ( 5.2- 6.6) ∼ ∼
Indiana
Michigan 5.0 ( 4.4- 5.7) 5.1 ( 4.5- 5.8) 5.8 ( 5.1- 6.6) 5.9 ( 5.2- 6.7) ∼ ∼
Detroit 4.8 ( 3.9- 5.9) 5.0 ( 4.0- 6.0) 5.9 ( 4.7- 7.3) 6.2 ( 5.0- 7.6) ∼ ∼
Ohio 5.5 ( 4.9- 6.2) 5.5 ( 4.9- 6.2) 6.0 ( 5.3- 6.7) 6.1 ( 5.4- 6.8) ∼ ∼
Wisconsin 7.5 ( 6.5- 8.7) 7.5 ( 6.5- 8.6) 7.8 ( 6.7- 9.0) 7.8 ( 6.7- 9.0) ∼ ∼
West North Central 6.1 ( 5.6- 6.6) 6.1 ( 5.5- 6.6) 6.3 ( 5.8- 6.9) 6.3 ( 5.8- 6.9) ∼ ∼
Iowa 6.0 ( 4.7- 7.4) 5.9 ( 4.7- 7.3) 5.8 ( 4.6- 7.3) 5.7 ( 4.5- 7.1) ∼ ∼
Kansas 6.3 ( 5.0- 7.8) 6.4 ( 5.1- 7.9) 6.8 ( 5.4- 8.4) 6.8 ( 5.4- 8.4) ∼ ∼
Minnesota 7.2 ( 6.2- 8.4) 7.3 ( 6.3- 8.5) 7.2 ( 6.1- 8.5) 7.3 ( 6.2- 8.5) ∼ ∼
Missouri 4.4 ( 3.7- 5.3) 4.4 ( 3.7- 5.3) 4.9 ( 4.0- 5.9) 4.9 ( 4.0- 5.9) ∼ ∼
Nebraska 8.0 ( 6.1- 10.2) 7.7 ( 5.9- 9.9) 8.4 ( 6.4- 10.8) 8.1 ( 6.2- 10.4) ∼ ∼




Delaware 4.9 ( 2.9- 8.1) 5.2 ( 3.1- 8.1) 5.3 ( 3.0- 9.1) 5.6 ( 3.2- 9.1) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼
Florida 5.1 ( 4.6- 5.7) 4.9 ( 4.4- 5.5) 5.8 ( 5.2- 6.5) 5.5 ( 4.9- 6.1) 1.6 ( 0.9- 3.2) 1.5 ( 0.9- 2.4)
Georgia
Atlanta 4.4 ( 3.4- 5.9) 5.2 ( 4.0- 6.6) 5.6 ( 4.2- 7.6) 6.7 ( 5.1- 8.6) ∼ ∼
Maryland 4.7 ( 3.9- 5.6) 5.0 ( 4.1- 5.9) 6.4 ( 5.2- 7.7) 6.7 ( 5.5- 8.0) ∼ ∼
North Carolina 4.2 ( 3.6- 5.0) 4.4 ( 3.7- 5.1) 5.1 ( 4.3- 6.0) 5.3 ( 4.5- 6.2) ∼ ∼
South Carolina 4.1 ( 3.3- 5.2) 4.3 ( 3.4- 5.4) 5.3 ( 4.2- 6.8) 5.6 ( 4.4- 7.1) ∼ ∼
Virginia
West Virginia 4.9 ( 3.5- 6.7) 4.8 ( 3.5- 6.5) 5.1 ( 3.7- 7.0) 5.0 ( 3.6- 6.8) ∼ ∼
East South Central
Alabama













Table 2.17: Cancer of the Testis. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 3.7 ( 2.9- 4.7) 3.6 ( 2.8- 4.5) 4.9 ( 3.8- 6.3) 4.9 ( 3.8- 6.2) ∼ ∼
Oklahoma
Texas
West 5.7 ( 5.4- 5.9) 5.9 ( 5.6- 6.2) 6.3 ( 6.0- 6.6) 6.5 ( 6.2- 6.8) 1.5 ( 0.9- 2.5) 1.5 ( 0.9- 2.2)
Mountain
Arizona 5.5 ( 4.6- 6.6) 5.4 ( 4.5- 6.4) 5.9 ( 4.9- 7.1) 5.8 ( 4.8- 6.9) ∼ ∼
Colorado 7.5 ( 6.4- 8.9) 7.7 ( 6.5- 9.0) 7.6 ( 6.4- 9.0) 7.7 ( 6.5- 9.1) ∼ ∼
Idaho 6.3 ( 4.5- 8.9) 5.9 ( 4.2- 8.2) 6.4 ( 4.5- 9.0) 5.9 ( 4.2- 8.2) ∼ ∼
Montana 6.3 ( 4.1- 9.4) 5.9 ( 3.9- 8.7) 6.2 ( 3.9- 9.4) 5.9 ( 3.8- 8.8) ∼ ∼
Nevada
New Mexico 5.7 ( 4.2- 7.7) 5.5 ( 4.0- 7.3) 5.8 ( 4.2- 8.0) 5.5 ( 4.0- 7.5) ∼ ∼
Utah 4.3 ( 3.1- 6.0) 4.4 ( 3.3- 5.9) 4.4 ( 3.2- 6.1) 4.6 ( 3.3- 6.1) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 5.5 ( 5.2- 5.9) 5.8 ( 5.5- 6.2) 6.3 ( 6.0- 6.7) 6.7 ( 6.3- 7.1) 1.3 ( 0.7- 2.4) 1.3 ( 0.8- 2.0)
Alaska 8.4 ( 5.5- 15.3) 8.3 ( 5.5- 12.1) 10.4 ( 6.7- 19.3) 10.5 ( 6.8- 15.4) ∼ ∼
California 5.3 ( 4.9- 5.6) 5.6 ( 5.2- 6.0) 6.1 ( 5.7- 6.6) 6.5 ( 6.1- 7.0) 1.3 ( 0.7- 2.5) 1.3 ( 0.7- 2.1)
San Francisco-Oakland 6.3 ( 5.2- 7.4) 6.9 ( 5.8- 8.1) 7.9 ( 6.6- 9.6) 8.8 ( 7.3- 10.5) ∼ ∼
San Jose-Monterey 5.5 ( 4.3- 7.1) 6.2 ( 4.9- 7.8) 6.6 ( 5.1- 8.5) 7.3 ( 5.6- 9.3) ∼ ∼
Los Angeles 3.9 ( 3.4- 4.5) 4.3 ( 3.7- 4.9) 4.9 ( 4.2- 5.7) 5.3 ( 4.6- 6.1) ∼ ∼
Hawaii 5.2 ( 3.6- 7.5) 5.3 ( 3.6- 7.5) ∼ ∼ ∼ ∼
Oregon 7.2 ( 5.9- 8.6) 7.2 ( 6.0- 8.6) 7.4 ( 6.1- 9.0) 7.4 ( 6.1- 8.9) ∼ ∼
Washington 6.1 ( 5.3- 7.1) 6.4 ( 5.5- 7.4) 6.4 ( 5.5- 7.5) 6.6 ( 5.6- 7.7) ∼ ∼
Seattle-Puget Sound 5.9 ( 4.9- 7.1) 6.3 ( 5.3- 7.5) 6.5 ( 5.4- 7.9) 7.0 ( 5.8- 8.3) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.18.1: Cancer of the Urinary Bladder. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 38.3 ( 37.9- 38.7) 33.5 ( 33.2- 33.9) 40.2 ( 39.8- 40.7) 37.7 ( 37.3- 38.1) 17.9 ( 16.9- 19.0) 10.0 ( 9.5- 10.6)
Northeast 43.0 ( 42.1- 43.9) 40.0 ( 39.2- 40.8) 45.4 ( 44.5- 46.3) 45.6 ( 44.6- 46.5) 17.6 ( 15.6- 19.8) 10.4 ( 9.3- 11.6)
New England 45.3 ( 43.5- 47.2) 41.5 ( 39.8- 43.2) 46.0 ( 44.1- 48.0) 44.5 ( 42.7- 46.4) 26.1 ( 18.2- 36.8) 11.0 ( 7.9- 14.9)
Connecticut 46.0 ( 42.6- 49.6) 43.5 ( 40.4- 46.9) 46.7 ( 43.2- 50.4) 47.1 ( 43.6- 50.9) 32.2 ( 19.5- 51.1) 15.1 ( 9.4- 22.8)
Maine
Massachusetts 43.5 ( 41.0- 46.1) 39.5 ( 37.3- 41.8) 44.0 ( 41.5- 46.7) 42.6 ( 40.1- 45.1) 21.3 ( 11.7- 37.2) 8.6 ( 5.0- 13.8)
New Hampshire 43.1 ( 37.3- 49.5) 35.5 ( 30.9- 40.7) 43.6 ( 37.8- 50.1) 36.4 ( 31.6- 41.7) ∼ ∼
Rhode Island 55.8 ( 49.2- 63.1) 54.3 ( 47.9- 61.4) 57.2 ( 50.4- 64.8) 58.6 ( 51.6- 66.2) ∼ ∼
Vermont
Middle Atlantic 42.3 ( 41.3- 43.3) 39.6 ( 38.7- 40.5) 45.2 ( 44.1- 46.3) 45.9 ( 44.8- 47.0) 16.7 ( 14.7- 19.0) 10.3 ( 9.1- 11.6)
New Jersey 45.9 ( 43.7- 48.2) 41.7 ( 39.8- 43.8) 50.3 ( 47.8- 52.8) 50.2 ( 47.8- 52.8) 16.2 ( 12.0- 21.6) 9.9 ( 7.4- 12.8)
New York 38.7 ( 37.3- 40.1) 34.5 ( 33.3- 35.8) 42.0 ( 40.4- 43.6) 41.2 ( 39.7- 42.8) 14.7 ( 12.2- 17.7) 8.8 ( 7.4- 10.5)
Pennsylvania 45.0 ( 43.3- 46.8) 45.9 ( 44.1- 47.7) 46.2 ( 44.4- 48.1) 49.4 ( 47.4- 51.3) 22.1 ( 17.5- 27.7) 15.0 ( 11.9- 18.6)
Midwest
East North Central
Illinois 37.8 ( 36.1- 39.6) 31.3 ( 29.9- 32.7) 39.1 ( 37.2- 41.0) 34.7 ( 33.1- 36.4) 18.8 ( 14.9- 23.4) 10.2 ( 8.2- 12.5)
Indiana
Michigan 41.9 ( 39.9- 44.0) 35.4 ( 33.8- 37.2) 44.1 ( 42.0- 46.4) 39.3 ( 37.4- 41.3) 22.6 ( 18.3- 27.9) 14.4 ( 11.6- 17.6)
Detroit 41.5 ( 38.4- 44.8) 34.9 ( 32.4- 37.7) 46.5 ( 42.8- 50.5) 41.8 ( 38.6- 45.3) 23.8 ( 18.7- 30.1) 16.6 ( 13.1- 20.8)
Ohio 41.2 ( 39.4- 43.1) 36.3 ( 34.7- 38.0) 41.4 ( 39.4- 43.4) 38.0 ( 36.3- 39.8) 22.1 ( 17.5- 27.8) 13.7 ( 10.9- 17.0)
Wisconsin 37.6 ( 35.1- 40.3) 33.5 ( 31.3- 35.8) 38.3 ( 35.8- 41.0) 35.9 ( 33.6- 38.4) ∼ ∼
West North Central 36.8 ( 35.5- 38.2) 33.2 ( 32.1- 34.5) 37.1 ( 35.8- 38.5) 35.0 ( 33.7- 36.3) 18.7 ( 13.6- 25.3) 9.6 ( 7.1- 12.7)
Iowa 38.6 ( 35.4- 42.1) 38.2 ( 35.1- 41.6) 38.2 ( 35.0- 41.7) 38.8 ( 35.5- 42.2) ∼ ∼
Kansas 34.7 ( 31.4- 38.3) 30.7 ( 27.8- 33.9) 34.3 ( 30.9- 37.9) 31.7 ( 28.6- 35.0) ∼ ∼
Minnesota 37.5 ( 34.8- 40.3) 31.5 ( 29.3- 33.9) 37.2 ( 34.5- 40.1) 32.9 ( 30.5- 35.4) ∼ ∼
Missouri 34.7 ( 32.3- 37.2) 31.6 ( 29.5- 33.8) 36.1 ( 33.6- 38.7) 34.5 ( 32.2- 37.0) 15.6 ( 10.2- 23.2) 9.7 ( 6.5- 14.0)
Nebraska 40.4 ( 35.9- 45.3) 36.7 ( 32.6- 41.1) 40.5 ( 36.0- 45.5) 38.3 ( 34.0- 42.9) ∼ ∼




Delaware 33.9 ( 27.8- 41.3) 30.3 ( 24.9- 36.5) 34.6 ( 28.1- 42.7) 34.5 ( 28.1- 42.0) ∼ ∼
District of Columbia 19.9 ( 14.4- 27.0) 18.0 ( 13.1- 24.2) ∼ ∼ 18.7 ( 12.2- 27.8) 17.8 ( 11.6- 26.0)
Florida 41.4 ( 40.1- 42.8) 49.5 ( 47.9- 51.2) 43.4 ( 41.9- 44.9) 57.9 ( 56.0- 59.8) 12.6 ( 9.6- 16.5) 6.4 ( 5.0- 8.0)
Georgia
Atlanta 29.2 ( 25.1- 34.0) 15.2 ( 13.2- 17.5) 32.4 ( 27.6- 38.1) 20.5 ( 17.6- 23.7) 18.6 ( 11.2- 29.8) 5.8 ( 3.7- 8.7)
Maryland 30.4 ( 28.0- 33.0) 24.2 ( 22.4- 26.2) 34.7 ( 31.8- 37.9) 31.6 ( 29.0- 34.4) 12.1 ( 8.8- 16.7) 7.3 ( 5.4- 9.6)
North Carolina 31.7 ( 29.6- 33.8) 26.3 ( 24.7- 28.0) 34.2 ( 31.9- 36.6) 31.4 ( 29.4- 33.6) 18.4 ( 14.4- 23.3) 9.9 ( 7.8- 12.3)
South Carolina 34.9 ( 32.0- 38.2) 28.9 ( 26.5- 31.4) 39.5 ( 36.0- 43.4) 37.0 ( 33.8- 40.4) 16.7 ( 12.3- 22.4) 9.5 ( 7.0- 12.4)
Virginia
West Virginia 39.8 ( 35.7- 44.3) 40.6 ( 36.5- 45.1) 40.1 ( 35.9- 44.7) 41.2 ( 37.0- 45.8) ∼ ∼
East South Central
Alabama













Table 2.18.1: Cancer of the Urinary Bladder. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 32.9 ( 30.1- 35.9) 25.7 ( 23.6- 28.0) 37.5 ( 34.1- 41.2) 33.4 ( 30.5- 36.6) 18.7 ( 14.4- 23.9) 10.5 ( 8.1- 13.2)
Oklahoma
Texas
West 34.8 ( 34.0- 35.5) 27.3 ( 26.7- 27.9) 36.6 ( 35.8- 37.5) 30.2 ( 29.5- 30.9) 18.3 ( 15.4- 21.5) 10.1 ( 8.7- 11.8)
Mountain
Arizona 39.3 ( 36.6- 42.1) 35.0 ( 32.6- 37.4) 40.2 ( 37.5- 43.2) 38.2 ( 35.6- 41.0) ∼ ∼
Colorado 32.0 ( 29.1- 35.1) 24.5 ( 22.4- 26.8) 31.7 ( 28.8- 34.9) 24.9 ( 22.7- 27.3) ∼ ∼
Idaho 35.5 ( 30.5- 41.1) 29.9 ( 25.8- 34.5) 35.3 ( 30.3- 40.9) 30.2 ( 26.0- 34.9) ∼ ∼
Montana 34.2 ( 28.8- 40.4) 32.8 ( 27.6- 38.6) 33.2 ( 27.9- 39.5) 33.4 ( 28.0- 39.5) ∼ ∼
Nevada
New Mexico 27.5 ( 23.8- 31.8) 22.9 ( 19.8- 26.4) 28.7 ( 24.7- 33.2) 25.7 ( 22.2- 29.6) ∼ ∼
Utah 36.0 ( 31.5- 40.9) 22.8 ( 20.0- 25.9) 36.8 ( 32.2- 41.9) 23.9 ( 21.0- 27.1) ∼ ∼
Wyoming 42.5 ( 33.8- 53.1) 35.7 ( 28.5- 44.0) 43.3 ( 34.4- 54.0) 37.1 ( 29.7- 45.8) ∼ ∼
Pacific 34.6 ( 33.7- 35.5) 26.9 ( 26.2- 27.6) 37.0 ( 36.0- 38.0) 30.1 ( 29.3- 31.0) 18.2 ( 15.2- 21.7) 10.3 ( 8.7- 12.1)
Alaska 33.8 ( 24.1- 47.5) 16.6 ( 12.5- 21.7) 36.4 ( 25.1- 52.9) 18.5 ( 13.6- 24.7) ∼ ∼
California 33.2 ( 32.1- 34.2) 25.0 ( 24.2- 25.8) 35.7 ( 34.5- 36.8) 28.4 ( 27.5- 29.3) 17.4 ( 14.4- 21.0) 10.2 ( 8.5- 12.1)
San Francisco-Oakland 30.2 ( 27.6- 32.9) 25.7 ( 23.6- 28.1) 34.4 ( 31.2- 37.9) 31.7 ( 28.8- 34.9) 15.6 ( 9.9- 23.9) 10.6 ( 6.9- 15.7)
San Jose-Monterey 28.9 ( 25.3- 32.9) 20.4 ( 17.9- 23.2) 31.3 ( 27.2- 35.9) 23.7 ( 20.6- 27.1) ∼ ∼
Los Angeles 30.3 ( 28.4- 32.3) 21.1 ( 19.8- 22.5) 33.3 ( 31.1- 35.7) 23.9 ( 22.3- 25.6) 17.6 ( 13.2- 23.2) 11.5 ( 8.7- 15.0)
Hawaii 20.9 ( 17.3- 25.1) 20.2 ( 16.7- 24.1) 40.2 ( 29.9- 53.1) 30.7 ( 22.9- 40.3) ∼ ∼
Oregon 42.8 ( 39.6- 46.3) 39.7 ( 36.7- 42.9) 42.6 ( 39.3- 46.2) 40.8 ( 37.7- 44.2) ∼ ∼
Washington 40.6 ( 38.0- 43.3) 32.9 ( 30.8- 35.1) 39.7 ( 37.1- 42.5) 34.0 ( 31.7- 36.3) ∼ ∼
Seattle-Puget Sound 43.1 ( 39.9- 46.6) 34.1 ( 31.6- 36.8) 44.0 ( 40.6- 47.6) 37.1 ( 34.2- 40.1) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Includes invasive and in situ
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.18.2: Cancer of the Urinary Bladder. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 10.0 ( 9.8- 10.2) 11.4 ( 11.2- 11.6) 10.4 ( 10.2- 10.6) 12.7 ( 12.4- 12.9) 7.1 ( 6.6- 7.7) 5.4 ( 5.0- 5.8)
Northeast 11.6 ( 11.2- 12.0) 14.2 ( 13.8- 14.7) 12.2 ( 11.7- 12.6) 16.0 ( 15.4- 16.5) 6.4 ( 5.5- 7.4) 5.3 ( 4.6- 6.2)
New England 12.9 ( 12.0- 13.7) 15.5 ( 14.5- 16.6) 12.9 ( 12.1- 13.9) 16.5 ( 15.4- 17.6) 7.9 ( 4.7- 12.5) 4.8 ( 2.9- 7.4)
Connecticut 13.3 ( 11.8- 15.1) 16.2 ( 14.4- 18.3) 13.7 ( 12.1- 15.6) 17.6 ( 15.6- 19.9) ∼ ∼
Maine
Massachusetts 12.3 ( 11.2- 13.5) 14.8 ( 13.5- 16.2) 12.3 ( 11.1- 13.5) 15.7 ( 14.2- 17.2) ∼ ∼
New Hampshire 12.5 ( 9.9- 15.6) 13.3 ( 10.6- 16.5) 12.3 ( 9.7- 15.4) 13.3 ( 10.5- 16.5) ∼ ∼
Rhode Island 14.9 ( 12.1- 18.3) 20.2 ( 16.5- 24.5) 15.2 ( 12.3- 18.8) 21.5 ( 17.6- 26.2) ∼ ∼
Vermont
Middle Atlantic 11.2 ( 10.8- 11.7) 13.8 ( 13.3- 14.4) 11.9 ( 11.4- 12.4) 15.8 ( 15.2- 16.4) 6.3 ( 5.4- 7.4) 5.4 ( 4.6- 6.3)
New Jersey 11.1 ( 10.2- 12.1) 13.4 ( 12.3- 14.5) 11.8 ( 10.8- 12.9) 15.6 ( 14.3- 17.0) 6.6 ( 4.5- 9.4) 5.1 ( 3.5- 7.2)
New York 11.0 ( 10.4- 11.6) 13.0 ( 12.3- 13.7) 12.0 ( 11.3- 12.8) 15.5 ( 14.6- 16.4) 4.9 ( 3.8- 6.2) 4.2 ( 3.3- 5.3)
Pennsylvania 11.6 ( 10.9- 12.4) 15.5 ( 14.5- 16.5) 11.8 ( 11.0- 12.6) 16.4 ( 15.3- 17.5) 9.7 ( 7.3- 12.6) 9.0 ( 6.8- 11.7)
Midwest
East North Central
Illinois 10.2 ( 9.5- 11.0) 11.4 ( 10.6- 12.3) 10.4 ( 9.6- 11.3) 12.5 ( 11.5- 13.5) 9.3 ( 7.2- 11.8) 6.8 ( 5.3- 8.7)
Indiana
Michigan 10.9 ( 10.0- 11.8) 11.9 ( 11.0- 12.9) 11.1 ( 10.2- 12.1) 12.9 ( 11.9- 14.1) 8.8 ( 6.6- 11.5) 7.0 ( 5.3- 9.2)
Detroit 11.1 ( 9.8- 12.6) 12.4 ( 11.0- 14.0) 11.5 ( 10.0- 13.1) 14.0 ( 12.2- 16.0) 9.8 ( 7.2- 13.1) 8.4 ( 6.2- 11.2)
Ohio 10.8 ( 10.0- 11.6) 12.5 ( 11.7- 13.5) 10.7 ( 9.9- 11.6) 13.1 ( 12.1- 14.1) 8.0 ( 5.8- 10.7) 6.5 ( 4.8- 8.7)
Wisconsin 10.4 ( 9.3- 11.7) 11.9 ( 10.6- 13.3) 10.7 ( 9.5- 11.9) 12.7 ( 11.4- 14.2) ∼ ∼
West North Central 8.8 ( 8.2- 9.4) 10.4 ( 9.7- 11.0) 8.7 ( 8.1- 9.3) 10.7 ( 10.0- 11.4) 6.8 ( 4.4- 10.1) 4.8 ( 3.1- 7.0)
Iowa 8.4 ( 7.1- 9.8) 10.8 ( 9.2- 12.6) 8.2 ( 6.9- 9.7) 10.8 ( 9.2- 12.7) ∼ ∼
Kansas 10.2 ( 8.6- 11.9) 12.2 ( 10.4- 14.2) 9.8 ( 8.3- 11.6) 12.3 ( 10.5- 14.5) ∼ ∼
Minnesota 10.1 ( 8.9- 11.4) 11.0 ( 9.7- 12.4) 10.0 ( 8.8- 11.3) 11.5 ( 10.1- 12.9) ∼ ∼
Missouri 7.7 ( 6.8- 8.8) 9.1 ( 8.0- 10.3) 7.7 ( 6.8- 8.8) 9.5 ( 8.3- 10.8) 7.7 ( 4.7- 12.0) 6.1 ( 3.7- 9.4)
Nebraska 7.3 ( 5.7- 9.3) 8.8 ( 6.9- 11.1) 7.3 ( 5.7- 9.3) 9.0 ( 7.1- 11.4) ∼ ∼




Delaware 13.2 ( 10.0- 17.2) 14.5 ( 10.9- 18.8) 13.2 ( 9.7- 17.7) 16.1 ( 11.8- 21.3) ∼ ∼
District of Columbia 11.7 ( 8.3- 16.3) 14.8 ( 10.6- 20.1) ∼ ∼ 10.6 ( 6.9- 16.5) 14.9 ( 9.8- 21.9)
Florida 11.1 ( 10.4- 11.7) 15.9 ( 15.1- 16.8) 11.5 ( 10.8- 12.2) 18.3 ( 17.2- 19.3) 7.9 ( 6.0- 10.2) 5.2 ( 4.0- 6.6)
Georgia
Atlanta 9.8 ( 8.0- 12.0) 7.2 ( 5.9- 8.8) 9.1 ( 7.1- 11.5) 8.1 ( 6.3- 10.2) 13.2 ( 8.7- 19.4) 6.2 ( 4.1- 9.0)
Maryland 9.8 ( 8.7- 11.0) 10.2 ( 9.1- 11.5) 10.7 ( 9.3- 12.2) 13.0 ( 11.4- 14.8) 5.2 ( 3.4- 7.7) 3.5 ( 2.3- 5.1)
North Carolina 8.4 ( 7.5- 9.3) 9.3 ( 8.4- 10.3) 9.2 ( 8.3- 10.3) 11.2 ( 10.0- 12.5) 4.5 ( 3.1- 6.3) 3.8 ( 2.6- 5.3)
South Carolina 7.6 ( 6.5- 8.8) 8.2 ( 7.0- 9.6) 7.6 ( 6.4- 9.1) 9.4 ( 7.8- 11.1) 7.1 ( 4.9- 9.8) 5.8 ( 4.1- 8.1)
Virginia
West Virginia 13.8 ( 11.8- 16.1) 17.9 ( 15.3- 20.9) 13.7 ( 11.6- 16.1) 17.9 ( 15.2- 20.9) ∼ ∼
East South Central
Alabama













Table 2.18.2: Cancer of the Urinary Bladder. Invasive Cancer Incidence Rates by U.S. Census Region and Division,
State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 7.4 ( 6.3- 8.6) 7.6 ( 6.5- 8.8) 7.7 ( 6.4- 9.1) 8.9 ( 7.5- 10.6) 6.6 ( 4.7- 9.1) 5.2 ( 3.7- 7.1)
Oklahoma
Texas
West 8.6 ( 8.2- 8.9) 8.6 ( 8.3- 8.9) 9.1 ( 8.7- 9.5) 9.6 ( 9.2- 10.0) 6.2 ( 4.8- 7.8) 4.3 ( 3.4- 5.5)
Mountain
Arizona 9.3 ( 8.2- 10.6) 10.2 ( 9.0- 11.6) 9.7 ( 8.5- 11.0) 11.3 ( 9.9- 12.8) ∼ ∼
Colorado 9.1 ( 7.8- 10.5) 8.7 ( 7.4- 10.0) 9.4 ( 8.0- 10.9) 9.2 ( 7.9- 10.7) ∼ ∼
Idaho 7.2 ( 5.2- 9.7) 7.2 ( 5.2- 9.6) 7.3 ( 5.3- 9.9) 7.4 ( 5.4- 9.9) ∼ ∼
Montana 10.4 ( 7.8- 13.7) 12.4 ( 9.3- 16.1) 10.5 ( 7.8- 13.9) 13.2 ( 9.9- 17.2) ∼ ∼
Nevada
New Mexico 7.9 ( 6.1- 10.0) 7.8 ( 6.1- 9.9) 8.4 ( 6.5- 10.7) 8.9 ( 6.9- 11.3) ∼ ∼
Utah 8.3 ( 6.5- 10.5) 6.5 ( 5.1- 8.2) 8.4 ( 6.6- 10.7) 6.8 ( 5.3- 8.6) ∼ ∼
Wyoming 9.2 ( 5.8- 14.1) 9.6 ( 6.1- 14.5) 9.4 ( 5.9- 14.4) 10.1 ( 6.4- 15.1) ∼ ∼
Pacific 8.5 ( 8.1- 8.9) 8.5 ( 8.1- 8.9) 9.1 ( 8.6- 9.5) 9.6 ( 9.1- 10.0) 6.4 ( 4.9- 8.1) 4.6 ( 3.6- 5.9)
Alaska 10.8 ( 6.0- 18.3) 5.4 ( 3.1- 8.8) ∼ ∼ ∼ ∼
California 8.2 ( 7.8- 8.7) 8.1 ( 7.7- 8.6) 8.9 ( 8.4- 9.4) 9.3 ( 8.8- 9.8) 6.3 ( 4.8- 8.2) 4.7 ( 3.6- 6.1)
San Francisco-Oakland 9.0 ( 7.8- 10.3) 9.9 ( 8.6- 11.4) 9.9 ( 8.4- 11.6) 12.0 ( 10.3- 14.0) ∼ ∼
San Jose-Monterey 7.4 ( 5.8- 9.2) 7.0 ( 5.5- 8.7) 7.9 ( 6.2- 10.0) 8.1 ( 6.3- 10.2) ∼ ∼
Los Angeles 7.3 ( 6.5- 8.1) 7.0 ( 6.2- 7.8) 8.0 ( 7.1- 9.0) 7.9 ( 7.0- 8.9) 7.1 ( 4.9- 10.0) 6.0 ( 4.1- 8.4)
Hawaii 5.4 ( 3.8- 7.6) 6.1 ( 4.3- 8.4) ∼ ∼ ∼ ∼
Oregon 9.8 ( 8.5- 11.4) 11.4 ( 9.8- 13.1) 9.9 ( 8.5- 11.5) 11.9 ( 10.2- 13.7) ∼ ∼
Washington 9.6 ( 8.5- 10.7) 9.8 ( 8.6- 11.0) 9.4 ( 8.3- 10.6) 10.1 ( 8.9- 11.4) ∼ ∼
Seattle-Puget Sound 10.0 ( 8.7- 11.5) 10.1 ( 8.7- 11.6) 10.4 ( 8.9- 12.0) 11.1 ( 9.6- 12.8) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Includes invasive and in situ
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.19.1: Cancer of the Kidney and Renal Pelvis. Invasive Cancer Incidence Rates by U.S. Census Region and
Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 16.0 ( 15.8- 16.3) 14.7 ( 14.5- 14.9) 16.1 ( 15.8- 16.4) 15.6 ( 15.4- 15.9) 16.3 ( 15.4- 17.3) 10.9 ( 10.3- 11.5)
Northeast 17.3 ( 16.8- 17.9) 16.7 ( 16.2- 17.3) 17.6 ( 17.0- 18.2) 18.0 ( 17.5- 18.6) 14.8 ( 13.1- 16.7) 10.2 ( 9.0- 11.4)
New England 16.8 ( 15.7- 17.9) 16.0 ( 14.9- 17.0) 16.6 ( 15.5- 17.8) 16.6 ( 15.5- 17.7) 18.8 ( 13.2- 27.0) 11.0 ( 7.9- 14.9)
Connecticut 16.3 ( 14.4- 18.5) 16.0 ( 14.1- 18.1) 16.3 ( 14.3- 18.5) 16.8 ( 14.8- 19.1) ∼ ∼
Maine
Massachusetts 17.4 ( 15.9- 19.0) 16.5 ( 15.0- 18.0) 17.1 ( 15.6- 18.8) 17.1 ( 15.5- 18.7) 20.3 ( 12.5- 33.7) 12.2 ( 7.8- 18.1)
New Hampshire 13.2 ( 10.2- 16.9) 11.7 ( 9.1- 14.8) 13.4 ( 10.3- 17.1) 12.0 ( 9.3- 15.1) ∼ ∼
Rhode Island 18.2 ( 14.5- 22.6) 17.8 ( 14.2- 22.0) 18.5 ( 14.7- 23.1) 19.0 ( 15.1- 23.5) ∼ ∼
Vermont
Middle Atlantic 17.5 ( 16.9- 18.1) 17.0 ( 16.4- 17.6) 17.9 ( 17.2- 18.6) 18.5 ( 17.9- 19.2) 14.3 ( 12.6- 16.3) 10.0 ( 8.9- 11.3)
New Jersey 18.1 ( 16.8- 19.6) 17.2 ( 16.0- 18.6) 18.5 ( 17.1- 20.1) 19.1 ( 17.6- 20.7) 17.6 ( 13.3- 23.3) 11.1 ( 8.5- 14.2)
New York 17.0 ( 16.1- 17.9) 15.9 ( 15.1- 16.8) 17.9 ( 16.9- 19.0) 18.1 ( 17.1- 19.2) 10.6 ( 8.7- 12.9) 7.6 ( 6.3- 9.2)
Pennsylvania 17.8 ( 16.8- 18.9) 18.4 ( 17.3- 19.6) 17.4 ( 16.3- 18.6) 18.8 ( 17.6- 20.0) 21.4 ( 17.1- 26.8) 15.5 ( 12.4- 19.2)
Midwest
East North Central
Illinois 16.4 ( 15.3- 17.5) 14.3 ( 13.4- 15.3) 16.2 ( 15.0- 17.5) 15.0 ( 13.9- 16.1) 16.9 ( 13.7- 20.9) 11.7 ( 9.5- 14.2)
Indiana
Michigan 16.6 ( 15.4- 17.9) 15.0 ( 13.9- 16.1) 16.2 ( 14.9- 17.6) 15.3 ( 14.1- 16.6) 20.2 ( 16.3- 24.8) 14.7 ( 11.9- 17.9)
Detroit 16.7 ( 14.8- 18.8) 15.1 ( 13.4- 16.9) 16.2 ( 14.1- 18.5) 15.6 ( 13.6- 17.7) 18.9 ( 14.6- 24.3) 14.4 ( 11.1- 18.3)
Ohio 15.8 ( 14.7- 16.9) 14.8 ( 13.8- 15.8) 15.7 ( 14.5- 16.9) 15.2 ( 14.1- 16.3) 14.9 ( 11.4- 19.3) 10.6 ( 8.2- 13.5)
Wisconsin 18.5 ( 16.8- 20.4) 17.1 ( 15.6- 18.8) 18.2 ( 16.5- 20.1) 17.6 ( 15.9- 19.4) 26.2 ( 13.5- 50.7) 11.2 ( 6.4- 18.2)
West North Central 16.8 ( 15.9- 17.7) 15.6 ( 14.8- 16.5) 16.6 ( 15.7- 17.6) 16.1 ( 15.2- 17.0) 22.0 ( 16.6- 28.9) 12.4 ( 9.5- 15.9)
Iowa 17.4 ( 15.3- 19.7) 17.5 ( 15.4- 19.8) 17.3 ( 15.1- 19.6) 17.8 ( 15.6- 20.1) ∼ ∼
Kansas 15.5 ( 13.4- 18.0) 14.2 ( 12.2- 16.4) 15.5 ( 13.2- 18.0) 14.6 ( 12.5- 16.9) ∼ ∼
Minnesota 16.1 ( 14.5- 18.0) 14.5 ( 13.0- 16.1) 16.0 ( 14.3- 17.9) 15.0 ( 13.4- 16.7) ∼ ∼
Missouri 17.5 ( 15.9- 19.3) 16.5 ( 14.9- 18.1) 17.3 ( 15.6- 19.1) 17.0 ( 15.4- 18.8) 22.9 ( 16.1- 32.1) 13.5 ( 9.6- 18.5)
Nebraska 16.0 ( 13.3- 19.2) 15.0 ( 12.4- 17.9) 16.2 ( 13.4- 19.4) 15.6 ( 12.9- 18.7) ∼ ∼




Delaware 15.3 ( 11.3- 20.5) 13.9 ( 10.4- 18.3) 15.4 ( 11.1- 21.2) 15.3 ( 11.1- 20.6) ∼ ∼
District of Columbia 14.8 ( 10.2- 20.9) 13.9 ( 9.6- 19.5) ∼ ∼ 17.3 ( 11.1- 26.0) 17.1 ( 11.1- 25.2)
Florida 16.4 ( 15.6- 17.3) 18.9 ( 18.0- 20.0) 16.6 ( 15.7- 17.6) 21.1 ( 19.9- 22.3) 13.2 ( 10.5- 16.7) 8.2 ( 6.6- 10.1)
Georgia
Atlanta 16.6 ( 13.8- 19.9) 11.0 ( 9.3- 13.0) 14.2 ( 11.3- 17.9) 10.6 ( 8.6- 13.1) 25.8 ( 18.3- 36.6) 12.6 ( 9.3- 16.6)
Maryland 15.1 ( 13.5- 16.9) 13.4 ( 12.0- 14.9) 15.4 ( 13.6- 17.5) 15.1 ( 13.3- 17.1) 14.6 ( 11.2- 19.1) 10.1 ( 7.8- 12.8)
North Carolina 14.2 ( 13.0- 15.6) 13.0 ( 11.8- 14.2) 13.9 ( 12.5- 15.4) 13.6 ( 12.3- 15.1) 15.1 ( 12.0- 19.0) 10.9 ( 8.7- 13.5)
South Carolina 16.6 ( 14.7- 18.7) 15.2 ( 13.5- 17.1) 17.6 ( 15.3- 20.1) 17.8 ( 15.6- 20.2) 13.6 ( 10.0- 18.2) 9.5 ( 7.0- 12.4)
Virginia
West Virginia 16.6 ( 14.1- 19.6) 17.3 ( 14.7- 20.3) 16.2 ( 13.6- 19.2) 16.9 ( 14.3- 19.9) ∼ ∼
East South Central
Alabama













Table 2.19.1: Cancer of the Kidney and Renal Pelvis. Invasive Cancer Incidence Rates by U.S. Census Region and
Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 19.0 ( 17.0- 21.2) 16.3 ( 14.6- 18.1) 18.0 ( 15.8- 20.5) 17.3 ( 15.2- 19.7) 22.8 ( 18.4- 28.2) 14.6 ( 11.8- 17.8)
Oklahoma
Texas
West 14.0 ( 13.5- 14.5) 11.7 ( 11.4- 12.1) 14.3 ( 13.8- 14.8) 12.5 ( 12.0- 12.9) 14.8 ( 12.5- 17.6) 9.6 ( 8.2- 11.3)
Mountain
Arizona 15.0 ( 13.4- 16.7) 13.8 ( 12.3- 15.4) 14.9 ( 13.3- 16.7) 14.5 ( 13.0- 16.3) ∼ ∼
Colorado 14.2 ( 12.4- 16.2) 11.8 ( 10.3- 13.4) 14.1 ( 12.2- 16.2) 12.0 ( 10.5- 13.7) ∼ ∼
Idaho 11.8 ( 9.1- 15.1) 10.4 ( 8.0- 13.3) 11.8 ( 9.1- 15.2) 10.6 ( 8.1- 13.5) ∼ ∼
Montana 14.5 ( 11.2- 18.7) 14.6 ( 11.2- 18.6) 13.9 ( 10.6- 18.1) 14.5 ( 11.0- 18.7) ∼ ∼
Nevada
New Mexico 12.6 ( 10.1- 15.5) 11.1 ( 9.0- 13.6) 12.6 ( 10.0- 15.6) 11.8 ( 9.4- 14.5) ∼ ∼
Utah 11.9 ( 9.5- 14.7) 8.4 ( 6.7- 10.3) 12.0 ( 9.6- 14.9) 8.6 ( 6.9- 10.6) ∼ ∼
Wyoming 14.1 ( 9.4- 20.7) 12.0 ( 8.1- 17.3) 14.0 ( 9.2- 20.6) 12.1 ( 8.0- 17.5) ∼ ∼
Pacific 14.1 ( 13.5- 14.6) 11.7 ( 11.2- 12.1) 14.6 ( 14.0- 15.2) 12.6 ( 12.0- 13.1) 15.0 ( 12.5- 18.0) 9.9 ( 8.3- 11.7)
Alaska 21.6 ( 14.4- 32.8) 13.5 ( 9.8- 18.2) 17.8 ( 11.3- 29.3) 13.3 ( 9.2- 18.7) ∼ ∼
California 13.7 ( 13.1- 14.3) 11.0 ( 10.5- 11.5) 14.4 ( 13.7- 15.1) 12.1 ( 11.5- 12.7) 14.6 ( 12.0- 17.8) 9.7 ( 8.1- 11.6)
San Francisco-Oakland 13.5 ( 11.8- 15.3) 12.1 ( 10.6- 13.7) 15.1 ( 13.0- 17.4) 14.6 ( 12.6- 16.7) 12.0 ( 7.2- 19.4) 8.5 ( 5.2- 13.1)
San Jose-Monterey 10.3 ( 8.3- 12.7) 8.3 ( 6.7- 10.1) 11.1 ( 8.9- 13.9) 9.4 ( 7.5- 11.6) ∼ ∼
Los Angeles 13.8 ( 12.6- 15.1) 10.5 ( 9.6- 11.5) 14.8 ( 13.3- 16.3) 11.4 ( 10.3- 12.5) 13.7 ( 10.2- 18.4) 10.7 ( 8.0- 14.0)
Hawaii 13.5 ( 10.7- 16.9) 13.4 ( 10.6- 16.7) 19.4 ( 12.8- 28.5) 17.1 ( 11.5- 24.6) ∼ ∼
Oregon 15.2 ( 13.3- 17.2) 14.7 ( 12.9- 16.7) 14.8 ( 12.9- 16.9) 14.7 ( 12.8- 16.8) ∼ ∼
Washington 15.1 ( 13.6- 16.8) 13.2 ( 11.9- 14.6) 14.7 ( 13.2- 16.4) 13.3 ( 11.9- 14.8) ∼ ∼
Seattle-Puget Sound 15.0 ( 13.1- 17.0) 12.8 ( 11.3- 14.5) 14.9 ( 13.0- 17.1) 13.4 ( 11.7- 15.2) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.19.2: Cancer of the Kidney and Renal Pelvis. Invasive Cancer Incidence Rates by U.S. Census Region and
Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 8.4 ( 8.2- 8.5) 9.1 ( 9.0- 9.3) 8.4 ( 8.2- 8.6) 9.7 ( 9.5- 9.9) 8.7 ( 8.2- 9.3) 7.2 ( 6.7- 7.7)
Northeast 9.0 ( 8.7- 9.3) 10.4 ( 10.1- 10.9) 9.0 ( 8.6- 9.4) 11.1 ( 10.7- 11.6) 8.5 ( 7.5- 9.6) 7.5 ( 6.6- 8.5)
New England 9.4 ( 8.7- 10.2) 10.7 ( 9.8- 11.5) 9.5 ( 8.7- 10.3) 11.2 ( 10.3- 12.2) 8.1 ( 5.2- 12.4) 6.3 ( 4.1- 9.2)
Connecticut 8.5 ( 7.2- 9.9) 9.8 ( 8.3- 11.4) 8.3 ( 7.0- 9.8) 10.1 ( 8.6- 11.9) ∼ ∼
Maine
Massachusetts 9.5 ( 8.5- 10.6) 10.8 ( 9.7- 12.0) 9.6 ( 8.6- 10.8) 11.5 ( 10.3- 12.8) ∼ ∼
New Hampshire 6.8 ( 4.9- 9.3) 6.9 ( 5.0- 9.3) 6.9 ( 5.0- 9.4) 7.0 ( 5.1- 9.5) ∼ ∼
Rhode Island 14.2 ( 11.3- 17.7) 17.1 ( 13.7- 21.1) 14.6 ( 11.6- 18.3) 18.2 ( 14.5- 22.4) ∼ ∼
Vermont
Middle Atlantic 8.9 ( 8.5- 9.3) 10.4 ( 9.9- 10.8) 8.8 ( 8.4- 9.3) 11.1 ( 10.5- 11.6) 8.5 ( 7.4- 9.7) 7.6 ( 6.7- 8.7)
New Jersey 9.7 ( 8.9- 10.7) 11.1 ( 10.2- 12.2) 9.8 ( 8.9- 10.8) 12.2 ( 11.0- 13.5) 9.5 ( 7.1- 12.6) 8.3 ( 6.2- 10.8)
New York 8.6 ( 8.0- 9.1) 9.6 ( 9.0- 10.3) 8.6 ( 8.0- 9.3) 10.5 ( 9.8- 11.3) 6.9 ( 5.6- 8.4) 6.2 ( 5.0- 7.5)
Pennsylvania 8.8 ( 8.2- 9.5) 11.0 ( 10.2- 11.9) 8.5 ( 7.8- 9.2) 11.1 ( 10.2- 12.0) 11.7 ( 9.1- 14.8) 11.1 ( 8.7- 14.1)
Midwest
East North Central
Illinois 9.1 ( 8.4- 9.9) 9.8 ( 9.0- 10.6) 9.4 ( 8.6- 10.2) 10.6 ( 9.7- 11.5) 8.7 ( 6.7- 11.1) 6.8 ( 5.3- 8.7)
Indiana
Michigan 8.8 ( 8.0- 9.6) 9.3 ( 8.5- 10.2) 8.3 ( 7.5- 9.2) 9.3 ( 8.4- 10.3) 11.9 ( 9.3- 15.0) 9.8 ( 7.7- 12.3)
Detroit 9.0 ( 7.8- 10.3) 9.8 ( 8.5- 11.2) 8.6 ( 7.2- 10.1) 10.1 ( 8.6- 11.8) 11.2 ( 8.3- 14.6) 9.7 ( 7.3- 12.7)
Ohio 8.6 ( 7.9- 9.3) 9.6 ( 8.8- 10.4) 8.4 ( 7.7- 9.2) 9.8 ( 8.9- 10.7) 8.7 ( 6.5- 11.5) 7.6 ( 5.6- 9.9)
Wisconsin 8.9 ( 7.8- 10.0) 9.6 ( 8.5- 10.9) 9.0 ( 7.9- 10.2) 10.2 ( 8.9- 11.5) ∼ ∼
West North Central 8.6 ( 8.1- 9.2) 9.6 ( 9.0- 10.2) 8.5 ( 7.9- 9.1) 9.8 ( 9.1- 10.4) 12.6 ( 9.4- 16.7) 9.4 ( 7.0- 12.3)
Iowa 8.8 ( 7.4- 10.3) 10.5 ( 8.9- 12.3) 8.7 ( 7.3- 10.3) 10.6 ( 9.0- 12.5) ∼ ∼
Kansas 8.9 ( 7.4- 10.6) 9.7 ( 8.1- 11.5) 8.6 ( 7.1- 10.4) 9.7 ( 8.1- 11.6) ∼ ∼
Minnesota 9.0 ( 7.9- 10.3) 9.3 ( 8.1- 10.6) 9.1 ( 7.9- 10.4) 9.8 ( 8.5- 11.1) ∼ ∼
Missouri 8.6 ( 7.6- 9.7) 9.7 ( 8.5- 10.9) 8.2 ( 7.1- 9.3) 9.5 ( 8.3- 10.8) 12.4 ( 8.6- 17.5) 10.3 ( 7.2- 14.4)
Nebraska 8.8 ( 7.0- 11.0) 9.6 ( 7.7- 12.0) 8.9 ( 7.0- 11.1) 10.0 ( 8.0- 12.5) ∼ ∼




Delaware 11.3 ( 8.2- 15.1) 11.9 ( 8.7- 15.9) 11.4 ( 8.1- 15.8) 13.1 ( 9.3- 17.8) ∼ ∼
District of Columbia 5.9 ( 3.5- 9.8) 6.5 ( 3.9- 10.3) ∼ ∼ ∼ ∼
Florida 8.1 ( 7.5- 8.6) 10.9 ( 10.2- 11.6) 8.2 ( 7.6- 8.9) 12.2 ( 11.3- 13.1) 6.7 ( 5.0- 8.8) 4.9 ( 3.7- 6.3)
Georgia
Atlanta 7.2 ( 5.7- 9.0) 5.9 ( 4.7- 7.3) 6.2 ( 4.6- 8.2) 5.7 ( 4.2- 7.5) 9.7 ( 6.2- 14.7) 6.4 ( 4.3- 9.2)
Maryland 8.3 ( 7.2- 9.5) 8.5 ( 7.4- 9.6) 8.5 ( 7.3- 9.9) 9.8 ( 8.4- 11.4) 7.7 ( 5.6- 10.4) 6.1 ( 4.5- 8.1)
North Carolina 8.1 ( 7.3- 9.1) 8.8 ( 7.9- 9.7) 8.1 ( 7.1- 9.1) 9.4 ( 8.3- 10.5) 7.8 ( 5.9- 10.0) 6.8 ( 5.2- 8.8)
South Carolina 8.2 ( 7.1- 9.5) 8.8 ( 7.5- 10.1) 7.4 ( 6.2- 9.0) 8.8 ( 7.3- 10.5) 10.2 ( 7.6- 13.3) 8.7 ( 6.6- 11.4)
Virginia
West Virginia 8.6 ( 7.0- 10.5) 11.0 ( 9.0- 13.3) 8.4 ( 6.8- 10.3) 10.8 ( 8.7- 13.1) ∼ ∼
East South Central
Alabama













Table 2.19.2: Cancer of the Kidney and Renal Pelvis. Invasive Cancer Incidence Rates by U.S. Census Region and
Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 9.9 ( 8.7- 11.3) 10.2 ( 8.9- 11.6) 10.1 ( 8.7- 11.8) 11.6 ( 10.0- 13.5) 9.5 ( 7.2- 12.3) 7.8 ( 6.0- 10.1)
Oklahoma
Texas
West 7.3 ( 7.0- 7.7) 7.2 ( 6.9- 7.5) 7.6 ( 7.3- 8.0) 7.8 ( 7.5- 8.2) 8.6 ( 7.0- 10.4) 6.7 ( 5.5- 8.1)
Mountain
Arizona 7.7 ( 6.6- 8.8) 8.1 ( 7.0- 9.3) 7.8 ( 6.7- 9.0) 8.7 ( 7.4- 10.0) ∼ ∼
Colorado 7.2 ( 6.0- 8.5) 7.0 ( 5.9- 8.2) 7.2 ( 6.0- 8.5) 7.2 ( 6.0- 8.5) ∼ ∼
Idaho 11.3 ( 8.8- 14.4) 11.0 ( 8.6- 13.9) 11.4 ( 8.8- 14.5) 11.2 ( 8.7- 14.2) ∼ ∼
Montana 9.8 ( 7.2- 13.1) 11.0 ( 8.2- 14.6) 9.8 ( 7.2- 13.2) 11.5 ( 8.4- 15.2) ∼ ∼
Nevada
New Mexico 8.6 ( 6.8- 10.8) 8.6 ( 6.8- 10.8) 8.9 ( 7.0- 11.3) 9.5 ( 7.4- 11.9) ∼ ∼
Utah 5.2 ( 3.8- 7.0) 4.0 ( 2.9- 5.4) 5.3 ( 3.8- 7.1) 4.1 ( 3.0- 5.6) ∼ ∼
Wyoming 6.6 ( 3.7- 10.9) 6.7 ( 3.8- 10.9) 6.7 ( 3.9- 11.3) 7.0 ( 4.0- 11.4) ∼ ∼
Pacific 7.2 ( 6.9- 7.6) 7.1 ( 6.7- 7.5) 7.6 ( 7.2- 8.0) 7.7 ( 7.3- 8.1) 9.1 ( 7.4- 11.1) 7.3 ( 5.9- 8.8)
Alaska 8.2 ( 4.8- 14.0) 6.5 ( 3.9- 10.1) ∼ ∼ ∼ ∼
California 7.0 ( 6.6- 7.5) 6.8 ( 6.4- 7.2) 7.4 ( 6.9- 7.9) 7.4 ( 7.0- 7.9) 8.8 ( 7.1- 10.9) 7.2 ( 5.8- 8.8)
San Francisco-Oakland 6.4 ( 5.3- 7.5) 6.8 ( 5.7- 8.1) 6.7 ( 5.5- 8.2) 7.7 ( 6.3- 9.4) 7.2 ( 4.2- 11.8) 6.8 ( 4.0- 10.9)
San Jose-Monterey 7.4 ( 5.9- 9.2) 7.0 ( 5.5- 8.7) 7.7 ( 6.0- 9.8) 7.8 ( 6.0- 9.8) ∼ ∼
Los Angeles 7.8 ( 7.0- 8.7) 7.3 ( 6.5- 8.1) 8.3 ( 7.3- 9.3) 7.8 ( 6.9- 8.8) 10.6 ( 7.9- 13.9) 9.4 ( 7.1- 12.4)
Hawaii 5.3 ( 3.7- 7.5) 5.9 ( 4.1- 8.2) ∼ ∼ ∼ ∼
Oregon 7.8 ( 6.5- 9.2) 8.6 ( 7.2- 10.1) 8.0 ( 6.7- 9.5) 9.1 ( 7.6- 10.7) ∼ ∼
Washington 8.1 ( 7.1- 9.2) 8.2 ( 7.2- 9.3) 8.1 ( 7.0- 9.2) 8.6 ( 7.5- 9.8) ∼ ∼
Seattle-Puget Sound 7.7 ( 6.6- 9.0) 7.8 ( 6.6- 9.1) 7.7 ( 6.4- 9.1) 8.1 ( 6.8- 9.6) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.20.1: Cancer of the Brain and Other Nervous System. Invasive Cancer Incidence Rates by U.S. Census Region
and Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 7.9 ( 7.7- 8.1) 7.5 ( 7.3- 7.7) 8.3 ( 8.1- 8.5) 8.2 ( 8.0- 8.4) 4.5 ( 4.1- 5.0) 3.8 ( 3.4- 4.1)
Northeast 8.1 ( 7.7- 8.5) 7.9 ( 7.6- 8.3) 8.4 ( 8.0- 8.8) 8.5 ( 8.1- 8.9) 4.8 ( 3.9- 5.9) 3.9 ( 3.2- 4.7)
New England 8.6 ( 7.9- 9.5) 8.3 ( 7.6- 9.1) 8.8 ( 8.0- 9.7) 8.7 ( 8.0- 9.6) ∼ ∼
Connecticut 9.0 ( 7.6- 10.6) 8.8 ( 7.4- 10.4) 9.3 ( 7.8- 11.1) 9.5 ( 7.9- 11.2) ∼ ∼
Maine
Massachusetts 8.1 ( 7.1- 9.2) 7.8 ( 6.8- 8.9) 8.2 ( 7.1- 9.3) 8.1 ( 7.0- 9.2) ∼ ∼
New Hampshire 8.9 ( 6.5- 12.0) 8.0 ( 5.8- 10.6) 8.8 ( 6.4- 12.0) 8.0 ( 5.8- 10.6) ∼ ∼
Rhode Island 10.6 ( 7.9- 14.1) 10.7 ( 8.0- 14.1) 11.1 ( 8.3- 14.8) 11.4 ( 8.5- 15.1) ∼ ∼
Vermont
Middle Atlantic 7.9 ( 7.5- 8.4) 7.8 ( 7.4- 8.2) 8.2 ( 7.8- 8.7) 8.4 ( 7.9- 8.9) 4.9 ( 3.9- 6.1) 4.0 ( 3.3- 4.9)
New Jersey 7.8 ( 6.9- 8.7) 7.6 ( 6.8- 8.5) 8.1 ( 7.1- 9.2) 8.3 ( 7.3- 9.3) 5.5 ( 3.4- 8.9) 4.4 ( 2.8- 6.5)
New York 7.9 ( 7.3- 8.5) 7.6 ( 7.0- 8.2) 8.2 ( 7.5- 8.9) 8.2 ( 7.6- 9.0) 5.3 ( 4.0- 7.0) 4.3 ( 3.3- 5.4)
Pennsylvania 8.1 ( 7.4- 8.9) 8.3 ( 7.6- 9.1) 8.3 ( 7.5- 9.1) 8.7 ( 7.9- 9.5) 3.3 ( 1.8- 5.8) 2.9 ( 1.7- 4.7)
Midwest
East North Central
Illinois 7.6 ( 6.9- 8.4) 7.0 ( 6.3- 7.7) 7.9 ( 7.1- 8.8) 7.5 ( 6.8- 8.4) 4.9 ( 3.3- 7.2) 3.9 ( 2.7- 5.4)
Indiana
Michigan 8.8 ( 7.9- 9.7) 8.1 ( 7.4- 9.0) 9.4 ( 8.4- 10.4) 9.0 ( 8.1- 9.9) 4.9 ( 3.1- 7.4) 4.1 ( 2.7- 5.9)
Detroit 8.7 ( 7.3- 10.2) 8.1 ( 6.9- 9.5) 9.6 ( 8.0- 11.4) 9.4 ( 7.9- 11.1) 5.2 ( 3.2- 8.2) 4.6 ( 2.8- 7.0)
Ohio 7.8 ( 7.1- 8.6) 7.5 ( 6.8- 8.2) 8.0 ( 7.2- 8.8) 7.7 ( 7.0- 8.6) 4.6 ( 2.9- 7.2) 4.2 ( 2.8- 6.2)
Wisconsin 7.6 ( 6.5- 8.8) 7.2 ( 6.2- 8.4) 7.7 ( 6.7- 9.0) 7.6 ( 6.5- 8.8) ∼ ∼
West North Central 7.9 ( 7.3- 8.5) 7.5 ( 7.0- 8.1) 8.1 ( 7.5- 8.8) 8.0 ( 7.4- 8.6) ∼ ∼
Iowa 7.9 ( 6.5- 9.5) 7.9 ( 6.5- 9.5) 8.0 ( 6.6- 9.7) 8.2 ( 6.7- 9.8) ∼ ∼
Kansas 6.8 ( 5.4- 8.4) 6.4 ( 5.1- 7.9) 6.9 ( 5.5- 8.6) 6.6 ( 5.2- 8.3) ∼ ∼
Minnesota 8.9 ( 7.7- 10.3) 8.4 ( 7.3- 9.7) 9.1 ( 7.9- 10.5) 8.8 ( 7.6- 10.2) ∼ ∼
Missouri 8.0 ( 6.9- 9.2) 7.6 ( 6.6- 8.7) 8.4 ( 7.3- 9.7) 8.3 ( 7.1- 9.5) ∼ ∼
Nebraska 7.2 ( 5.4- 9.4) 7.0 ( 5.3- 9.1) 7.6 ( 5.7- 9.8) 7.5 ( 5.7- 9.7) ∼ ∼




Delaware 7.0 ( 4.5- 10.7) 6.8 ( 4.4- 10.1) 7.6 ( 4.8- 11.8) 8.0 ( 5.1- 12.0) ∼ ∼
District of Columbia 10.6 ( 6.9- 15.8) 10.7 ( 7.0- 15.6) ∼ ∼ ∼ ∼
Florida 7.9 ( 7.3- 8.5) 8.6 ( 8.0- 9.3) 8.3 ( 7.6- 9.0) 9.6 ( 8.8- 10.4) 4.6 ( 3.3- 6.8) 3.7 ( 2.6- 5.0)
Georgia
Atlanta 7.2 ( 5.6- 9.3) 6.2 ( 4.9- 7.7) 8.1 ( 6.1- 10.7) 7.4 ( 5.7- 9.4) ∼ ∼
Maryland 7.2 ( 6.2- 8.5) 6.7 ( 5.7- 7.8) 7.9 ( 6.6- 9.4) 7.8 ( 6.5- 9.2) 5.9 ( 3.8- 9.3) 4.5 ( 3.1- 6.4)
North Carolina 8.4 ( 7.4- 9.4) 7.8 ( 6.9- 8.7) 9.6 ( 8.5- 10.9) 9.4 ( 8.3- 10.6) 2.7 ( 1.7- 4.6) 2.7 ( 1.6- 4.1)
South Carolina 7.8 ( 6.6- 9.3) 7.5 ( 6.3- 8.9) 8.7 ( 7.2- 10.5) 9.1 ( 7.5- 10.8) 4.7 ( 2.8- 7.8) 3.9 ( 2.4- 6.0)
Virginia
West Virginia 7.5 ( 5.8- 9.7) 7.7 ( 6.0- 9.8) 7.7 ( 5.9- 9.9) 7.9 ( 6.1- 10.0) ∼ ∼
East South Central
Alabama













Table 2.20.1: Cancer of the Brain and Other Nervous System. Invasive Cancer Incidence Rates by U.S. Census Region
and Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 6.5 ( 5.4- 7.8) 5.8 ( 4.8- 6.9) 7.6 ( 6.1- 9.3) 7.3 ( 6.0- 8.9) 3.3 ( 1.9- 5.7) 2.9 ( 1.7- 4.5)
Oklahoma
Texas
West 7.8 ( 7.4- 8.1) 7.1 ( 6.8- 7.4) 8.3 ( 8.0- 8.7) 7.7 ( 7.4- 8.1) 4.6 ( 3.4- 6.2) 3.7 ( 2.8- 4.7)
Mountain
Arizona 7.6 ( 6.5- 8.8) 7.2 ( 6.2- 8.4) 7.8 ( 6.7- 9.2) 7.8 ( 6.6- 9.1) ∼ ∼
Colorado 8.1 ( 6.8- 9.6) 7.5 ( 6.4- 8.8) 8.2 ( 6.9- 9.8) 7.7 ( 6.5- 9.1) ∼ ∼
Idaho 11.2 ( 8.6- 14.4) 10.4 ( 8.0- 13.3) 11.5 ( 8.8- 14.8) 10.7 ( 8.3- 13.7) ∼ ∼
Montana 5.1 ( 3.2- 7.8) 5.2 ( 3.3- 7.9) 5.2 ( 3.2- 8.0) 5.4 ( 3.4- 8.2) ∼ ∼
Nevada
New Mexico 7.8 ( 6.0- 10.1) 7.2 ( 5.6- 9.3) 8.0 ( 6.1- 10.5) 7.7 ( 5.8- 10.0) ∼ ∼
Utah 8.0 ( 6.1- 10.3) 6.5 ( 5.1- 8.2) 8.1 ( 6.3- 10.5) 6.6 ( 5.1- 8.4) ∼ ∼
Wyoming 10.1 ( 6.3- 15.8) 9.5 ( 6.0- 14.3) 10.4 ( 6.5- 16.2) 9.9 ( 6.3- 14.9) ∼ ∼
Pacific 7.7 ( 7.3- 8.1) 6.9 ( 6.6- 7.3) 8.4 ( 8.0- 8.9) 7.7 ( 7.3- 8.2) 4.5 ( 3.2- 6.2) 3.6 ( 2.6- 4.7)
Alaska 7.2 ( 3.9- 14.7) 5.2 ( 3.0- 8.4) ∼ ∼ ∼ ∼
California 7.6 ( 7.1- 8.0) 6.7 ( 6.3- 7.1) 8.3 ( 7.7- 8.8) 7.4 ( 7.0- 7.9) 4.8 ( 3.5- 6.7) 3.9 ( 2.9- 5.1)
San Francisco-Oakland 8.2 ( 6.9- 9.6) 7.7 ( 6.6- 9.1) 9.3 ( 7.7- 11.2) 9.3 ( 7.7- 11.0) ∼ ∼
San Jose-Monterey 8.1 ( 6.4- 10.1) 7.0 ( 5.6- 8.7) 8.7 ( 6.8- 11.2) 7.7 ( 6.0- 9.7) ∼ ∼
Los Angeles 6.8 ( 6.0- 7.7) 5.8 ( 5.1- 6.5) 7.6 ( 6.6- 8.7) 6.5 ( 5.7- 7.4) 4.2 ( 2.5- 7.3) 3.6 ( 2.2- 5.8)
Hawaii 4.8 ( 3.2- 6.9) 4.7 ( 3.2- 6.9) ∼ ∼ ∼ ∼
Oregon 8.1 ( 6.8- 9.6) 8.0 ( 6.7- 9.5) 8.3 ( 7.0- 10.0) 8.4 ( 7.0- 9.9) ∼ ∼
Washington 9.2 ( 8.1- 10.5) 8.5 ( 7.5- 9.7) 9.6 ( 8.4- 10.9) 9.0 ( 7.9- 10.3) ∼ ∼
Seattle-Puget Sound 9.3 ( 7.9- 10.9) 8.6 ( 7.3- 10.0) 10.0 ( 8.5- 11.8) 9.5 ( 8.1- 11.1) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.20.2: Cancer of the Brain and Other Nervous System. Invasive Cancer Incidence Rates by U.S. Census Region
and Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 5.7 ( 5.5- 5.8) 6.0 ( 5.8- 6.1) 6.0 ( 5.8- 6.1) 6.5 ( 6.4- 6.7) 3.6 ( 3.3- 4.0) 3.2 ( 2.9- 3.5)
Northeast 5.9 ( 5.7- 6.2) 6.6 ( 6.3- 6.9) 6.3 ( 6.0- 6.6) 7.2 ( 6.8- 7.5) 3.6 ( 2.9- 4.3) 3.3 ( 2.7- 4.0)
New England 6.4 ( 5.8- 7.0) 6.9 ( 6.3- 7.6) 6.5 ( 5.9- 7.2) 7.3 ( 6.6- 8.0) ∼ ∼
Connecticut 5.9 ( 4.9- 7.2) 6.5 ( 5.3- 7.8) 6.1 ( 4.9- 7.4) 6.8 ( 5.6- 8.3) ∼ ∼
Maine
Massachusetts 6.7 ( 5.9- 7.7) 7.3 ( 6.4- 8.3) 7.0 ( 6.1- 8.0) 7.8 ( 6.8- 8.9) ∼ ∼
New Hampshire 5.4 ( 3.7- 7.6) 5.3 ( 3.6- 7.4) 5.3 ( 3.6- 7.6) 5.2 ( 3.5- 7.4) ∼ ∼
Rhode Island 6.7 ( 4.7- 9.2) 8.0 ( 5.7- 10.8) 6.8 ( 4.7- 9.5) 8.2 ( 5.9- 11.3) ∼ ∼
Vermont
Middle Atlantic 5.8 ( 5.5- 6.2) 6.5 ( 6.1- 6.8) 6.2 ( 5.8- 6.6) 7.2 ( 6.7- 7.6) 3.6 ( 2.9- 4.4) 3.3 ( 2.7- 4.1)
New Jersey 6.4 ( 5.7- 7.2) 7.0 ( 6.3- 7.9) 6.9 ( 6.1- 7.8) 8.0 ( 7.1- 9.1) 3.5 ( 2.1- 5.6) 3.2 ( 1.9- 4.9)
New York 5.8 ( 5.3- 6.3) 6.3 ( 5.8- 6.8) 6.3 ( 5.7- 6.8) 7.1 ( 6.5- 7.7) 3.4 ( 2.6- 4.5) 3.2 ( 2.4- 4.2)
Pennsylvania 5.6 ( 5.0- 6.2) 6.4 ( 5.8- 7.0) 5.7 ( 5.1- 6.4) 6.7 ( 6.0- 7.4) 4.0 ( 2.6- 6.0) 3.9 ( 2.5- 5.8)
Midwest
East North Central
Illinois 5.4 ( 4.8- 5.9) 5.6 ( 5.0- 6.2) 5.7 ( 5.0- 6.3) 6.2 ( 5.5- 6.9) 3.5 ( 2.4- 5.1) 3.2 ( 2.1- 4.5)
Indiana
Michigan 6.0 ( 5.3- 6.7) 6.3 ( 5.6- 7.0) 6.3 ( 5.6- 7.1) 6.9 ( 6.1- 7.7) 3.4 ( 2.1- 5.2) 2.9 ( 1.8- 4.4)
Detroit 5.1 ( 4.2- 6.1) 5.4 ( 4.4- 6.5) 5.5 ( 4.4- 6.8) 6.2 ( 5.0- 7.6) 3.2 ( 1.8- 5.3) 2.9 ( 1.7- 4.8)
Ohio 5.8 ( 5.2- 6.4) 6.2 ( 5.6- 6.9) 5.9 ( 5.3- 6.6) 6.5 ( 5.8- 7.2) 4.0 ( 2.6- 6.0) 3.5 ( 2.2- 5.2)
Wisconsin 6.2 ( 5.3- 7.2) 6.5 ( 5.6- 7.6) 6.2 ( 5.3- 7.2) 6.7 ( 5.7- 7.8) ∼ ∼
West North Central 5.8 ( 5.3- 6.3) 6.2 ( 5.7- 6.7) 6.0 ( 5.5- 6.5) 6.5 ( 6.0- 7.1) ∼ ∼
Iowa 5.0 ( 4.0- 6.3) 5.7 ( 4.6- 7.1) 5.1 ( 4.0- 6.4) 5.8 ( 4.7- 7.2) ∼ ∼
Kansas 5.3 ( 4.2- 6.7) 5.7 ( 4.5- 7.1) 5.6 ( 4.4- 7.0) 6.1 ( 4.8- 7.6) ∼ ∼
Minnesota 6.1 ( 5.2- 7.2) 6.2 ( 5.2- 7.2) 6.4 ( 5.4- 7.6) 6.6 ( 5.6- 7.7) ∼ ∼
Missouri 5.9 ( 5.1- 6.9) 6.5 ( 5.6- 7.5) 6.3 ( 5.4- 7.3) 7.0 ( 6.0- 8.2) ∼ ∼
Nebraska 6.5 ( 5.0- 8.5) 7.2 ( 5.5- 9.2) 6.3 ( 4.7- 8.2) 7.0 ( 5.3- 9.1) ∼ ∼




Delaware 6.7 ( 4.4- 9.8) 7.0 ( 4.6- 10.2) 7.0 ( 4.4- 10.7) 7.7 ( 4.9- 11.5) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼
Florida 5.8 ( 5.3- 6.4) 6.9 ( 6.3- 7.5) 6.0 ( 5.5- 6.6) 7.6 ( 6.9- 8.3) 3.7 ( 2.6- 5.2) 3.3 ( 2.4- 4.5)
Georgia
Atlanta 5.4 ( 4.1- 6.9) 4.6 ( 3.6- 5.9) 6.7 ( 5.0- 8.7) 6.4 ( 4.8- 8.3) ∼ ∼
Maryland 5.3 ( 4.5- 6.3) 5.4 ( 4.6- 6.4) 5.5 ( 4.5- 6.7) 6.0 ( 4.9- 7.2) 4.0 ( 2.7- 6.0) 3.8 ( 2.5- 5.4)
North Carolina 4.8 ( 4.2- 5.6) 5.0 ( 4.4- 5.8) 5.5 ( 4.7- 6.4) 5.9 ( 5.0- 6.8) 2.7 ( 1.7- 4.1) 2.5 ( 1.5- 3.7)
South Carolina 5.0 ( 4.1- 6.1) 5.2 ( 4.2- 6.3) 5.4 ( 4.3- 6.8) 5.9 ( 4.7- 7.4) 4.0 ( 2.5- 6.2) 3.6 ( 2.2- 5.4)
Virginia
West Virginia 6.0 ( 4.6- 7.8) 6.7 ( 5.2- 8.6) 6.0 ( 4.6- 7.8) 6.8 ( 5.2- 8.7) ∼ ∼
East South Central
Alabama













Table 2.20.2: Cancer of the Brain and Other Nervous System. Invasive Cancer Incidence Rates by U.S. Census Region
and Division, State and Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 4.9 ( 4.0- 5.9) 4.9 ( 4.1- 5.9) 5.0 ( 4.0- 6.3) 5.4 ( 4.3- 6.7) 4.8 ( 3.2- 6.9) 4.1 ( 2.8- 5.8)
Oklahoma
Texas
West 5.5 ( 5.2- 5.8) 5.5 ( 5.2- 5.7) 5.9 ( 5.6- 6.2) 6.0 ( 5.7- 6.3) 3.3 ( 2.4- 4.4) 2.9 ( 2.1- 3.9)
Mountain
Arizona 6.2 ( 5.3- 7.3) 6.5 ( 5.5- 7.6) 6.7 ( 5.6- 7.8) 7.1 ( 6.0- 8.3) ∼ ∼
Colorado 5.4 ( 4.4- 6.5) 5.3 ( 4.3- 6.4) 5.4 ( 4.4- 6.5) 5.3 ( 4.3- 6.4) ∼ ∼
Idaho 6.0 ( 4.2- 8.4) 5.9 ( 4.2- 8.1) 6.2 ( 4.4- 8.6) 6.1 ( 4.3- 8.4) ∼ ∼
Montana 7.0 ( 4.8- 10.0) 7.4 ( 5.1- 10.4) 6.9 ( 4.7- 10.0) 7.6 ( 5.1- 10.7) ∼ ∼
Nevada
New Mexico 5.3 ( 3.9- 7.1) 5.2 ( 3.8- 6.9) 5.5 ( 4.0- 7.5) 5.6 ( 4.1- 7.6) ∼ ∼
Utah 5.3 ( 3.9- 7.0) 4.7 ( 3.5- 6.1) 5.4 ( 4.0- 7.2) 4.8 ( 3.6- 6.4) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 5.4 ( 5.1- 5.7) 5.4 ( 5.1- 5.7) 5.9 ( 5.5- 6.2) 5.9 ( 5.6- 6.3) 3.4 ( 2.5- 4.7) 3.1 ( 2.2- 4.1)
Alaska 7.4 ( 4.2- 13.1) 5.8 ( 3.4- 9.2) ∼ ∼ ∼ ∼
California 5.2 ( 4.8- 5.5) 5.1 ( 4.7- 5.4) 5.7 ( 5.3- 6.1) 5.7 ( 5.3- 6.1) 3.5 ( 2.5- 4.9) 3.2 ( 2.3- 4.3)
San Francisco-Oakland 5.5 ( 4.5- 6.6) 5.8 ( 4.8- 6.9) 6.7 ( 5.4- 8.2) 7.3 ( 5.9- 8.9) ∼ ∼
San Jose-Monterey 5.9 ( 4.6- 7.6) 5.8 ( 4.5- 7.4) 6.3 ( 4.7- 8.2) 6.3 ( 4.8- 8.2) ∼ ∼
Los Angeles 4.8 ( 4.2- 5.5) 4.6 ( 4.0- 5.3) 5.5 ( 4.7- 6.3) 5.3 ( 4.6- 6.2) 4.5 ( 2.8- 6.8) 4.2 ( 2.6- 6.3)
Hawaii 3.8 ( 2.4- 5.8) 3.9 ( 2.5- 5.8) ∼ ∼ ∼ ∼
Oregon 5.1 ( 4.1- 6.3) 5.4 ( 4.3- 6.6) 5.2 ( 4.1- 6.4) 5.5 ( 4.4- 6.8) ∼ ∼
Washington 7.2 ( 6.3- 8.3) 7.2 ( 6.3- 8.3) 7.4 ( 6.4- 8.5) 7.5 ( 6.5- 8.6) ∼ ∼
Seattle-Puget Sound 7.0 ( 5.9- 8.2) 6.9 ( 5.8- 8.2) 7.3 ( 6.1- 8.7) 7.4 ( 6.2- 8.9) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.21.1: Cancer of the Thyroid. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 3.6 ( 3.5- 3.7) 3.5 ( 3.4- 3.6) 3.8 ( 3.6- 3.9) 3.8 ( 3.6- 3.9) 1.8 ( 1.5- 2.1) 1.3 ( 1.1- 1.5)
Northeast 4.1 ( 3.8- 4.4) 4.1 ( 3.8- 4.4) 4.3 ( 4.0- 4.6) 4.4 ( 4.2- 4.7) 2.0 ( 1.4- 2.7) 1.5 ( 1.1- 2.0)
New England 4.0 ( 3.5- 4.6) 4.0 ( 3.5- 4.5) 4.0 ( 3.5- 4.6) 4.1 ( 3.6- 4.7) ∼ ∼
Connecticut 4.3 ( 3.3- 5.4) 4.3 ( 3.3- 5.4) 4.5 ( 3.4- 5.7) 4.6 ( 3.5- 5.8) ∼ ∼
Maine
Massachusetts 3.9 ( 3.2- 4.7) 3.8 ( 3.2- 4.6) 3.8 ( 3.1- 4.6) 3.9 ( 3.2- 4.7) ∼ ∼
New Hampshire 4.3 ( 2.7- 6.5) 4.2 ( 2.7- 6.2) 4.3 ( 2.8- 6.6) 4.3 ( 2.8- 6.4) ∼ ∼
Rhode Island 3.5 ( 2.1- 5.8) 3.6 ( 2.1- 5.7) 3.8 ( 2.2- 6.2) 3.9 ( 2.3- 6.2) ∼ ∼
Vermont
Middle Atlantic 4.1 ( 3.8- 4.4) 4.1 ( 3.8- 4.4) 4.4 ( 4.1- 4.7) 4.5 ( 4.2- 4.9) 2.0 ( 1.5- 2.9) 1.6 ( 1.2- 2.2)
New Jersey 4.2 ( 3.6- 4.9) 4.2 ( 3.6- 4.9) 4.6 ( 3.9- 5.4) 4.7 ( 4.0- 5.6) ∼ ∼
New York 3.9 ( 3.5- 4.3) 3.8 ( 3.4- 4.2) 4.2 ( 3.8- 4.8) 4.3 ( 3.9- 4.9) ∼ ∼
Pennsylvania 4.4 ( 3.9- 5.0) 4.6 ( 4.0- 5.1) 4.4 ( 3.9- 5.0) 4.7 ( 4.1- 5.3) 4.1 ( 2.3- 6.8) 3.1 ( 1.8- 5.0)
Midwest
East North Central
Illinois 3.7 ( 3.2- 4.3) 3.5 ( 3.1- 4.0) 3.9 ( 3.4- 4.6) 3.9 ( 3.3- 4.5) ∼ ∼
Indiana
Michigan 3.4 ( 2.9- 4.0) 3.2 ( 2.7- 3.8) 3.7 ( 3.1- 4.3) 3.7 ( 3.1- 4.3) ∼ ∼
Detroit 3.6 ( 2.8- 4.6) 3.5 ( 2.7- 4.4) 4.3 ( 3.3- 5.5) 4.4 ( 3.3- 5.6) ∼ ∼
Ohio 3.3 ( 2.8- 3.8) 3.2 ( 2.7- 3.7) 3.3 ( 2.8- 3.8) 3.3 ( 2.8- 3.8) ∼ ∼
Wisconsin 3.2 ( 2.5- 4.0) 3.1 ( 2.4- 3.8) 3.1 ( 2.4- 3.9) 3.1 ( 2.4- 3.9) ∼ ∼
West North Central 3.8 ( 3.4- 4.2) 3.6 ( 3.2- 4.1) 3.8 ( 3.4- 4.3) 3.8 ( 3.4- 4.2) ∼ ∼
Iowa 4.0 ( 3.1- 5.3) 4.0 ( 3.0- 5.2) 4.1 ( 3.1- 5.3) 4.1 ( 3.1- 5.3) ∼ ∼
Kansas 4.3 ( 3.3- 5.7) 4.1 ( 3.1- 5.4) 4.2 ( 3.1- 5.6) 4.1 ( 3.0- 5.4) ∼ ∼
Minnesota 3.9 ( 3.2- 4.9) 3.7 ( 3.0- 4.6) 4.1 ( 3.3- 5.1) 4.0 ( 3.2- 4.9) ∼ ∼
Missouri 3.5 ( 2.8- 4.3) 3.4 ( 2.7- 4.2) 3.7 ( 2.9- 4.6) 3.7 ( 2.9- 4.5) ∼ ∼
Nebraska 3.3 ( 2.1- 4.9) 3.1 ( 2.0- 4.5) 3.3 ( 2.1- 5.0) 3.1 ( 2.0- 4.7) ∼ ∼




Delaware ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia 6.3 ( 3.6- 10.5) 6.6 ( 3.7- 10.6) ∼ ∼ ∼ ∼
Florida 3.2 ( 2.8- 3.6) 3.5 ( 3.1- 3.9) 3.4 ( 3.0- 3.9) 3.9 ( 3.4- 4.4) ∼ ∼
Georgia
Atlanta 2.5 ( 1.6- 4.0) 2.2 ( 1.5- 3.2) 2.7 ( 1.6- 4.5) 2.6 ( 1.6- 3.9) ∼ ∼
Maryland 3.1 ( 2.4- 3.9) 3.0 ( 2.3- 3.7) 3.5 ( 2.7- 4.5) 3.6 ( 2.8- 4.6) ∼ ∼
North Carolina 2.8 ( 2.3- 3.5) 2.7 ( 2.2- 3.2) 3.3 ( 2.6- 4.1) 3.3 ( 2.6- 4.0) ∼ ∼
South Carolina 2.9 ( 2.2- 3.9) 2.8 ( 2.1- 3.7) 3.2 ( 2.4- 4.5) 3.4 ( 2.5- 4.6) ∼ ∼
Virginia
West Virginia 3.5 ( 2.4- 5.0) 3.6 ( 2.4- 5.0) 3.6 ( 2.4- 5.2) 3.7 ( 2.5- 5.2) ∼ ∼
East South Central
Alabama













Table 2.21.1: Cancer of the Thyroid. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 3.0 ( 2.3- 4.0) 2.8 ( 2.1- 3.6) 3.4 ( 2.5- 4.6) 3.5 ( 2.6- 4.6) ∼ ∼
Oklahoma
Texas
West 3.7 ( 3.5- 3.9) 3.4 ( 3.2- 3.6) 3.7 ( 3.5- 4.0) 3.5 ( 3.3- 3.7) 1.9 ( 1.2- 3.0) 1.5 ( 0.9- 2.2)
Mountain
Arizona 3.7 ( 2.9- 4.6) 3.5 ( 2.8- 4.3) 3.8 ( 3.0- 4.8) 3.7 ( 2.9- 4.6) ∼ ∼
Colorado 3.3 ( 2.6- 4.4) 3.2 ( 2.5- 4.1) 3.3 ( 2.5- 4.3) 3.2 ( 2.4- 4.1) ∼ ∼
Idaho 4.0 ( 2.6- 6.2) 3.7 ( 2.3- 5.5) 4.1 ( 2.6- 6.3) 3.8 ( 2.4- 5.7) ∼ ∼
Montana 5.5 ( 3.5- 8.4) 5.5 ( 3.5- 8.1) 5.4 ( 3.3- 8.3) 5.4 ( 3.4- 8.2) ∼ ∼
Nevada
New Mexico 4.0 ( 2.8- 5.9) 3.7 ( 2.6- 5.3) 4.5 ( 3.1- 6.5) 4.3 ( 3.0- 6.1) ∼ ∼
Utah 3.8 ( 2.6- 5.6) 3.1 ( 2.1- 4.4) 3.8 ( 2.5- 5.6) 3.1 ( 2.1- 4.4) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 3.6 ( 3.4- 3.9) 3.4 ( 3.1- 3.6) 3.6 ( 3.3- 3.9) 3.4 ( 3.2- 3.7) 1.8 ( 1.1- 3.1) 1.4 ( 0.9- 2.2)
Alaska 6.4 ( 3.6- 13.6) 5.5 ( 3.3- 8.7) ∼ ∼ ∼ ∼
California 3.4 ( 3.1- 3.7) 3.0 ( 2.8- 3.3) 3.5 ( 3.1- 3.8) 3.2 ( 2.9- 3.5) 1.9 ( 1.1- 3.3) 1.5 ( 0.9- 2.3)
San Francisco-Oakland 3.0 ( 2.3- 4.0) 3.1 ( 2.3- 3.9) 3.0 ( 2.1- 4.1) 3.1 ( 2.3- 4.2) ∼ ∼
San Jose-Monterey 4.9 ( 3.6- 6.6) 4.3 ( 3.2- 5.7) 5.4 ( 3.9- 7.3) 4.8 ( 3.5- 6.5) ∼ ∼
Los Angeles 3.5 ( 2.9- 4.1) 3.0 ( 2.5- 3.5) 3.6 ( 3.0- 4.4) 3.1 ( 2.6- 3.8) ∼ ∼
Hawaii 6.3 ( 4.5- 8.8) 6.3 ( 4.4- 8.6) ∼ ∼ ∼ ∼
Oregon 3.9 ( 3.0- 5.0) 3.9 ( 3.0- 5.0) 3.7 ( 2.9- 4.9) 3.9 ( 2.9- 5.0) ∼ ∼
Washington 4.2 ( 3.5- 5.1) 4.1 ( 3.3- 4.9) 4.0 ( 3.3- 4.9) 4.0 ( 3.2- 4.8) ∼ ∼
Seattle-Puget Sound 4.4 ( 3.5- 5.5) 4.3 ( 3.4- 5.3) 4.5 ( 3.5- 5.7) 4.5 ( 3.6- 5.7) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.21.2: Cancer of the Thyroid. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 9.9 ( 9.7- 10.1) 10.0 ( 9.8- 10.2) 10.2 ( 10.0- 10.4) 10.4 ( 10.2- 10.7) 5.9 ( 5.5- 6.4) 5.4 ( 5.0- 5.8)
Northeast 11.4 ( 11.0- 11.8) 11.8 ( 11.4- 12.2) 11.7 ( 11.3- 12.2) 12.2 ( 11.8- 12.7) 6.6 ( 5.7- 7.6) 6.2 ( 5.4- 7.1)
New England 10.6 ( 9.8- 11.4) 11.0 ( 10.1- 11.8) 10.6 ( 9.7- 11.5) 11.1 ( 10.2- 12.0) 7.9 ( 5.1- 11.9) 6.8 ( 4.5- 9.8)
Connecticut 10.9 ( 9.4- 12.6) 11.3 ( 9.8- 13.0) 11.1 ( 9.4- 12.9) 11.6 ( 9.9- 13.4) ∼ ∼
Maine
Massachusetts 10.6 ( 9.5- 11.7) 11.0 ( 9.9- 12.2) 10.5 ( 9.3- 11.7) 11.1 ( 9.9- 12.4) ∼ ∼
New Hampshire 7.0 ( 5.0- 9.4) 7.2 ( 5.2- 9.7) 7.1 ( 5.1- 9.6) 7.4 ( 5.4- 9.9) ∼ ∼
Rhode Island 13.9 ( 10.9- 17.6) 14.0 ( 11.0- 17.6) 14.0 ( 10.8- 17.9) 14.2 ( 11.0- 18.0) ∼ ∼
Vermont
Middle Atlantic 11.6 ( 11.1- 12.1) 12.0 ( 11.5- 12.5) 12.1 ( 11.6- 12.6) 12.6 ( 12.1- 13.2) 6.4 ( 5.5- 7.5) 6.1 ( 5.3- 7.1)
New Jersey 11.0 ( 10.0- 12.0) 11.4 ( 10.4- 12.5) 11.8 ( 10.7- 13.1) 12.4 ( 11.2- 13.6) 5.1 ( 3.4- 7.5) 4.6 ( 3.1- 6.6)
New York 11.3 ( 10.6- 12.0) 11.7 ( 11.0- 12.4) 12.0 ( 11.3- 12.9) 12.5 ( 11.7- 13.4) 5.3 ( 4.2- 6.6) 5.1 ( 4.0- 6.2)
Pennsylvania 12.5 ( 11.6- 13.4) 13.0 ( 12.1- 13.9) 12.3 ( 11.4- 13.3) 13.0 ( 12.0- 14.0) 11.3 ( 8.7- 14.4) 10.7 ( 8.2- 13.6)
Midwest
East North Central
Illinois 10.1 ( 9.4- 11.0) 10.1 ( 9.4- 11.0) 10.9 ( 10.0- 11.9) 11.0 ( 10.1- 12.0) 3.7 ( 2.6- 5.3) 3.5 ( 2.4- 4.8)
Indiana
Michigan 10.2 ( 9.3- 11.1) 10.3 ( 9.5- 11.3) 10.3 ( 9.4- 11.3) 10.6 ( 9.6- 11.6) 8.1 ( 6.1- 10.6) 7.3 ( 5.5- 9.5)
Detroit 10.3 ( 9.0- 11.7) 10.6 ( 9.3- 12.1) 11.0 ( 9.4- 12.8) 11.6 ( 10.0- 13.5) 7.4 ( 5.2- 10.2) 7.0 ( 4.9- 9.5)
Ohio 7.6 ( 6.9- 8.4) 7.8 ( 7.1- 8.5) 7.8 ( 7.1- 8.6) 8.1 ( 7.3- 8.9) 3.5 ( 2.2- 5.4) 3.2 ( 2.0- 4.8)
Wisconsin 8.5 ( 7.5- 9.7) 8.6 ( 7.5- 9.8) 9.0 ( 7.8- 10.2) 9.1 ( 8.0- 10.4) ∼ ∼
West North Central 9.9 ( 9.3- 10.6) 9.9 ( 9.3- 10.6) 10.0 ( 9.3- 10.7) 10.1 ( 9.5- 10.8) 6.8 ( 4.6- 9.8) 5.7 ( 3.9- 8.1)
Iowa 9.7 ( 8.1- 11.4) 9.8 ( 8.3- 11.5) 9.6 ( 8.1- 11.4) 9.8 ( 8.2- 11.6) ∼ ∼
Kansas 10.5 ( 8.8- 12.4) 10.5 ( 8.9- 12.4) 10.5 ( 8.7- 12.5) 10.6 ( 8.9- 12.6) ∼ ∼
Minnesota 9.9 ( 8.7- 11.2) 9.8 ( 8.6- 11.2) 9.8 ( 8.6- 11.2) 9.9 ( 8.6- 11.2) ∼ ∼
Missouri 10.0 ( 8.9- 11.2) 10.2 ( 9.0- 11.4) 10.3 ( 9.1- 11.7) 10.6 ( 9.3- 12.0) 7.0 ( 4.2- 10.9) 6.1 ( 3.7- 9.4)
Nebraska 9.2 ( 7.3- 11.6) 9.1 ( 7.1- 11.3) 9.6 ( 7.5- 12.0) 9.4 ( 7.4- 11.8) ∼ ∼




Delaware 13.2 ( 9.8- 17.3) 13.7 ( 10.3- 17.9) 13.5 ( 9.8- 18.3) 14.4 ( 10.4- 19.4) ∼ ∼
District of Columbia 14.8 ( 10.8- 20.2) 16.6 ( 12.2- 22.1) ∼ ∼ 14.7 ( 9.7- 21.9) 16.6 ( 11.1- 23.9)
Florida 8.8 ( 8.1- 9.5) 9.2 ( 8.5- 9.8) 9.4 ( 8.6- 10.2) 9.9 ( 9.1- 10.7) 6.1 ( 4.7- 7.9) 5.3 ( 4.1- 6.7)
Georgia
Atlanta 9.4 ( 7.8- 11.2) 9.3 ( 7.7- 11.0) 9.9 ( 8.0- 12.3) 10.4 ( 8.4- 12.8) 7.5 ( 4.8- 11.7) 6.4 ( 4.3- 9.2)
Maryland 10.6 ( 9.4- 11.9) 10.9 ( 9.7- 12.2) 11.9 ( 10.4- 13.6) 12.4 ( 10.8- 14.2) 7.0 ( 5.2- 9.4) 6.9 ( 5.2- 9.0)
North Carolina 6.5 ( 5.8- 7.4) 6.6 ( 5.8- 7.5) 7.3 ( 6.3- 8.3) 7.5 ( 6.5- 8.5) 3.7 ( 2.5- 5.3) 3.5 ( 2.4- 4.9)
South Carolina 6.7 ( 5.7- 8.0) 7.0 ( 5.9- 8.2) 7.6 ( 6.3- 9.2) 8.1 ( 6.7- 9.8) 4.6 ( 3.0- 6.8) 4.2 ( 2.8- 6.2)
Virginia
West Virginia 10.9 ( 8.9- 13.3) 11.4 ( 9.4- 13.8) 11.1 ( 9.1- 13.6) 11.7 ( 9.5- 14.1) ∼ ∼
East South Central
Alabama













Table 2.21.2: Cancer of the Thyroid. Invasive Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 7.6 ( 6.5- 8.8) 7.5 ( 6.4- 8.8) 8.5 ( 7.1- 10.2) 8.8 ( 7.4- 10.4) 6.1 ( 4.3- 8.4) 5.2 ( 3.7- 7.1)
Oklahoma
Texas
West 10.1 ( 9.7- 10.5) 10.0 ( 9.6- 10.3) 10.1 ( 9.7- 10.5) 10.0 ( 9.6- 10.4) 5.0 ( 3.9- 6.3) 4.8 ( 3.8- 6.0)
Mountain
Arizona 9.6 ( 8.4- 10.9) 9.3 ( 8.2- 10.6) 10.0 ( 8.7- 11.5) 9.9 ( 8.6- 11.3) ∼ ∼
Colorado 10.7 ( 9.3- 12.2) 10.9 ( 9.5- 12.4) 10.6 ( 9.2- 12.2) 10.9 ( 9.4- 12.5) ∼ ∼
Idaho 8.5 ( 6.3- 11.2) 8.1 ( 6.1- 10.7) 8.4 ( 6.2- 11.2) 8.1 ( 6.0- 10.7) ∼ ∼
Montana 15.3 ( 11.9- 19.5) 15.3 ( 11.9- 19.4) 15.3 ( 11.7- 19.7) 15.4 ( 11.8- 19.6) ∼ ∼
Nevada
New Mexico 11.5 ( 9.4- 14.0) 11.3 ( 9.2- 13.8) 12.4 ( 10.0- 15.2) 12.5 ( 10.1- 15.3) ∼ ∼
Utah 12.4 ( 10.2- 15.0) 10.7 ( 8.9- 12.9) 12.2 ( 10.0- 14.8) 10.5 ( 8.6- 12.7) ∼ ∼
Wyoming 8.3 ( 5.0- 13.3) 8.0 ( 4.8- 12.4) 8.3 ( 4.9- 13.4) 7.9 ( 4.7- 12.4) ∼ ∼
Pacific 9.9 ( 9.5- 10.3) 9.8 ( 9.4- 10.2) 9.8 ( 9.4- 10.3) 9.8 ( 9.3- 10.3) 5.1 ( 3.9- 6.5) 4.9 ( 3.8- 6.2)
Alaska 10.7 ( 7.2- 16.5) 10.2 ( 6.9- 14.5) 9.1 ( 5.4- 15.8) 9.2 ( 5.6- 14.1) ∼ ∼
California 9.6 ( 9.2- 10.1) 9.5 ( 9.0- 10.0) 9.8 ( 9.3- 10.4) 9.7 ( 9.2- 10.3) 4.5 ( 3.4- 6.0) 4.4 ( 3.3- 5.7)
San Francisco-Oakland 8.1 ( 7.0- 9.5) 8.6 ( 7.4- 10.0) 8.6 ( 7.2- 10.4) 9.2 ( 7.7- 11.0) ∼ ∼
San Jose-Monterey 10.1 ( 8.3- 12.1) 10.2 ( 8.4- 12.2) 9.8 ( 7.9- 12.1) 9.9 ( 7.9- 12.2) ∼ ∼
Los Angeles 10.4 ( 9.5- 11.4) 10.1 ( 9.2- 11.0) 11.2 ( 10.1- 12.4) 10.8 ( 9.7- 11.9) 4.2 ( 2.7- 6.4) 4.2 ( 2.6- 6.3)
Hawaii 12.0 ( 9.4- 15.2) 12.4 ( 9.7- 15.5) ∼ ∼ ∼ ∼
Oregon 8.6 ( 7.3- 10.1) 8.8 ( 7.5- 10.4) 8.8 ( 7.4- 10.4) 9.1 ( 7.6- 10.7) ∼ ∼
Washington 11.5 ( 10.3- 12.8) 11.6 ( 10.4- 12.9) 10.8 ( 9.6- 12.2) 11.0 ( 9.8- 12.4) ∼ ∼
Seattle-Puget Sound 12.2 ( 10.7- 13.8) 12.4 ( 10.9- 14.1) 11.9 ( 10.4- 13.7) 12.4 ( 10.8- 14.1) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.22.1: Hodgkin Lymphoma. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan
Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 3.2 ( 3.1- 3.3) 3.1 ( 3.0- 3.2) 3.2 ( 3.1- 3.4) 3.2 ( 3.1- 3.4) 2.9 ( 2.6- 3.2) 2.7 ( 2.4- 3.0)
Northeast 3.6 ( 3.4- 3.9) 3.6 ( 3.4- 3.9) 3.7 ( 3.5- 4.0) 3.8 ( 3.5- 4.0) 3.2 ( 2.5- 4.1) 2.8 ( 2.2- 3.5)
New England 3.7 ( 3.2- 4.2) 3.7 ( 3.2- 4.2) 3.8 ( 3.3- 4.4) 3.9 ( 3.4- 4.5) ∼ ∼
Connecticut 3.2 ( 2.4- 4.2) 3.2 ( 2.4- 4.2) 3.4 ( 2.5- 4.5) 3.4 ( 2.5- 4.5) ∼ ∼
Maine
Massachusetts 3.9 ( 3.2- 4.7) 3.9 ( 3.2- 4.7) 4.0 ( 3.3- 4.8) 4.1 ( 3.4- 4.9) ∼ ∼
New Hampshire 3.6 ( 2.3- 5.7) 3.7 ( 2.3- 5.6) 3.7 ( 2.3- 5.9) 3.8 ( 2.4- 5.8) ∼ ∼
Rhode Island 4.2 ( 2.5- 6.5) 4.2 ( 2.6- 6.5) 4.3 ( 2.6- 6.9) 4.3 ( 2.6- 6.8) ∼ ∼
Vermont
Middle Atlantic 3.6 ( 3.3- 3.9) 3.6 ( 3.3- 3.9) 3.7 ( 3.4- 4.0) 3.7 ( 3.4- 4.0) 3.4 ( 2.6- 4.4) 3.0 ( 2.4- 3.8)
New Jersey 3.8 ( 3.2- 4.4) 3.7 ( 3.1- 4.3) 3.8 ( 3.2- 4.6) 3.8 ( 3.1- 4.5) 5.1 ( 3.0- 8.7) 4.0 ( 2.6- 6.1)
New York 3.4 ( 3.1- 3.9) 3.4 ( 3.1- 3.9) 3.6 ( 3.1- 4.1) 3.6 ( 3.2- 4.1) 2.9 ( 2.0- 4.2) 2.7 ( 1.9- 3.6)
Pennsylvania 3.7 ( 3.3- 4.3) 3.8 ( 3.3- 4.3) 3.8 ( 3.3- 4.3) 3.8 ( 3.3- 4.4) 3.2 ( 1.8- 5.6) 2.9 ( 1.7- 4.7)
Midwest
East North Central
Illinois 3.1 ( 2.7- 3.6) 3.0 ( 2.6- 3.5) 3.0 ( 2.5- 3.5) 3.0 ( 2.5- 3.5) 2.2 ( 1.3- 3.9) 2.1 ( 1.2- 3.3)
Indiana
Michigan 3.9 ( 3.3- 4.5) 3.8 ( 3.3- 4.4) 4.0 ( 3.4- 4.7) 3.9 ( 3.4- 4.6) 3.9 ( 2.5- 6.2) 3.5 ( 2.2- 5.2)
Detroit 3.8 ( 2.9- 4.8) 3.7 ( 2.9- 4.7) 3.8 ( 2.8- 5.0) 3.8 ( 2.9- 5.0) 4.1 ( 2.4- 6.9) 3.7 ( 2.2- 5.9)
Ohio 3.2 ( 2.8- 3.8) 3.2 ( 2.7- 3.7) 3.2 ( 2.7- 3.7) 3.2 ( 2.7- 3.7) 2.7 ( 1.6- 4.9) 2.8 ( 1.6- 4.4)
Wisconsin 3.4 ( 2.7- 4.2) 3.4 ( 2.7- 4.2) 3.3 ( 2.6- 4.1) 3.3 ( 2.6- 4.1) ∼ ∼
West North Central 3.5 ( 3.1- 3.9) 3.4 ( 3.1- 3.8) 3.5 ( 3.1- 3.9) 3.5 ( 3.1- 3.9) ∼ ∼
Iowa 2.8 ( 2.0- 3.9) 2.9 ( 2.0- 3.9) 2.8 ( 2.0- 3.9) 2.9 ( 2.1- 4.0) ∼ ∼
Kansas 3.8 ( 2.8- 5.1) 3.8 ( 2.8- 5.0) 3.8 ( 2.8- 5.1) 3.8 ( 2.8- 5.0) ∼ ∼
Minnesota 3.8 ( 3.0- 4.7) 3.7 ( 3.0- 4.6) 3.6 ( 2.9- 4.6) 3.6 ( 2.8- 4.5) ∼ ∼
Missouri 3.4 ( 2.7- 4.2) 3.4 ( 2.7- 4.1) 3.5 ( 2.7- 4.3) 3.4 ( 2.7- 4.3) ∼ ∼
Nebraska 3.8 ( 2.6- 5.5) 3.7 ( 2.5- 5.3) 4.0 ( 2.7- 5.8) 3.9 ( 2.7- 5.6) ∼ ∼




Delaware 5.1 ( 3.1- 8.4) 5.2 ( 3.1- 8.1) ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼
Florida 3.1 ( 2.7- 3.5) 3.1 ( 2.7- 3.5) 3.2 ( 2.7- 3.7) 3.2 ( 2.8- 3.7) 2.5 ( 1.6- 4.2) 2.3 ( 1.5- 3.4)
Georgia
Atlanta 2.8 ( 1.9- 4.3) 2.8 ( 1.9- 3.8) 2.4 ( 1.4- 4.3) 2.3 ( 1.4- 3.6) ∼ ∼
Maryland 3.0 ( 2.4- 3.8) 3.1 ( 2.4- 3.8) 3.2 ( 2.4- 4.2) 3.3 ( 2.5- 4.2) 2.4 ( 1.4- 4.7) 2.6 ( 1.6- 4.2)
North Carolina 2.8 ( 2.3- 3.4) 2.8 ( 2.3- 3.4) 2.7 ( 2.1- 3.4) 2.7 ( 2.2- 3.4) 2.9 ( 1.7- 4.8) 2.7 ( 1.6- 4.1)
South Carolina 2.4 ( 1.7- 3.3) 2.3 ( 1.7- 3.2) 2.4 ( 1.6- 3.5) 2.4 ( 1.7- 3.4) ∼ ∼
Virginia
West Virginia 3.4 ( 2.3- 4.9) 3.4 ( 2.3- 4.9) 3.4 ( 2.3- 5.0) 3.5 ( 2.3- 5.0) ∼ ∼
East South Central
Alabama













Table 2.22.1: Hodgkin Lymphoma. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan
Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
(continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 2.6 ( 2.0- 3.5) 2.6 ( 1.9- 3.3) 2.3 ( 1.5- 3.3) 2.3 ( 1.6- 3.2) 3.4 ( 2.1- 5.6) 3.2 ( 2.0- 4.9)
Oklahoma
Texas
West 2.8 ( 2.6- 3.0) 2.7 ( 2.5- 2.9) 3.0 ( 2.8- 3.2) 2.9 ( 2.7- 3.1) 2.1 ( 1.4- 3.2) 2.1 ( 1.4- 2.9)
Mountain
Arizona 2.1 ( 1.6- 2.9) 2.1 ( 1.6- 2.8) 2.2 ( 1.6- 3.0) 2.2 ( 1.6- 2.9) ∼ ∼
Colorado 3.2 ( 2.5- 4.2) 3.2 ( 2.4- 4.1) 3.4 ( 2.6- 4.4) 3.3 ( 2.5- 4.2) ∼ ∼
Idaho ∼ ∼ ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼
Nevada
New Mexico 3.5 ( 2.3- 5.2) 3.3 ( 2.2- 4.7) 3.8 ( 2.5- 5.7) 3.7 ( 2.4- 5.3) ∼ ∼
Utah 2.7 ( 1.7- 4.1) 2.5 ( 1.7- 3.7) 2.7 ( 1.7- 4.1) 2.6 ( 1.7- 3.8) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 2.8 ( 2.5- 3.0) 2.7 ( 2.5- 2.9) 3.0 ( 2.8- 3.3) 2.9 ( 2.7- 3.2) 2.1 ( 1.4- 3.2) 2.1 ( 1.4- 3.0)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 2.7 ( 2.5- 3.0) 2.6 ( 2.3- 2.8) 3.0 ( 2.7- 3.4) 2.9 ( 2.6- 3.2) 2.2 ( 1.4- 3.5) 2.2 ( 1.4- 3.2)
San Francisco-Oakland 2.8 ( 2.1- 3.7) 2.7 ( 2.0- 3.5) 2.8 ( 2.0- 3.9) 2.8 ( 1.9- 3.8) ∼ ∼
San Jose-Monterey 3.0 ( 2.1- 4.4) 2.9 ( 2.0- 4.0) 3.7 ( 2.5- 5.3) 3.5 ( 2.4- 5.0) ∼ ∼
Los Angeles 2.8 ( 2.3- 3.4) 2.6 ( 2.2- 3.1) 3.3 ( 2.7- 4.0) 3.0 ( 2.5- 3.6) ∼ ∼
Hawaii ∼ ∼ ∼ ∼ ∼ ∼
Oregon 3.0 ( 2.3- 4.0) 3.1 ( 2.3- 4.0) 3.1 ( 2.2- 4.1) 3.1 ( 2.3- 4.1) ∼ ∼
Washington 3.1 ( 2.5- 3.9) 3.1 ( 2.5- 3.8) 3.2 ( 2.6- 4.0) 3.2 ( 2.5- 4.0) ∼ ∼
Seattle-Puget Sound 3.0 ( 2.3- 3.9) 3.0 ( 2.3- 3.9) 3.3 ( 2.4- 4.3) 3.3 ( 2.5- 4.3) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.22.2: Hodgkin Lymphoma. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan
Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 2.5 ( 2.4- 2.6) 2.6 ( 2.5- 2.7) 2.7 ( 2.6- 2.8) 2.7 ( 2.6- 2.8) 1.9 ( 1.7- 2.2) 1.9 ( 1.7- 2.2)
Northeast 2.8 ( 2.6- 3.1) 2.9 ( 2.7- 3.1) 3.0 ( 2.8- 3.3) 3.1 ( 2.9- 3.4) 1.8 ( 1.4- 2.4) 1.9 ( 1.5- 2.4)
New England 3.1 ( 2.7- 3.6) 3.2 ( 2.8- 3.7) 3.2 ( 2.8- 3.8) 3.3 ( 2.9- 3.9) ∼ ∼
Connecticut 3.1 ( 2.3- 4.1) 3.1 ( 2.4- 4.1) 3.2 ( 2.3- 4.3) 3.2 ( 2.3- 4.2) ∼ ∼
Maine
Massachusetts 3.2 ( 2.6- 3.8) 3.3 ( 2.7- 3.9) 3.3 ( 2.7- 4.1) 3.5 ( 2.8- 4.2) ∼ ∼
New Hampshire 2.9 ( 1.7- 4.6) 3.1 ( 1.9- 4.9) 2.9 ( 1.8- 4.7) 3.2 ( 1.9- 5.0) ∼ ∼
Rhode Island 3.0 ( 1.7- 5.0) 3.1 ( 1.8- 5.1) 3.3 ( 1.9- 5.6) 3.4 ( 1.9- 5.5) ∼ ∼
Vermont
Middle Atlantic 2.8 ( 2.5- 3.0) 2.8 ( 2.6- 3.1) 3.0 ( 2.7- 3.2) 3.0 ( 2.8- 3.3) 1.9 ( 1.4- 2.4) 1.9 ( 1.5- 2.5)
New Jersey 3.0 ( 2.5- 3.6) 3.0 ( 2.5- 3.6) 3.2 ( 2.6- 3.9) 3.3 ( 2.7- 3.9) 2.6 ( 1.5- 4.3) 2.7 ( 1.6- 4.3)
New York 2.7 ( 2.4- 3.1) 2.8 ( 2.5- 3.1) 3.0 ( 2.6- 3.5) 3.1 ( 2.7- 3.5) 1.6 ( 1.1- 2.4) 1.7 ( 1.1- 2.4)
Pennsylvania 2.6 ( 2.3- 3.1) 2.8 ( 2.4- 3.2) 2.7 ( 2.3- 3.2) 2.9 ( 2.5- 3.4) ∼ ∼
Midwest
East North Central
Illinois 2.4 ( 2.0- 2.8) 2.4 ( 2.0- 2.8) 2.6 ( 2.2- 3.1) 2.6 ( 2.2- 3.1) ∼ ∼
Indiana
Michigan 2.7 ( 2.3- 3.2) 2.7 ( 2.3- 3.2) 2.8 ( 2.3- 3.4) 2.9 ( 2.4- 3.4) 2.4 ( 1.4- 3.8) 2.4 ( 1.4- 3.8)
Detroit 3.0 ( 2.3- 3.9) 3.1 ( 2.4- 4.0) 3.4 ( 2.5- 4.4) 3.5 ( 2.6- 4.6) ∼ ∼
Ohio 2.2 ( 1.8- 2.6) 2.3 ( 1.9- 2.7) 2.2 ( 1.8- 2.7) 2.3 ( 1.9- 2.8) ∼ ∼
Wisconsin 2.7 ( 2.1- 3.4) 2.7 ( 2.1- 3.4) 2.9 ( 2.2- 3.6) 2.9 ( 2.3- 3.7) ∼ ∼
West North Central 2.8 ( 2.5- 3.2) 2.8 ( 2.5- 3.2) 2.8 ( 2.4- 3.1) 2.8 ( 2.4- 3.2) ∼ ∼
Iowa 2.9 ( 2.1- 3.9) 2.9 ( 2.1- 3.9) 2.9 ( 2.1- 4.0) 2.9 ( 2.1- 3.9) ∼ ∼
Kansas 2.3 ( 1.5- 3.3) 2.3 ( 1.6- 3.3) 2.4 ( 1.6- 3.5) 2.4 ( 1.6- 3.5) ∼ ∼
Minnesota 3.1 ( 2.4- 3.9) 3.2 ( 2.5- 4.0) 2.9 ( 2.3- 3.7) 3.1 ( 2.4- 3.9) ∼ ∼
Missouri 2.9 ( 2.3- 3.6) 2.9 ( 2.3- 3.6) 2.9 ( 2.3- 3.7) 2.9 ( 2.3- 3.7) ∼ ∼
Nebraska 2.7 ( 1.7- 4.1) 2.7 ( 1.7- 4.1) 2.3 ( 1.4- 3.7) 2.4 ( 1.4- 3.7) ∼ ∼




Delaware ∼ ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼
Florida 2.6 ( 2.2- 3.0) 2.6 ( 2.3- 3.0) 2.7 ( 2.3- 3.2) 2.8 ( 2.4- 3.2) 1.9 ( 1.1- 3.0) 1.7 ( 1.1- 2.6)
Georgia
Atlanta 2.5 ( 1.7- 3.6) 2.4 ( 1.6- 3.4) 2.9 ( 1.8- 4.3) 2.7 ( 1.8- 4.1) ∼ ∼
Maryland 2.4 ( 1.8- 3.0) 2.4 ( 1.9- 3.1) 2.6 ( 1.9- 3.4) 2.7 ( 1.9- 3.5) ∼ ∼
North Carolina 2.4 ( 1.9- 2.9) 2.4 ( 2.0- 2.9) 2.4 ( 1.9- 3.1) 2.4 ( 1.9- 3.1) 2.4 ( 1.5- 3.7) 2.5 ( 1.5- 3.7)
South Carolina 2.0 ( 1.4- 2.7) 2.0 ( 1.5- 2.8) 2.1 ( 1.4- 3.1) 2.1 ( 1.4- 3.0) ∼ ∼
Virginia
West Virginia 3.0 ( 2.0- 4.4) 3.2 ( 2.2- 4.6) 3.1 ( 2.0- 4.5) 3.2 ( 2.2- 4.6) ∼ ∼
East South Central
Alabama













Table 2.22.2: Hodgkin Lymphoma. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan
Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
(continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 2.7 ( 2.1- 3.5) 2.8 ( 2.1- 3.6) 3.0 ( 2.2- 4.0) 3.0 ( 2.2- 4.1) 2.3 ( 1.4- 3.8) 2.4 ( 1.4- 3.8)
Oklahoma
Texas
West 2.3 ( 2.1- 2.5) 2.3 ( 2.1- 2.5) 2.4 ( 2.2- 2.6) 2.4 ( 2.2- 2.6) 1.7 ( 1.1- 2.5) 1.7 ( 1.1- 2.4)
Mountain
Arizona 2.1 ( 1.6- 2.8) 2.1 ( 1.5- 2.7) 2.1 ( 1.5- 2.8) 2.1 ( 1.5- 2.8) ∼ ∼
Colorado 2.2 ( 1.6- 3.0) 2.2 ( 1.6- 2.9) 2.2 ( 1.6- 3.0) 2.1 ( 1.5- 2.9) ∼ ∼
Idaho 2.8 ( 1.7- 4.5) 2.9 ( 1.7- 4.5) 2.9 ( 1.7- 4.7) 3.0 ( 1.8- 4.7) ∼ ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼
Nevada
New Mexico ∼ ∼ ∼ ∼ ∼ ∼
Utah 2.3 ( 1.5- 3.5) 2.4 ( 1.6- 3.6) 2.5 ( 1.6- 3.7) 2.6 ( 1.7- 3.7) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 2.3 ( 2.1- 2.5) 2.3 ( 2.1- 2.5) 2.5 ( 2.3- 2.8) 2.5 ( 2.3- 2.8) 1.6 ( 1.0- 2.5) 1.6 ( 1.0- 2.5)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 2.3 ( 2.1- 2.5) 2.3 ( 2.1- 2.5) 2.5 ( 2.2- 2.8) 2.5 ( 2.2- 2.8) 1.5 ( 0.9- 2.4) 1.5 ( 0.9- 2.4)
San Francisco-Oakland 2.2 ( 1.6- 3.0) 2.3 ( 1.7- 3.1) 2.4 ( 1.7- 3.5) 2.5 ( 1.7- 3.5) ∼ ∼
San Jose-Monterey 2.0 ( 1.3- 3.0) 2.0 ( 1.3- 3.0) 2.4 ( 1.5- 3.6) 2.4 ( 1.5- 3.6) ∼ ∼
Los Angeles 2.7 ( 2.2- 3.2) 2.7 ( 2.2- 3.2) 3.0 ( 2.5- 3.7) 3.0 ( 2.5- 3.6) ∼ ∼
Hawaii ∼ ∼ ∼ ∼ ∼ ∼
Oregon 2.7 ( 1.9- 3.6) 2.6 ( 1.9- 3.5) 2.7 ( 1.9- 3.7) 2.6 ( 1.9- 3.6) ∼ ∼
Washington 2.6 ( 2.1- 3.3) 2.6 ( 2.1- 3.3) 2.6 ( 2.0- 3.3) 2.6 ( 2.0- 3.3) ∼ ∼
Seattle-Puget Sound 2.9 ( 2.2- 3.7) 2.9 ( 2.2- 3.8) 3.2 ( 2.4- 4.2) 3.2 ( 2.4- 4.2) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.23.1: Non-Hodgkin Lymphoma. Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 22.0 ( 21.7- 22.3) 20.0 ( 19.7- 20.3) 22.1 ( 21.8- 22.5) 21.3 ( 21.0- 21.6) 16.7 ( 15.8- 17.6) 12.4 ( 11.7- 13.0)
Northeast 23.2 ( 22.5- 23.8) 22.2 ( 21.6- 22.8) 23.0 ( 22.3- 23.6) 23.3 ( 22.6- 24.0) 19.0 ( 17.2- 21.0) 14.7 ( 13.4- 16.2)
New England 23.3 ( 22.0- 24.6) 22.1 ( 20.9- 23.4) 23.1 ( 21.8- 24.5) 22.9 ( 21.6- 24.3) 18.2 ( 12.7- 26.1) 12.1 ( 8.8- 16.1)
Connecticut 26.2 ( 23.7- 28.9) 25.5 ( 23.1- 28.1) 26.4 ( 23.8- 29.2) 27.0 ( 24.3- 29.8) 23.8 ( 14.2- 39.1) 15.7 ( 10.0- 23.6)
Maine
Massachusetts 22.4 ( 20.6- 24.2) 21.1 ( 19.5- 22.9) 21.9 ( 20.2- 23.8) 21.8 ( 20.1- 23.6) 13.0 ( 7.6- 24.2) 9.7 ( 5.8- 15.1)
New Hampshire 19.3 ( 15.6- 23.6) 16.9 ( 13.8- 20.6) 19.4 ( 15.7- 23.8) 17.2 ( 13.9- 20.9) ∼ ∼
Rhode Island 23.8 ( 19.6- 28.8) 23.1 ( 19.0- 27.8) 24.1 ( 19.7- 29.3) 24.3 ( 19.9- 29.3) ∼ ∼
Vermont
Middle Atlantic 23.1 ( 22.4- 23.9) 22.2 ( 21.6- 22.9) 22.9 ( 22.2- 23.7) 23.4 ( 22.6- 24.2) 19.1 ( 17.2- 21.2) 15.1 ( 13.7- 16.7)
New Jersey 25.1 ( 23.5- 26.8) 23.7 ( 22.2- 25.2) 25.4 ( 23.7- 27.2) 25.6 ( 23.9- 27.5) 19.3 ( 15.3- 24.5) 15.5 ( 12.4- 19.1)
New York 21.8 ( 20.8- 22.9) 20.4 ( 19.4- 21.3) 21.6 ( 20.5- 22.8) 21.5 ( 20.4- 22.6) 18.6 ( 16.1- 21.4) 15.1 ( 13.2- 17.2)
Pennsylvania 23.6 ( 22.4- 24.9) 24.1 ( 22.9- 25.4) 23.1 ( 21.8- 24.4) 24.5 ( 23.2- 25.9) 19.5 ( 15.4- 24.6) 14.8 ( 11.7- 18.4)
Midwest
East North Central
Illinois 23.3 ( 22.0- 24.7) 20.3 ( 19.2- 21.5) 23.9 ( 22.5- 25.4) 22.0 ( 20.7- 23.3) 14.9 ( 11.8- 18.6) 10.8 ( 8.7- 13.2)
Indiana
Michigan 22.4 ( 21.0- 23.9) 20.1 ( 18.8- 21.4) 23.1 ( 21.6- 24.7) 21.6 ( 20.2- 23.1) 15.3 ( 12.0- 19.3) 11.9 ( 9.5- 14.9)
Detroit 22.3 ( 20.1- 24.6) 20.0 ( 18.1- 22.1) 23.8 ( 21.3- 26.7) 22.6 ( 20.2- 25.2) 15.4 ( 11.6- 20.2) 12.2 ( 9.2- 15.9)
Ohio 21.9 ( 20.6- 23.2) 20.3 ( 19.2- 21.6) 21.9 ( 20.6- 23.4) 21.1 ( 19.8- 22.4) 16.8 ( 13.1- 21.4) 12.6 ( 9.9- 15.7)
Wisconsin 23.0 ( 21.1- 25.0) 21.0 ( 19.3- 22.9) 22.6 ( 20.7- 24.7) 21.6 ( 19.8- 23.5) 22.9 ( 12.9- 43.9) 12.6 ( 7.5- 19.9)
West North Central 22.2 ( 21.2- 23.3) 20.6 ( 19.6- 21.5) 22.2 ( 21.2- 23.3) 21.3 ( 20.3- 22.3) 15.4 ( 11.4- 20.8) 10.6 ( 8.0- 13.9)
Iowa 21.8 ( 19.4- 24.5) 21.6 ( 19.2- 24.2) 21.7 ( 19.3- 24.4) 21.9 ( 19.5- 24.6) ∼ ∼
Kansas 21.2 ( 18.6- 24.0) 19.4 ( 17.1- 22.0) 20.8 ( 18.2- 23.7) 19.7 ( 17.3- 22.4) ∼ ∼
Minnesota 25.6 ( 23.4- 27.9) 22.5 ( 20.6- 24.5) 25.1 ( 22.9- 27.4) 23.0 ( 21.0- 25.1) ∼ ∼
Missouri 20.9 ( 19.1- 22.9) 19.3 ( 17.7- 21.1) 21.3 ( 19.4- 23.3) 20.5 ( 18.7- 22.4) 14.1 ( 9.3- 21.1) 10.1 ( 6.7- 14.4)
Nebraska 19.2 ( 16.2- 22.6) 18.0 ( 15.2- 21.2) 19.2 ( 16.2- 22.7) 18.6 ( 15.7- 21.9) ∼ ∼




Delaware 16.5 ( 12.6- 21.7) 16.1 ( 12.3- 20.8) 18.3 ( 13.8- 24.3) 19.2 ( 14.4- 25.0) ∼ ∼
District of Columbia 19.9 ( 14.6- 26.6) 19.7 ( 14.5- 26.1) 21.1 ( 12.1- 36.9) 19.0 ( 11.1- 30.5) 18.9 ( 12.6- 27.8) 19.1 ( 12.7- 27.7)
Florida 22.6 ( 21.5- 23.6) 25.3 ( 24.2- 26.5) 22.7 ( 21.6- 23.9) 27.9 ( 26.6- 29.3) 16.2 ( 13.4- 19.8) 12.2 ( 10.2- 14.4)
Georgia
Atlanta 21.7 ( 18.4- 25.6) 14.8 ( 12.8- 17.0) 21.7 ( 18.0- 26.1) 16.5 ( 13.9- 19.5) 20.2 ( 13.4- 30.4) 11.3 ( 8.3- 15.2)
Maryland 20.1 ( 18.2- 22.1) 17.7 ( 16.1- 19.4) 20.2 ( 18.1- 22.6) 19.4 ( 17.3- 21.5) 14.8 ( 11.6- 19.1) 11.8 ( 9.4- 14.7)
North Carolina 18.0 ( 16.5- 19.5) 16.1 ( 14.8- 17.4) 19.1 ( 17.5- 20.9) 18.3 ( 16.8- 20.0) 11.4 ( 8.8- 14.8) 8.7 ( 6.8- 11.1)
South Carolina 18.9 ( 16.8- 21.3) 16.5 ( 14.7- 18.4) 19.3 ( 16.9- 22.1) 18.3 ( 16.1- 20.8) 16.5 ( 12.5- 21.6) 11.9 ( 9.1- 15.2)
Virginia
West Virginia 22.2 ( 19.2- 25.6) 22.7 ( 19.7- 26.1) 22.4 ( 19.3- 25.9) 23.0 ( 19.9- 26.5) ∼ ∼
East South Central
Alabama













Table 2.23.1: Non-Hodgkin Lymphoma. Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 20.8 ( 18.6- 23.1) 17.4 ( 15.7- 19.3) 21.5 ( 19.0- 24.3) 20.0 ( 17.7- 22.4) 18.6 ( 14.7- 23.4) 12.7 ( 10.2- 15.8)
Oklahoma
Texas
West 21.3 ( 20.8- 21.9) 17.9 ( 17.4- 18.4) 21.6 ( 21.0- 22.3) 18.8 ( 18.3- 19.4) 16.7 ( 14.2- 19.6) 11.5 ( 9.9- 13.3)
Mountain
Arizona 19.2 ( 17.4- 21.2) 17.7 ( 16.0- 19.5) 19.9 ( 18.0- 21.9) 19.3 ( 17.4- 21.2) ∼ ∼
Colorado 20.6 ( 18.4- 23.1) 17.0 ( 15.3- 18.9) 20.9 ( 18.6- 23.4) 17.6 ( 15.8- 19.6) ∼ ∼
Idaho 18.8 ( 15.2- 22.9) 16.2 ( 13.2- 19.6) 18.7 ( 15.2- 22.9) 16.3 ( 13.3- 19.9) ∼ ∼
Montana 20.5 ( 16.4- 25.4) 20.3 ( 16.3- 24.9) 20.6 ( 16.4- 25.6) 21.1 ( 16.9- 26.1) ∼ ∼
Nevada
New Mexico 15.9 ( 13.1- 19.2) 13.8 ( 11.4- 16.5) 16.5 ( 13.5- 20.0) 15.1 ( 12.5- 18.2) ∼ ∼
Utah 23.5 ( 20.0- 27.4) 16.2 ( 13.9- 18.8) 23.8 ( 20.3- 27.9) 16.7 ( 14.3- 19.5) ∼ ∼
Wyoming 15.0 ( 10.2- 21.8) 13.3 ( 9.1- 18.7) 14.5 ( 9.7- 21.2) 12.9 ( 8.7- 18.5) ∼ ∼
Pacific 22.0 ( 21.3- 22.7) 18.3 ( 17.7- 18.9) 22.3 ( 21.6- 23.1) 19.3 ( 18.6- 19.9) 16.8 ( 14.2- 19.9) 12.0 ( 10.2- 13.9)
Alaska 19.8 ( 13.4- 30.0) 13.8 ( 10.1- 18.5) 21.8 ( 14.2- 34.5) 15.3 ( 10.8- 21.0) ∼ ∼
California 21.6 ( 20.8- 22.4) 17.6 ( 17.0- 18.3) 22.2 ( 21.3- 23.1) 18.7 ( 18.0- 19.5) 16.3 ( 13.6- 19.5) 11.9 ( 10.0- 14.0)
San Francisco-Oakland 25.8 ( 23.5- 28.3) 23.6 ( 21.5- 25.8) 27.4 ( 24.6- 30.5) 26.6 ( 23.9- 29.5) 19.4 ( 13.6- 27.7) 16.1 ( 11.4- 22.1)
San Jose-Monterey 20.2 ( 17.3- 23.5) 15.8 ( 13.6- 18.2) 19.8 ( 16.6- 23.4) 16.2 ( 13.7- 19.0) ∼ ∼
Los Angeles 22.4 ( 20.8- 24.1) 17.3 ( 16.1- 18.6) 23.8 ( 22.0- 25.8) 18.7 ( 17.3- 20.2) 16.3 ( 12.4- 21.4) 12.8 ( 9.8- 16.3)
Hawaii 20.2 ( 16.7- 24.4) 19.3 ( 15.9- 23.2) 21.9 ( 14.7- 31.8) 17.7 ( 12.0- 25.3) ∼ ∼
Oregon 22.6 ( 20.3- 25.2) 21.5 ( 19.3- 23.9) 22.1 ( 19.8- 24.7) 21.6 ( 19.3- 24.0) ∼ ∼
Washington 23.7 ( 21.8- 25.7) 20.8 ( 19.1- 22.5) 23.2 ( 21.3- 25.3) 21.2 ( 19.4- 23.0) ∼ ∼
Seattle-Puget Sound 25.3 ( 23.0- 27.9) 22.0 ( 20.0- 24.2) 25.0 ( 22.6- 27.7) 22.8 ( 20.5- 25.1) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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100 Table 2.23.2: Non-Hodgkin Lymphoma. Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 15.7 ( 15.5- 16.0) 17.4 ( 17.1- 17.6) 16.1 ( 15.8- 16.3) 18.9 ( 18.6- 19.1) 10.8 ( 10.2- 11.4) 9.2 ( 8.7- 9.7)
Northeast 17.0 ( 16.5- 17.5) 20.0 ( 19.5- 20.5) 17.2 ( 16.7- 17.7) 21.5 ( 20.9- 22.2) 12.2 ( 11.0- 13.6) 11.0 ( 9.9- 12.2)
New England 17.4 ( 16.4- 18.4) 20.2 ( 19.1- 21.3) 17.4 ( 16.4- 18.5) 21.1 ( 19.9- 22.4) 12.0 ( 8.2- 17.1) 8.5 ( 5.9- 11.9)
Connecticut 17.8 ( 16.0- 19.8) 21.0 ( 18.9- 23.3) 18.5 ( 16.5- 20.6) 22.8 ( 20.5- 25.4) ∼ ∼
Maine
Massachusetts 16.8 ( 15.5- 18.2) 19.5 ( 18.0- 21.1) 16.4 ( 15.1- 17.8) 20.1 ( 18.5- 21.8) 16.4 ( 10.2- 25.5) 11.1 ( 7.0- 16.6)
New Hampshire 16.3 ( 13.2- 19.8) 16.7 ( 13.7- 20.3) 16.2 ( 13.1- 19.7) 16.8 ( 13.7- 20.4) ∼ ∼
Rhode Island 20.9 ( 17.4- 25.0) 25.5 ( 21.3- 30.2) 21.5 ( 17.8- 25.9) 27.3 ( 22.8- 32.4) ∼ ∼
Vermont
Middle Atlantic 16.9 ( 16.3- 17.4) 19.9 ( 19.3- 20.6) 17.1 ( 16.5- 17.7) 21.7 ( 21.0- 22.4) 12.3 ( 11.0- 13.8) 11.3 ( 10.1- 12.6)
New Jersey 17.8 ( 16.7- 19.1) 20.7 ( 19.3- 22.1) 18.2 ( 17.0- 19.6) 22.9 ( 21.3- 24.6) 15.7 ( 12.5- 19.7) 13.4 ( 10.7- 16.5)
New York 16.5 ( 15.7- 17.3) 18.7 ( 17.9- 19.6) 16.8 ( 15.9- 17.7) 20.6 ( 19.6- 21.7) 11.8 ( 10.2- 13.7) 10.9 ( 9.4- 12.6)
Pennsylvania 16.7 ( 15.8- 17.6) 21.3 ( 20.2- 22.5) 16.7 ( 15.7- 17.7) 22.3 ( 21.1- 23.6) 10.8 ( 8.3- 13.8) 10.3 ( 8.0- 13.2)
Midwest
East North Central
Illinois 15.9 ( 15.0- 16.9) 17.3 ( 16.2- 18.3) 16.7 ( 15.6- 17.8) 19.3 ( 18.1- 20.5) 8.7 ( 6.7- 11.0) 7.1 ( 5.6- 9.0)
Indiana
Michigan 17.0 ( 15.9- 18.1) 18.3 ( 17.1- 19.5) 17.6 ( 16.4- 18.9) 20.0 ( 18.7- 21.4) 11.8 ( 9.3- 14.8) 10.1 ( 8.0- 12.6)
Detroit 16.1 ( 14.5- 17.9) 17.6 ( 15.9- 19.5) 17.2 ( 15.4- 19.3) 20.4 ( 18.2- 22.8) 11.7 ( 8.8- 15.2) 10.4 ( 7.9- 13.5)
Ohio 16.9 ( 15.9- 17.9) 19.3 ( 18.2- 20.4) 16.8 ( 15.8- 17.9) 20.0 ( 18.8- 21.3) 12.9 ( 10.2- 16.2) 11.5 ( 9.1- 14.3)
Wisconsin 15.1 ( 13.8- 16.6) 16.9 ( 15.4- 18.6) 15.3 ( 13.9- 16.8) 17.9 ( 16.3- 19.6) ∼ ∼
West North Central 16.4 ( 15.6- 17.2) 18.7 ( 17.8- 19.6) 16.2 ( 15.4- 17.0) 19.1 ( 18.2- 20.0) 15.2 ( 11.6- 19.7) 11.2 ( 8.6- 14.4)
Iowa 16.1 ( 14.2- 18.1) 19.8 ( 17.6- 22.2) 16.0 ( 14.2- 18.1) 20.1 ( 17.9- 22.6) ∼ ∼
Kansas 16.1 ( 14.1- 18.3) 18.2 ( 16.0- 20.7) 15.8 ( 13.7- 18.0) 18.4 ( 16.1- 21.0) ∼ ∼
Minnesota 18.4 ( 16.7- 20.1) 19.6 ( 17.9- 21.4) 17.8 ( 16.2- 19.6) 19.9 ( 18.1- 21.8) ∼ ∼
Missouri 15.8 ( 14.5- 17.3) 18.0 ( 16.5- 19.7) 15.7 ( 14.3- 17.2) 18.6 ( 17.0- 20.4) 16.9 ( 12.3- 22.7) 13.7 ( 10.0- 18.3)
Nebraska 15.6 ( 13.2- 18.3) 18.0 ( 15.2- 21.1) 15.4 ( 13.0- 18.2) 18.3 ( 15.5- 21.6) ∼ ∼




Delaware 13.2 ( 9.9- 17.2) 14.2 ( 10.7- 18.5) 12.3 ( 8.9- 16.7) 14.7 ( 10.7- 19.8) ∼ ∼
District of Columbia 10.0 ( 6.9- 14.5) 11.9 ( 8.2- 16.7) ∼ ∼ 7.5 ( 4.2- 13.3) 9.2 ( 5.3- 14.9)
Florida 15.3 ( 14.5- 16.1) 20.4 ( 19.4- 21.4) 15.6 ( 14.8- 16.4) 22.9 ( 21.7- 24.1) 9.5 ( 7.6- 11.8) 7.8 ( 6.3- 9.6)
Georgia
Atlanta 12.8 ( 10.7- 15.1) 10.3 ( 8.7- 12.1) 13.2 ( 10.8- 16.0) 12.1 ( 9.9- 14.6) 9.9 ( 6.6- 14.8) 6.9 ( 4.7- 9.7)
Maryland 13.3 ( 11.9- 14.7) 13.7 ( 12.4- 15.2) 13.7 ( 12.1- 15.4) 16.1 ( 14.3- 18.1) 9.7 ( 7.4- 12.7) 7.9 ( 6.1- 10.2)
North Carolina 12.0 ( 11.0- 13.1) 13.1 ( 12.0- 14.3) 12.8 ( 11.6- 14.0) 14.9 ( 13.6- 16.4) 9.1 ( 7.1- 11.5) 8.0 ( 6.3- 10.1)
South Carolina 13.2 ( 11.7- 14.8) 14.1 ( 12.5- 15.8) 14.3 ( 12.5- 16.3) 16.9 ( 14.8- 19.2) 8.7 ( 6.3- 11.6) 7.5 ( 5.5- 9.9)
Virginia
West Virginia 16.8 ( 14.5- 19.4) 21.3 ( 18.4- 24.4) 16.6 ( 14.3- 19.2) 21.2 ( 18.3- 24.5) ∼ ∼
East South Central
Alabama













Table 2.23.2: Non-Hodgkin Lymphoma. Cancer Incidence Rates by U.S. Census Region and Division, State and
Metropolitan Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria∗† (continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 15.6 ( 14.1- 17.3) 16.0 ( 14.4- 17.7) 17.8 ( 15.9- 20.0) 20.5 ( 18.3- 23.0) 9.5 ( 7.2- 12.3) 8.0 ( 6.1- 10.2)
Oklahoma
Texas
West 15.2 ( 14.7- 15.6) 15.1 ( 14.6- 15.5) 15.6 ( 15.1- 16.1) 16.1 ( 15.6- 16.6) 10.5 ( 8.8- 12.5) 8.4 ( 7.1- 10.0)
Mountain
Arizona 13.1 ( 11.7- 14.6) 14.0 ( 12.6- 15.6) 13.6 ( 12.1- 15.1) 15.2 ( 13.6- 17.0) ∼ ∼
Colorado 17.6 ( 15.8- 19.5) 17.0 ( 15.2- 18.8) 17.8 ( 15.9- 19.8) 17.6 ( 15.8- 19.6) ∼ ∼
Idaho 17.8 ( 14.6- 21.5) 17.4 ( 14.3- 21.0) 17.2 ( 14.1- 21.0) 17.1 ( 14.0- 20.8) ∼ ∼
Montana 12.4 ( 9.5- 15.9) 14.4 ( 11.1- 18.4) 12.8 ( 9.9- 16.6) 15.6 ( 12.0- 19.9) ∼ ∼
Nevada
New Mexico 13.2 ( 10.9- 15.9) 13.1 ( 10.8- 15.7) 13.5 ( 11.1- 16.3) 14.3 ( 11.8- 17.3) ∼ ∼
Utah 14.6 ( 12.1- 17.4) 11.4 ( 9.4- 13.6) 14.9 ( 12.4- 17.9) 11.9 ( 9.8- 14.2) ∼ ∼
Wyoming 13.4 ( 9.2- 19.0) 13.8 ( 9.5- 19.4) 13.3 ( 9.1- 19.0) 14.0 ( 9.6- 19.8) ∼ ∼
Pacific 15.3 ( 14.8- 15.9) 15.2 ( 14.7- 15.7) 15.8 ( 15.2- 16.4) 16.3 ( 15.7- 16.9) 11.0 ( 9.1- 13.2) 9.0 ( 7.5- 10.7)
Alaska 18.2 ( 12.8- 26.0) 14.3 ( 10.3- 19.3) 20.4 ( 14.0- 29.8) 16.9 ( 11.9- 23.3) ∼ ∼
California 14.9 ( 14.3- 15.5) 14.6 ( 14.0- 15.2) 15.4 ( 14.8- 16.1) 15.7 ( 15.0- 16.4) 10.9 ( 8.9- 13.2) 9.0 ( 7.4- 10.8)
San Francisco-Oakland 15.0 ( 13.4- 16.7) 16.4 ( 14.7- 18.2) 16.0 ( 14.0- 18.1) 18.8 ( 16.6- 21.3) 11.1 ( 7.1- 16.6) 10.0 ( 6.5- 14.7)
San Jose-Monterey 16.4 ( 14.1- 19.0) 15.7 ( 13.5- 18.2) 15.8 ( 13.2- 18.6) 15.8 ( 13.3- 18.6) ∼ ∼
Los Angeles 14.4 ( 13.3- 15.5) 13.7 ( 12.7- 14.8) 15.6 ( 14.3- 17.0) 15.2 ( 13.9- 16.6) 10.0 ( 7.4- 13.2) 9.1 ( 6.7- 12.0)
Hawaii 12.2 ( 9.6- 15.2) 13.6 ( 10.7- 16.9) 12.9 ( 7.9- 20.4) 13.2 ( 8.0- 20.3) ∼ ∼
Oregon 16.0 ( 14.2- 17.9) 18.0 ( 16.0- 20.2) 15.9 ( 14.1- 17.8) 18.3 ( 16.3- 20.6) ∼ ∼
Washington 17.3 ( 15.8- 18.9) 17.6 ( 16.1- 19.2) 17.1 ( 15.6- 18.8) 18.3 ( 16.6- 20.0) ∼ ∼
Seattle-Puget Sound 17.5 ( 15.7- 19.5) 17.6 ( 15.8- 19.6) 17.8 ( 15.9- 19.9) 18.9 ( 16.9- 21.0) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.24.1: Multiple Myeloma. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan
Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 6.0 ( 5.8- 6.2) 5.3 ( 5.2- 5.5) 5.6 ( 5.4- 5.7) 5.3 ( 5.1- 5.4) 10.8 ( 10.0- 11.6) 6.6 ( 6.2- 7.1)
Northeast 6.1 ( 5.7- 6.4) 5.7 ( 5.4- 6.0) 5.6 ( 5.3- 6.0) 5.7 ( 5.3- 6.0) 10.2 ( 8.8- 11.9) 6.5 ( 5.7- 7.5)
New England 5.8 ( 5.2- 6.5) 5.4 ( 4.8- 6.0) 5.7 ( 5.1- 6.4) 5.6 ( 4.9- 6.2) 9.3 ( 5.2- 16.2) 4.6 ( 2.7- 7.3)
Connecticut 6.4 ( 5.2- 7.9) 6.1 ( 5.0- 7.5) 6.3 ( 5.0- 7.7) 6.3 ( 5.1- 7.8) ∼ ∼
Maine
Massachusetts 5.4 ( 4.5- 6.3) 5.0 ( 4.2- 5.8) 5.2 ( 4.4- 6.2) 5.1 ( 4.3- 6.0) ∼ ∼
New Hampshire 6.8 ( 4.6- 9.7) 5.6 ( 3.8- 7.8) 6.8 ( 4.7- 9.8) 5.7 ( 3.9- 8.0) ∼ ∼
Rhode Island 5.4 ( 3.5- 8.1) 5.2 ( 3.4- 7.7) 5.4 ( 3.4- 8.2) 5.5 ( 3.5- 8.2) ∼ ∼
Vermont
Middle Atlantic 6.1 ( 5.8- 6.5) 5.8 ( 5.5- 6.2) 5.6 ( 5.2- 6.0) 5.7 ( 5.3- 6.1) 10.4 ( 8.8- 12.1) 6.8 ( 5.9- 7.9)
New Jersey 6.4 ( 5.6- 7.4) 6.0 ( 5.2- 6.8) 5.9 ( 5.1- 6.9) 6.0 ( 5.1- 6.9) 12.1 ( 8.6- 17.0) 7.7 ( 5.6- 10.4)
New York 6.3 ( 5.7- 6.9) 5.7 ( 5.2- 6.2) 5.9 ( 5.3- 6.5) 5.8 ( 5.2- 6.4) 8.4 ( 6.6- 10.5) 5.7 ( 4.6- 7.1)
Pennsylvania 5.7 ( 5.1- 6.3) 5.9 ( 5.3- 6.5) 5.1 ( 4.5- 5.8) 5.5 ( 4.9- 6.2) 13.1 ( 9.7- 17.6) 8.9 ( 6.6- 11.8)
Midwest
East North Central
Illinois 6.2 ( 5.5- 6.9) 5.3 ( 4.7- 5.9) 5.5 ( 4.8- 6.2) 5.0 ( 4.3- 5.6) 10.5 ( 7.9- 13.9) 6.8 ( 5.1- 8.7)
Indiana
Michigan 6.9 ( 6.1- 7.8) 5.9 ( 5.2- 6.6) 6.2 ( 5.4- 7.1) 5.6 ( 4.9- 6.3) 13.1 ( 9.8- 17.1) 8.6 ( 6.5- 11.2)
Detroit 7.7 ( 6.4- 9.2) 6.6 ( 5.5- 7.8) 6.1 ( 4.9- 7.7) 5.7 ( 4.5- 7.0) 14.5 ( 10.6- 19.5) 10.3 ( 7.5- 13.6)
Ohio 6.2 ( 5.5- 7.0) 5.7 ( 5.1- 6.4) 5.5 ( 4.9- 6.3) 5.3 ( 4.6- 6.0) 12.6 ( 9.3- 16.8) 8.5 ( 6.3- 11.1)
Wisconsin 5.6 ( 4.7- 6.7) 5.0 ( 4.2- 6.0) 5.6 ( 4.6- 6.6) 5.3 ( 4.4- 6.3) ∼ ∼
West North Central 5.7 ( 5.2- 6.3) 5.3 ( 4.8- 5.8) 5.5 ( 5.0- 6.1) 5.3 ( 4.8- 5.8) 11.1 ( 7.5- 16.2) 6.5 ( 4.5- 9.1)
Iowa 5.8 ( 4.6- 7.2) 5.8 ( 4.6- 7.2) 5.7 ( 4.5- 7.1) 5.8 ( 4.6- 7.2) ∼ ∼
Kansas 6.1 ( 4.8- 7.7) 5.5 ( 4.3- 6.9) 6.0 ( 4.7- 7.7) 5.6 ( 4.4- 7.1) ∼ ∼
Minnesota 6.4 ( 5.3- 7.6) 5.5 ( 4.6- 6.5) 6.2 ( 5.2- 7.5) 5.6 ( 4.7- 6.7) ∼ ∼
Missouri 5.0 ( 4.2- 6.0) 4.6 ( 3.9- 5.5) 4.4 ( 3.6- 5.4) 4.3 ( 3.5- 5.2) 11.5 ( 7.0- 18.3) 7.3 ( 4.5- 11.1)
Nebraska 6.2 ( 4.6- 8.3) 5.8 ( 4.2- 7.7) 6.2 ( 4.5- 8.3) 5.9 ( 4.3- 7.9) ∼ ∼




Delaware 6.5 ( 4.0- 10.2) 6.0 ( 3.8- 9.1) ∼ ∼ ∼ ∼
District of Columbia 8.6 ( 5.2- 13.7) 7.8 ( 4.7- 12.2) ∼ ∼ ∼ ∼
Florida 6.0 ( 5.5- 6.5) 7.0 ( 6.4- 7.6) 5.5 ( 5.0- 6.1) 7.2 ( 6.5- 7.9) 11.8 ( 9.1- 15.3) 6.6 ( 5.2- 8.3)
Georgia
Atlanta 5.9 ( 4.2- 8.1) 3.7 ( 2.8- 5.0) 4.5 ( 2.9- 6.9) 3.3 ( 2.2- 4.7) 12.1 ( 6.8- 21.1) 5.0 ( 3.1- 7.8)
Maryland 6.3 ( 5.2- 7.6) 5.1 ( 4.2- 6.0) 5.3 ( 4.2- 6.7) 4.8 ( 3.8- 6.0) 9.9 ( 6.8- 14.2) 5.8 ( 4.2- 8.0)
North Carolina 5.2 ( 4.4- 6.0) 4.5 ( 3.9- 5.3) 4.7 ( 3.9- 5.7) 4.5 ( 3.8- 5.4) 7.7 ( 5.4- 10.8) 4.8 ( 3.4- 6.6)
South Carolina 5.5 ( 4.4- 6.9) 4.9 ( 3.9- 6.0) 4.6 ( 3.5- 6.1) 4.6 ( 3.5- 5.9) 8.3 ( 5.5- 12.4) 5.4 ( 3.6- 7.7)
Virginia
West Virginia 5.3 ( 3.9- 7.2) 5.4 ( 4.0- 7.2) 5.4 ( 3.9- 7.3) 5.5 ( 4.0- 7.3) ∼ ∼
East South Central
Alabama













Table 2.24.1: Multiple Myeloma. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan
Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
(continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 7.0 ( 5.8- 8.4) 5.8 ( 4.9- 7.0) 5.3 ( 4.1- 6.7) 5.2 ( 4.1- 6.5) 13.1 ( 9.7- 17.6) 7.6 ( 5.6- 10.0)
Oklahoma
Texas
West 5.8 ( 5.5- 6.1) 4.6 ( 4.4- 4.9) 5.6 ( 5.3- 6.0) 4.7 ( 4.4- 5.0) 10.9 ( 8.9- 13.4) 6.5 ( 5.3- 7.9)
Mountain
Arizona 4.5 ( 3.6- 5.5) 3.9 ( 3.2- 4.8) 4.3 ( 3.4- 5.3) 4.0 ( 3.2- 5.0) ∼ ∼
Colorado 6.4 ( 5.1- 7.9) 4.7 ( 3.8- 5.8) 6.3 ( 5.0- 7.8) 4.8 ( 3.9- 5.9) ∼ ∼
Idaho 7.4 ( 5.2- 10.3) 6.1 ( 4.3- 8.3) 7.3 ( 5.1- 10.2) 6.1 ( 4.3- 8.4) ∼ ∼
Montana 5.7 ( 3.6- 8.6) 5.5 ( 3.5- 8.1) 5.2 ( 3.2- 8.2) 5.2 ( 3.2- 7.9) ∼ ∼
Nevada
New Mexico 5.0 ( 3.5- 6.9) 4.6 ( 3.2- 6.2) 4.9 ( 3.4- 6.9) 4.7 ( 3.3- 6.6) ∼ ∼
Utah 6.9 ( 5.0- 9.3) 4.2 ( 3.1- 5.7) 6.8 ( 4.9- 9.2) 4.3 ( 3.1- 5.7) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 5.9 ( 5.5- 6.3) 4.7 ( 4.4- 5.0) 5.7 ( 5.3- 6.1) 4.8 ( 4.4- 5.1) 11.1 ( 8.9- 13.8) 6.8 ( 5.5- 8.3)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 5.7 ( 5.3- 6.2) 4.5 ( 4.2- 4.8) 5.4 ( 5.0- 5.9) 4.5 ( 4.1- 4.8) 11.2 ( 8.9- 14.0) 7.0 ( 5.6- 8.6)
San Francisco-Oakland 5.9 ( 4.8- 7.2) 5.1 ( 4.2- 6.2) 4.6 ( 3.5- 6.1) 4.3 ( 3.3- 5.6) 11.3 ( 6.8- 18.3) 8.5 ( 5.2- 13.1)
San Jose-Monterey 3.6 ( 2.4- 5.2) 2.7 ( 1.9- 3.8) 3.6 ( 2.3- 5.4) 2.9 ( 1.9- 4.2) ∼ ∼
Los Angeles 7.0 ( 6.1- 7.9) 5.1 ( 4.4- 5.8) 6.4 ( 5.4- 7.5) 4.7 ( 4.0- 5.5) 13.9 ( 10.2- 18.7) 10.1 ( 7.5- 13.4)
Hawaii 3.9 ( 2.4- 6.0) 3.7 ( 2.3- 5.6) ∼ ∼ ∼ ∼
Oregon 6.1 ( 4.9- 7.6) 5.7 ( 4.6- 7.0) 6.1 ( 4.9- 7.5) 5.8 ( 4.7- 7.2) ∼ ∼
Washington 6.9 ( 5.9- 8.1) 5.7 ( 4.9- 6.6) 6.9 ( 5.8- 8.1) 5.9 ( 5.0- 6.9) ∼ ∼
Seattle-Puget Sound 7.4 ( 6.1- 8.9) 5.8 ( 4.8- 7.0) 7.4 ( 6.0- 9.0) 6.1 ( 5.0- 7.4) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.24.2: Multiple Myeloma. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan
Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 4.1 ( 4.0- 4.3) 4.6 ( 4.5- 4.8) 3.7 ( 3.6- 3.8) 4.5 ( 4.3- 4.6) 8.2 ( 7.7- 8.8) 6.4 ( 6.0- 6.9)
Northeast 4.3 ( 4.1- 4.5) 5.2 ( 4.9- 5.5) 3.8 ( 3.5- 4.0) 4.9 ( 4.6- 5.2) 8.6 ( 7.6- 9.8) 7.2 ( 6.3- 8.1)
New England 3.6 ( 3.1- 4.0) 4.2 ( 3.7- 4.8) 3.3 ( 2.9- 3.8) 4.2 ( 3.7- 4.8) 6.6 ( 3.9- 10.8) 4.5 ( 2.7- 7.1)
Connecticut 3.6 ( 2.8- 4.6) 4.3 ( 3.4- 5.4) 3.2 ( 2.5- 4.2) 4.2 ( 3.2- 5.4) ∼ ∼
Maine
Massachusetts 3.4 ( 2.8- 4.0) 4.0 ( 3.4- 4.8) 3.1 ( 2.5- 3.7) 4.0 ( 3.3- 4.8) ∼ ∼
New Hampshire 3.2 ( 2.0- 5.1) 3.3 ( 2.0- 5.1) 3.3 ( 2.0- 5.1) 3.4 ( 2.1- 5.2) ∼ ∼
Rhode Island 5.1 ( 3.5- 7.3) 6.4 ( 4.4- 9.0) 5.2 ( 3.5- 7.6) 6.8 ( 4.6- 9.5) ∼ ∼
Vermont
Middle Atlantic 4.5 ( 4.2- 4.8) 5.5 ( 5.2- 5.9) 3.9 ( 3.6- 4.2) 5.2 ( 4.8- 5.5) 8.8 ( 7.7- 10.1) 7.5 ( 6.6- 8.6)
New Jersey 4.4 ( 3.8- 5.0) 5.2 ( 4.5- 5.9) 3.7 ( 3.2- 4.4) 4.9 ( 4.2- 5.7) 9.3 ( 6.7- 12.5) 7.2 ( 5.2- 9.6)
New York 4.6 ( 4.2- 5.0) 5.4 ( 5.0- 5.9) 4.0 ( 3.6- 4.4) 5.2 ( 4.7- 5.7) 7.8 ( 6.5- 9.4) 6.7 ( 5.5- 8.0)
Pennsylvania 4.4 ( 4.0- 4.9) 5.9 ( 5.3- 6.5) 3.9 ( 3.4- 4.3) 5.3 ( 4.7- 6.0) 10.9 ( 8.3- 13.9) 10.2 ( 7.8- 13.0)
Midwest
East North Central
Illinois 4.8 ( 4.3- 5.3) 5.2 ( 4.7- 5.8) 3.7 ( 3.2- 4.2) 4.4 ( 3.9- 5.1) 11.7 ( 9.4- 14.4) 9.4 ( 7.6- 11.5)
Indiana
Michigan 4.1 ( 3.6- 4.7) 4.5 ( 4.0- 5.1) 3.5 ( 3.0- 4.1) 4.1 ( 3.5- 4.8) 8.6 ( 6.4- 11.3) 6.9 ( 5.2- 9.1)
Detroit 4.9 ( 4.0- 5.9) 5.4 ( 4.5- 6.5) 3.8 ( 3.0- 4.9) 4.7 ( 3.7- 6.0) 8.8 ( 6.3- 11.9) 7.5 ( 5.4- 10.2)
Ohio 4.0 ( 3.5- 4.5) 4.5 ( 4.0- 5.1) 3.6 ( 3.2- 4.2) 4.3 ( 3.8- 5.0) 7.2 ( 5.2- 9.8) 6.1 ( 4.4- 8.2)
Wisconsin 4.1 ( 3.4- 4.9) 4.6 ( 3.8- 5.5) 4.0 ( 3.3- 4.9) 4.8 ( 4.0- 5.7) ∼ ∼
West North Central 4.1 ( 3.7- 4.5) 4.8 ( 4.3- 5.2) 3.7 ( 3.3- 4.1) 4.5 ( 4.1- 5.0) 10.8 ( 7.8- 14.7) 7.7 ( 5.6- 10.4)
Iowa 3.7 ( 2.9- 4.8) 4.9 ( 3.8- 6.2) 3.8 ( 2.9- 4.8) 5.0 ( 3.9- 6.3) ∼ ∼
Kansas 4.3 ( 3.3- 5.5) 5.0 ( 3.9- 6.3) 3.7 ( 2.8- 4.9) 4.5 ( 3.4- 5.8) ∼ ∼
Minnesota 3.9 ( 3.1- 4.7) 4.2 ( 3.4- 5.1) 3.6 ( 2.9- 4.4) 4.1 ( 3.3- 5.0) ∼ ∼
Missouri 4.1 ( 3.4- 4.9) 4.8 ( 4.1- 5.7) 3.4 ( 2.8- 4.1) 4.2 ( 3.4- 5.1) 11.5 ( 7.8- 16.5) 9.1 ( 6.2- 13.0)
Nebraska 4.0 ( 2.8- 5.5) 4.8 ( 3.5- 6.5) 4.0 ( 2.8- 5.6) 5.0 ( 3.6- 6.8) ∼ ∼




Delaware 4.2 ( 2.5- 6.7) 4.7 ( 2.8- 7.4) 4.3 ( 2.5- 7.3) 5.4 ( 3.1- 8.7) ∼ ∼
District of Columbia 6.4 ( 3.9- 10.2) 7.6 ( 4.7- 11.6) ∼ ∼ 7.4 ( 4.3- 12.8) 9.8 ( 5.7- 15.6)
Florida 4.1 ( 3.8- 4.6) 5.8 ( 5.3- 6.4) 4.0 ( 3.6- 4.4) 6.2 ( 5.6- 6.8) 6.5 ( 4.8- 8.6) 4.1 ( 3.1- 5.4)
Georgia
Atlanta 4.4 ( 3.2- 5.9) 3.4 ( 2.5- 4.5) 3.4 ( 2.2- 5.0) 3.1 ( 2.0- 4.5) 7.9 ( 4.7- 12.9) 4.2 ( 2.5- 6.6)
Maryland 4.2 ( 3.5- 5.0) 4.3 ( 3.5- 5.2) 3.3 ( 2.6- 4.2) 4.0 ( 3.1- 5.0) 7.2 ( 5.1- 9.9) 5.3 ( 3.8- 7.2)
North Carolina 3.7 ( 3.2- 4.4) 4.1 ( 3.5- 4.8) 3.2 ( 2.6- 3.9) 3.8 ( 3.2- 4.6) 6.0 ( 4.4- 8.0) 5.1 ( 3.8- 6.9)
South Carolina 4.2 ( 3.4- 5.2) 4.5 ( 3.6- 5.6) 3.3 ( 2.5- 4.4) 3.9 ( 3.0- 5.1) 7.1 ( 4.9- 9.9) 5.7 ( 3.9- 7.9)
Virginia
West Virginia 3.6 ( 2.6- 4.9) 4.8 ( 3.5- 6.4) 3.4 ( 2.4- 4.7) 4.4 ( 3.2- 6.1) ∼ ∼
East South Central
Alabama













Table 2.24.2: Multiple Myeloma. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan
Area, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
(continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 4.8 ( 3.9- 5.8) 4.9 ( 4.0- 5.9) 3.4 ( 2.6- 4.5) 4.0 ( 3.0- 5.2) 9.0 ( 6.7- 11.8) 6.9 ( 5.1- 9.0)
Oklahoma
Texas
West 3.8 ( 3.6- 4.1) 3.8 ( 3.6- 4.0) 3.7 ( 3.4- 3.9) 3.8 ( 3.6- 4.1) 8.7 ( 7.1- 10.6) 6.3 ( 5.1- 7.7)
Mountain
Arizona 3.2 ( 2.6- 4.0) 3.5 ( 2.8- 4.3) 3.0 ( 2.3- 3.8) 3.4 ( 2.7- 4.3) ∼ ∼
Colorado 4.0 ( 3.1- 5.0) 3.8 ( 3.0- 4.8) 4.1 ( 3.2- 5.1) 4.0 ( 3.2- 5.0) ∼ ∼
Idaho 3.9 ( 2.5- 5.9) 4.0 ( 2.6- 5.9) 4.0 ( 2.6- 6.0) 4.1 ( 2.7- 6.1) ∼ ∼
Montana 4.0 ( 2.4- 6.3) 4.5 ( 2.8- 7.0) 4.1 ( 2.5- 6.6) 4.9 ( 3.0- 7.5) ∼ ∼
Nevada
New Mexico 3.7 ( 2.6- 5.3) 3.7 ( 2.6- 5.2) 3.6 ( 2.4- 5.2) 3.8 ( 2.6- 5.5) ∼ ∼
Utah 3.0 ( 1.9- 4.4) 2.3 ( 1.5- 3.4) 3.1 ( 2.0- 4.5) 2.5 ( 1.6- 3.6) ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 3.9 ( 3.7- 4.2) 3.9 ( 3.6- 4.2) 3.8 ( 3.5- 4.0) 3.9 ( 3.6- 4.2) 9.1 ( 7.3- 11.1) 6.7 ( 5.4- 8.2)
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 4.0 ( 3.7- 4.3) 3.9 ( 3.6- 4.2) 3.8 ( 3.5- 4.1) 3.9 ( 3.5- 4.2) 8.9 ( 7.1- 11.1) 6.8 ( 5.4- 8.4)
San Francisco-Oakland 4.0 ( 3.2- 4.9) 4.3 ( 3.5- 5.3) 3.6 ( 2.7- 4.7) 4.2 ( 3.2- 5.5) 9.4 ( 5.7- 14.7) 8.0 ( 4.9- 12.3)
San Jose-Monterey 4.1 ( 3.0- 5.5) 3.9 ( 2.9- 5.2) 4.2 ( 2.9- 5.8) 4.3 ( 3.0- 5.9) ∼ ∼
Los Angeles 4.1 ( 3.5- 4.7) 3.8 ( 3.3- 4.4) 3.6 ( 3.0- 4.3) 3.4 ( 2.9- 4.1) 9.2 ( 6.7- 12.4) 8.0 ( 5.8- 10.7)
Hawaii 3.4 ( 2.1- 5.1) 3.9 ( 2.5- 5.8) ∼ ∼ ∼ ∼
Oregon 3.3 ( 2.5- 4.2) 3.8 ( 2.9- 4.8) 3.2 ( 2.5- 4.2) 3.8 ( 2.9- 4.9) ∼ ∼
Washington 4.1 ( 3.4- 4.9) 4.1 ( 3.4- 4.9) 4.0 ( 3.2- 4.8) 4.2 ( 3.5- 5.1) ∼ ∼
Seattle-Puget Sound 4.3 ( 3.4- 5.3) 4.3 ( 3.5- 5.3) 4.2 ( 3.3- 5.2) 4.5 ( 3.5- 5.6) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.25.1: Leukemias. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan Area,
and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 14.5 ( 14.3- 14.8) 13.0 ( 12.8- 13.3) 14.8 ( 14.5- 15.1) 14.0 ( 13.8- 14.3) 10.5 ( 9.8- 11.3) 7.2 ( 6.7- 7.7)
Northeast 14.9 ( 14.4- 15.4) 14.0 ( 13.5- 14.5) 15.3 ( 14.7- 15.8) 15.2 ( 14.7- 15.8) 9.2 ( 7.9- 10.8) 6.4 ( 5.6- 7.4)
New England 13.7 ( 12.7- 14.8) 12.9 ( 12.0- 13.9) 13.9 ( 12.9- 15.0) 13.7 ( 12.7- 14.7) ∼ ∼
Connecticut 13.2 ( 11.4- 15.2) 12.7 ( 11.0- 14.6) 13.2 ( 11.4- 15.3) 13.3 ( 11.5- 15.4) ∼ ∼
Maine
Massachusetts 13.6 ( 12.2- 15.0) 12.7 ( 11.5- 14.1) 13.9 ( 12.5- 15.4) 13.6 ( 12.2- 15.1) ∼ ∼
New Hampshire 14.2 ( 11.1- 18.1) 12.4 ( 9.7- 15.5) 14.2 ( 11.1- 18.1) 12.5 ( 9.8- 15.7) ∼ ∼
Rhode Island 16.1 ( 12.6- 20.3) 15.5 ( 12.2- 19.5) 16.5 ( 12.9- 20.9) 16.5 ( 12.9- 20.7) ∼ ∼
Vermont
Middle Atlantic 15.2 ( 14.6- 15.8) 14.3 ( 13.8- 14.9) 15.7 ( 15.1- 16.4) 15.7 ( 15.1- 16.4) 9.5 ( 8.1- 11.2) 6.8 ( 5.8- 7.9)
New Jersey 15.3 ( 14.1- 16.7) 14.0 ( 12.9- 15.3) 15.8 ( 14.4- 17.3) 15.5 ( 14.2- 17.0) 10.7 ( 7.6- 15.1) 7.7 ( 5.6- 10.4)
New York 15.0 ( 14.1- 15.8) 13.6 ( 12.8- 14.4) 15.7 ( 14.8- 16.7) 15.4 ( 14.4- 16.3) 8.4 ( 6.6- 10.6) 5.9 ( 4.7- 7.2)
Pennsylvania 15.5 ( 14.5- 16.6) 15.6 ( 14.6- 16.7) 15.6 ( 14.5- 16.7) 16.3 ( 15.2- 17.5) 10.9 ( 7.9- 15.0) 8.4 ( 6.1- 11.2)
Midwest
East North Central
Illinois 15.3 ( 14.2- 16.4) 13.3 ( 12.4- 14.2) 15.8 ( 14.6- 17.0) 14.4 ( 13.3- 15.5) 9.2 ( 6.9- 12.3) 6.8 ( 5.1- 8.7)
Indiana
Michigan 14.7 ( 13.6- 16.0) 12.9 ( 11.9- 13.9) 15.2 ( 14.0- 16.6) 13.9 ( 12.7- 15.1) 10.3 ( 7.5- 13.9) 7.1 ( 5.2- 9.4)
Detroit 15.1 ( 13.3- 17.1) 13.4 ( 11.9- 15.2) 16.6 ( 14.4- 19.0) 15.5 ( 13.5- 17.7) 10.2 ( 7.0- 14.5) 7.4 ( 5.1- 10.4)
Ohio 13.3 ( 12.3- 14.4) 12.1 ( 11.2- 13.1) 13.1 ( 12.1- 14.3) 12.3 ( 11.3- 13.3) 11.0 ( 7.9- 15.0) 8.0 ( 5.9- 10.6)
Wisconsin 15.9 ( 14.3- 17.6) 14.6 ( 13.1- 16.1) 15.9 ( 14.3- 17.7) 15.2 ( 13.7- 16.8) ∼ ∼
West North Central 16.1 ( 15.3- 17.1) 14.8 ( 14.0- 15.6) 15.8 ( 14.9- 16.8) 15.0 ( 14.2- 15.9) 12.9 ( 9.1- 18.1) 8.7 ( 6.3- 11.6)
Iowa 18.1 ( 15.9- 20.5) 17.7 ( 15.6- 20.1) 17.9 ( 15.7- 20.3) 17.9 ( 15.7- 20.3) ∼ ∼
Kansas 15.2 ( 13.0- 17.6) 13.7 ( 11.8- 15.9) 14.9 ( 12.7- 17.4) 13.9 ( 11.9- 16.2) ∼ ∼
Minnesota 18.7 ( 16.9- 20.7) 16.3 ( 14.7- 18.0) 17.8 ( 16.0- 19.8) 16.1 ( 14.5- 17.9) ∼ ∼
Missouri 14.2 ( 12.7- 15.8) 12.9 ( 11.5- 14.3) 14.1 ( 12.6- 15.8) 13.3 ( 11.9- 14.9) 15.2 ( 10.0- 22.7) 10.4 ( 7.0- 14.8)
Nebraska 14.4 ( 11.8- 17.4) 13.6 ( 11.2- 16.4) 13.7 ( 11.2- 16.7) 13.4 ( 10.9- 16.2) ∼ ∼




Delaware 12.9 ( 9.3- 17.8) 12.0 ( 8.7- 16.1) 13.8 ( 9.8- 19.4) 13.6 ( 9.7- 18.6) ∼ ∼
District of Columbia 11.1 ( 7.1- 16.6) 10.2 ( 6.6- 15.1) ∼ ∼ 11.9 ( 6.9- 19.5) 11.6 ( 6.8- 18.6)
Florida 15.0 ( 14.2- 15.9) 17.1 ( 16.1- 18.0) 15.3 ( 14.4- 16.2) 19.0 ( 18.0- 20.2) 10.3 ( 7.8- 13.6) 6.7 ( 5.3- 8.4)
Georgia
Atlanta 11.2 ( 8.9- 14.0) 7.9 ( 6.4- 9.6) 10.9 ( 8.4- 14.2) 8.4 ( 6.6- 10.6) 12.0 ( 6.7- 21.0) 5.5 ( 3.5- 8.4)
Maryland 11.7 ( 10.2- 13.4) 9.6 ( 8.4- 10.9) 12.0 ( 10.4- 14.0) 10.9 ( 9.4- 12.6) 10.6 ( 7.4- 15.1) 7.0 ( 5.2- 9.3)
North Carolina 11.7 ( 10.5- 13.0) 10.3 ( 9.3- 11.4) 12.5 ( 11.2- 14.0) 11.8 ( 10.6- 13.2) 7.8 ( 5.5- 10.8) 5.4 ( 3.9- 7.3)
South Carolina 11.8 ( 10.1- 13.8) 10.0 ( 8.6- 11.5) 11.8 ( 9.8- 14.1) 10.7 ( 9.0- 12.6) 12.5 ( 8.9- 17.2) 8.5 ( 6.2- 11.4)
Virginia
West Virginia 16.8 ( 14.1- 19.9) 16.5 ( 13.9- 19.5) 16.5 ( 13.8- 19.6) 16.2 ( 13.6- 19.2) ∼ ∼
East South Central
Alabama













Table 2.25.1: Leukemias. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan Area,
and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
(continued)
Males, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 14.4 ( 12.7- 16.4) 12.1 ( 10.7- 13.7) 15.4 ( 13.3- 17.8) 14.2 ( 12.3- 16.3) 11.9 ( 8.8- 16.0) 8.2 ( 6.2- 10.7)
Oklahoma
Texas
West 14.0 ( 13.6- 14.5) 11.8 ( 11.4- 12.2) 14.3 ( 13.8- 14.8) 12.4 ( 12.0- 12.9) 12.6 ( 10.4- 15.2) 8.2 ( 6.9- 9.8)
Mountain
Arizona 11.3 ( 9.9- 12.9) 10.5 ( 9.2- 11.8) 11.6 ( 10.2- 13.3) 11.3 ( 9.9- 12.8) ∼ ∼
Colorado 16.4 ( 14.4- 18.8) 12.4 ( 10.9- 14.0) 16.8 ( 14.6- 19.2) 12.9 ( 11.3- 14.6) ∼ ∼
Idaho 16.7 ( 13.3- 20.7) 14.1 ( 11.3- 17.3) 17.0 ( 13.6- 21.1) 14.5 ( 11.6- 17.9) ∼ ∼
Montana 16.2 ( 12.5- 20.7) 15.2 ( 11.8- 19.4) 15.3 ( 11.7- 19.8) 15.0 ( 11.5- 19.2) ∼ ∼
Nevada
New Mexico 12.8 ( 10.3- 15.8) 11.1 ( 9.0- 13.6) 12.9 ( 10.3- 16.0) 11.8 ( 9.4- 14.5) ∼ ∼
Utah 13.2 ( 10.7- 16.2) 10.0 ( 8.2- 12.1) 13.6 ( 11.0- 16.7) 10.5 ( 8.6- 12.7) ∼ ∼
Wyoming 16.3 ( 11.2- 23.4) 14.1 ( 9.8- 19.7) 16.7 ( 11.5- 23.9) 14.7 ( 10.2- 20.5) ∼ ∼
Pacific 14.1 ( 13.6- 14.7) 11.8 ( 11.4- 12.3) 14.4 ( 13.8- 15.0) 12.5 ( 12.0- 13.0) 12.5 ( 10.2- 15.3) 8.3 ( 6.8- 9.9)
Alaska 11.2 ( 6.6- 19.9) 7.4 ( 4.7- 11.0) 10.8 ( 5.8- 21.1) 7.7 ( 4.6- 12.0) ∼ ∼
California 13.6 ( 12.9- 14.2) 11.2 ( 10.7- 11.7) 13.9 ( 13.2- 14.6) 11.9 ( 11.4- 12.5) 11.6 ( 9.2- 14.5) 7.6 ( 6.1- 9.3)
San Francisco-Oakland 12.9 ( 11.2- 14.7) 11.5 ( 10.0- 13.0) 12.5 ( 10.6- 14.7) 11.7 ( 10.0- 13.7) 12.8 ( 8.0- 20.0) 10.2 ( 6.5- 15.1)
San Jose-Monterey 11.0 ( 8.9- 13.5) 8.7 ( 7.1- 10.5) 11.8 ( 9.4- 14.7) 9.7 ( 7.8- 11.9) ∼ ∼
Los Angeles 14.5 ( 13.2- 15.8) 11.3 ( 10.3- 12.3) 15.4 ( 13.9- 16.9) 12.3 ( 11.1- 13.5) 11.3 ( 7.9- 15.9) 8.1 ( 5.8- 11.0)
Hawaii 13.4 ( 10.6- 16.8) 13.0 ( 10.3- 16.3) 19.2 ( 12.5- 28.5) 15.9 ( 10.5- 23.2) ∼ ∼
Oregon 13.8 ( 12.0- 15.8) 13.1 ( 11.4- 15.0) 14.0 ( 12.1- 16.0) 13.6 ( 11.8- 15.6) ∼ ∼
Washington 17.4 ( 15.7- 19.2) 14.7 ( 13.3- 16.2) 17.0 ( 15.3- 18.8) 14.9 ( 13.4- 16.4) ∼ ∼
Seattle-Puget Sound 18.4 ( 16.3- 20.7) 15.1 ( 13.4- 16.9) 18.1 ( 15.9- 20.4) 15.4 ( 13.6- 17.4) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
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Table 2.25.2: Leukemias. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan Area,
and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
United States 8.8 ( 8.6- 8.9) 9.6 ( 9.5- 9.8) 8.9 ( 8.7- 9.1) 10.3 ( 10.1- 10.5) 7.0 ( 6.5- 7.5) 5.9 ( 5.5- 6.3)
Northeast 9.1 ( 8.8- 9.5) 10.6 ( 10.2- 11.0) 9.3 ( 9.0- 9.7) 11.5 ( 11.0- 11.9) 6.4 ( 5.6- 7.4) 5.7 ( 5.0- 6.6)
New England 9.1 ( 8.4- 9.8) 10.3 ( 9.5- 11.1) 9.1 ( 8.3- 9.9) 10.7 ( 9.8- 11.6) 7.7 ( 4.8- 12.0) 6.0 ( 3.9- 8.9)
Connecticut 8.5 ( 7.2- 9.9) 9.7 ( 8.3- 11.3) 8.3 ( 7.0- 9.8) 9.9 ( 8.3- 11.6) ∼ ∼
Maine
Massachusetts 9.4 ( 8.4- 10.4) 10.6 ( 9.5- 11.8) 9.4 ( 8.3- 10.5) 11.1 ( 9.9- 12.4) ∼ ∼
New Hampshire 10.1 ( 7.8- 13.0) 10.3 ( 7.9- 13.2) 10.3 ( 7.9- 13.2) 10.6 ( 8.1- 13.5) ∼ ∼
Rhode Island 8.5 ( 6.3- 11.4) 9.9 ( 7.4- 13.0) 8.9 ( 6.5- 12.0) 10.6 ( 7.8- 13.9) ∼ ∼
Vermont
Middle Atlantic 9.2 ( 8.8- 9.6) 10.7 ( 10.3- 11.2) 9.4 ( 9.0- 9.9) 11.8 ( 11.2- 12.3) 6.3 ( 5.4- 7.3) 5.7 ( 4.9- 6.6)
New Jersey 8.9 ( 8.1- 9.8) 10.1 ( 9.2- 11.2) 9.4 ( 8.4- 10.4) 11.4 ( 10.3- 12.6) 6.5 ( 4.5- 9.3) 5.4 ( 3.7- 7.6)
New York 9.1 ( 8.5- 9.7) 10.4 ( 9.7- 11.1) 9.6 ( 8.9- 10.3) 11.8 ( 11.1- 12.7) 4.9 ( 3.9- 6.2) 4.6 ( 3.6- 5.7)
Pennsylvania 9.4 ( 8.7- 10.1) 11.7 ( 10.8- 12.6) 9.3 ( 8.6- 10.1) 11.9 ( 11.0- 12.8) 9.5 ( 7.2- 12.3) 9.0 ( 6.8- 11.7)
Midwest
East North Central
Illinois 9.2 ( 8.5- 10.0) 10.0 ( 9.2- 10.8) 9.4 ( 8.6- 10.2) 10.7 ( 9.8- 11.7) 8.1 ( 6.3- 10.4) 6.9 ( 5.4- 8.8)
Indiana
Michigan 9.4 ( 8.6- 10.2) 10.0 ( 9.2- 10.9) 9.4 ( 8.6- 10.4) 10.5 ( 9.6- 11.5) 8.8 ( 6.7- 11.5) 7.4 ( 5.6- 9.7)
Detroit 10.2 ( 8.9- 11.6) 11.0 ( 9.6- 12.5) 10.7 ( 9.2- 12.3) 12.3 ( 10.6- 14.2) 8.6 ( 6.2- 11.7) 7.7 ( 5.5- 10.4)
Ohio 8.4 ( 7.7- 9.2) 9.5 ( 8.7- 10.3) 8.7 ( 7.9- 9.5) 10.1 ( 9.2- 11.0) 5.8 ( 4.1- 8.1) 5.2 ( 3.7- 7.2)
Wisconsin 10.3 ( 9.2- 11.6) 11.7 ( 10.4- 13.0) 10.4 ( 9.2- 11.7) 12.2 ( 10.8- 13.6) ∼ ∼
West North Central 9.4 ( 8.8- 10.0) 10.7 ( 10.0- 11.4) 9.1 ( 8.5- 9.7) 10.8 ( 10.1- 11.5) 6.1 ( 4.0- 8.9) 5.1 ( 3.4- 7.4)
Iowa 9.0 ( 7.6- 10.5) 11.3 ( 9.6- 13.1) 8.8 ( 7.5- 10.4) 11.3 ( 9.6- 13.2) ∼ ∼
Kansas 8.3 ( 6.9- 9.9) 9.3 ( 7.8- 11.1) 8.1 ( 6.7- 9.8) 9.4 ( 7.8- 11.3) ∼ ∼
Minnesota 11.2 ( 9.9- 12.5) 12.1 ( 10.7- 13.5) 10.4 ( 9.1- 11.7) 11.7 ( 10.3- 13.2) ∼ ∼
Missouri 8.4 ( 7.4- 9.5) 9.6 ( 8.5- 10.8) 8.4 ( 7.4- 9.5) 10.1 ( 8.8- 11.4) 7.0 ( 4.3- 10.9) 6.4 ( 4.0- 9.8)
Nebraska 10.4 ( 8.5- 12.7) 12.0 ( 9.8- 14.6) 10.2 ( 8.2- 12.6) 12.1 ( 9.8- 14.7) ∼ ∼




Delaware 8.0 ( 5.5- 11.3) 8.5 ( 5.9- 12.0) 7.8 ( 5.1- 11.5) 9.0 ( 6.0- 13.1) ∼ ∼
District of Columbia 5.3 ( 3.0- 9.0) 6.1 ( 3.6- 9.8) ∼ ∼ ∼ ∼
Florida 9.4 ( 8.8- 10.0) 12.3 ( 11.5- 13.1) 9.4 ( 8.7- 10.1) 13.3 ( 12.4- 14.2) 10.1 ( 8.1- 12.6) 7.3 ( 5.8- 8.9)
Georgia
Atlanta 5.3 ( 4.0- 6.9) 4.4 ( 3.4- 5.7) 5.5 ( 4.0- 7.4) 5.0 ( 3.7- 6.7) ∼ ∼
Maryland 6.7 ( 5.8- 7.8) 6.9 ( 5.9- 8.0) 6.4 ( 5.3- 7.6) 7.3 ( 6.1- 8.7) 6.9 ( 5.0- 9.5) 5.6 ( 4.0- 7.5)
North Carolina 7.4 ( 6.6- 8.3) 8.0 ( 7.1- 8.9) 7.6 ( 6.7- 8.7) 8.7 ( 7.7- 9.9) 6.3 ( 4.7- 8.3) 5.8 ( 4.3- 7.6)
South Carolina 6.5 ( 5.4- 7.7) 6.9 ( 5.8- 8.1) 7.0 ( 5.7- 8.5) 8.1 ( 6.7- 9.8) 4.1 ( 2.6- 6.3) 3.6 ( 2.2- 5.4)
Virginia
West Virginia 9.9 ( 8.1- 12.0) 12.2 ( 10.0- 14.6) 10.0 ( 8.1- 12.1) 12.2 ( 10.0- 14.7) ∼ ∼
East South Central
Alabama













Table 2.25.2: Leukemias. Cancer Incidence Rates by U.S. Census Region and Division, State and Metropolitan Area,
and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality Criteria∗†
(continued)
Females, 1999
All Races White Black
Age-Adjusted Crude Age-Adjusted Crude Age-Adjusted Crude
Area Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI) Rate‡§ (CI) Rate‡ (CI)
West South Central
Arkansas
Louisiana 8.0 ( 6.9- 9.2) 8.2 ( 7.1- 9.5) 7.9 ( 6.6- 9.4) 9.1 ( 7.6- 10.7) 8.0 ( 5.9- 10.6) 6.8 ( 5.0- 8.9)
Oklahoma
Texas
West 8.4 ( 8.0- 8.7) 8.4 ( 8.1- 8.8) 8.5 ( 8.2- 8.9) 8.9 ( 8.5- 9.3) 6.8 ( 5.4- 8.4) 5.4 ( 4.4- 6.7)
Mountain
Arizona 8.4 ( 7.3- 9.6) 8.9 ( 7.7- 10.1) 8.5 ( 7.4- 9.8) 9.4 ( 8.1- 10.8) ∼ ∼
Colorado 9.6 ( 8.3- 11.1) 9.3 ( 8.0- 10.7) 9.8 ( 8.4- 11.3) 9.6 ( 8.3- 11.2) ∼ ∼
Idaho 8.9 ( 6.8- 11.6) 9.1 ( 6.9- 11.8) 9.0 ( 6.8- 11.7) 9.2 ( 7.0- 12.0) ∼ ∼
Montana 8.2 ( 5.8- 11.2) 9.2 ( 6.6- 12.5) 8.3 ( 5.9- 11.5) 9.7 ( 7.0- 13.3) ∼ ∼
Nevada
New Mexico 8.4 ( 6.6- 10.6) 8.5 ( 6.7- 10.6) 9.3 ( 7.3- 11.7) 9.7 ( 7.6- 12.2) ∼ ∼
Utah 8.1 ( 6.3- 10.2) 7.1 ( 5.6- 8.9) 7.5 ( 5.8- 9.6) 6.8 ( 5.3- 8.6) ∼ ∼
Wyoming 10.8 ( 7.0- 16.0) 10.9 ( 7.1- 16.0) 11.1 ( 7.2- 16.5) 11.4 ( 7.4- 16.7) ∼ ∼
Pacific 8.2 ( 7.9- 8.6) 8.3 ( 7.9- 8.7) 8.4 ( 8.0- 8.8) 8.8 ( 8.4- 9.2) 6.9 ( 5.5- 8.7) 5.5 ( 4.4- 6.9)
Alaska 13.1 ( 7.9- 20.9) 8.5 ( 5.5- 12.5) 13.4 ( 7.4- 23.0) 8.2 ( 4.9- 13.0) ∼ ∼
California 8.0 ( 7.6- 8.4) 8.0 ( 7.5- 8.4) 8.2 ( 7.8- 8.7) 8.5 ( 8.0- 9.0) 6.7 ( 5.2- 8.5) 5.4 ( 4.2- 6.9)
San Francisco-Oakland 7.5 ( 6.4- 8.7) 8.1 ( 6.9- 9.4) 7.7 ( 6.4- 9.3) 9.0 ( 7.5- 10.7) ∼ ∼
San Jose-Monterey 9.1 ( 7.4- 11.1) 8.9 ( 7.2- 10.8) 9.9 ( 8.0- 12.2) 10.1 ( 8.1- 12.4) ∼ ∼
Los Angeles 7.4 ( 6.6- 8.2) 7.1 ( 6.4- 7.9) 7.7 ( 6.8- 8.6) 7.7 ( 6.8- 8.7) 6.4 ( 4.3- 9.1) 5.6 ( 3.8- 8.0)
Hawaii 8.2 ( 6.1- 10.8) 8.6 ( 6.4- 11.4) ∼ ∼ ∼ ∼
Oregon 8.7 ( 7.4- 10.2) 9.7 ( 8.3- 11.3) 8.7 ( 7.4- 10.3) 10.0 ( 8.5- 11.7) ∼ ∼
Washington 9.1 ( 8.0- 10.3) 9.3 ( 8.2- 10.5) 9.1 ( 8.0- 10.3) 9.7 ( 8.5- 11.0) ∼ ∼
Seattle-Puget Sound 9.3 ( 8.0- 10.7) 9.4 ( 8.1- 10.9) 9.4 ( 8.0- 10.9) 10.0 ( 8.6- 11.6) ∼ ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites combined: case
ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate only; ≤ 3% of
cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information on age. See Appendix H for registry-specific
data quality information. U.S. rates cover approximately 78% of the U.S. population.
† Invasive cancers only
‡ Rates are per 100,000 persons. Population denominators for 1999 are projected from the 1990 census and may not accurately reflect the 1999 population size. Caution
should be used in interpreting rates based on these projected populations.
§ Rates are age-adjusted to the 2000 U.S. standard population.
∼ Rates are suppressed if fewer than 16 cases were reported in the specific area-race category.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 78% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see technical notes) for
each of those cancers. U.S rates are as presented in Table 1.2. California, Washington, and Michigan state rates each include cases from the SEER metropolitan
areas.
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Figure 3.1: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.2: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.3: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.4: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.5: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.6: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.7: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.8: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.9: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.10: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
Age-Adjusted Incidence Rates within Race- and Sex-Specific Categories
District of Columbia,*† 1999
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.11: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.12: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
State and Metropolitan Area Incidence Rates for Most Common Cancers
123
Figure 3.13: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.14: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.15: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.16: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.17: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.18: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.19: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.20: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.21: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.22: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.23: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.24: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.25: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.26: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.27: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.28: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.29: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.30: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.31: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.32: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.33: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest






Melanomas of the Skin
Stomach
Leukemias
Oral Cavity & Pharynx





















Oral Cavity & Pharynx
Kidney & Renal Pelvis
Multiple Myeloma
Cervix Uteri































Melanomas of the Skin
Stomach
Leukemias
Oral Cavity & Pharynx





















Oral Cavity & Pharynx
Multiple Myeloma
Kidney & Renal Pelvis
Cervix Uteri



























0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000.
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000.
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000





∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.34: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.35: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.36: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.37: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.38: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.39: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.40: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.41: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest








Oral Cavity & Pharynx
Kidney & Renal Pelvis
Leukemias























Oral Cavity & Pharynx
Brain & ONS






Melanomas of the Skin
Ovary


























Kidney & Renal Pelvis
Oral Cavity & Pharynx
Leukemias
Non-Hodgkin Lymphoma






















Oral Cavity & Pharynx
Brain & ONS






Melanomas of the Skin
Ovary


































Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000





∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.42: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.43: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.
Urinary bladder cases include invasive and in situ.
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Figure 3.44: Invasive Cancer Incidence Rates for the 15 Primary Sites with the Highest
Age-Adjusted Incidence Rates within Race- and Sex-Specific Categories
Wyoming,*† 1999
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∗ Data meet the following data quality criteria for all invasive cancer sites combined: case ascertainment is at least
90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death certificate
only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are
missing information on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population. See Table 2.1.1-2.25.2 for 95% confidence intervals for rates
and footnote regarding 1999 population denominators. Rates are suppressed and not ranked if case counts are fewer than 16 or
if the population of the specific race-sex category is less than 50,000.
Note: ONS - Other Nervous System; NOS - Not Otherwise Specified; IBD - Intrahepatic Bile Duct.







Registries in bold contributed data to this report.
Alabama
Alabama Statewide Cancer Registry















Arizona Department of Health Services
Arizona Cancer Registry







Arkansas Central Cancer Registry
Arkansas Department of Health
Division of Chronic Disease/Disability Prevention
4815 West Markham Street, Slot 7






California Department of Health Services
Cancer Surveillance Section





Greater Bay Area Cancer
Registry 
(San Francisco-Oakland and 
San Jose-Monterey)
Greater Bay Area Cancer Registry
32960 Alvarado-Niles Road, Suite 600






Los Angeles Cancer Surveillance Program
1540 Alcazar, CHP-204







Colorado Department of Public Health 
and Environment
Colorado Central Cancer Registry
PPD-CR-A5






State and Metropolitan Area Cancer Registries
National Program of Cancer Registries (NPCR) and Surveillance, 










Delaware Department of Health 
and Social Services






District of Columbia Cancer Registry
District of Columbia Department of Health






Florida Cancer Data System






Georgia Department of Human Resources
Division of Public Health







Georgia Center for Cancer Statistics














Cancer Data Registry of Idaho








United States Cancer Statistics: 1999 Incidence 
A–2
Registries in bold contributed data to this report.
llinois
Illinois State Cancer Registry
Illinois Department of Public Health






Indiana State Department of Health
State Cancer Registry







State Health Registry of Iowa
250 FB Building






University of Kansas Medical Center
3901 Rainbow Boulevard













Louisiana State University Health Sciences 
Center—New Orleans
1600 Canal Street, Suite 900A






Division of Family and Community Health
Bureau of Health
11 State House Station
Key Bank Plaza 4th Floor
Augusta, ME 04333-0011






Maryland Department of Health 
and Mental Hygiene
201 West Preston Street, Suite 400
Baltimore, MD 21201
Phone: (410) 767-4055 or -5521
Fax: (410) 333-5218
Massachusetts
Massachusetts Department of Public Health
Massachusetts Cancer Registry








Registries in bold contributed data to this report.
Michigan
Michigan Cancer Surveillance Program












110 East Warren Avenue
Detroit, MI 48201




Minnesota Cancer Surveillance System
Minnesota Department of Health
















Missouri Department of Health
Office of Surveillance, Research and Evaluation
Division of Chronic Disease Prevention 
and Health Promotion
P.O. Box 570




Montana Central Tumor Registry
Montana Department of Public Health 
and Human Services
Health Policy and Services Division






Nebraska Department of Health 
and Human Services







Nevada State Cancer Registry
3811 West Charleston Boulevard, Suite 208
Las Vegas, NV 89102
Phone: (702) 486-6260, ext. 224
Fax: (702) 486-7602
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Registries in bold contributed data to this report.
New Hampshire
Bureau of Health Statistics and Data
Management
New Hampshire Department of Health 
and Human Services
Office of Community and Public Health






New Jersey State Cancer Registry









New Mexico Tumor Registry






New York State Cancer Registry
New York State Department of Health








North Carolina Central Cancer Registry






North Dakota Department of Health
Division of Health Promotion






Ohio Department of Health









Oklahoma Central Cancer Registry
Chronic Disease Service
Oklahoma Department of Health
1000 Northeast 10th Street
Oklahoma City, OK 73117-1299





Registries in bold contributed data to this report.
Oregon
Oregon State Cancer Registry
Oregon Health Division








Division of Statistical Registries
Pennsylvania Department of Health






Departamento de Salud de Puerto Rico
Registro Central de Puerto Rico
P.O. Box 70184
























South Dakota Cancer Registry
Office of Health Promotion, Health 
and Medical Services
Department of Health






Cordell Hull Building, 6th Floor North





Texas Department of Health
Cancer Registry Division
Bureau of Epidemiology







546 Chipeta Way, Suite 410
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Registries in bold contributed data to this report.
Vermont
Vermont Cancer Registry







Virgin Islands Department of Health
3500 Estate Richmond
Charles Harwood Complex 
Christiansted, St. Croix, VI 00820-4370
Phone: (340) 773-1311, ext. 3082
Fax: (340) 773-0850
Virginia








Washington State Cancer Registry
Department of Health















West Virginia Department of Health 
and Human Resources
Bureau for Public Health
West Virginia Cancer Registry







Wisconsin Department of Health 
and Family Services
Bureau of Health Information







Wyoming Cancer Surveillance Program
Wyoming Department of Health













National Program of Cancer Registries
Scientific Workgroup Members
Toni H. Bounds, PhD, MPH, Tennessee Cancer Registry
Judy Brockhouse, Wyoming Cancer Surveillance Program
Vivien W. Chen, PhD, Louisiana Tumor Registry
Catherine N. Correa, PhD, MPH, Louisiana Tumor Registry
Susan T. Gershman, PhD, MS, MPH, CTR, Massachusetts Cancer Registry
Georgette G. Haydu, MS, Ohio Cancer Incidence Surveillance System
Dale Herman, MSPH, North Carolina Central Cancer Registry
Holly L. Howe, PhD, North American Association of Central Cancer Registries
Jeannette Jackson-Thompson, PhD, MSPH, Missouri Cancer Registry
Amy Kahn, MS, CTR, New York State Cancer Registry
Betsy Kohler, MPH, CTR, New Jersey State Cancer Registry
Sue Min Lai, PhD, MS, MBA, Kansas Cancer Registry
Jill A. MacKinnon, CTR, Florida Cancer Data System
Stacey Neloms, MPH, Maryland Cancer Registry
Margaret Parsons, MD, MPH, Maine Cancer Registry
Maria J. Schymura, PhD, New York State Cancer Registry
Tiefu Shen, MD, PhD, Illinois State Cancer Registry
Laura Stephenson, Wisconsin Cancer Reporting System
Thomas C. Tucker, PhD, MPH, Kentucky Cancer Registry
Nancy S. Weiss, PhD, Texas Cancer Registry
Brian D. Wright, BS, Pennsylvania Cancer Registry
William E. Wright, PhD, California Cancer Registry
Xiao Cheng Wu, MD, MPH, CTR, Louisiana Tumor Registry
Logistics Workgroup Members
Toshi Abe, MSW, CTR, New Jersey State Cancer Registry
Glenn Copeland, MBA, Michigan Cancer Surveillance Program
Colleen C. McLaughlin, MPH, CTR, New York State Cancer Registry
Frances Michaud, CTR, Metropolitan Atlanta & Rural Georgia SEER Registry
Lynn A.G. Ries, MS, National Cancer Institute
Frances E. Ross, CTR, Kentucky Cancer Registry
Jennifer E. Seiffert, MLIS, CTR, TRW under contract to CDC
Donald K. Shipley, MS, Oregon State Cancer Registry
Jan Snodgrass, CTR, Illinois State Cancer Registry
Laura Stephenson, Wisconsin Cancer Reporting System







National partner organizations are crucial to the success of cancer registration and cancer surveillance in
the United States. This document, and many advances in cancer surveillance in the United States, would
not have been possible without the tireless efforts and many achievements of the following organizations:
American Cancer Society (ACS)





American College of Surgeons (ACoS) Commission on Cancer (COC)
633 North Saint Clair Street
Chicago, IL 60611-3211
Phone: (312) 202-5085
Fax: (312) 202-5009 
http://www.facs.org/dept/cancer/index.html
American Joint Committee on Cancer (AJCC)





National Cancer Registrars Association (NCRA)





North American Association of Central Cancer Registries (NAACCR)












All Races White Black All Races White Black
All Sites 515,975 446,622 46,680 495,954 434,366 41,465
Oral Cavity and Pharynx 15,125 12,770 1,625 7,461 6,365 698
Lip 1,446 1,366 ~ 397 371 ~
Tongue 3,664 3,194 345 1,831 1,587 136
Salivary Gland 1,408 1,254 95 1,015 877 86
Floor of Mouth 1,139 966 142 572 497 58
Gum and Other Mouth 1,972 1,647 245 1,668 1,450 140
Nasopharynx 834 530 99 412 265 59
Tonsil 2,089 1,766 250 686 581 89
Oropharynx 613 470 121 229 185 38
Hypopharynx 1,418 1,135 231 414 349 56
Other Oral Cavity and Pharynx 542 442 87 237 203 29
Digestive System 102,879 88,471 9,625 92,522 79,288 9,382
Esophagus 8,207 6,987 994 2,654 2,203 379
Stomach 10,082 8,077 1,231 6,345 4,896 932
Small Intestine 1,858 1,568 222 1,676 1,390 231
Colon and Rectum 60,642 53,370 4,936 59,892 52,062 5,622
Colon excluding Rectum 42,428 37,201 3,715 45,394 39,321 4,483
Rectum and Rectosigmoid Junction 18,214 16,169 1,221 14,498 12,741 1,139
Anus, Anal Canal and Anorectum 1,114 958 119 1,722 1,523 143
Liver and Intrahepatic Bile Duct 6,664 5,055 782 3,428 2,722 368
Gallbladder 715 609 60 1,863 1,607 163
Other Biliary 1,403 1,244 91 1,392 1,227 99
Pancreas 11,303 9,821 1,124 11,876 10,151 1,332
Retroperitoneum 409 355 35 417 354 50
Peritoneum, Omentum and Mesentery 191 176 ~ 919 853 37
Other Digestive Organs 291 251 23 338 300 26
Respiratory System 93,162 81,230 9,354 67,128 59,864 5,650
Nose, Nasal Cavity and Middle Ear 804 683 80 625 545 50
Larynx 7,513 6,355 950 2,018 1,708 268
Lung and Bronchus 82,869 72,372 8,233 63,929 57,099 5,305
Pleura 1,651 1,546 60 416 392 16
Trachea and Other Respiratory Organs 325 274 31 140 120 ~
Bones and Joints 1,066 924 93 883 758 82 
Soft Tissue including Heart 3,215 2,722 332 2,777 2,367 275
Skin excluding Basal and Squamous 20,522 19,027 396 15,084 13,942 237
Melanomas of the Skin 18,178 17,142 94 13,739 12,839 96
Other Non-Epithelial Skin 2,344 1,885 302 1,345 1,103 141
Breast 1,399 1,197 155 155,069 136,064 12,564
continued
Table D.1: Invasive Cancer Incidence, Case Counts by Primary Site, Sex,
and Race (All Races, White, Black), United States: NPCR and SEER Program
Registries That Meet Quality Criteria, 1999*




All Races White Black All Races White Black
Female Genital System 62,166 54,131 5,179
Cervix 10,525 8,186 1,634
Corpus 27,748 24,720 1,853
Uterus, NOS 865 686 145
Ovary 18,673 16,730 1,176
Vagina 817 645 127
Vulva 2,802 2,542 173
Other Female Genital Organs 736 622 71
Male Genital System 158,531 132,773 17,087
Prostate 151,711 126,500 16,855
Testis 5,815 5,415 159
Penis 793 687 53
Other Male Genital Organs 212 171 20
Urinary System 51,123 46,989 2,559 23,023 20,645 1,722
Urinary Bladder 34,696 32,438 1,202 12,345 11,280 719
Kidney and Renal Pelvis 15,222 13,438 1,304 9,907 8,673 953
Ureter 777 741 19 564 531 18
Other Urinary Organs 428 372 34 207 161 32
Eye and Orbit 828 740 31 738 668 31
Brain and Other Nervous System 7,757 7,022 452 6,466 5,812 427
Brain 7,344 6,666 416 6,033 5,447 384
Cranial Nerves and Other Nervous System 413 356 36 433 365 43
Endocrine System 4,324 3,818 239 11,453 9,790 789
Thyroid 3,622 3,232 159 10,862 9,307 718
Other Endocrine including Thymus 702 586 80 591 483 71
Lymphomas 23,981 21,072 1,804 21,600 19,224 1,468
Hodgkin’s Disease 3,248 2,790 321 2,777 2,415 255
Non-Hodgkin’s Lymphoma 20,733 18,282 1,483 18,823 16,809 1,213
Multiple Myeloma 5,535 4,546 793 5,028 3,975 851
Leukemias 13,515 12,052 859 10,438 9,197 777
Acute Lymphocytic 1,593 1,382 111 1,254 1,073 96
Chronic Lymphocytic 3,785 3,433 213 2,592 2,336 148
Acute Myeloid 4,133 3,684 277 3,637 3,191 297
Chronic Myeloid 1,691 1,468 123 1,288 1,105 108
Other Leukemias 2,313 2,085 135 1,667 1,492 128
Miscellaneous 13,013 11,269 1,276 14,118 12,276 1,333
Breast, in situ 32,579 28,290 2,495
* Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive
cancer sites combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of
cases were ascertained by death certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on
race; and ≤ 3% of cases are missing information on age.
~ Case counts are suppressed for site-sex-race categories with fewer than 16 cases.
NPCR = National Program of Cancer Registries; SEER = Surveillance, Epidemiology, and End Results.
Table D.1: Invasive Cancer Incidence, Case Counts by Primary Site, Sex,
and Race (All Races, White, Black), United States: NPCR and SEER
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Table E.1: All Cancer Sites Combined. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 8,907 8,131 530 8,990 8,264 496
Maine
Massachusetts 16,331 15,179 614 16,488 15,422 479
New Hampshire 2,702 2,663 ∼ 2,662 2,607 ∼
Rhode Island 2,998 2,901 77 3,005 2,921 59
Vermont
Middle Atlantic 100,790 86,303 10,596 100,703 86,969 9,769
New Jersey 22,354 19,341 2,480 21,565 18,849 2,106
New York 43,416 35,668 5,296 45,288 37,535 5,125
Pennsylvania 35,020 31,294 2,820 33,850 30,585 2,538
Midwest
East North Central
Illinois 28,386 23,756 3,454 28,302 24,029 3,336
Indiana
Michigan 25,667 21,856 3,202 23,263 20,131 2,720
Detroit 10,973 8,283 2,481 10,037 7,758 2,122
Ohio 27,746 24,051 2,652 27,444 24,363 2,324
Wisconsin 12,744 12,092 452 11,839 11,264 404
West North Central
Iowa 7,723 7,470 106 7,351 7,187 82
Kansas 6,529 5,978 318 6,214 5,795 230
Minnesota 11,491 10,926 190 10,726 10,223 147
Missouri 13,196 11,847 1,191 12,995 11,683 1,140
Nebraska 4,149 3,868 101 3,886 3,666 78




Delaware 1,918 1,589 298 1,893 1,597 258
District of Columbia 1,554 365 1,111 1,373 388 916
Florida 50,472 45,601 4,011 44,912 40,856 3,359
Georgia
Atlanta 4,375 2,967 1,259 4,576 3,230 1,204
Maryland 11,956 8,764 2,497 11,295 8,544 2,309
North Carolina 16,302 13,233 2,825 15,884 13,006 2,636
South Carolina 9,528 7,179 2,235 8,078 6,084 1,881
Virginia
West Virginia 5,228 4,999 138 5,017 4,810 141
East South Central
Alabama







Table E.1: All Cancer Sites Combined. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 9,960 9,500 213 9,551 9,141 149
Colorado 7,975 7,557 231 7,818 7,425 200
Idaho 2,678 2,647 ∼ 2,468 2,440 ∼
Montana 2,177 2,028 ∼ 1,927 1,822 ∼
Nevada
New Mexico 3,445 3,270 57 3,174 3,015 27
Utah 3,511 3,448 ∼ 2,984 2,920 ∼
Wyoming 1,147 1,127 ∼ 958 934 ∼
Pacific 92,413 77,158 5,014 90,223 76,777 4,213
Alaska 996 791 33 907 691 17
California 66,149 54,574 4,518 65,183 55,197 3,856
San Francisco-Oakland 9,096 6,496 966 9,166 6,908 808
San Jose-Monterey 4,302 3,448 112 4,348 3,626 70
Los Angeles 16,991 12,890 2,142 17,070 13,397 1,853
Hawaii 2,736 857 22 2,544 673 22
Oregon 8,601 8,201 109 8,273 7,972 80
Washington 13,931 12,735 332 13,316 12,244 238
Seattle-Puget Sound 9,632 8,883 307 9,319 8,580 211
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except
urinary bladder.
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.2: Cancer of the Oral Cavity and Pharynx. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 247 220 23 133 121 ∼
Maine
Massachusetts 456 418 20 269 248 ∼
New Hampshire 80 78 ∼ 41 41 ∼
Rhode Island 74 71 ∼ 45 41 ∼
Vermont
Middle Atlantic 2,736 2,217 338 1,411 1,166 169
New Jersey 543 450 69 339 284 43
New York 1,273 978 174 608 479 83
Pennsylvania 920 789 95 464 403 43
Midwest
East North Central
Illinois 852 691 136 423 351 57
Indiana
Michigan 677 564 104 354 304 39
Detroit 295 200 90 155 120 30
Ohio 666 576 69 385 336 37
Wisconsin 420 385 26 180 171 ∼
West North Central
Iowa 233 227 ∼ 90 88 ∼
Kansas 196 175 ∼ 85 80 ∼
Minnesota 355 338 ∼ 154 142 ∼
Missouri 392 344 38 172 155 ∼
Nebraska 116 107 ∼ 62 58 ∼




Delaware 61 47 ∼ 23 21 ∼
District of Columbia 60 ∼ 43 21 ∼ ∼
Florida 1,635 1,447 142 798 723 58
Georgia
Atlanta 133 83 47 67 50 16
Maryland 372 265 91 167 116 41
North Carolina 537 397 133 251 200 49
South Carolina 348 252 92 145 105 39
Virginia
West Virginia 155 144 ∼ 69 68 ∼
East South Central
Alabama







Table E.2: Cancer of the Oral Cavity and Pharynx. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 265 252 ∼ 146 140 ∼
Colorado 189 181 ∼ 89 81 ∼
Idaho 81 80 ∼ 33 33 ∼
Montana 57 55 ∼ 32 30 ∼
Nevada
New Mexico 107 103 ∼ 39 38 ∼
Utah 78 77 ∼ 41 40 ∼
Wyoming 30 28 ∼ 16 ∼ ∼
Pacific 2,814 2,379 136 ∼ ∼ 70
Alaska 41 26 ∼ ∼ ∼ ∼
California 2,073 1,735 130 1,013 819 66
San Francisco-Oakland 296 212 25 155 101 ∼
San Jose-Monterey 131 101 ∼ 55 42 ∼
Los Angeles 495 377 65 260 192 33
Hawaii 80 25 ∼ 57 19 ∼
Oregon 262 256 ∼ 124 117 ∼
Washington 358 337 ∼ 191 169 ∼
Seattle-Puget Sound 251 240 ∼ 131 116 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–6
Table E.3: Cancer of the Esophagus. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 144 131 ∼ 61 48 ∼
Maine
Massachusetts 300 280 ∼ 84 73 ∼
New Hampshire 48 47 ∼ 16 16 ∼
Rhode Island 44 42 ∼ 21 20 ∼
Vermont
Middle Atlantic 1,577 1,304 230 550 443 95
New Jersey 317 270 44 127 106 19
New York 694 538 129 263 198 57
Pennsylvania 566 496 57 160 139 19
Midwest
East North Central
Illinois 514 415 89 139 107 28
Indiana
Michigan 439 384 54 116 94 21
Detroit 153 117 36 50 33 17
Ohio 514 458 48 159 128 22
Wisconsin 224 208 ∼ 71 65 ∼
West North Central
Iowa 120 114 ∼ 32 32 ∼
Kansas 83 72 ∼ 24 24 ∼
Minnesota 181 178 ∼ 55 53 ∼
Missouri 195 177 17 61 49 ∼
Nebraska 64 62 ∼ 16 16 ∼




Delaware 28 24 ∼ ∼ ∼ ∼
District of Columbia 33 ∼ 31 ∼ ∼ ∼
Florida 837 737 87 279 242 32
Georgia
Atlanta 66 36 27 26 ∼ ∼
Maryland 219 156 58 67 47 18
North Carolina 238 175 60 79 54 24
South Carolina 196 111 85 58 26 31
Virginia
West Virginia 70 66 ∼ 24 23 ∼
East South Central
Alabama







Table E.3: Cancer of the Esophagus. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 149 143 ∼ 43 42 ∼
Colorado 100 95 ∼ 35 32 ∼
Idaho 33 33 ∼ ∼ ∼ ∼
Montana 54 51 ∼ ∼ ∼ ∼
Nevada
New Mexico 57 56 ∼ ∼ ∼ ∼
Utah 41 40 ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ 1,127 63 474 416 35
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 904 777 57 356 303 35
San Francisco-Oakland 134 99 ∼ 54 40 ∼
San Jose-Monterey 63 61 ∼ 26 23 ∼
Los Angeles 212 162 22 83 66 16
Hawaii 42 ∼ ∼ ∼ ∼ ∼
Oregon 120 116 ∼ 46 45 ∼
Washington 223 210 ∼ 64 64 ∼
Seattle-Puget Sound 157 149 ∼ 47 47 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.4: Cancer of the Stomach. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 197 176 ∼ 134 122 ∼
Maine
Massachusetts 323 282 24 191 175 ∼
New Hampshire 46 46 ∼ 27 26 ∼
Rhode Island 60 58 ∼ 46 43 ∼
Vermont
Middle Atlantic 2,409 1,948 306 1,518 1,185 232
New Jersey 536 452 66 335 267 45
New York 1,158 882 156 741 543 131
Pennsylvania 715 614 84 442 375 56
Midwest
East North Central
Illinois 554 436 87 358 277 63
Indiana
Michigan 440 364 65 296 223 66
Detroit 224 169 50 160 109 47
Ohio 456 365 74 315 255 52
Wisconsin 231 216 ∼ 111 103 ∼
West North Central
Iowa 127 125 ∼ 61 59 ∼
Kansas 112 100 ∼ 54 49 ∼
Minnesota 205 190 ∼ 116 112 ∼
Missouri 206 171 31 106 87 ∼
Nebraska 47 42 ∼ 40 34 ∼




Delaware 34 25 ∼ 28 20 ∼
District of Columbia 35 ∼ 25 37 ∼ 26
Florida 921 779 114 539 438 85
Georgia
Atlanta 76 38 24 57 34 21
Maryland 210 134 63 118 70 39
North Carolina 282 175 100 187 124 61
South Carolina 172 104 67 98 62 36
Virginia
West Virginia 69 67 ∼ 43 41 ∼
East South Central
Alabama







Table E.4: Cancer of the Stomach. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 185 172 ∼ 100 87 ∼
Colorado 120 108 ∼ 87 77 ∼
Idaho 38 36 ∼ 24 24 ∼
Montana 36 34 ∼ ∼ ∼ ∼
Nevada
New Mexico 62 52 ∼ 52 43 ∼
Utah 54 52 ∼ 39 39 ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 1,999 ∼ 111 1,284 882 106
Alaska 22 ∼ ∼ 16 ∼ ∼
California 1,488 1,118 106 1,001 711 99
San Francisco-Oakland 210 124 32 173 100 25
San Jose-Monterey 98 59 ∼ 76 55 ∼
Los Angeles 494 345 46 333 213 50
Hawaii 119 18 ∼ 75 ∼ ∼
Oregon 131 119 ∼ 56 51 ∼
Washington 239 213 ∼ 136 106 ∼
Seattle-Puget Sound 178 151 ∼ 92 68 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
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Table E.5: Cancer of the Colon and Rectum. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 1,091 1,022 46 1,148 1,052 82
Maine
Massachusetts 1,904 1,797 57 2,016 1,907 61
New Hampshire 280 276 ∼ 306 298 ∼
Rhode Island 356 351 ∼ 416 405 ∼
Vermont
Middle Atlantic 12,739 11,209 1,109 13,169 11,403 1,356
New Jersey 2,770 2,445 266 2,653 2,326 279
New York 5,566 4,722 545 6,000 4,960 741
Pennsylvania 4,403 4,042 298 4,516 4,117 336
Midwest
East North Central
Illinois 3,520 3,033 379 3,505 2,974 444
Indiana
Michigan 2,580 2,237 308 2,624 2,250 336
Detroit 1,089 829 244 1,134 854 270
Ohio 3,452 3,064 290 3,407 2,988 323
Wisconsin 1,643 1,571 40 1,471 1,393 52
West North Central
Iowa 1,062 1,048 ∼ 1,068 1,055 ∼
Kansas 787 733 35 769 716 34
Minnesota 1,267 1,226 ∼ 1,225 1,173 20
Missouri 1,676 1,515 144 1,645 1,486 144
Nebraska 539 512 ∼ 524 504 ∼




Delaware 214 173 39 231 187 43
District of Columbia 149 38 109 190 37 150
Florida 6,270 5,701 480 5,862 5,285 486
Georgia
Atlanta 432 304 121 461 307 150
Maryland 1,289 963 262 1,256 919 278
North Carolina 1,701 1,388 290 1,833 1,452 363
South Carolina 1,031 781 234 954 678 263
Virginia
West Virginia 643 619 ∼ 640 617 20
East South Central
Alabama







Table E.5: Cancer of the Colon and Rectum. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 1,166 1,120 24 1,053 1,018 17
Colorado 829 782 24 768 722 27
Idaho 271 267 ∼ 250 246 ∼
Montana 266 242 ∼ 218 202 ∼
Nevada
New Mexico 389 371 ∼ 284 276 ∼
Utah 349 342 ∼ 297 290 ∼
Wyoming 136 136 ∼ 121 118 ∼
Pacific 10,027 8,352 519 9,707 8,031 562
Alaska 117 77 ∼ 87 49 ∼
California 7,232 6,020 475 7,028 5,800 522
San Francisco-Oakland 1,014 742 84 1,051 747 117
San Jose-Monterey 459 374 18 420 352 ∼
Los Angeles 1,872 1,412 234 1,890 1,414 250
Hawaii 351 79 ∼ 319 67 ∼
Oregon 864 826 ∼ 947 910 ∼
Washington 1,463 1,350 29 1,326 1,205 27
Seattle-Puget Sound 965 888 28 927 844 27
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
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Table E.6: Cancer of the Liver and Intrahepatic Bile Duct. Invasive Cancer Incidence Counts by U.S. Census
Region and Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States:
SEER and NPCR Registries that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 116 97 ∼ 54 53 ∼
Maine
Massachusetts 190 164 ∼ 98 82 ∼
New Hampshire 32 31 ∼ ∼ ∼ ∼
Rhode Island 30 25 ∼ ∼ ∼ ∼
Vermont
Middle Atlantic 1,443 1,073 209 732 566 ∼
New Jersey 256 200 39 137 115 ∼
New York 750 546 101 403 291 69
Pennsylvania 437 327 69 192 160 26
Midwest
East North Central
Illinois 383 282 68 235 187 36
Indiana
Michigan 344 282 48 149 122 24
Detroit 156 113 37 77 53 22
Ohio 276 210 52 163 139 23
Wisconsin 141 134 ∼ 71 67 ∼
West North Central
Iowa 73 67 ∼ 42 40 ∼
Kansas 56 50 ∼ 45 42 ∼
Minnesota 109 87 ∼ 54 49 ∼
Missouri 132 103 24 71 54 ∼
Nebraska 37 34 ∼ ∼ ∼ ∼




Delaware 16 ∼ ∼ ∼ ∼ ∼
District of Columbia 29 ∼ 22 20 ∼ 19
Florida 594 507 68 317 283 28
Georgia
Atlanta 49 23 ∼ 30 ∼ ∼
Maryland 124 77 34 67 48 ∼
North Carolina 141 111 26 75 58 ∼
South Carolina 89 66 21 40 29 ∼
Virginia
West Virginia 48 43 ∼ 28 27 ∼
East South Central
Alabama







Table E.6: Cancer of the Liver and Intrahepatic Bile Duct. Invasive Cancer Incidence Counts by U.S. Census
Region and Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States:
SEER and NPCR Registries that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 128 121 ∼ 58 52 ∼
Colorado 100 91 ∼ 47 43 ∼
Idaho 20 20 ∼ 17 17 ∼
Montana 21 19 ∼ ∼ ∼ ∼
Nevada
New Mexico 60 52 ∼ 29 26 ∼
Utah 31 29 ∼ 23 22 ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 1,607 1,037 99 ∼ 533 37
Alaska 19 ∼ ∼ ∼ ∼ ∼
California 1,245 791 89 586 405 33
San Francisco-Oakland 225 112 25 82 38 ∼
San Jose-Monterey 102 53 ∼ 36 18 ∼
Los Angeles 353 216 33 198 138 17
Hawaii 70 ∼ ∼ 29 ∼ ∼
Oregon 90 80 ∼ 52 45 ∼
Washington 183 143 ∼ 97 73 ∼
Seattle-Puget Sound 139 103 ∼ 75 55 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
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Table E.7: Cancer of the Pancreas. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 201 185 16 217 205 ∼
Maine
Massachusetts 363 341 ∼ 386 368 ∼
New Hampshire 64 63 ∼ 60 59 ∼
Rhode Island 56 55 ∼ 64 62 ∼
Vermont
Middle Atlantic 2,371 2,030 272 2,639 2,237 329
New Jersey 497 411 66 561 483 65
New York 1,086 924 127 1,282 1,045 189
Pennsylvania 788 695 79 796 709 75
Midwest
East North Central
Illinois 664 555 88 706 586 101
Indiana
Michigan 509 423 84 601 489 105
Detroit 212 149 62 277 195 82
Ohio 567 514 48 605 526 75
Wisconsin 280 266 ∼ 314 288 21
West North Central
Iowa 148 142 ∼ 151 145 ∼
Kansas 155 141 ∼ 142 133 ∼
Minnesota 213 203 ∼ 181 172 ∼
Missouri 312 282 27 347 298 46
Nebraska 88 82 ∼ 83 79 ∼




Delaware 41 35 ∼ 51 45 ∼
District of Columbia 40 ∼ 28 37 ∼ 28
Florida 1,122 1,010 101 1,131 1,016 103
Georgia
Atlanta 100 64 34 93 55 36
Maryland 238 176 56 250 184 61
North Carolina 386 319 64 408 309 95
South Carolina 194 152 42 203 134 69
Virginia
West Virginia 96 91 ∼ 80 78 ∼
East South Central
Alabama







Table E.7: Cancer of the Pancreas. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 211 203 ∼ 221 208 ∼
Colorado 167 156 ∼ 161 153 ∼
Idaho 51 51 ∼ 82 82 ∼
Montana 53 52 ∼ 40 39 ∼
Nevada
New Mexico 101 90 ∼ 75 72 ∼
Utah 76 75 ∼ 54 52 ∼
Wyoming 35 33 ∼ 16 ∼ ∼
Pacific 1,962 ∼ 105 1,995 ∼ 110
Alaska 19 ∼ ∼ 21 17 ∼
California 1,399 1,188 97 1,417 1,188 100
San Francisco-Oakland 187 128 26 191 143 18
San Jose-Monterey 105 81 ∼ 93 76 ∼
Los Angeles 358 291 41 365 287 40
Hawaii 61 17 ∼ 77 ∼ ∼
Oregon 191 181 ∼ 205 197 ∼
Washington 292 273 ∼ 275 252 ∼
Seattle-Puget Sound 207 193 ∼ 216 197 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.8: Cancer of the Larynx. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 130 118 ∼ 49 46 ∼
Maine
Massachusetts 240 220 16 63 56 ∼
New Hampshire 44 44 ∼ ∼ ∼ ∼
Rhode Island 47 44 ∼ ∼ ∼ ∼
Vermont
Middle Atlantic 1,467 1,229 192 385 311 ∼
New Jersey 282 229 48 74 61 ∼
New York 666 547 90 186 149 32
Pennsylvania 519 453 54 125 101 22
Midwest
East North Central
Illinois 475 372 89 98 77 20
Indiana
Michigan 348 283 62 142 102 38
Detroit 132 86 46 74 45 29
Ohio 426 374 42 97 77 16
Wisconsin 162 148 ∼ 56 52 ∼
West North Central
Iowa 113 110 ∼ 29 28 ∼
Kansas 86 77 ∼ 18 17 ∼
Minnesota 139 135 ∼ 30 30 ∼
Missouri 224 195 27 57 50 ∼
Nebraska 52 50 ∼ ∼ ∼ ∼




Delaware 37 30 ∼ ∼ ∼ ∼
District of Columbia 34 ∼ 26 ∼ ∼ ∼
Florida 844 751 75 228 206 17
Georgia
Atlanta 59 41 18 20 ∼ ∼
Maryland 195 132 57 48 37 ∼
North Carolina 308 233 71 67 56 ∼
South Carolina 156 110 46 47 36 ∼
Virginia
West Virginia 99 93 ∼ 27 27 ∼
East South Central
Alabama







Table E.8: Cancer of the Larynx. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 124 115 ∼ 43 42 ∼
Colorado 87 84 ∼ 25 24 ∼
Idaho 41 41 ∼ ∼ ∼ ∼
Montana 28 25 ∼ ∼ ∼ ∼
Nevada
New Mexico 49 47 ∼ ∼ ∼ ∼
Utah 25 25 ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ ∼ 96 279 242 25
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 776 634 88 192 164 20
San Francisco-Oakland 129 93 23 24 20 ∼
San Jose-Monterey 47 41 ∼ ∼ ∼ ∼
Los Angeles 220 162 39 47 34 ∼
Hawaii 34 19 ∼ ∼ ∼ ∼
Oregon 96 92 ∼ 28 28 ∼
Washington 160 148 ∼ 47 42 ∼
Seattle-Puget Sound 98 91 ∼ 29 24 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.9: Cancer of the Lung and Bronchus. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 1,293 1,198 81 1,079 1,009 62
Maine
Massachusetts 2,440 2,302 83 2,185 2,063 66
New Hampshire 419 415 ∼ 375 370 ∼
Rhode Island 493 476 ∼ 406 398 ∼
Vermont
Middle Atlantic 15,312 13,238 1,707 12,453 10,989 1,190
New Jersey 3,164 2,712 393 2,710 2,407 264
New York 6,480 5,508 748 5,595 4,861 556
Pennsylvania 5,668 5,018 566 4,148 3,721 370
Midwest
East North Central
Illinois 4,831 4,050 684 3,654 3,099 489
Indiana
Michigan 3,973 3,362 571 3,098 2,663 410
Detroit 1,734 1,272 449 1,387 1,074 301
Ohio 5,132 4,529 516 3,712 3,301 360
Wisconsin 1,950 1,850 82 1,366 1,298 55
West North Central
Iowa 1,232 1,209 20 826 810 ∼
Kansas 1,079 1,011 57 787 753 28
Minnesota 1,514 1,448 38 1,148 1,096 29
Missouri 2,610 2,332 253 1,894 1,709 164
Nebraska 596 558 24 436 410 ∼




Delaware 368 311 53 274 234 36
District of Columbia 258 48 197 168 39 125
Florida 8,851 8,081 688 6,767 6,372 340
Georgia
Atlanta 674 462 199 571 434 126
Maryland 1,904 1,440 428 1,542 1,209 308
North Carolina 3,336 2,742 557 2,208 1,891 289
South Carolina 1,820 1,419 392 1,003 831 167
Virginia
West Virginia 1,164 1,131 21 817 783 28
East South Central
Alabama







Table E.9: Cancer of the Lung and Bronchus. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 1,643 1,573 42 1,254 1,215 16
Colorado 952 906 27 785 748 25
Idaho 361 358 ∼ 260 257 ∼
Montana 327 307 ∼ 247 231 ∼
Nevada
New Mexico 435 415 ∼ 320 313 ∼
Utah 306 294 ∼ 185 181 ∼
Wyoming 144 142 ∼ 116 112 ∼
Pacific 12,910 10,933 801 11,053 9,744 571
Alaska 140 113 ∼ 125 102 ∼
California 8,995 7,519 714 7,828 6,834 530
San Francisco-Oakland 1,172 786 151 1,104 863 120
San Jose-Monterey 521 426 19 481 410 ∼
Los Angeles 2,131 1,546 337 1,826 1,433 250
Hawaii 397 118 ∼ 265 82 ∼
Oregon 1,319 1,264 22 1,144 1,116 ∼
Washington 2,059 1,919 62 1,691 1,610 28
Seattle-Puget Sound 1,436 1,324 56 1,248 1,186 25
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.10: Melanomas of the Skin. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 400 376 ∼ 292 266 ∼
Maine
Massachusetts 564 542 ∼ 482 460 ∼
New Hampshire 123 123 ∼ 120 119 ∼
Rhode Island 118 118 ∼ 77 77 ∼
Vermont
Middle Atlantic 2,691 2,584 ∼ 1,995 1,907 ∼
New Jersey 721 716 ∼ 536 528 ∼
New York 972 933 ∼ 755 719 ∼
Pennsylvania 998 935 ∼ 704 660 ∼
Midwest
East North Central
Illinois 791 743 ∼ 558 531 ∼
Indiana
Michigan 970 898 ∼ 795 737 ∼
Detroit 364 351 ∼ 296 283 ∼
Ohio 845 757 ∼ 677 612 ∼
Wisconsin 317 313 ∼ 251 243 ∼
West North Central
Iowa 278 257 ∼ 228 212 ∼
Kansas 261 229 ∼ 177 150 ∼
Minnesota 425 403 ∼ 385 361 ∼
Missouri 309 302 ∼ 226 215 ∼
Nebraska 113 84 ∼ 119 93 ∼




Delaware 55 53 ∼ 43 40 ∼
District of Columbia 27 17 ∼ 20 ∼ ∼
Florida 1,806 1,713 ∼ 1,134 1,068 ∼
Georgia
Atlanta 204 184 ∼ 141 126 ∼
Maryland 486 472 ∼ 397 385 ∼
North Carolina 575 567 ∼ 461 445 ∼
South Carolina 368 359 ∼ 275 260 ∼
Virginia
West Virginia 174 156 ∼ 120 105 ∼
East South Central
Alabama







Table E.10: Melanomas of the Skin. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 434 421 ∼ 301 300 ∼
Colorado 424 421 ∼ 348 345 ∼
Idaho 134 134 ∼ 96 96 ∼
Montana 56 48 ∼ 43 38 ∼
Nevada
New Mexico 135 135 ∼ 85 82 ∼
Utah 216 216 ∼ 157 157 ∼
Wyoming 62 62 ∼ 31 31 ∼
Pacific 4,167 3,848 ∼ 3,184 2,872 16
Alaska 27 25 ∼ 19 19 ∼
California 3,040 2,765 ∼ 2,245 1,973 ∼
San Francisco-Oakland 348 326 ∼ 291 272 ∼
San Jose-Monterey 196 158 ∼ 163 121 ∼
Los Angeles 624 586 ∼ 494 457 ∼
Hawaii 113 80 ∼ 61 42 ∼
Oregon 380 373 ∼ 292 277 ∼
Washington 607 605 ∼ 567 561 ∼
Seattle-Puget Sound 417 414 ∼ 382 373 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.11: Cancer of the Breast. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 32 28 ∼ 2,865 2,609 159
Maine
Massachusetts 48 41 ∼ 5,123 4,807 140
New Hampshire ∼ ∼ ∼ 844 823 ∼
Rhode Island ∼ ∼ ∼ 821 795 20
Vermont
Middle Atlantic 283 245 27 30,099 26,038 2,742
New Jersey 59 51 ∼ 6,529 5,725 592
New York 123 104 ∼ 13,412 11,117 1,427
Pennsylvania 101 90 ∼ 10,158 9,196 723
Midwest
East North Central
Illinois 76 61 ∼ 8,879 7,532 1,004
Indiana
Michigan 66 59 ∼ 6,977 6,094 778
Detroit 21 16 ∼ 2,951 2,299 610
Ohio 58 50 ∼ 8,631 7,657 712
Wisconsin 36 36 ∼ 3,798 3,609 136
West North Central
Iowa ∼ ∼ ∼ 2,254 2,218 25
Kansas ∼ ∼ ∼ 1,965 1,831 69
Minnesota 21 17 ∼ 3,484 3,354 40
Missouri 27 22 ∼ 3,914 3,528 343
Nebraska ∼ ∼ ∼ 1,216 1,164 28




Delaware 16 ∼ ∼ 563 470 79
District of Columbia ∼ ∼ ∼ 435 156 262
Florida 206 183 18 12,934 11,808 927
Georgia
Atlanta ∼ ∼ ∼ 1,648 1,171 426
Maryland 38 25 ∼ 3,711 2,751 822
North Carolina 34 26 ∼ 5,159 4,204 872
South Carolina 33 25 ∼ 2,667 2,014 615
Virginia
West Virginia ∼ ∼ ∼ 1,403 1,348 38
East South Central
Alabama







Table E.11: Cancer of the Breast. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 56 54 ∼ 3,099 2,957 51
Colorado 19 18 ∼ 2,829 2,693 65
Idaho ∼ ∼ ∼ 807 796 ∼
Montana ∼ ∼ ∼ 606 575 ∼
Nevada
New Mexico ∼ ∼ ∼ 1,077 1,033 ∼
Utah ∼ ∼ ∼ 994 978 ∼
Wyoming ∼ ∼ ∼ 325 321 ∼
Pacific 185 157 ∼ 29,871 25,582 1,347
Alaska ∼ ∼ ∼ 294 244 ∼
California 138 112 ∼ 21,439 18,269 1,234
San Francisco-Oakland ∼ ∼ ∼ 3,135 2,413 251
San Jose-Monterey ∼ ∼ ∼ 1,482 1,278 22
Los Angeles 43 31 ∼ 5,460 4,265 580
Hawaii ∼ ∼ ∼ 869 239 ∼
Oregon 24 24 ∼ 2,792 2,699 28
Washington 20 19 ∼ 4,477 4,131 71
Seattle-Puget Sound 16 ∼ ∼ 3,109 2,875 63
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.12: Cancer of the Breast. In Situ Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut ∼ ∼ ∼ 735 666 42
Maine
Massachusetts ∼ ∼ ∼ 1,589 1,465 38
New Hampshire ∼ ∼ ∼ 222 218 ∼
Rhode Island ∼ ∼ ∼ 201 198 ∼
Vermont
Middle Atlantic ∼ 40 ∼ 6,922 5,903 639
New Jersey ∼ ∼ ∼ 1,556 1,381 127
New York 19 ∼ ∼ 3,157 2,558 321
Pennsylvania 19 18 ∼ 2,209 1,964 191
Midwest
East North Central
Illinois ∼ ∼ ∼ 1,714 1,451 160
Indiana
Michigan ∼ ∼ ∼ 1,663 1,436 196
Detroit ∼ ∼ ∼ 881 687 168
Ohio ∼ ∼ ∼ 1,706 1,511 133
Wisconsin ∼ ∼ ∼ 740 703 26
West North Central
Iowa ∼ ∼ ∼ 418 417 ∼
Kansas ∼ ∼ ∼ 319 291 ∼
Minnesota ∼ ∼ ∼ 692 661 ∼
Missouri ∼ ∼ ∼ 650 600 43
Nebraska ∼ ∼ ∼ 223 218 ∼




Delaware ∼ ∼ ∼ 157 134 19
District of Columbia ∼ ∼ ∼ 91 34 50
Florida 28 25 ∼ 2,564 2,337 175
Georgia
Atlanta ∼ ∼ ∼ 358 266 85
Maryland ∼ ∼ ∼ 885 638 191
North Carolina ∼ ∼ ∼ 1,051 874 161
South Carolina ∼ ∼ ∼ 496 377 112
Virginia
West Virginia ∼ ∼ ∼ 270 262 ∼
East South Central
Alabama







Table E.12: Cancer of the Breast. In Situ Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona ∼ ∼ ∼ 613 582 ∼
Colorado ∼ ∼ ∼ 568 540 ∼
Idaho ∼ ∼ ∼ 163 159 ∼
Montana ∼ ∼ ∼ 129 124 ∼
Nevada
New Mexico ∼ ∼ ∼ 188 183 ∼
Utah ∼ ∼ ∼ 186 183 ∼
Wyoming ∼ ∼ ∼ 59 58 ∼
Pacific 30 25 ∼ 5,960 4,909 245
Alaska ∼ ∼ ∼ 74 56 ∼
California 26 22 ∼ 4,172 3,458 220
San Francisco-Oakland ∼ ∼ ∼ 680 456 56
San Jose-Monterey ∼ ∼ ∼ 356 298 ∼
Los Angeles ∼ ∼ ∼ 1,056 832 100
Hawaii ∼ ∼ ∼ 228 45 ∼
Oregon ∼ ∼ ∼ 553 523 ∼
Washington ∼ ∼ ∼ 933 827 16
Seattle-Puget Sound ∼ ∼ ∼ 675 604 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† In situ cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.13: Cancer of the Cervix Uteri. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 151 128 16
Maine
Massachusetts 231 186 24
New Hampshire 41 39 ∼
Rhode Island 51 49 ∼
Vermont
Middle Atlantic 2,087 1,526 411
New Jersey 472 365 94
New York 999 658 226
Pennsylvania 616 503 91
Midwest
East North Central
Illinois 678 485 159
Indiana
Michigan 429 328 89
Detroit 200 114 78
Ohio 524 455 59
Wisconsin 261 220 25
West North Central
Iowa 149 136 ∼
Kansas 125 110 ∼
Minnesota 184 166 ∼
Missouri 255 212 37
Nebraska 71 62 ∼




Delaware 33 26 ∼
District of Columbia 41 ∼ 29
Florida 946 750 176
Georgia
Atlanta 139 72 55
Maryland 226 130 73
North Carolina 390 273 103
South Carolina 236 140 88
Virginia
West Virginia 134 130 ∼
East South Central
Alabama







Table E.13: Cancer of the Cervix Uteri. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 183 170 ∼
Colorado 135 124 ∼
Idaho 37 37 ∼
Montana 38 35 ∼
Nevada
New Mexico 65 60 ∼
Utah 55 53 ∼
Wyoming 23 23 ∼
Pacific 2,087 ∼ 122
Alaska 18 ∼ ∼
California 1,643 1,323 111
San Francisco-Oakland 149 101 18
San Jose-Monterey 85 61 ∼
Los Angeles 574 458 55
Hawaii 58 18 ∼
Oregon 146 136 ∼
Washington 222 188 ∼
Seattle-Puget Sound 126 110 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–28
Table E.14: Cancer of the Corpus Uteri. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 536 506 18
Maine
Massachusetts 1,006 937 21
New Hampshire 158 155 ∼
Rhode Island 168 165 ∼
Vermont
Middle Atlantic 6,414 5,611 544
New Jersey 1,395 1,244 117
New York 2,780 2,270 328
Pennsylvania 2,239 2,097 99
Midwest
East North Central
Illinois 1,574 1,376 137
Indiana
Michigan 1,418 1,294 106
Detroit 586 485 92
Ohio 1,717 1,555 107
Wisconsin 735 713 ∼
West North Central
Iowa 483 476 ∼
Kansas 388 368 ∼
Minnesota 681 655 ∼
Missouri 812 746 55
Nebraska 262 252 ∼




Delaware 111 101 ∼
District of Columbia 56 23 30
Florida 2,324 2,087 202
Georgia
Atlanta 204 156 41
Maryland 631 510 89
North Carolina 851 684 153
South Carolina 415 301 108
Virginia
West Virginia 300 291 ∼
East South Central
Alabama







Table E.14: Cancer of the Corpus Uteri. Invasive Cancer Incidence Counts by U.S. Census Region and Division,
State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 459 444 ∼
Colorado 385 369 ∼
Idaho 155 155 ∼
Montana 84 78 ∼
Nevada
New Mexico 173 161 ∼
Utah 209 204 ∼
Wyoming 41 39 ∼
Pacific 4,989 4,264 189
Alaska 43 37 ∼
California 3,537 3,029 177
San Francisco-Oakland 502 381 38
San Jose-Monterey 242 205 ∼
Los Angeles 953 765 95
Hawaii 172 44 ∼
Oregon 452 436 ∼
Washington 785 718 ∼
Seattle-Puget Sound 533 491 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–30
Table E.15: Cancer of the Ovary. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 303 286 ∼
Maine
Massachusetts 567 527 ∼
New Hampshire 87 87 ∼
Rhode Island 95 93 ∼
Vermont
Middle Atlantic 3,863 3,385 312
New Jersey 839 736 66
New York 1,704 1,431 173
Pennsylvania 1,320 1,218 73
Midwest
East North Central
Illinois 1,061 939 90
Indiana
Michigan 880 777 88
Detroit 377 301 74
Ohio 974 895 61
Wisconsin 396 383 ∼
West North Central
Iowa 295 285 ∼
Kansas 220 210 ∼
Minnesota 441 418 ∼
Missouri 479 446 28
Nebraska 157 151 ∼




Delaware 63 57 ∼
District of Columbia 32 ∼ 16
Florida 1,733 1,609 107
Georgia
Atlanta 175 134 34
Maryland 355 292 51
North Carolina 630 553 70
South Carolina 274 213 58
Virginia
West Virginia 165 164 ∼
East South Central
Alabama







Table E.15: Cancer of the Ovary. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 346 336 ∼
Colorado 340 327 ∼
Idaho 99 99 ∼
Montana 83 81 ∼
Nevada
New Mexico 150 137 ∼
Utah 141 139 ∼
Wyoming 32 29 ∼
Pacific 3,571 3,088 130
Alaska 38 33 ∼
California 2,587 2,222 122
San Francisco-Oakland 370 287 27
San Jose-Monterey 192 161 ∼
Los Angeles 688 541 54
Hawaii 91 25 ∼
Oregon 300 293 ∼
Washington 555 515 ∼
Seattle-Puget Sound 411 385 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–32
Table E.16: Cancer of the Prostate. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 2,559 2,242 195
Maine
Massachusetts 5,002 4,565 246
New Hampshire 764 746 ∼
Rhode Island 861 828 28
Vermont
Middle Atlantic 29,505 24,230 4,024
New Jersey 6,989 5,859 978
New York 12,280 9,418 2,100
Pennsylvania 10,236 8,953 946
Midwest
East North Central
Illinois 7,861 6,334 1,085
Indiana
Michigan 8,534 6,933 1,277
Detroit 3,805 2,700 996
Ohio 7,709 6,304 945
Wisconsin 3,787 3,562 162
West North Central
Iowa 2,164 2,048 42
Kansas 1,990 1,785 110
Minnesota 3,668 3,486 43
Missouri 3,515 3,087 381
Nebraska 1,329 1,218 29




Delaware 559 440 105
District of Columbia 542 115 405
Florida 13,820 12,171 1,417
Georgia
Atlanta 1,383 877 470
Maryland 3,866 2,555 904
North Carolina 4,630 3,563 982
South Carolina 2,888 1,994 842
Virginia
West Virginia 1,322 1,251 47
East South Central
Alabama







Table E.16: Cancer of the Prostate. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 2,525 2,389 62
Colorado 2,621 2,486 85
Idaho 828 821 ∼
Montana 684 635 ∼
Nevada
New Mexico 1,096 1,056 20
Utah 1,269 1,252 ∼
Wyoming 367 361 ∼
Pacific 28,034 22,519 ∼
Alaska 280 235 17
California 19,886 15,547 1,720
San Francisco-Oakland 2,785 1,917 353
San Jose-Monterey 1,413 1,103 35
Los Angeles 5,261 3,737 851
Hawaii 774 236 ∼
Oregon 2,715 2,572 39
Washington 4,379 3,929 114
Seattle-Puget Sound 3,026 2,803 104
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–34
Table E.17: Cancer of the Testis. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 99 96 ∼
Maine
Massachusetts 205 197 ∼
New Hampshire 39 38 ∼
Rhode Island 26 26 ∼
Vermont
Middle Atlantic 1,059 981 35
New Jersey 235 220 ∼
New York 497 447 18
Pennsylvania 327 314 ∼
Midwest
East North Central
Illinois 318 283 ∼
Indiana
Michigan 245 238 ∼
Detroit 97 90 ∼
Ohio 302 288 ∼
Wisconsin 194 186 ∼
West North Central
Iowa 82 77 ∼
Kansas 83 81 ∼
Minnesota 172 159 ∼
Missouri 117 113 ∼
Nebraska 63 62 ∼




Delaware 19 16 ∼
District of Columbia ∼ ∼ ∼
Florida 361 334 17
Georgia
Atlanta 68 57 ∼
Maryland 125 115 ∼
North Carolina 162 149 ∼
South Carolina 81 74 ∼
Virginia
West Virginia 42 42 ∼
East South Central
Alabama







Table E.17: Cancer of the Testis. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 128 121 ∼
Colorado 154 143 ∼
Idaho 37 36 ∼
Montana 26 24 ∼
Nevada
New Mexico 47 41 ∼
Utah 47 46 ∼
Wyoming ∼ ∼ ∼
Pacific 1,286 ∼ 18
Alaska 27 26 ∼
California 928 860 16
San Francisco-Oakland 137 118 ∼
San Jose-Monterey 73 66 ∼
Los Angeles 197 186 ∼
Hawaii 31 ∼ ∼
Oregon 118 113 ∼
Washington 182 168 ∼
Seattle-Puget Sound 124 118 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–36
Table E.18: Cancer of the Urinary Bladder. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 694 661 22 274 261 ∼
Maine
Massachusetts 1,177 1,133 17 474 448 ∼
New Hampshire 210 210 ∼ 81 79 ∼
Rhode Island 259 256 ∼ 104 102 ∼
Vermont
Middle Atlantic 7,323 6,876 271 2,753 2,523 160
New Jersey 1,650 1,578 56 562 518 32
New York 3,027 2,775 133 1,228 1,108 72
Pennsylvania 2,646 2,523 82 963 897 56
Midwest
East North Central
Illinois 1,850 1,674 89 711 625 67
Indiana
Michigan 1,702 1,584 95 603 542 53
Detroit 684 605 76 264 213 46
Ohio 1,977 1,807 84 729 658 45
Wisconsin 866 854 ∼ 317 312 ∼
West North Central
Iowa 535 522 ∼ 159 154 ∼
Kansas 401 378 ∼ 164 152 ∼
Minnesota 743 719 ∼ 267 258 ∼
Missouri 837 802 28 256 232 20
Nebraska 299 292 ∼ 75 72 ∼




Delaware 111 99 ∼ 56 48 ∼
District of Columbia 44 ∼ 26 41 ∼ 26
Florida 3,631 3,504 71 1,239 1,166 63
Georgia
Atlanta 199 175 23 100 71 28
Maryland 610 544 50 272 230 27
North Carolina 976 887 78 366 329 34
South Carolina 542 486 51 165 128 36
Virginia
West Virginia 354 346 ∼ 168 161 ∼
East South Central
Alabama







Table E.18: Cancer of the Urinary Bladder. Invasive Cancer Incidence Counts by U.S. Census Region and
Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR
Registries that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 826 802 ∼ 246 242 ∼
Colorado 493 463 ∼ 177 174 ∼
Idaho 187 183 ∼ 45 45 ∼
Montana 144 136 ∼ 55 54 ∼
Nevada
New Mexico 196 190 ∼ 69 68 ∼
Utah 242 241 ∼ 70 69 ∼
Wyoming 86 86 ∼ 23 23 ∼
Pacific 5,907 5,340 145 1,872 1,682 65
Alaska 54 46 ∼ 16 ∼ ∼
California 4,143 3,753 126 1,347 1,216 59
San Francisco-Oakland 512 425 25 203 162 ∼
San Jose-Monterey 240 215 ∼ 80 72 ∼
Los Angeles 977 834 57 329 277 33
Hawaii 119 52 ∼ 36 ∼ ∼
Oregon 650 625 ∼ 191 186 ∼
Washington 941 864 ∼ 282 259 ∼
Seattle-Puget Sound 669 629 ∼ 200 189 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Includes invasive and in situ
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–38
Table E.19: Cancer of the Kidney and Renal Pelvis. Invasive Cancer Incidence Counts by U.S. Census Region
and Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and
NPCR Registries that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 255 236 ∼ 165 150 ∼
Maine
Massachusetts 491 454 24 345 329 ∼
New Hampshire 69 69 ∼ 42 42 ∼
Rhode Island 85 83 ∼ 88 86 ∼
Vermont
Middle Atlantic 3,140 2,777 263 2,065 1,765 227
New Jersey 681 599 63 468 405 52
New York 1,396 1,218 115 911 753 106
Pennsylvania 1,063 960 85 686 607 69
Midwest
East North Central
Illinois 846 722 102 607 528 67
Indiana
Michigan 721 616 97 472 391 74
Detroit 296 225 66 208 154 53
Ohio 803 722 65 556 493 52
Wisconsin 442 418 16 257 249 ∼
West North Central
Iowa 245 239 ∼ 155 151 ∼
Kansas 185 174 ∼ 131 120 ∼
Minnesota 341 327 ∼ 225 220 ∼
Missouri 436 395 39 272 233 34
Nebraska 122 119 ∼ 82 80 ∼




Delaware 51 44 ∼ 46 39 ∼
District of Columbia 34 ∼ 25 18 ∼ ∼
Florida 1,389 1,275 92 847 777 59
Georgia
Atlanta 144 91 50 81 50 29
Maryland 338 260 69 225 174 47
North Carolina 482 385 86 345 275 61
South Carolina 285 234 51 176 120 54
Virginia
West Virginia 151 142 ∼ 103 97 ∼
East South Central
Alabama







Table E.19: Cancer of the Kidney and Renal Pelvis. Invasive Cancer Incidence Counts by U.S. Census Region
and Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and
NPCR Registries that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 326 305 ∼ 195 185 ∼
Colorado 237 223 ∼ 143 135 ∼
Idaho 65 64 ∼ 69 68 ∼
Montana 64 59 ∼ 49 47 ∼
Nevada
New Mexico 95 87 ∼ 76 72 ∼
Utah 89 87 ∼ 43 42 ∼
Wyoming 29 28 ∼ 16 16 ∼
Pacific 2,569 2,226 139 1,563 1,357 102
Alaska 44 33 ∼ 19 ∼ ∼
California 1,828 1,600 120 1,127 973 90
San Francisco-Oakland 240 195 20 140 104 17
San Jose-Monterey 97 85 ∼ 80 69 ∼
Los Angeles 487 397 53 344 273 52
Hawaii 79 29 ∼ 35 ∼ ∼
Oregon 241 225 ∼ 144 142 ∼
Washington 377 339 ∼ 238 219 ∼
Seattle-Puget Sound 251 227 ∼ 155 139 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–40
Table E.20: Cancer of the Brain and Other Nervous System. Invasive Cancer Incidence Counts by U.S. Census
Region and Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER
and NPCR Registries that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 141 133 ∼ 109 101 ∼
Maine
Massachusetts 232 215 ∼ 233 222 ∼
New Hampshire 47 46 ∼ 32 31 ∼
Rhode Island 51 50 ∼ 41 39 ∼
Vermont
Middle Atlantic 1,445 1,259 105 1,283 1,142 99
New Jersey 300 260 25 296 267 20
New York 667 555 64 591 509 55
Pennsylvania 478 444 16 396 366 24
Midwest
East North Central
Illinois 413 364 34 348 308 31
Indiana
Michigan 391 361 27 318 289 22
Detroit 159 136 21 114 94 16
Ohio 407 368 26 360 326 24
Wisconsin 187 181 ∼ 174 164 ∼
West North Central
Iowa 110 110 ∼ 84 83 ∼
Kansas 83 79 ∼ 77 75 ∼
Minnesota 199 193 ∼ 149 148 ∼
Missouri 202 192 ∼ 182 172 ∼
Nebraska 57 57 ∼ 61 56 ∼




Delaware 25 23 ∼ 27 23 ∼
District of Columbia 26 ∼ ∼ ∼ ∼ ∼
Florida 633 580 41 537 484 40
Georgia
Atlanta 81 63 ∼ 64 56 ∼
Maryland 168 134 31 144 106 29
North Carolina 289 265 21 198 173 22
South Carolina 141 119 21 104 81 22
Virginia
West Virginia 67 66 ∼ 63 61 ∼
East South Central
Alabama







Table E.20: Cancer of the Brain and Other Nervous System. Invasive Cancer Incidence Counts by U.S. Census
Region and Division, State and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER
and NPCR Registries that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 171 163 ∼ 156 152 ∼
Colorado 151 143 ∼ 108 100 ∼
Idaho 65 65 ∼ 37 37 ∼
Montana 23 22 ∼ 33 31 ∼
Nevada
New Mexico 62 57 ∼ 46 43 ∼
Utah 69 67 ∼ 50 49 ∼
Wyoming 23 23 ∼ ∼ ∼ ∼
Pacific 1,525 1,370 50 1,182 1,044 43
Alaska 17 ∼ ∼ 17 ∼ ∼
California 1,105 984 48 843 744 40
San Francisco-Oakland 154 124 ∼ 118 98 ∼
San Jose-Monterey 82 70 ∼ 67 56 ∼
Los Angeles 267 227 18 217 186 23
Hawaii 28 ∼ ∼ 23 ∼ ∼
Oregon 131 128 ∼ 90 86 ∼
Washington 244 230 ∼ 209 192 ∼
Seattle-Puget Sound 168 161 ∼ 138 127 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–42
Table E.21: Cancer of the Thyroid. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 68 64 ∼ 191 171 ∼
Maine
Massachusetts 114 103 ∼ 352 317 ∼
New Hampshire 25 25 ∼ 44 44 ∼
Rhode Island 17 17 ∼ 72 67 ∼
Vermont
Middle Atlantic 764 681 42 2,390 2,019 182
New Jersey 167 149 ∼ 479 410 29
New York 334 292 ∼ 1,104 898 87
Pennsylvania 263 240 17 807 711 66
Midwest
East North Central
Illinois 209 187 ∼ 630 551 34
Indiana
Michigan 155 147 ∼ 523 445 55
Detroit 68 63 ∼ 226 177 38
Ohio 174 155 ∼ 453 407 22
Wisconsin 79 73 ∼ 229 223 ∼
West North Central
Iowa 56 55 ∼ 144 139 ∼
Kansas 54 49 ∼ 142 131 ∼
Minnesota 88 87 ∼ 238 222 ∼
Missouri 90 85 ∼ 286 259 20
Nebraska 25 24 ∼ 77 75 ∼




Delaware ∼ ∼ ∼ 53 43 ∼
District of Columbia 16 ∼ ∼ 46 ∼ 29
Florida 254 234 ∼ 712 630 64
Georgia
Atlanta 29 22 ∼ 128 91 29
Maryland 75 62 ∼ 290 220 53
North Carolina 99 92 ∼ 261 219 31
South Carolina 53 45 ∼ 140 111 26
Virginia
West Virginia 31 31 ∼ 107 105 ∼
East South Central
Alabama







Table E.21: Cancer of the Thyroid. Invasive Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 82 78 ∼ 225 211 ∼
Colorado 65 59 ∼ 222 205 ∼
Idaho 23 23 ∼ 51 49 ∼
Montana 24 22 ∼ 68 63 ∼
Nevada
New Mexico 32 32 ∼ 100 95 ∼
Utah 33 31 ∼ 115 107 ∼
Wyoming ∼ ∼ ∼ 19 18 ∼
Pacific 740 608 20 2,164 ∼ 69
Alaska 18 ∼ ∼ 30 20 ∼
California 505 422 18 1,577 1,271 55
San Francisco-Oakland 61 42 ∼ 177 124 ∼
San Jose-Monterey 51 44 ∼ 117 88 ∼
Los Angeles 138 109 ∼ 474 375 23
Hawaii 37 ∼ ∼ 73 ∼ ∼
Oregon 64 59 ∼ 148 142 ∼
Washington 116 101 ∼ 336 282 ∼
Seattle-Puget Sound 84 77 ∼ 247 211 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or




ancer Statistics: 1999 Incidence
E–44
Table E.22: Hodgkin Lymphoma. Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 51 48 ∼ 53 47 ∼
Maine
Massachusetts 116 109 ∼ 104 99 ∼
New Hampshire 22 22 ∼ 19 19 ∼
Rhode Island 20 19 ∼ 16 16 ∼
Vermont
Middle Atlantic 664 556 79 564 486 ∼
New Jersey 145 119 23 128 108 17
New York 302 242 40 264 219 29
Pennsylvania 217 195 16 172 159 ∼
Midwest
East North Central
Illinois 180 144 18 149 132 ∼
Indiana
Michigan 184 159 23 138 120 18
Detroit 73 55 17 66 53 ∼
Ohio 174 150 17 131 117 ∼
Wisconsin 87 78 ∼ 73 71 ∼
West North Central
Iowa 40 39 ∼ 42 41 ∼
Kansas 49 45 ∼ 31 30 ∼
Minnesota 87 78 ∼ 77 69 ∼
Missouri 89 80 ∼ 81 71 ∼
Nebraska 30 30 ∼ 23 19 ∼




Delaware 19 ∼ ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼ ∼ ∼
Florida 225 195 26 204 178 21
Georgia
Atlanta 36 20 ∼ 33 24 ∼
Maryland 77 56 18 64 47 ∼
North Carolina 103 77 21 95 71 22
South Carolina 44 32 ∼ 41 29 ∼
Virginia
West Virginia 30 29 ∼ 30 29 ∼
East South Central
Alabama







Table E.22: Hodgkin Lymphoma. Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 50 46 ∼ 50 45 ∼
Colorado 64 61 ∼ 44 40 ∼
Idaho ∼ ∼ ∼ 18 18 ∼
Montana ∼ ∼ ∼ ∼ ∼ ∼
Nevada
New Mexico 28 27 ∼ ∼ ∼ ∼
Utah 27 26 ∼ 26 26 ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific 586 518 29 514 443 23
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 429 381 27 379 326 19
San Francisco-Oakland 53 37 ∼ 47 34 ∼
San Jose-Monterey 34 32 ∼ 23 21 ∼
Los Angeles 120 105 ∼ 125 105 ∼
Hawaii ∼ ∼ ∼ ∼ ∼ ∼
Oregon 50 47 ∼ 44 41 ∼
Washington 88 81 ∼ 76 67 ∼
Seattle-Puget Sound 59 56 ∼ 58 55 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.23: Non-Hodgkin Lymphoma. Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 407 378 23 355 338 ∼
Maine
Massachusetts 630 580 19 624 574 23
New Hampshire 100 99 ∼ 102 100 ∼
Rhode Island 110 106 ∼ 131 129 ∼
Vermont
Middle Atlantic 4,114 3,506 396 3,963 3,460 336
New Jersey 936 805 88 868 761 84
New York 1,786 1,446 227 1,770 1,476 188
Pennsylvania 1,392 1,255 81 1,325 1,223 64
Midwest
East North Central
Illinois 1,203 1,060 94 1,072 963 70
Indiana
Michigan 964 870 79 925 838 76
Detroit 392 327 56 374 311 57
Ohio 1,107 1,002 77 1,120 1,009 79
Wisconsin 543 513 18 452 438 ∼
West North Central
Iowa 302 295 ∼ 291 286 ∼
Kansas 254 235 ∼ 246 227 ∼
Minnesota 530 502 ∼ 474 447 ∼
Missouri 512 476 29 508 456 45
Nebraska 147 142 ∼ 153 146 ∼




Delaware 59 55 ∼ 55 44 ∼
District of Columbia 48 17 28 33 ∼ 16
Florida 1,858 1,690 136 1,585 1,463 95
Georgia
Atlanta 193 141 45 142 106 31
Maryland 445 333 81 365 286 61
North Carolina 598 518 69 515 438 72
South Carolina 309 241 64 283 231 46
Virginia
West Virginia 198 193 ∼ 199 191 ∼
East South Central
Alabama







Table E.23: Non-Hodgkin Lymphoma. Cancer Incidence Counts by U.S. Census Region and Division, State
and Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries
that Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 418 404 ∼ 338 326 ∼
Colorado 343 327 ∼ 347 332 ∼
Idaho 101 99 ∼ 109 104 ∼
Montana 89 86 ∼ 64 64 ∼
Nevada
New Mexico 118 112 ∼ 116 109 ∼
Utah 172 169 ∼ 122 121 ∼
Wyoming 32 30 ∼ 33 32 ∼
Pacific 4,023 3,414 168 3,355 2,867 126
Alaska 45 38 ∼ 42 37 ∼
California 2,918 2,478 147 2,422 2,056 113
San Francisco-Oakland 469 356 38 336 253 25
San Jose-Monterey 185 147 ∼ 181 140 ∼
Los Angeles 800 652 63 647 530 50
Hawaii 114 30 ∼ 80 20 ∼
Oregon 352 330 ∼ 302 287 ∼
Washington 594 538 ∼ 509 467 ∼
Seattle-Puget Sound 432 386 ∼ 350 322 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.24: Multiple Myeloma. Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 98 89 ∼ 73 62 ∼
Maine
Massachusetts 148 136 ∼ 129 113 ∼
New Hampshire 33 33 ∼ 20 20 ∼
Rhode Island 25 24 ∼ 33 32 ∼
Vermont
Middle Atlantic 1,072 856 179 1,097 825 223
New Jersey 236 187 44 218 162 45
New York 498 388 86 514 371 115
Pennsylvania 338 281 49 365 292 63
Midwest
East North Central
Illinois 311 239 59 325 222 92
Indiana
Michigan 284 224 57 229 173 52
Detroit 129 82 47 115 72 41
Ohio 310 251 52 264 219 42
Wisconsin 130 125 ∼ 123 117 ∼
West North Central
Iowa 81 78 ∼ 72 71 ∼
Kansas 72 67 ∼ 67 55 ∼
Minnesota 129 123 ∼ 102 92 ∼
Missouri 123 99 21 136 103 30
Nebraska 47 45 ∼ 41 40 ∼




Delaware 22 ∼ ∼ 18 16 ∼
District of Columbia 19 ∼ ∼ 21 ∼ 17
Florida 513 436 74 453 396 50
Georgia
Atlanta 49 28 20 47 27 19
Maryland 128 83 40 114 70 41
North Carolina 168 128 38 162 113 46
South Carolina 91 60 29 91 54 35
Virginia
West Virginia 47 46 ∼ 45 40 ∼
East South Central
Alabama







Table E.24: Multiple Myeloma. Cancer Incidence Counts by U.S. Census Region and Division, State and
Metropolitan Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries that
Meet Quality Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 93 84 ∼ 84 73 ∼
Colorado 95 89 ∼ 78 76 ∼
Idaho 38 37 ∼ 25 25 ∼
Montana 24 21 ∼ 20 20 ∼
Nevada
New Mexico 39 35 ∼ 33 29 ∼
Utah 45 43 ∼ 25 25 ∼
Wyoming ∼ ∼ ∼ ∼ ∼ ∼
Pacific ∼ 844 95 ∼ 685 94
Alaska ∼ ∼ ∼ ∼ ∼ ∼
California 744 589 86 647 507 85
San Francisco-Oakland 102 58 20 89 57 20
San Jose-Monterey 32 26 ∼ 45 38 ∼
Los Angeles 234 165 50 179 120 44
Hawaii 22 ∼ ∼ 23 ∼ ∼
Oregon 93 89 ∼ 63 60 ∼
Washington 163 150 ∼ 119 108 ∼
Seattle-Puget Sound 114 104 ∼ 86 76 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or
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Table E.25: Leukemias. Cancer Incidence Counts by U.S. Census Region and Division, State and Metropolitan
Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria,*† 1999
Male Female
Area All Races White Black All Races White Black
Northeast
New England
Connecticut 203 187 ∼ 164 146 ∼
Maine
Massachusetts 379 362 ∼ 340 317 ∼
New Hampshire 73 72 ∼ 63 63 ∼
Rhode Island 74 72 ∼ 51 50 ∼
Vermont
Middle Atlantic 2,645 2,356 178 2,134 1,878 169
New Jersey 555 488 44 426 378 34
New York 1,190 1,034 88 982 849 79
Pennsylvania 900 834 46 726 651 56
Midwest
East North Central
Illinois 786 694 59 621 537 68
Indiana
Michigan 619 558 47 507 441 56
Detroit 263 224 34 233 187 42
Ohio 658 583 49 552 509 36
Wisconsin 376 361 ∼ 311 298 ∼
West North Central
Iowa 248 241 ∼ 166 160 ∼
Kansas 179 166 ∼ 126 116 ∼
Minnesota 384 353 ∼ 292 263 ∼
Missouri 341 309 30 271 246 21
Nebraska 111 102 ∼ 102 96 ∼




Delaware 44 39 ∼ 33 27 ∼
District of Columbia 25 ∼ 17 17 ∼ ∼
Florida 1,251 1,153 75 954 848 88
Georgia
Atlanta 103 72 22 61 44 ∼
Maryland 241 188 48 183 130 43
North Carolina 382 334 43 313 256 52
South Carolina 187 140 46 138 111 22
Virginia
West Virginia 144 136 ∼ 114 110 ∼
East South Central
Alabama







Table E.25: Leukemias. Cancer Incidence Counts by U.S. Census Region and Division, State and Metropolitan
Area, Sex, and Race (All Races, White, Black), United States: SEER and NPCR Registries that Meet Quality
Criteria,*† 1999 (continued)
Male Female
Area All Races White Black All Races White Black
West South Central
Arkansas





Arizona 247 236 ∼ 214 201 ∼
Colorado 249 239 ∼ 190 182 ∼
Idaho 88 88 ∼ 57 56 ∼
Montana 67 61 ∼ 41 40 ∼
Nevada
New Mexico 95 87 ∼ 75 74 ∼
Utah 106 106 ∼ 76 69 ∼
Wyoming 34 34 ∼ 26 26 ∼
Pacific 2,596 2,212 116 1,827 ∼ 78
Alaska 24 19 ∼ 25 18 ∼
California 1,860 1,580 94 1,319 1,115 68
San Francisco-Oakland 228 157 24 166 121 ∼
San Jose-Monterey 102 88 ∼ 102 90 ∼
Los Angeles 521 428 40 336 268 31
Hawaii 77 27 ∼ 51 ∼ ∼
Oregon 215 208 ∼ 163 156 ∼
Washington 420 378 ∼ 269 248 ∼
Seattle-Puget Sound 296 262 ∼ 187 171 ∼
∗ Data are from selected statewide and metropolitan area cancer registries that meet the following data quality criteria for all invasive cancer sites
combined: case ascertainment is at least 90% complete; ≥ 97% of cases pass a standard set of computerized edits; ≤ 5% of cases were ascertained by death
certificate only; ≤ 3% of cases are missing information on sex; ≤ 5% of cases are missing information on race; ≤ 3% of cases are missing information
on age. See Appendix H for registry-specific data quality information.
† Invasive cancers only
∼ Counts are suppressed if fewer than 16 cases were reported in the specific area-sex-race category.
Notes: Cases from suppressed counts are included in region/division counts. Region/division counts are presented for regions/divisions with 100% of the
population covered by registries that meet the data quality criteria specified above unless the count for exactly one state in the region or













Table G.1: State and Metropolitan Area Cancer Registries by Federal Funding
Source and First Diagnosis Year* for Which Cancer Cases Were Reportable to
CDC’s NPCR or NCI’s SEER Program
Alabama 1996 NPCR NPCR
Alaska 1996 NPCR NPCR
Arizona 1995 NPCR NPCR
Arkansas 1996 NPCR NPCR
California 1995/2000 NPCR NPCR/SEER
Los Angeles 1992 SEER SEER
San Francisco-Oakland 1973 SEER SEER
San Jose-Monterey 1992 SEER SEER
Colorado 1995 NPCR NPCR
Connecticut 1973 SEER SEER
Delaware 1997 NPCR NPCR
District of Columbia 1996 NPCR NPCR
Florida 1995 NPCR NPCR
Georgia 1995 NPCR NPCR
Atlanta 1975 SEER SEER
Hawaii 1973 SEER SEER
Idaho 1995 NPCR NPCR
Illinois 1995 NPCR NPCR
Indiana 1995 NPCR NPCR
Iowa 1973 SEER SEER
Kansas 1995 NPCR NPCR
Kentucky 1995/2000 NPCR NPCR/SEER
Louisiana 1995/2000 NPCR NPCR/SEER
Maine 1995 NPCR NPCR
Maryland 1996 NPCR NPCR
Massachusetts 1995 NPCR NPCR
Michigan 1995 NPCR NPCR
Detroit 1973 SEER SEER
Minnesota 1995 NPCR NPCR
Mississippi 1996 NPCR NPCR
Missouri 1996 NPCR NPCR
Montana 1995 NPCR NPCR
Nebraska 1995 NPCR NPCR
Nevada 1995 NPCR NPCR
First Diagnosis Year for
Which Cases Were 
Reportable to Federal Funding Source
State or Territory NPCR or SEER* 1999 2002
continued
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New Hampshire 1995 NPCR NPCR
New Jersey 1995/2000 NPCR NPCR/SEER
New Mexico 1973 SEER SEER
New York 1996 NPCR NPCR
North Carolina 1995 NPCR NPCR
North Dakota 1997 NPCR NPCR
Ohio 1996 NPCR NPCR
Oklahoma 1997 NPCR NPCR
Oregon 1996 NPCR NPCR
Palau 1999 NPCR NPCR
Pennsylvania 1995 NPCR NPCR
Puerto Rico 1998 NPCR NPCR
Rhode Island 1995 NPCR NPCR
South Carolina 1996 NPCR NPCR
South Dakota 2000 NPCR NPCR
Tennessee 1999 NPCR NPCR
Texas 1995 NPCR NPCR
Utah 1973 SEER SEER
Vermont 1996 NPCR NPCR
Virgin Islands 1999 NPCR NPCR
Virginia 1996 NPCR NPCR
Washington 1995 NPCR NPCR
Seattle-Puget Sound 1974 SEER SEER
West Virginia 1995 NPCR NPCR
Wisconsin 1995 NPCR NPCR
Wyoming 1996 NPCR NPCR
Table G.1: State and Metropolitan Area Cancer Registries by Federal Funding
Source and First Diagnosis Year* for Which Cancer Cases Were Reportable to
CDC’s NPCR or NCI’s SEER Program (continued)
First Diagnosis Year for
Which Cases Were 
Reportable to Federal Funding Source
State or Territory NPCR or SEER* 1999 2002
* Diagnosis year is the year during which a reported case of cancer was first diagnosed.
CDC = Centers for Disease Control and Prevention; NCI = National Cancer Institute; NPCR = National Program
of Cancer Registries; SEER = Surveillance, Epidemiology, and End Results.
Appendix H

Alabama <90 100.0 3.4 0.04 4.55 0.06
Alaska >95 100.0 0.3 0.00 0.95 0.05
Arizona >95 100.0 2.1 0.00 0.98 0.01
Arkansas <90 100.0 0.0 0.00 0.43 0.00
California >95 100.0 1.0 0.00 2.61 0.00
Greater Bay¶ 90-94 100.0 2.0 0.00 3.96 0.00
Los Angeles >95 100.0 0.8 0.00 1.43 0.00
Colorado >95 100.0 1.0 0.01 1.13 0.11
Connecticut >95 100.0 1.0 0.00 1.06 0.00
Delaware >95 100.0 1.4 0.05 0.58 0.00
District of Columbia >95 100.0 2.9 0.00 2.83 0.07
Florida >95 100.0 3.8 0.02 0.91 0.01
Georgia <90 100.0 0.8 0.00 1.11 0.01
Atlanta >95 100.0 1.7 0.00 0.72 0.00
Hawaii 90-94 100.0 0.5 0.00 3.90 0.00
Idaho >95 100.0 2.8 0.00 0.02 0.00
Illinois >95 100.0 2.0 0.00 2.10 0.00
Indiana 90-94 100.0 NA 0.00 0.54 0.00
Iowa >95 100.0 1.6 0.00 1.07 0.00
Kansas >95 100.0 3.7 0.00 2.39 0.00
Kentucky >95 100.0 1.8 0.01 2.61 0.00
Louisiana >95 100.0 0.8 0.00 0.05 0.00
Maine
Maryland >95 100.0 3.1 0.00 2.39 0.06
Massachusetts >95 100.0 2.5 0.00 2.04 0.00
Michigan >95 100.0 1.0 0.01 1.24 0.02
Detroit >95 100.0 1.0 0.00 0.84 0.00
Minnesota >95 99.9 2.2 0.00 1.97 0.01
Mississippi
Missouri >95 100.0 3.3 0.00 0.62 0.00
Montana 90-94 100.0 5.0 0.00 2.73 0.05
Nebraska >95 100.0 1.5 0.00 3.31 0.00
Nevada <90 99.9 9.5 0.03 0.40 0.00
New Hampshire 90-94 100.0 2.6 0.00 1.03 0.02
New Jersey >95 100.0 1.1 0.00 0.23 0.01
New Mexico 90-94 100.0 4.1 0.00 0.00 0.00
New York >95 100.0 2.5 0.00 2.10 0.00
North Carolina 90-94 100.0 2.0 0.00 0.36 0.01
North Dakota >95 100.0 0.0 0.00 0.10 0.00
Ohio >95 100.0 3.3 0.00 2.54 0.00
Oklahoma <90 100.0 NA 0.00 3.53 0.01
Oregon >95 100.0 4.1 0.00 1.58 0.00
Pennsylvania >95 100.0 0.4 0.00 1.70 0.00
Rhode Island >95 100.0 2.6 0.00 0.02 0.00
South Carolina >95 100.0 2.2 0.00 0.70 0.00
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Table H.1: Achievement of Selected Data Quality Criteria by State and SEER
Metropolitan Area Cancer Registries, 1999
Only data from the shaded states and metropolitan areas are included in United States
Cancer Statistics: 1999 Incidence.*
% Case % Passing % % Missing % Missing % Missing
Cancer Registry Ascertainment† Edits‡ DCOs§ Sex Race Age
continued
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Table H.1: Achievement of Selected Data Quality Criteria by State and SEER
Metropolitan Area Cancer Registries, 1999 (continued)
Only data from the shaded states and metropolitan areas are included in United States
Cancer Statistics: 1999 Incidence.*
% Case % Passing % % Missing % Missing % Missing




Utah >95 100.0 0.3 0.00 0.00 0.00
Vermont <90 100.0 NA 0.04 2.05 0.15
Virginia 90-94 100.0 NA 0.00 0.93 0.02
Washington >95 100.0 0.6 0.00 2.69 0.00
Seattle-Puget Sound >95 100.0 0.8 0.00 0.73 0.00
West Virginia >95 100.0 1.7 0.01 1.32 0.00
Wisconsin >95 100.0 2.7 0.00 0.73 0.00
Wyoming >95 100.0 1.2 0.00 0.00 0.00
* Registry members of the National Program of Cancer Registries whose data are not included in this report chose whether to have their
data quality information listed.
† Completeness of case ascertainment was estimated by methods developed by the North American Association of Central Cancer
Registries (Howe 2001; Tucker 1999; Wu 2002).
‡ Computerized edits test the validity and logic of data components reported for selected items.
§ DCOs, or death-certificate only cases, are cancer cases ascertained solely on the basis of a death certificate after the registry has
completed a routine procedure known as death clearance and followback. 24–26
¶ Greater Bay includes San Francisco-Oakland and San Jose-Monterey Registries.
||Registry reference year is after 1999.





Table I.1: SEER Site Groups for Primary Cancer Sites Based on ICD–O–2 
Buccal cavity and pharynx
Lip C000:C009 M-9590:9989
Tongue C019:C029 M-9590:9989
Salivary gland C079:C089 M-9590:9989
Floor of mouth C040:C049 M-9590:9989














Ascending colon C182 M-9590:9989
Hepatic flexure C183 M-9590:9989
Transverse colon C184 M-9590:9989
Splenic flexure C185 M-9590:9989
Descending colon C186 M-9590:9989
Sigmoid colon C187 M-9590:9989
Large intestine, NOS C188:C189,C260 M-9590:9989
Rectum & rectosigmoid
Rectosigmoid junction C199 M-9590:9989
Rectum C209 M-9590:9989
Anus, anal canal & anorectum C210:C212,C218 M-9590:9989
Liver & intrahepatic bile duct
Liver C220 M-9590:9989
Intrahepatic bile duct C221 M-9590:9989
Gallbladder C239 M-9590:9989
Other biliary C240:C249 M-9590:9989
Pancreas C250:C259 M-9590:9989
Retroperitoneum C480 M-9590:9989
Peritoneum, omentum & C481:C482 M-9590:9989
mesentery
Other digestive organs C268:C269,C488 M-9590:9989
Respiratory system 
Nasal cavity, middle ear & C300:C301,C310:C319 M-9590:9989
accessory sinuses
Larynx C320:C329 M-9590:9989
Lung and bronchus C340:C349 M-9590:9989
Pleura C384 M-9590:9989
Trachea, mediastinum & other C339,C381:C383,C388,C390 M-9590:9989
respiratory organs C398,C399
Primary Site/ Excluding
Primary Site Group Histologic Type Histologic Type
continued
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Bones and joints C400:C419 M-9590:9989
Soft tissue (including heart) C380,C470:C479,C490:C499 M-9590:9989
Skin (excluding basal and squamous)
Melanomas—skin C440:C449 (types 8720:8790)



















Other male genital organs C630:C639 M-9590:9989
Urinary system
Bladder C670:C679 M-9590:9989
Kidney and renal pelvis C649,C659 M-9590:9989
Ureter C669 M-9590:9989
Other urinary organs C680:C689 M-9590:9989
Eye & orbit C690:C699 M-9590:9989
Brain and other nervous system 
Brain C710:C719 M-9530:9539,
9590:9989




Other endocrine C379,C740:C749,C750:C759 M-9590:9989
(including thymus)




Primary Site Group Histologic Type Histologic Type
Lymphomas
Hodgkin lymphoma types 9650:9667
Nodal for sites:C024,C098,C099,C111,
C142,C379,C422,C770:C779
Extranodal for all other sites
Non-Hodgkin lymphoma types 9590:9595,9670:9717,9823,9827
Nodal for sites:C024,C098,C099,C111,C142,C379,
C422,C770:C779
Extranodal types 9590:9595, 9670:9717 
for all other sites
types 9823,9827
for all other sites except C420,C421,C424
Multiple myeloma type 9731:9732
Leukemias
Lymphocytic
Acute lymphocytic types 9821,9828
Chronic lymphocytic C420,C421,C424 (type 9823)
Other lymphocytic types 9820,9822,9824,9825,9826
Myeloid
Acute myeloid types 9840,9861,9866,9867,9871-9874
Chronic myeloid types 9863,9868
Other myeloid types 9860,9862,9864
Monocytic
Acute monocytic type 9891
Chronic monocytic type 9893
Other monocytic types 9890,9892,9894
Other
Other acute types 9801,9841,9931,9932
Other chronic types 9803,9842
Aleukemic, subleukemic types 9800,9802,9804,9830,9850,9870,
and NOS 9880,9900,9910,9930,9940:9941
C420,C421,C424 (type 9827)




Invalid site Site or histology code not within valid range or 
site code not found in this table.
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Table I.1: SEER Site Groups for Primary Cancer Sites Based on ICD–O–2
(continued)
Primary Site/ Excluding
Primary Site Group Histologic Type Histologic Type
ICD–O–2 = International Classification of Diseases for Oncology, 2nd ed.; SEER = Surveillance, Epidemiology, and End Results.
Source: Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L. Edwards BK, editors. SEER Cancer Statistics Review,
1973–1999 (Table A–3). Bethesda (MD); National Cancer Institute; 2002. Also available from: URL:






Table J.1: Projected Population Counts by U.S. Census Region and Division, State
and SEER Metropolitan Area, Sex, and Race (All Races, White, Black), 1999*
United States 133,349,782 110,321,683 16,555,757 139,437,703 114,250,059 18,301,941
Northeast Census Region 25,035,338 20,943,696 2,998,634 26,826,675 22,300,890 3,372,345
New England Division 6,544,836 5,963,667 378,342 6,948,797 6,333,408 403,385
Connecticut 1,594,082 1,402,101 146,123 1,688,963 1,479,609 161,621
Maine 610,143 599,396 3,541 639,568 628,771 2,784
Massachusetts 2,980,618 2,660,527 196,783 3,195,630 2,859,461 207,630
New Hampshire 591,015 577,105 4,983 609,027 595,817 4,104
Rhode Island 476,746 437,037 25,181 514,297 473,324 25,769
Vermont 292,232 287,501 1,731 301,312 296,426 1,477
Middle Atlantic Division 18,490,502 14,980,029 2,620,292 19,877,878 15,967,482 2,968,960
New Jersey 3,952,320 3,140,307 568,465 4,201,145 3,317,317 628,607
New York 8,770,904 6,727,305 1,503,596 9,455,387 7,165,718 1,720,784
Pennsylvania 5,767,278 5,112,417 548,231 6,221,346 5,484,447 619,569
Midwest Census Region 30,840,459 27,033,602 3,039,023 32,402,640 28,213,808 3,382,736
East North Central Division 21,638,223 18,601,007 2,527,657 22,802,600 19,432,832 2,836,020
Illinois 5,916,262 4,824,734 874,010 6,212,197 5,001,499 980,787
Indiana 2,892,566 2,619,519 236,287 3,047,309 2,747,647 261,430
Michigan 4,803,696 4,027,357 661,446 5,062,808 4,194,065 752,675
Detroit† 1,957,737 1,446,258 458,143 2,123,229 1,523,270 546,664
Ohio 5,442,355 4,752,381 613,184 5,811,240 5,041,360 688,298
Wisconsin 2,583,344 2,377,016 142,730 2,669,046 2,448,261 152,830
West North Central Division 9,202,236 8,432,595 511,366 9,600,040 8,780,976 546,716
Iowa 1,399,035 1,346,463 29,753 1,471,690 1,420,081 28,150
Kansas 1,306,160 1,193,279 78,189 1,348,474 1,232,470 78,721
Minnesota 2,355,710 2,186,797 76,451 2,421,214 2,251,774 72,103
Missouri 2,650,374 2,321,542 288,459 2,817,380 2,445,815 328,816
Nebraska 815,142 763,344 33,183 850,699 796,291 34,997
North Dakota 314,940 294,944 2,319 318,184 298,039 1,840
South Dakota 360,875 326,226 3,012 372,399 336,506 2,089
South Census Region 46,959,277 36,882,052 8,818,684 49,554,322 38,344,020 9,860,562
South Atlantic Division 24,072,748 18,352,260 5,080,545 25,495,852 19,114,881 5,686,314
Delaware 366,530 286,792 70,805 386,862 298,836 78,261
District of Columbia 244,005 89,325 146,282 277,059 93,110 174,187
Florida 7,333,414 6,053,646 1,116,074 7,779,773 6,386,787 1,212,852
Georgia 3,791,682 2,660,087 1,043,508 3,994,493 2,714,653 1,187,978
Atlanta† 1,307,258 854,668 397,282 1,380,609 875,331 451,796
Maryland 2,515,847 1,720,562 684,647 2,657,985 1,771,058 769,302
continued
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All Races White Black All Races White Black
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North Carolina 3,713,183 2,822,968 789,314 3,936,974 2,935,607 895,093
South Carolina 1,874,780 1,314,354 538,921 2,009,987 1,368,307 617,229
Virginia 3,361,948 2,565,538 663,972 3,516,603 2,646,613 721,415
West Virginia 871,359 838,988 27,022 936,116 899,910 29,997
East South Central Division 7,998,890 6,354,102 1,560,526 8,586,683 6,705,611 1,790,770
Alabama 2,098,014 1,551,736 526,174 2,273,152 1,637,849 612,716
Kentucky 1,923,406 1,768,730 137,339 2,036,644 1,868,539 150,976
Mississippi 1,328,964 842,050 472,020 1,442,275 887,033 539,741
Tennessee 2,648,506 2,191,586 424,993 2,834,612 2,312,190 487,337
West South Central Division 14,887,639 12,175,690 2,177,613 15,471,787 12,523,528 2,383,478
Arkansas 1,236,966 1,029,547 191,724 1,321,616 1,084,472 220,070
Louisiana 2,103,538 1,406,913 659,208 2,269,021 1,477,392 754,112
Oklahoma 1,646,239 1,366,806 129,815 1,722,683 1,428,407 135,175
Texas 9,900,896 8,372,424 1,196,866 10,158,467 8,533,257 1,274,121
West Census Region 30,514,708 25,462,333 1,699,416 30,654,066 25,391,341 1,686,298
Mountain Division 8,520,945 7,741,954 293,680 8,612,615 7,807,439 280,644
Arizona 2,362,679 2,097,320 89,238 2,411,702 2,138,420 86,006
Colorado 2,012,093 1,856,301 89,868 2,045,614 1,886,188 86,817
Idaho 625,182 606,066 3,959 626,646 606,958 3,588
Montana 439,393 407,282 1,793 443,762 410,303 1,431
Nevada 924,000 794,334 72,141 890,035 756,182 69,684
New Mexico 855,563 739,568 23,607 883,706 761,484 22,353
Utah 1,060,918 1,009,293 10,871 1,072,684 1,019,382 8,777
Wyoming 241,117 231,790 2,203 238,466 228,522 1,988
Pacific Division 21,993,763 17,720,379 1,405,736 22,041,451 17,583,902 1,405,654
Alaska 325,227 248,093 12,647 294,385 218,474 11,372
California 16,579,347 13,228,889 1,235,844 16,589,374 13,089,930 1,252,823
San Francisco-Oakland† 1,989,602 1,339,764 235,788 2,049,064 1,345,945 250,283
San Jose-Monterey† 1,174,520 907,604 48,789 1,149,775 888,746 40,853
Los Angeles† 4,620,176 3,492,101 493,637 4,714,892 3,486,712 550,524
Hawaii 590,114 169,355 19,035 590,366 151,881 14,840
Oregon 1,637,560 1,530,542 32,200 1,676,382 1,565,372 29,816
Washington 2,861,515 2,543,500 106,010 2,890,944 2,558,245 96,803
Seattle-Puget Sound† 1,961,054 1,696,116 92,924 1,985,892 1,706,701 86,208
Males Females
All Races White Black All Races White Black
Table J.1: Projected Population Counts by U.S. Census Region and Division, State
and SEER Metropolitan Area, Sex, and Race (All Races, White, Black), 1999*
(continued)
* The 1999 race- and sex-specific population estimates from the U.S. Bureau of the Census, as available from SEER*Stat (www.SEER.cancer.gov/
population), are projected from estimates and do not take into consideration results from the enumerated 2000 census.
† The populations of the metropolitan areas of Detroit, Atlanta, San Francisco-Oakland, San Jose-Monterey, Los Angeles, and Seattle-
Puget Sound are shown separately because these populations have separate metropolitan area Surveillance, Epidemiology, and End
Results (SEER) cancer registries. State population totals include the populations of the SEER metropolitan areas.
Source: Census Bureau population figures, as modified by the SEER Program. Available from: http://www.seer.cancer.gov/popdata





Table K.1: 1970 and 2000 U.S. Standard Population Weights 




5-9    0.098204 0.072533
10-14  0.102304 0.073032
15-19  0.093845 0.072169
20-24  0.080561 0.066478
25-29  0.066320 0.064529
30-34  0.056249 0.071044
35-39  0.054656 0.080762
40-44  0.058958 0.081851
45-49  0.059622 0.072118
50-54  0.054643 0.062716
55-59  0.049077 0.048454
60-64  0.042403 0.038793
65-69  0.034406 0.034264
70-74  0.026789 0.031773
75-79  0.018871 0.026999
80-84  0.011241 0.017842
85+    0.007435 0.015508
* Department of Health and Human Services policy mandates that, beginning with the 1999 data year, the 2000 U.S. standard
population will be used for reporting age-adjusted disease rates. 
Sources: Klein, RJ, and Schoenborn, CA. Age adjustment using the 2000 projected U.S. population. Healthy People Statistical 
Notes, No. 20. Hyattsville, MD: National Center for Health Statistics, 2001.
Surveillance, Epidemiology, and End Results (SEER) Program public-use data (1973-1999). Available from:
http://www.SEER.cancer.gov.publicdata/ [accessed Aug 8, 2002].
Year 1970 Year 2000 






The bias-corrected incidence rate for a cancer site was
computed on the basis of the relationship between
mortality from that cancer site in an entire U.S. census
region or division and mortality from that cancer site in
the states in the region or division for which incidence
data were eligible for inclusion in United States Cancer
Statistics: 1999 Incidence.
To estimate the bias-corrected incidence rate for a cancer
site for a U.S. census region or division, we first
calculated the observed age-adjusted incidence rate using
data from cancer registries in the region or division
whose data are included in this report. In addition, the
age-adjusted mortality rate for the same included portion
of the region or division was calculated, as well as the
age-adjusted mortality rate for the areas in the region or
division whose incidence data are not included in the
observed incidence rate. The true mortality rate for the
region or division was then calculated as the weighted
sum of the two age-adjusted mortality rates, where the
weights are based on the population in the two areas (i.e.,
included and excluded) of the region or division. An
estimate of the bias in the observed mortality rate was
therefore the difference between the true and observed
mortality rates expressed as a proportion of the observed
mortality rate. This estimate of bias was then used to
calculate a bias-corrected estimate of the incidence rate
for the region or division. 
As an example, consider female invasive breast cancer in
the New England census region. Incidence data for
Connecticut, Massachusetts, New Hampshire, and
Rhode Island (states that have 86.3% of the region’s total
population) were eligible for inclusion in the calculation
of the regional incidence rate; data for Maine and
Vermont were not eligible. The invasive female breast
cancer mortality rate for the eligible areas is 27.3 per
100,000, and the rate for Maine and Vermont combined
is 27.7. The true mortality rate is the weighted sum of
the two rates and is computed as follows: 
27.4 = [0.863 * 27.3 + (1- 0.863) * 27.7].
The observed incidence rate for the region therefore has
an estimated bias (expressed as a proportion of the
observed rate) of
-0.0037 = (27.3–27.4)/27.3.
The observed age-adjusted incidence rate for New
England is 145.1 per 100,000. Because the sign for the
estimated bias is negative, this proportion of the rate
must be added to the observed rate to compensate for
bias. The bias-corrected rate, then, is
145.64 = 145.1 + (0.0037 * 145.1).
In this example, the confidence interval for the observed
incidence rate (142.2–148.1) includes the bias-corrected
rate. 
For this report, the bias-corrected, age-adjusted
incidence rate was calculated for four major cancer sites
(female breast, male prostate, male and female
colorectal, male and female lung and bronchus) for each
U.S. census region or division. Then, if the bias-
corrected, age-adjusted incidence rates for all four sites
fell within the confidence interval of the observed age-
adjusted incidence rates for all four sites, the rates for all
cancer sites in the region or division were published.
Estimating Bias-Corrected Incidence Rates 






Table M.1: U.S. Population Median Age in Years by State, Sex, and Race 
(All Races, White, Black), 2000 
United States 34.0 36.5 28.5 36.5 38.9 31.7
Alabama 34.4 36.8 27.8 37.2 39.5 31.8
Alaska 32.4 35.4 27.8 32.5 35.2 26.7
Arizona 32.9 36.6 29.0 35.5 39.2 29.0
Arkansas 34.6 36.7 25.9 37.4 39.5 29.7
California 32.2 36.2 30.5 34.4 38.5 32.6
Colorado 33.2 35.2 30.3 35.4 37.3 30.3
Connecticut 36.1 38.4 27.9 38.6 40.7 31.5
Delaware 34.9 37.3 28.8 37.1 39.5 31.9
District of Columbia 33.7 34.8 34.3 35.6 34.2 37.6
Florida 37.3 40.1 27.3 40.1 43.1 30.0
Georgia 32.1 35.0 27.7 34.6 37.4 30.7
Hawaii 35.1 38.8 28.2 37.4 41.0 25.6
Idaho 32.2 33.5 25.7 34.2 35.5 21.6
Illinois 33.3 35.9 27.7 36.0 38.5 31.6
Indiana 33.9 35.1 27.8 36.5 37.6 30.7
Iowa 35.2 36.2 25.1 38.0 38.9 25.5
Kansas 33.7 35.5 27.5 36.5 38.2 29.8
Kentucky 34.6 35.4 28.5 37.1 37.9 31.8
Louisiana 32.6 35.9 26.1 35.3 38.2 30.1
Maine 37.6 38.0 24.7 39.6 40.0 20.7
Maryland 34.9 37.5 30.5 37.0 39.5 33.7
Massachusetts 35.4 37.0 28.4 37.7 39.6 30.8
Michigan 34.3 36.2 28.3 36.6 38.4 31.3
Minnesota 34.4 36.0 25.5 36.3 37.9 24.8
Mississippi 32.2 36.2 25.3 35.3 39.1 29.3
Missouri 34.8 36.2 27.7 37.4 38.6 31.2
Montana 36.6 37.9 24.8 38.5 39.6 21.0
Nebraska 34.0 35.6 25.9 36.6 38.1 28.0
Nevada 34.5 37.1 30.4 35.6 38.1 30.9
New Hampshire 36.4 36.8 29.7 37.8 38.2 26.5
New Jersey 35.5 37.9 29.8 38.0 40.6 33.2
New Mexico 33.4 37.6 30.0 35.6 39.8 29.6
New York 34.5 37.2 29.3 37.2 40.0 33.6
North Carolina 33.8 36.2 29.3 36.7 39.0 32.7
North Dakota 34.8 36.1 23.6 37.5 38.7 20.5
Ohio 34.9 36.1 28.7 37.5 38.7 32.1
Oklahoma 33.9 36.9 26.9 36.9 39.6 29.4
Oregon 35.1 37.2 30.0 37.5 39.4 28.8
Males Females
State All Races White Black All Races White Black
continued
Pennsylvania 36.5 38.1 29.1 39.4 40.8 33.2
Rhode Island 35.4 37.4 26.0 38.0 40.1 27.6
South Carolina 34.0 36.7 28.4 36.7 39.2 32.3
South Dakota 34.4 36.3 26.9 36.7 38.5 20.4
Tennessee 34.5 36.3 27.6 37.2 38.9 31.1
Texas 31.3 33.9 28.5 33.4 36.2 31.0
Utah 26.7 27.3 26.8 27.7 28.4 21.8
Vermont 36.6 37.0 24.4 38.7 39.0 21.7
Virginia 34.5 36.6 30.4 36.8 38.7 33.4
Washington 34.4 36.4 30.0 36.3 38.3 29.3
West Virginia 37.5 37.9 30.7 40.2 40.5 36.5
Wisconsin 35.0 36.6 23.8 37.1 38.6 26.9
Wyoming 35.3 36.3 26.6 37.1 38.0 26.3
Source: United States Census 2000 (http://www.census.gov).
U.S. Cancer Statistics: 1999 Incidence
M–2
Table M.1: U.S. Population Median Age in Years by State, Sex, and Race 
(All Races, White, Black), 2000 (continued)
Males Females
State All Races White Black All Races White Black
List of Abbreviations
CDC Centers for Disease Control and Prevention
CI Confidence interval
ICD–O International Classification of Diseases for Oncology
IBD Intrahepatic bile duct 
NAACCR North American Association of Central Cancer Registries
NCI National Cancer Institute
NIH National Institutes of Health
NOS Not otherwise specified
NPCR National Program of Cancer Registries
ONS Other nervous system
SEER Surveillance, Epidemiology, and End Results
USCS United States Cancer Statistics

